rowid,mAb_name,format,chain,corrected_isotype,identity_species,v_gene,v_identity,j_gene,j_identity,aaSeqFR1,aaSeqCDR1,aaSeqFR2,aaSeqCDR2,aaSeqFR3,aaSeqCDR3,aaSeqFR4,number_of_chains,highest_clin_trial,aaSeqAbChain,status,number_of_chains_after_filter
1,Abagovomab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-87,0.89,IGHJ2,0.86,QVKLQESGAELARPGASVKLSCKAS,GYTFTNYW,MQWVKQRPGQGLDWIGA,IYPGDGNT,RYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYC,ARGEGNYAWFAY,WGQGTTVTVSS,2,Phase-III,QVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSS,yes,2
2,Abagovomab,Whole_mAb,light_sequence,IgK,mouse,IGKV12-44,0.9,IGKJ1,0.92,DIELTQSPASLSASVGETVTITCQAS,ENIYSY,LAWHQQKQGKSPQLLVY,"NAK",TLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYC,QHHYGILPT,FGGGTKLEIK,2,Phase-III,DIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIK,yes,2
3,Abelacimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.92,IGHJ4,1,QVQLLESGGGLVQPGGSLRLSCAAS,GFTFSTAA,MSWVRQAPGKGLEWVSG,ISGSGSST,YYADSVKGRFTISRDNSKNTLYLQMNSLRATAVYYC,ARELSYLYSGYYFDY,WGQGTLVTVSS,2,Phase-II,QVQLLESGGGLVQPGGSLRLSCAASGFTFSTAAMSWVRQAPGKGLEWVSGISGSGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRATAVYYCARELSYLYSGYYFDYWGQGTLVTVSS,yes,2
4,Abelacimab,Whole_mAb,light_sequence,IgL,human,IGLV1-44,0.89,IGLJ3,1,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGSND,VSWYQQLPGTAPKLLIY,KNY,NRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYA,WDQRQFDVV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNDVSWYQQLPGTAPKLLIYKNYNRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYAWDQRQFDVVFGGGTKLTVL,yes,2
5,Abituzumab,Whole_mAb,heavy_sequence,IgG2,mouse,IGHV1-7,0.8,IGHJ4,0.93,QVQLQQSGGELAKPGASVKVSCKAS,GYTFSSFW,MHWVRQAPGQGLEWIGY,INPRSGYT,EYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYC,ASFLGRGAMDY,WGQGTTVTVSS,2,Phase-II,QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSS,yes,2
6,Abituzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.88,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISNY,LAWYQQKPGKAPKLLIY,YTS,KIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYC,QQGNTFPYT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIK,yes,2
7,Abrezekimab,Fab,heavy_sequence,IgG1,human,IGHV2-26,0.76,IGHJ4,1,QVTLKESGPVLVKPTETLTLTCTVS,GFSLTNYH,VQWIRQPPGKALEWLGV,MWSDGDT,SFNSVLKSRLTISRDTSKSQVVLTMTNMDPVATYYC,ARDGTIAAMDYFDY,WGQGTLVTVSS,2,Phase-I,QVTLKESGPVLVKPTETLTLTCTVSGFSLTNYHVQWIRQPPGKALEWLGVMWSDGDTSFNSVLKSRLTISRDTSKSQVVLTMTNMDPVATYYCARDGTIAAMDYFDYWGQGTLVTVSS,yes,2
8,Abrezekimab,Fab,light_sequence,IgK,human,IGKV1-16,0.86,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCLAS,EDISNY,LAWYQQKPGKAPKLLIY,HTS,RLQDGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,GYRFPLT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCLASEDISNYLAWYQQKPGKAPKLLIYHTSRLQDGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGYRFPLTFGGGTKVEIK,yes,2
15,Acasunlimab,Bispecific_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.87,IGHJ1,1,EVQLLEPGGGLVQPGGSLRLSCEAS,GSTFSTYA,MSWVRQAPGKGLEWVSG,FSGSGGFT,FYADSVRGRFTISRDSSKNTLFLQMSSLRAEDTAVYYC,AIPARGYNYGSFQH,WGQGTLVTVSS,4,Phase-I/II,EVQLLEPGGGLVQPGGSLRLSCEASGSTFSTYAMSWVRQAPGKGLEWVSGFSGSGGFTFYADSVRGRFTISRDSSKNTLFLQMSSLRAEDTAVYYCAIPARGYNYGSFQHWGQGTLVTVSS,yes,4
16,Acasunlimab,Bispecific_mAb,light_sequence,IgL,human,IGLV3-21,0.98,IGLJ3,1,SYVLTQPPSVSVAPGQTARITCGGN,NIGSKS,VHWYQQKPGQAPVLVVY,DDN,DRPSGLPERFSGSNSGNTATLTISRVEAGDEADYYC,QVWDSSSDHVV,FGGGTKLTVL,4,Phase-I/II,SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDNDRPSGLPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,yes,4
17,Acasunlimab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV3-49,0.85,IGHJ4,0.93,EVQLVESGGGLVQPGRSLRLSCTAS,GFSLNDYW,MSWVRQAPGKGLEWVGY,IDVGGSL,YYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYC,ARGGLTYGFDL,WGQGTLVTVSS,4,Phase-I/II,EVQLVESGGGLVQPGRSLRLSCTASGFSLNDYWMSWVRQAPGKGLEWVGYIDVGGSLYYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCARGGLTYGFDLWGQGTLVTVSS,yes,4
18,Acasunlimab,Bispecific_mAb,light_sequence_bispec,IgK,human,IGKV1-33,0.85,IGKJ4,0.83,DIVMTQSPSSLSASVGDRVTITCQAS,EDISSY,LAWYQQKPGKAPKRLIY,GAS,DLASGVPSRFSASGSGTDYTFTISSLQPEDIATYYC,HYYATISGLGVA,FGGGTKVEIK,4,Phase-I/II,DIVMTQSPSSLSASVGDRVTITCQASEDISSYLAWYQQKPGKAPKRLIYGASDLASGVPSRFSASGSGTDYTFTISSLQPEDIATYYCHYYATISGLGVAFGGGTKVEIK,yes,4
21,Adalimumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-9,0.93,IGHJ4,0.93,EVQLVESGGGLVQPGRSLRLSCAAS,GFTFDDYA,MHWVRQAPGKGLEWVSA,ITWNSGHI,DYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AKVSYLSTASSLDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS,yes,2
22,Adalimumab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.97,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGIRNY,LAWYQQKPGKAPKLLIY,AAS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYC,QRYNRAPYT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK,yes,2
23,Adebrelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.9,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYW,MHWVRQAPGQGLEWMGR,IGPNSGFT,SYNEKFKNRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARGGSSYDYFDY,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWMGRIGPNSGFTSYNEKFKNRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGGSSYDYFDYWGQGTTVTVSS,yes,2
24,Adebrelimab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-5,0.84,IGKJ4,0.83,DIVLTQSPASLAVSPGQRATITCRAS,ESVSIHGTHL,MHWYQQKPGQPPKLLIY,AAS,NLESGVPARFSGSGSGTDFTLTINPVEAEDTANYYC,QQSFEDPLT,FGQGTKLEIK,2,Phase-III,DIVLTQSPASLAVSPGQRATITCRASESVSIHGTHLMHWYQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLTINPVEAEDTANYYCQQSFEDPLTFGQGTKLEIK,yes,2
25,Aducanumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.94,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFAFSSYG,MHWVRQAPGKGLEWVAV,IWFDGTKK,YYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYC,ARDRGIGARRGPYYMDV,WGKGTTVTVSS,2,Preregistration,QVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSS,yes,2
26,Aducanumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,1,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCRAS,QSISSY,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSYSTPLT,FGGGTKVEIK,2,Preregistration,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,yes,2
27,Afasevikumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-9,0.96,IGHJ2,0.93,EVQLVESGGGLVQPGRSLRLSCAAS,GFTFDDYA,MHWVRQAPGKGLEWVSG,INWSSGGI,GYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYC,ARDIGGFGEFYWNFGL,WGRGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGINWSSGGIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCARDIGGFGEFYWNFGLWGRGTLVTVSS,yes,2
28,Afasevikumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVRSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPAT,FGGGTKVEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPATFGGGTKVEIK,yes,2
31,Alacizumab,di-Fab,heavy_sequence,undefined,human,IGHV3-7,0.91,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYG,MSWVRQAPGKGLEWVAT,ITSGGSYT,YYVDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYC,VRIGEDALDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATITSGGSYTYYVDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCVRIGEDALDYWGQGTLVTVSS,yes,2
32,Alacizumab,di-Fab,light_sequence,IgK,human,IGKV1-17,0.83,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDIAGS,LNWLQQKPGKAIKRLIY,ATS,SLDSGVPKRFSGSRSGSDYTLTISSLQPEDFATYYC,LQYGSFPPT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQDIAGSLNWLQQKPGKAIKRLIYATSSLDSGVPKRFSGSRSGSDYTLTISSLQPEDFATYYCLQYGSFPPTFGQGTKVEIK,yes,2
35,Alirocumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.9,IGHJ2,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFNNYA,MNWVRQAPGKGLDWVST,ISGSGGTT,NYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYC,AKDSNWGNFDL,WGRGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS,yes,2
36,Alirocumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.95,IGKJ2,1,DIVMTQSPDSLAVSLGERATINCKSS,QSVLYRSNNRNF,LGWYQQKPGQPPNLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQYYTTPYT,FGQGTKLEIK,2,Approved,DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK,yes,2
37,Alomfilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-20,0.95,IGHJ4,0.93,EVQLVESGGGVVRPGGSLRLSCVAS,GVTFDDYG,MSWVRQAPGKGLEWVSG,INWNGGDT,DYSDSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYC,ARDFYGSGSYYHVPFDY,WGQGILVTVSS,2,Phase-I/II,EVQLVESGGGVVRPGGSLRLSCVASGVTFDDYGMSWVRQAPGKGLEWVSGINWNGGDTDYSDSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCARDFYGSGSYYHVPFDYWGQGILVTVSS,yes,2
38,Alomfilimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.92,IGKJ3,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSRSY,LAWYQQKRGQAPRLLIY,GAS,SRATGIPDRFSGDGSGTDFTLSISRLEPEDFAVYYC,HQYDMSPFT,FGPGTKVDIK,2,Phase-I/II,EIVLTQSPGTLSLSPGERATLSCRASQSVSRSYLAWYQQKRGQAPRLLIYGASSRATGIPDRFSGDGSGTDFTLSISRLEPEDFAVYYCHQYDMSPFTFGPGTKVDIK,yes,2
39,Alnuctamab,Bispecific_mAb_with_Domain_Crossover,heavy_sequence,IgG1,human,IGHV3-23D,0.95,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSDNA,MGWVRQAPGKGLEWVSA,ISGPGSST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKVLGWFDY,WGQGTLVTVSS,4,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSDNAMGWVRQAPGKGLEWVSAISGPGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVLGWFDYWGQGTLVTVSS,yes,4
40,Alnuctamab,Bispecific_mAb_with_Domain_Crossover,light_sequence,IgK,human,IGKV3-20,0.91,IGKJ1,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSDEY,LSWYQQKPGQAPRLLIH,SAS,TRATGIPDRFSGSGSGTDFTLAISRLEPEDFAVYYC,QQYGYPPDFT,FGQGTKVEIK,4,Phase-I,EIVLTQSPGTLSLSPGERATLSCRASQSVSDEYLSWYQQKPGQAPRLLIHSASTRATGIPDRFSGSGSGTDFTLAISRLEPEDFAVYYCQQYGYPPDFTFGQGTKVEIK,yes,4
41,Alnuctamab,Bispecific_mAb_with_Domain_Crossover,heavy_sequence_bispec,IgG1,human,IGHV3-23,0.89,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSTYA,MNWVRQAPGKGLEWVSR,IRSKYNNYAT,YYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYC,VRHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVSRIRSKYNNYATYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
42,Alnuctamab,Bispecific_mAb_with_Domain_Crossover,light_sequence_bispec,IgL,mouse,IGLV1,0.81,IGLJ1,1,QAVVTQEPSLTVSPGGTVTLTCGSS,TGAVTTSNY,ANWVQEKPGQAFRGLIG,GTN,KRAPGTPARFSGSLLGGKAALTLSGAQPEDEAEYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-I,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQEKPGQAFRGLIGGTNKRAPGTPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNLWVFGGGTKLTVL,yes,4
43,Alsevalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-39,0.96,IGHJ5,1,QLQLQESGPGLVKPSETLSLTCTVS,GGSIKSGSYY,WGWIRQPPGKGLEWIGN,IYYSGST,YYNPSLRSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,AREGSYPNQFDP,WGQGTLVTVSS,2,Phase-I,QLQLQESGPGLVKPSETLSLTCTVSGGSIKSGSYYWGWIRQPPGKGLEWIGNIYYSGSTYYNPSLRSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAREGSYPNQFDPWGQGTLVTVSS,yes,2
44,Alsevalimab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.99,IGKJ4,0.92,EIVMTQSPATLSVSPGERATLSCRAS,QSVSSN,LAWYQQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQYHSFPFT,FGGGTKVEIK,2,Phase-I,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYHSFPFTFGGGTKVEIK,yes,2
45,Amatuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-37,0.87,IGHJ2,0.79,QVQLQQSGPELEKPGASVKISCKAS,GYSFTGYT,MNWVKQSHGKSLEWIGL,ITPYNGAS,SYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFC,ARGGYDGRGFDY,WGSGTPVTVSS,2,Phase-II,QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSS,yes,2
46,Amatuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-59,0.93,IGKJ4,0.83,DIELTQSPAIMSASPGEKVTMTCSAS,SSVSY,MHWYQQKSGTSPKRWIY,DTS,KLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYC,QQWSKHPLT,FGSGTKVEIK,2,Phase-II,DIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIK,yes,2
47,Amivantamab,Bispecific_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.96,IGHJ4,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSTYG,MHWVRQAPGKGLEWVAV,IWDDGSYK,YYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDGITMVRGVMKDYFDY,WGQGTLVTVSS,4,Preregistration,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS,yes,4
48,Amivantamab,Bispecific_mAb,light_sequence,IgK,human,IGKV1-13,0.97,IGKJ4,1,AIQLTQSPSSLSASVGDRVTITCRAS,QDISSA,LVWYQQKPGKAPKLLIY,DAS,SLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYC,QQFNSYPLT,FGGGTKVEIK,4,Preregistration,AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,yes,4
49,Amivantamab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV1-18,0.96,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCETS,GYTFTSYG,ISWVRQAPGHGLEWMGW,ISAYNGYT,NYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARDLRGTNYFDY,WGQGTLVTVSS,4,Preregistration,QVQLVQSGAEVKKPGASVKVSCETSGYTFTSYGISWVRQAPGHGLEWMGWISAYNGYTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDLRGTNYFDYWGQGTLVTVSS,yes,4
50,Amivantamab,Bispecific_mAb,light_sequence_bispec,IgK,human,IGKV1-12,0.96,IGKJ5,1,DIQMTQSPSSVSASVGDRVTITCRAS,QGISNW,LAWFQHKPGKAPKLLIY,AAS,SLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQANSFPIT,FGQGTRLEIK,4,Preregistration,DIQMTQSPSSVSASVGDRVTITCRASQGISNWLAWFQHKPGKAPKLLIYAASSLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPITFGQGTRLEIK,yes,4
51,Amlitelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.9,IGHJ6,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSNYA,MNWVRQAPGKGLEWVST,ISGSGGAT,RYADSVKGRFTISRDNSRNTVYLQMNSLRVEDTAVFYC,TKDRLIMATVRGPYYYGMDV,WGQGTTVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYAMNWVRQAPGKGLEWVSTISGSGGATRYADSVKGRFTISRDNSRNTVYLQMNSLRVEDTAVFYCTKDRLIMATVRGPYYYGMDVWGQGTTVTVSS,yes,2
52,Amlitelimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.97,IGKJ3,1,DIQMTQSPSSLSASVGDRVTITCRAS,QSISSY,LNWYQQKPGKAPNLLIY,AAS,SLQSGVPSRFSGSGSETDFTLTISSLQPEDFATYYC,QQSHSVSFT,FGPGTKVDIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSETDFTLTISSLQPEDFATYYCQQSHSVSFTFGPGTKVDIK,yes,2
57,Andecaliximab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV2-9,0.82,IGHJ4,0.93,QVQLQESGPGLVKPSETLSLTCTVS,GFSLLSYG,VHWVRQPPGKGLEWLGV,IWTGGTT,NYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYC,ARYYYGMDY,WGQGTLVTVSS,2,Phase-III,QVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSS,yes,2
58,Andecaliximab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-17,0.8,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVRNT,VAWYQQKPGKAPKLLIY,SSS,YRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQHYITPYT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIK,yes,2
59,Anetumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV5-51,0.95,IGHJ4,0.86,QVELVQSGAEVKKPGESLKISCKGS,GYSFTSYW,IGWVRQAPGKGLEWMGI,IDPGDSRT,RYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYC,ARGQLYGGTYMDG,WGQGTLVTVSS,2,Phase-II,QVELVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSS,yes,2
60,Anetumab,Whole_mAb_ADC,light_sequence,IgL,human,IGLV2-14,0.93,IGLJ3,0.92,DIALTQPASVSGSPGQSITISCTGT,SSDIGGYNS,VSWYQQHPGKAPKLMIY,GVN,NRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,SSYDIESATPV,FGGGTKLTVL,2,Phase-II,DIALTQPASVSGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYDIESATPVFGGGTKLTVL,yes,2
61,Anifrolumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.94,IGHJ4,0.93,EVQLVQSGAEVKKPGESLKISCKGS,GYIFTNYW,IAWVRQMPGKGLESMGI,IYPGDSDI,RYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYC,ARHDIEGFDY,WGRGTLVTVSS,2,Preregistration,EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS,yes,2
62,Anifrolumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.94,IGKJ5,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSF,FAWYQQKPGQAPRLLIY,GAS,SRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYC,QQYDSSAIT,FGQGTRLEIK,2,Preregistration,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK,yes,2
65,Ansuvimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-13,0.78,IGHJ5,0.93,EVQLVESGGGLIQPGGSLRLSCAAS,GFALRMYD,MHWVRQTIDKRLEWVSA,VGPSGDT,TYADSVKGRFAVSRENAKNSLSLQMNSLTAGDTAIYYC,VRSDRGVAGLFDS,WGQGILVTVSS,2,Approved,EVQLVESGGGLIQPGGSLRLSCAASGFALRMYDMHWVRQTIDKRLEWVSAVGPSGDTTYADSVKGRFAVSRENAKNSLSLQMNSLTAGDTAIYYCVRSDRGVAGLFDSWGQGILVTVSS,yes,2
66,Ansuvimab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.87,IGKJ4,1,DIQMTQSPSSLSASVGDRITITCRAS,QAFDNY,VAWYQQRPGKVPKLLIS,AAS,ALHAGVPSRFSGSGSGTHFTLTISSLQPEDVATYYC,QNYNSAPLT,FGGGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRITITCRASQAFDNYVAWYQQRPGKVPKLLISAASALHAGVPSRFSGSGSGTHFTLTISSLQPEDVATYYCQNYNSAPLTFGGGTKVEIK,yes,2
67,Apamistamab,Whole_mAb_Radiolabelled,heavy_sequence,IgG1,mouse,IGHV4-1,0.96,IGHJ4,1,EVKLLESGGGLVQPGGSLKLSCAAS,GFDFSRYW,MSWVRQAPGKGLEWIGE,INPTSSTI,NFTPSLKDKVFISRDNAKNTLYLQMSKVRSEDTALYYC,ARGNYYRYGDAMDY,WGQGTSVTVSS,2,Phase-III,EVKLLESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPTSSTINFTPSLKDKVFISRDNAKNTLYLQMSKVRSEDTALYYCARGNYYRYGDAMDYWGQGTSVTVSS,yes,2
68,Apamistamab,Whole_mAb_Radiolabelled,light_sequence,IgK,mouse,IGKV3-12,0.96,IGKJ4,1,DIALTQSPASLAVSLGQRATISCRAS,KSVSTSGYSY,LHWYQQKPGQPPKLLIY,LAS,NLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYC,QHSRELPFT,FGSGTKLEIK,2,Phase-III,DIALTQSPASLAVSLGQRATISCRASKSVSTSGYSYLHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPFTFGSGTKLEIK,yes,2
69,Apitegromab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-30,1,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,ISYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDLLVRFLEWSHYYGMDV,WGQGTTVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLLVRFLEWSHYYGMDVWGQGTTVTVSS,yes,2
70,Apitegromab,Whole_mAb,light_sequence,IgL,human,IGLV1-44,0.98,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGSNT,VHWYQQLPGTAPKLLIY,SDN,QRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYC,AAWDDSLNGV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVHWYQQLPGTAPKLLIYSDNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGVFGGGTKLTVL,yes,2
71,Aprutumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-23D,0.98,IGHJ5,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSA,ISGSGTST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARVRYNWNHGDWFDP,WGQGTLVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGTSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARVRYNWNHGDWFDPWGQGTLVTVSS,yes,2
72,Aprutumab,Whole_mAb_ADC,light_sequence,IgL,human,IGLV1-47,0.91,IGLJ3,1,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGNNY,VSWYQQLPGTAPKLLIY,ENY,NRPAGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,SSWDDSLNYWV,FGGGTKLTVL,2,Phase-I,QSVLTQPPSASGTPGQRVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENYNRPAGVPDRFSGSKSGTSASLAISGLRSEDEADYYCSSWDDSLNYWVFGGGTKLTVL,yes,2
73,Ascrinvacumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-31,0.98,IGHJ4,1,QVQLQESGPGLVKPSQTLSLTCTVS,GGSISSGEYY,WNWIRQHPGKGLEWIGY,IYYSGST,YYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARESVAGFDY,WGQGTLVTVSS,2,Phase-II,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGEYYWNWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARESVAGFDYWGQGTLVTVSS,yes,2
74,Ascrinvacumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.98,IGKJ5,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GTS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSSPIT,FGQGTRLEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPITFGQGTRLEIK,yes,2
75,Astegolimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV5-51,0.96,IGHJ6,0.93,EVQLVQSGAEVKKPGESLKISCKGS,GYSFTNYW,IGWVRQMPGKGLEWMGI,IYPGNSDT,RFSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYC,ARHGTSSDYYGLDV,WGQGTTVTVSS,2,Phase-II,EVQLVQSGAEVKKPGESLKISCKGSGYSFTNYWIGWVRQMPGKGLEWMGIIYPGNSDTRFSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHGTSSDYYGLDVWGQGTTVTVSS,yes,2
76,Astegolimab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.99,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCQAS,QDISNY,LNWYQQKPGKAPKLLIY,DAS,NLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQDDNFPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQDDNFPLTFGGGTKVEIK,yes,2
77,Atezolizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.87,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSDSW,IHWVRQAPGKGLEWVAW,ISPYGGST,YYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYC,ARRHWPGGFDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS,yes,2
78,Atezolizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.88,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDVSTA,VAWYQQKPGKAPKLLIY,SAS,FLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYLYHPAT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK,yes,2
79,Atibuclimab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV3-2,0.95,IGHJ3,0.93,DVQLQQSGPGLVKPSQSLSLTCTVT,GYSITSDSA,WNWIRQFPGNRLEWMGY,ISYSGST,SYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYC,VRGLRFAY,WGQGTLVTVSS,2,Phase-II,DVQLQQSGPGLVKPSQSLSLTCTVTGYSITSDSAWNWIRQFPGNRLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCVRGLRFAYWGQGTLVTVSS,yes,2
80,Atibuclimab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-5,0.95,IGKJ2,1,DIVLTQSPASLAVSLGQRATISCRAS,ESVDSYVNSF,LHWYQQKPGQPPKLLIY,RAS,NLQSGIPARFSGSGSRTDFTLTINPVEADDVATYYC,QQSNEDPYT,FGGGTKLEIK,2,Phase-II,DIVLTQSPASLAVSLGQRATISCRASESVDSYVNSFLHWYQQKPGQPPKLLIYRASNLQSGIPARFSGSGSRTDFTLTINPVEADDVATYYCQQSNEDPYTFGGGTKLEIK,yes,2
81,Atidortoxumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-38-2,0.93,IGHJ6,1,EVQLQESGPGLVRPSETLSLTCAVS,GYSISSGMG,WGWIRQPPGKGLEWIGS,IDQRGST,YYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARDAGHAVDMDV,WGKGTTVTVSS,2,Phase-II,EVQLQESGPGLVRPSETLSLTCAVSGYSISSGMGWGWIRQPPGKGLEWIGSIDQRGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDAGHAVDMDVWGKGTTVTVSS,yes,2
82,Atidortoxumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.97,IGKJ4,1,DIQMTQSPSSVSASVGDRVTITCRAS,QGISRW,LAWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQGYVFPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSVSASVGDRVTITCRASQGISRWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYVFPLTFGGGTKVEIK,yes,2
83,Atinumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-7,0.93,IGHJ2,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSNYW,MSWVRQAPGKGLEWVAT,IKQDGSQK,NYVDSVKGRFTISRDNAKNSLYLRLNSLRAEDTAVYYC,ATELFDL,WGRGSLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMSWVRQAPGKGLEWVATIKQDGSQKNYVDSVKGRFTISRDNAKNSLYLRLNSLRAEDTAVYYCATELFDLWGRGSLVTVSS,yes,2
84,Atinumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ5,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPIT,FGQGTKLEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTKLEIK,yes,2
85,Atoltivimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.95,IGHJ4,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFNNYG,MHWVRQAPGMGLEWVAV,IWHDGSDK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARNWNLFDY,WGQGTLVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCAASGFTFNNYGMHWVRQAPGMGLEWVAVIWHDGSDKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNWNLFDYWGQGTLVTVSS,yes,2
86,Atoltivimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.95,IGKJ5,0.83,DIQMTQSPSSLSASVGDRITITCRAS,QSISTY,LHWYQQKPGKAPKLLIY,AAS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSFSTPPIN,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRITITCRASQSISTYLHWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSTPPINFGQGTKLEIK,yes,2
87,Avdoralimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-13,0.94,IGHJ3,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYV,MHWVRQATGKGLEWVSA,IDTGGGT,YYADSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYC,ARDYYYYASGSYYKAFDI,WGQGTMVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMHWVRQATGKGLEWVSAIDTGGGTYYADSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARDYYYYASGSYYKAFDIWGQGTMVTVSS,yes,2
88,Avdoralimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.98,IGKJ2,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSRY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSPLT,FGQGTKLEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSPLTFGQGTKLEIK,yes,2
89,Avelumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYI,MMWVRQAPGKGLEWVSS,IYPSGGIT,FYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARIKLGTVTTVDY,WGQGTLVTVSS,2,Approved,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS,yes,2
90,Avelumab,Whole_mAb,light_sequence,IgL,human,IGLV2-14,1,IGLJ1,0.92,QSALTQPASVSGSPGQSITISCTGT,SSDVGGYNY,VSWYQQHPGKAPKLMIY,DVS,NRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,SSYTSSSTRV,FGTGTKVTVL,2,Approved,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,yes,2
91,Avizakimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.89,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYW,MHWVRQAPGQGLEWMGT,IDPSDQYT,IYSQNFKGRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARYGFAMDY,WGQGTLVTVSS,2,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYWMHWVRQAPGQGLEWMGTIDPSDQYTIYSQNFKGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYGFAMDYWGQGTLVTVSS,yes,2
92,Avizakimab,Whole_mAb,light_sequence,IgK,human,IGKV1-NL1,0.88,IGKJ4,0.92,DIQLTQSPSSLSASVGDRVTITCRAS,QDISNF,LNWYQQKPGKAVKLLIY,YTS,RLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,QQGHTLPRT,FGGGTKVEIK,2,Phase-I/II,DIQLTQSPSSLSASVGDRVTITCRASQDISNFLNWYQQKPGKAVKLLIYYTSRLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQGHTLPRTFGGGTKVEIK,yes,2
97,Balstilimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-33,0.99,IGHJ4,0.86,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,IWYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ASNGDH,WGQGTLVTVSS,2,Preregistration,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASNGDHWGQGTLVTVSS,yes,2
98,Balstilimab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,1,IGKJ1,0.92,EIVMTQSPATLSVSPGERATLSCRAS,QSVSSN,LAWYQQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQYNNWPRT,FGQGTKVEIK,2,Preregistration,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK,yes,2
103,Bapotulimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-69,1,IGHJ5,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,IIPILGIA,NYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARGRLPYGDFWDS,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGRLPYGDFWDSWGQGTLVTVSS,yes,2
104,Bapotulimab,Whole_mAb,light_sequence,IgK,human,IGKV2D-28,0.99,IGKJ4,0.83,DIVMTQSPLSLPVTPGEPASISCRSS,QSLLYSNGYNY,LDWYLQKPGQSPQLLIY,LGS,NRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,MQALQTPLT,FGGGTKLEIR,2,Phase-I,DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKLEIR,yes,2
105,Barecetamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSDYD,MSWVRQAPGKGLEWVST,IDLDSGSI,YYADSVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKDLHMGPEGPFDY,WGQGTLVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSDYDMSWVRQAPGKGLEWVSTIDLDSGSIYYADSVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLHMGPEGPFDYWGQGTLVTVSS,yes,2
106,Barecetamab,Whole_mAb,light_sequence,IgL,human,IGLV1-47,0.94,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGSNS,VSWYQQLPGTAPKLLIY,SDN,HRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,QGWDTSLSGHV,FGGGTKLTVL,2,Phase-I,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYSDNHRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCQGWDTSLSGHVFGGGTKLTVL,yes,2
107,Basiliximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-5,0.92,IGHJ2,0.93,QVQLQQSGTVLARPGASVKMSCKAS,GYSFTRYW,MHWIKQRPGQGLEWIGA,IYPGNSDT,SYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYC,SRDYGYYFDF,WGQGTTLTVSS,2,Approved,QVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS,yes,2
108,Basiliximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-70,0.97,IGKJ2,1,QIVSTQSPAIMSASPGEKVTMTCSAS,SSRSY,MQWYQQKPGTSPKRWIY,DTS,KLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYC,HQRSSYT,FGGGTKLEIK,2,Approved,QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK,yes,2
109,Batoclimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-39,0.92,IGHJ5,0.93,QLLLQESGPGLVKPSETLSLTCTVS,GGSLSSSFSY,WVWIRQPPGKGLEWIGT,IYYSGNT,YYNPSLKSRLTISVDTSKNHFSLKLSSVTAADTAVYYC,ARRAGILTGYLDS,WGQGTLVTVSS,2,Phase-II/III,QLLLQESGPGLVKPSETLSLTCTVSGGSLSSSFSYWVWIRQPPGKGLEWIGTIYYSGNTYYNPSLKSRLTISVDTSKNHFSLKLSSVTAADTAVYYCARRAGILTGYLDSWGQGTLVTVSS,yes,2
110,Batoclimab,Whole_mAb,light_sequence,IgL,human,IGLV3-21,0.98,IGLJ3,1,SYVLTQSPSVSVAPGQTARITCGGN,NIGSKS,VHWYQQKPGQAPVLVVY,DDS,DRPSGIPERFSASNSGNTATLTISRVEAGDEADYYC,QVWDSSSDHVV,FGGGTKLTVL,2,Phase-II/III,SYVLTQSPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSASNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,yes,2
111,Bavituximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-39,0.86,IGHJ1,1,EVQLQQSGPELEKPGASVKLSCKAS,GYSFTGYN,MNWVKQSHGKSLEWIGH,IDPYYGDT,SYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYC,VKGGYYGHWYFDV,WGAGTTVTVSS,2,Phase-III,EVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSS,yes,2
112,Bavituximab,Whole_mAb,light_sequence,IgK,mouse,IGKV9-120,0.98,IGKJ5,0.92,DIQMTQSPSSLSASLGERVSLTCRAS,QDIGSS,LNWLQQGPDGTIKRLIY,ATS,SLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYC,LQYVSSPPT,FGAGTKLELK,2,Phase-III,DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELK,yes,2
113,Befovacimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23,0.94,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYG,MDWVRQAPGKGLEWVSS,IRGSRGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARLYRYWFDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMDWVRQAPGKGLEWVSSIRGSRGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLYRYWFDYWGQGTLVTVSS,yes,2
114,Befovacimab,Whole_mAb,light_sequence,IgL,human,IGLV3-1,0.86,IGLJ3,0.92,SYELTQPPSVSVSPGQTARITCSGD,NLPKYY,AHWYQQKPGQAPVVVIF,YDV,NRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYC,QAWWSSTPV,FGGGTKLTVL,2,Phase-II,SYELTQPPSVSVSPGQTARITCSGDNLPKYYAHWYQQKPGQAPVVVIFYDVNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWWSSTPVFGGGTKLTVL,yes,2
115,Begelomab,Whole_mAb,heavy_sequence,IgG2b,mouse,IGHV1-85,0.89,IGHJ1,1,QVQLQQSGAELVKPGASVKLSCKAS,GYTFRSYD,INWVRQRPEQGLEWIGW,IFPGDGST,KYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFC,ARWTVVGPGYFDV,WGAGTTVTVSS,2,Phase-II/III,QVQLQQSGAELVKPGASVKLSCKASGYTFRSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCARWTVVGPGYFDVWGAGTTVTVSS,yes,2
116,Begelomab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-57,0.99,IGKJ1,0.92,QIVLTQSPAIMSASPGEKVTITCSAS,SSVSY,MNWFQQKPGTSPKLWIY,STS,NLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYC,QQRSSYPNT,FGGGTKLEIK,2,Phase-II/III,QIVLTQSPAIMSASPGEKVTITCSASSSVSYMNWFQQKPGTSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPNTFGGGTKLEIK,yes,2
117,Belantamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-69,0.84,IGHJ4,0.86,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSNYW,MHWVRQAPGQGLEWMGA,TYRGHSDT,YYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARGAIYDGYDVLDN,WGQGTLVTVSS,2,Approved,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYWMHWVRQAPGQGLEWMGATYRGHSDTYYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGAIYDGYDVLDNWGQGTLVTVSS,yes,2
118,Belantamab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1-33,0.91,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCSAS,QDISNY,LNWYQQKPGKAPKLLIY,YTS,NLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYRKLPWT,FGQGTKLEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKLLIYYTSNLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYRKLPWTFGQGTKLEIK,yes,2
119,Belimumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.87,IGHJ3,0.71,QVQLQQSGAEVKKPGSSVRVSCKAS,GGTFNNNA,INWVRQAPGQGLEWMGG,IIPMFGTA,KYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYC,ARSRDLLLFPHHALSP,WGRGTMVTVSS,2,Approved,QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSS,yes,2
120,Belimumab,Whole_mAb,light_sequence,IgL,human,IGLV3-19,0.98,IGLJ3,0.92,SSELTQDPAVSVALGQTVRVTCQGD,SLRSYY,ASWYQQKPGQAPVLVIY,GKN,NRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYC,SSRDSSGNHWV,FGGGTELTVL,2,Approved,SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVL,yes,2
121,Bemarituzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.81,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYIFTTYN,VHWVRQAPGQGLEWIGS,IYPDNGDT,SYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYC,ARGDFAY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGSSVKVSCKASGYIFTTYNVHWVRQAPGQGLEWIGSIYPDNGDTSYNQNFKGRATITADKSTSTAYMELSSLRSEDTAVYYCARGDFAYWGQGTLVTVSS,yes,2
122,Bemarituzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.87,IGKJ2,1,DIQMTQSPSSLSASVGDRVTITCKAS,QGVSND,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQHSTTPYT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCKASQGVSNDVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHSTTPYTFGQGTKLEIK,yes,2
123,Benralizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.79,IGHJ4,0.93,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYV,IHWVRQRPGQGLAWMGY,INPYNDGT,KYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLC,GREGIRYYGLLGDY,WGQGTLVTVSS,2,Approved,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS,yes,2
124,Benralizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCGTS,EDIINY,LNWYQQKPGKAPKLLIY,HTS,RLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQGYTLPYT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK,yes,2
125,Bentracimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.86,IGHJ4,0.79,QVQLQESGAEVKKPGSSVRVSCKAS,GGTFDSYS,IHWVRQAPGQGLEWMGG,IIPAFGTL,SSAQDFQARVTISADKSTSTAYMELSGLRSEDTAVYYC,ARGSFDYYFWSASHPPNDALAI,WGQGTLVTVSS,2,Phase-III,QVQLQESGAEVKKPGSSVRVSCKASGGTFDSYSIHWVRQAPGQGLEWMGGIIPAFGTLSSAQDFQARVTISADKSTSTAYMELSGLRSEDTAVYYCARGSFDYYFWSASHPPNDALAIWGQGTLVTVSS,yes,2
126,Bentracimab,Whole_mAb,light_sequence,IgL,human,IGLV1-51,0.94,IGLJ6,0.75,QSVVTQPPSVSAAPGQKVTISCSGS,NSDIGNNY,VSWYQQLPGTAPKLLIY,DNN,KRPSGIPDRFSGSKSGTSATLAITGLQAGDEADYYC,GTWLYDRAVGL,FGGGTKVTVL,2,Phase-III,QSVVTQPPSVSAAPGQKVTISCSGSNSDIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLAITGLQAGDEADYYCGTWLYDRAVGLFGGGTKVTVL,yes,2
127,Benufutamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV14-3,0.88,IGHJ2,0.86,EVQLQQSGAEVVKPGASVKLSCKAS,GFNIKDTF,IHWVKQAPGQGLEWIGR,IDPANTNT,KYDPKFQGKATITTDTSSNTAYMELSSLRSEDTAVYYC,VRGLYTYYFDY,WGQGTLVTVSS,2,Phase-I/II,EVQLQQSGAEVVKPGASVKLSCKASGFNIKDTFIHWVKQAPGQGLEWIGRIDPANTNTKYDPKFQGKATITTDTSSNTAYMELSSLRSEDTAVYYCVRGLYTYYFDYWGQGTLVTVSS,yes,2
128,Benufutamab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.9,IGKJ2,1,EIVMTQSPATLSVSPGERATLSCRAS,QSISNN,LHWYQQKPGQAPRLLIK,FAS,QSITGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQGNSWPYT,FGQGTKLEIK,2,Phase-I/II,EIVMTQSPATLSVSPGERATLSCRASQSISNNLHWYQQKPGQAPRLLIKFASQSITGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQGNSWPYTFGQGTKLEIK,yes,2
129,Bepranemab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-4,0.84,IGHJ4,0.93,EVQLQESGPGLVKPSETLSLTCTVS,GFSLTSND,IAWIRQPPGKGLEWMGT,IWTDGST,NYNTAVQSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARHRLYYGAFDY,WGQGTMVTVSS,2,Phase-I,EVQLQESGPGLVKPSETLSLTCTVSGFSLTSNDIAWIRQPPGKGLEWMGTIWTDGSTNYNTAVQSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHRLYYGAFDYWGQGTMVTVSS,yes,2
130,Bepranemab,Whole_mAb,light_sequence,IgK,human,IGKV2D-29,0.92,IGKJ2,1,DIVMTQTPLSLSVTPGQPASISCRSS,QSLEYSDGYTY,LEWYLQKPGQSPQLLIY,EVS,NRFSGVPDRFSGSGSGTDDFTLKISRVEAEDVGVYYC,FQATHNPYT,FGQGTKLEIK,2,Phase-I,DIVMTQTPLSLSVTPGQPASISCRSSQSLEYSDGYTYLEWYLQKPGQSPQLLIYEVSNRFSGVPDRFSGSGSGTDDFTLKISRVEAEDVGVYYCFQATHNPYTFGQGTKLEIK,yes,2
131,Berlimatoxumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-39,0.95,IGHJ6,1,ELQLQESGPGLVKPSETLSLTCTVS,GGSISSGSYY,WDWIRQPPGKGLEWIGN,IYKSGST,YYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARERGMHYMDV,WGKGTTVTVSS,2,Phase-II,ELQLQESGPGLVKPSETLSLTCTVSGGSISSGSYYWDWIRQPPGKGLEWIGNIYKSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARERGMHYMDVWGKGTTVTVSS,yes,2
132,Berlimatoxumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.97,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSINSY,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQQFDPPFT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQQFDPPFTFGGGTKVEIK,yes,2
133,Bermekimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.89,IGHJ1,0.79,QVQLVESGGGVVQPGRSLRLSCTAS,GFTFSMFG,VHWVRQAPGKGLEWVAA,VSYDGSNK,YYAESVKGRFTISRDNSKNILFLQMDSLRLEDTAVYYC,ARGRPKVVIPAPLAH,WGQGTLVTFSS,2,Preregistration,QVQLVESGGGVVQPGRSLRLSCTASGFTFSMFGVHWVRQAPGKGLEWVAAVSYDGSNKYYAESVKGRFTISRDNSKNILFLQMDSLRLEDTAVYYCARGRPKVVIPAPLAHWGQGTLVTFSS,yes,2
134,Bermekimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.92,IGKJ4,0.83,DIQMTQSPSSVSASVGDRVTITCRAS,QGISSW,LAWYQQKPGKAPKLLIY,EAS,NLETGVPSRFSGSGSGSDFTLTISSLQPEDFATYYC,QQTSSFLLS,FGGGTKVEHK,2,Preregistration,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYEASNLETGVPSRFSGSGSGSDFTLTISSLQPEDFATYYCQQTSSFLLSFGGGTKVEHK,yes,2
135,Bersanlimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.91,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSNAW,MSWVRQAPGKGLEWVAF,IWYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARYSGWYFDY,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVAFIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARYSGWYFDYWGQGTLVTVSS,yes,2
136,Bersanlimab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.93,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCTGS,SSNIGAGYD,VHWYQQLPGTAPKLLIY,DNN,NRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,QSYDSSLSAWL,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYDNNNRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCQSYDSSLSAWLFGGGTKLTVL,yes,2
139,Bexmarilimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV2-5,0.9,IGHJ4,0.93,QVTLKESGPTLVKPTQTLTLTCSFS,GFSLSTSGMG,IGWIRQPPGKALEWLAH,IWWDDDK,RYNPALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYC,ARHYGYDPYYAMDY,WGQGTLVTVSS,2,Phase-I/II,QVTLKESGPTLVKPTQTLTLTCSFSGFSLSTSGMGIGWIRQPPGKALEWLAHIWWDDDKRYNPALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCARHYGYDPYYAMDYWGQGTLVTVSS,yes,2
140,Bexmarilimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.8,IGKJ2,0.92,EIVLTQSPGTLSLSPGERATLSCTAS,SSVSSSY,LHWYQQKPGKAPKLLIY,RTS,NLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,HQYHRSPPT,FGQGTKLEIK,2,Phase-I/II,EIVLTQSPGTLSLSPGERATLSCTASSSVSSSYLHWYQQKPGKAPKLLIYRTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYHRSPPTFGQGTKLEIK,yes,2
145,Bimagrumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.92,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSSY,INWVRQAPGQGLEWMGT,INPVSGST,SYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYC,ARGGWFDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSSYINWVRQAPGQGLEWMGTINPVSGSTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGWFDYWGQGTLVTVSS,yes,2
146,Bimagrumab,Whole_mAb,light_sequence,IgL,human,IGLV2-23,0.94,IGLJ3,0.92,QSALTQPASVSGSPGQSITISCTGT,SSDVGSYNY,VNWYQQHPGKAPKLMIY,GVS,KRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,GTFAGGSYYGV,FGGGTKLTVL,2,Phase-II,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVNWYQQHPGKAPKLMIYGVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCGTFAGGSYYGVFGGGTKLTVL,yes,2
149,Bintrafusp,Whole_mAb_Fusion,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYI,MMWVRQAPGKGLEWVSS,IYPSGGIT,FYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARIKLGTVTTVDY,WGQGTLVTVSS,2,Approved,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS,yes,2
150,Bintrafusp,Whole_mAb_Fusion,light_sequence,IgL,human,IGLV2-14,1,IGLJ1,0.92,QSALTQPASVSGSPGQSITISCTGT,SSDVGGYNY,VSWYQQHPGKAPKLMIY,DVS,NRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,SSYTSSSTRV,FGTGTKVTVL,2,Approved,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,yes,2
153,Bleselumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-39,0.93,IGHJ5,1,QLQLQESGPGLLKPSETLSLTCTVS,GGSISSPGYY,GGWIRQPPGKGLEWIGS,IYKSGST,YHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,TRPVVRYFGWFDP,WGQGTLVTVSS,2,Phase-II,QLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSS,yes,2
154,Bleselumab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,0.99,IGKJ1,0.92,AIQLTQSPSSLSASVGDRVTITCRAS,QGISSA,LAWYQQKPGKAPKLLIY,DAS,NLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFNSYPT,FGQGTKVEIK,2,Phase-II,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIK,yes,2
159,Blosozumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-24,0.86,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKVS,GFPIKDTF,QHWVRQAPGKGLEWMGW,SDPEIGDT,EYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYC,ATGDTTYKFDF,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSS,yes,2
160,Blosozumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.85,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVHTA,VAWYQQKPGKAPKLLIY,WAS,TRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYSDYPWT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIK,yes,2
161,Bococizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.91,IGHJ6,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYY,MHWVRQAPGQGLEWMGE,ISPFGGRT,NYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARERPLYASDL,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,yes,2
162,Bococizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.88,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSA,LAWYQQKPGKAPKLLIY,SAS,YRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQRYSLWRT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK,yes,2
165,Brazikumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-33,0.99,IGHJ3,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,IWYDGSNE,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDRGYTSSWYPDAFDI,WGQGTMVTVSS,2,Phase-III,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSS,yes,2
166,Brazikumab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.96,IGLJ3,0.92,QSVLTQPPSVSGAPGQRVTISCTGS,SSNTGAGYD,VHWYQQVPGTAPKLLIY,GSG,NRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYC,QSYDSSLSGWV,FGGGTRLTVL,2,Phase-III,QSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL,yes,2
167,Brentuximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-84,0.94,IGHJ3,0.93,QIQLQQSGPEVVKPGASVKISCKAS,GYTFTDYY,ITWVKQKPGQGLEWIGW,IYPGSGNT,KYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFC,ANYGNYWFAY,WGQGTQVTVSA,2,Approved,QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSA,yes,2
168,Brentuximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV3-4,0.97,IGKJ1,1,DIVLTQSPASLAVSLGQRATISCKAS,QSVDFDGDSY,MNWYQQKPGQPPKVLIY,AAS,NLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYC,QQSNEDPWT,FGGGTKLEIK,2,Approved,DIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIK,yes,2
169,Briakinumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.97,IGHJ3,0.86,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAF,IRYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,KTHGSHDN,WGQGTMVTVSS,2,Preregistration (w),QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIRYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHGSHDNWGQGTMVTVSS,yes,2
170,Briakinumab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.88,IGLJ1,0.83,QSVLTQPPSVSGAPGQRVTISCSGS,RSNIGSNT,VKWYQQLPGTAPKLLIY,YND,QRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYC,QSYDRYTHPALL,FGTGTKVTVL,2,Preregistration (w),QSVLTQPPSVSGAPGQRVTISCSGSRSNIGSNTVKWYQQLPGTAPKLLIYYNDQRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDRYTHPALLFGTGTKVTVL,yes,2
171,Brodalumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-18,0.97,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTRYG,ISWVRQAPGQGLEWMGW,ISTYSGNT,NYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARRQLYFDY,WGQGTLVTVSS,2,Approved,QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS,yes,2
172,Brodalumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.93,IGKJ4,1,EIVMTQSPATLSVSPGERATLSCRAS,QSVSSN,LAWFQQKPGQAPRPLIY,DAS,TRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYC,QQYDNWPLT,FGGGTKVEIK,2,Approved,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK,yes,2
173,Brolucizumab,scFv,heavy_sequence,undefined,human,IGHV3-66,0.8,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCTAS,GFSLTDYYY,MTWVRQAPGKGLEWVGF,IDPDDDP,YYATWAKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AGGDHNSGWGLDI,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCTASGFSLTDYYYMTWVRQAPGKGLEWVGFIDPDDDPYYATWAKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAGGDHNSGWGLDIWGQGTLVTVSS,yes,2
174,Brolucizumab,scFv,light_sequence,IgK,human,IGKV1-5,0.85,IGKJ2,0.58,EIVMTQSPSTLSASVGDRVIITCQAS,EIIHSW,LAWYQQKPGKAPKLLIY,LAS,TLASGVPSRFSGSGSGAEFTLTISSLQPDDFATYYC,QNVYLASTNGAN,FGQGTKLTVL,2,Approved,EIVMTQSPSTLSASVGDRVIITCQASEIIHSWLAWYQQKPGKAPKLLIYLASTLASGVPSRFSGSGSGAEFTLTISSLQPDDFATYYCQNVYLASTNGANFGQGTKLTVL,yes,2
175,Brontictuzumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-24,0.8,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKISCKVS,GYTLRGYW,IEWVRQAPGKGLEWIGQ,ILPGTGRT,NYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYC,ARFDGNYGYYAMDY,WGQGTTVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKISCKVSGYTLRGYWIEWVRQAPGKGLEWIGQILPGTGRTNYNEKFKGRVTMTADTSTDTAYMELSSLRSEDTAVYYCARFDGNYGYYAMDYWGQGTTVTVSS,yes,2
176,Brontictuzumab,Whole_mAb,light_sequence,IgL,human,IGLV7-46,0.83,IGLJ3,1,QAVVTQEPSLTVSPGGTVTLTCRSS,TGAVTTSNY,ANWFQQKPGQAPRTLIG,GTN,NRAPGVPARFSGSLLGGKAALTLSGAQPEDEAEYYC,ALWYSNHWV,FGGGTKLTVL,2,Phase-I,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWFQQKPGQAPRTLIGGTNNRAPGVPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNHWVFGGGTKLTVL,yes,2
179,Burosumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.95,IGHJ3,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTNHY,MHWVRQAPGQGLEWMGI,INPISGST,SNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARDIVDAFDF,WGQGTMVTVSS,2,Approved,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSS,yes,2
180,Burosumab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,0.99,IGKJ3,1,AIQLTQSPSSLSASVGDRVTITCRAS,QGISSA,LVWYQQKPGKAPKLLIY,DAS,SLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFNDYFT,FGPGTKVDIK,2,Approved,AIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIK,yes,2
181,Cabiralizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.84,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTDNY,MIWVRQAPGQGLEWMGD,INPYNGGT,TFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARESPYFSNLYVMDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDNYMIWVRQAPGQGLEWMGDINPYNGGTTFNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARESPYFSNLYVMDYWGQGTLVTVSS,yes,2
182,Cabiralizumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.86,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCKAS,QSVDYDGDNY,MNWYQQKPGQAPRLLIY,AAS,NLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,HLSNEDLST,FGGGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCKASQSVDYDGDNYMNWYQQKPGQAPRLLIYAASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHLSNEDLSTFGGGTKVEIK,yes,2
183,Cadonilimab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence,IgG1,human,IGHV1-2,0.84,IGHJ4,0.79,QVVLVESGAEVKKPGASVKVSCKAS,GYSFTGYT,MNWVRQAPGQCLEWIGL,INPYNNIT,NYAQKFQGRVTFTVDTSISTAYMELSRLRSDDTGVYFC,ARLDYRSY,WGQGTLVTVSA,4,Phase-II,QVVLVESGAEVKKPGASVKVSCKASGYSFTGYTMNWVRQAPGQCLEWIGLINPYNNITNYAQKFQGRVTFTVDTSISTAYMELSRLRSDDTGVYFCARLDYRSYWGQGTLVTVSA,yes,4
184,Cadonilimab,Bispecific_Mixed_mAb_and_scFv,light_sequence,IgK,mouse,IGKV14-111,0.85,IGKJ5,1,DIQMTQSPSSMSASVGDRVTFTCRAS,QDINTY,LSWGQQKPGKSPKTLIY,RAN,RLVSGVPSRFSGSGSGQDYTLTISSLQPEDMATYYC,LQYDEFPLT,FGAGTKLELK,4,Phase-II,DIQMTQSPSSMSASVGDRVTFTCRASQDINTYLSWGQQKPGKSPKTLIYRANRLVSGVPSRFSGSGSGQDYTLTISSLQPEDMATYYCLQYDEFPLTFGAGTKLELK,yes,4
185,Cadonilimab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence_bispec,undefined,human,IGHV1-2,0.84,IGHJ4,0.79,QVVLVESGAEVKKPGASVKVSCKAS,GYSFTGYT,MNWVRQAPGQCLEWIGL,INPYNNIT,NYAQKFQGRVTFTVDTSISTAYMELSRLRSDDTGVYFC,ARLDYRSY,WGQGTLVTVSA,4,Phase-II,QVVLVESGAEVKKPGASVKVSCKASGYSFTGYTMNWVRQAPGQCLEWIGLINPYNNITNYAQKFQGRVTFTVDTSISTAYMELSRLRSDDTGVYFCARLDYRSYWGQGTLVTVSA,yes,4
186,Cadonilimab,Bispecific_Mixed_mAb_and_scFv,light_sequence_bispec,IgL,human,IGLV7-46,0.85,IGLJ3,0.92,QAVVTQEPSLTVSPGGTVTLTCGSS,TGAVTTSNF,PNWVQQKPGQAPRSLIG,GTN,NKASWTPARFSGSLLGGKAALTISGAQPEDEAEYYC,ALWYSNHWV,FGCGTKLTVL,4,Phase-II,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNFPNWVQQKPGQAPRSLIGGTNNKASWTPARFSGSLLGGKAALTISGAQPEDEAEYYCALWYSNHWVFGCGTKLTVL,yes,4
187,Camidanlumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-69,0.95,IGHJ4,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSRYI,INWVRQAPGQGLEWMGR,IIPILGVE,NYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARKDWFDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYIINWVRQAPGQGLEWMGRIIPILGVENYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARKDWFDYWGQGTLVTVSS,yes,2
188,Camidanlumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-20,0.99,IGKJ4,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSSPLT,FGGGTKVEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,yes,2
191,Canakinumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.94,IGHJ4,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSVYG,MNWVRQAPGKGLEWVAI,IWYDGDNQ,YYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYC,ARDLRTGPFDY,WGQGTLVTVSS,2,Approved,QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPGKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSS,yes,2
192,Canakinumab,Whole_mAb,light_sequence,IgK,human,IGKV6D-21,0.99,IGKJ3,1,EIVLTQSPDFQSVTPKEKVTITCRAS,QSIGSS,LHWYQQKPDQSPKLLIK,YAS,QSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYC,HQSSSLPFT,FGPGTKVDIK,2,Approved,EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIK,yes,2
193,Cantuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV9-3,0.85,IGHJ1,0.93,QVQLVQSGAEVKKPGETVKISCKAS,DYTFTYYG,MNWVKQAPGQGLKWMGW,IDTTTGEP,TYAQKFQGRIAFSLETSASTAYLQIKSLKSEDTATYFC,ARRGPYNWYFDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGETVKISCKASDYTFTYYGMNWVKQAPGQGLKWMGWIDTTTGEPTYAQKFQGRIAFSLETSASTAYLQIKSLKSEDTATYFCARRGPYNWYFDVWGQGTTVTVSS,yes,2
194,Cantuzumab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV2-137,0.94,IGKJ4,0.83,DIVMTQSPLSVPVTPGEPVSISCRSS,KSLLHSNGNTY,LYWFLQRPGQSPQLLIY,RMS,NLVSGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYC,LQHLEYPFT,FGPGTKLELK,2,Phase-II,DIVMTQSPLSVPVTPGEPVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLVSGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGPGTKLELK,yes,2
195,Caplacizumab,Nanobody,heavy_sequence,undefined,human,IGHV3-23,0.82,IGHJ4,0.71,EVQLVESGGGLVQPGGSLRLSCAAS,GRTFSYNP,MGWFRQAPGKGRELVAA,ISRTGGST,YYPDSVEGRFTISRDNAKRMVYLQMNSLRAEDTAVYYC,AAAGVRAEDGRVRTLPSEYTF,WGQGTQVTVSS,1,Approved,EVQLVESGGGLVQPGGSLRLSCAASGRTFSYNPMGWFRQAPGKGRELVAAISRTGGSTYYPDSVEGRFTISRDNAKRMVYLQMNSLRAEDTAVYYCAAAGVRAEDGRVRTLPSEYTFWGQGTQVTVSS,yes,1
196,Carlumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.99,IGHJ4,0.86,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYG,ISWVRQAPGQGLEWMGG,IIPIFGTA,NYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYC,ARYDGIYGELDF,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDGIYGELDFWGQGTLVTVSS,yes,2
197,Carlumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.92,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSDAY,LAWYQQKPGQAPRLLIY,DAS,SRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYC,HQYIQLHSFT,FGQGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCRASQSVSDAYLAWYQQKPGQAPRLLIYDASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYIQLHSFTFGQGTKVEIK,yes,2
198,Carotuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV6-3,0.19,IGHJ2,0.93,EVKLEESGGGLVQPGGSMKLSCAA,SGFTFSD,AWMDWVRQSPEKGLEWV,AEIRSKASNH,ATYYAESVKGRFTISRDDSKSSVYLQMNSLRAEDTGIY,YCTRWRRFFDS,WGQGTTLTVSS,2,Phase-II,EVKLEESGGGLVQPGGSMKLSCAASGFTFSDAWMDWVRQSPEKGLEWVAEIRSKASNHATYYAESVKGRFTISRDDSKSSVYLQMNSLRAEDTGIYYCTRWRRFFDSWGQGTTLTVSS,yes,2
199,Carotuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.99,IGKJ5,1,QIVLSQSPAILSASPGEKVTMTCRAS,SSVSY,MHWYQQKPGSSPKPWIY,ATS,NLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYC,QQWSSNPLT,FGAGTKLELK,2,Phase-II,QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWSSNPLTFGAGTKLELK,yes,2
202,Cemiplimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23D,0.87,IGHJ4,1,EVQLLESGGVLVQPGGSLRLSCAAS,GFTFSNFG,MTWVRQAPGKGLEWVSG,ISGGGRDT,YFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYC,VKWGNIYFDY,WGQGTLVTVSS,2,Approved,EVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSS,yes,2
203,Cemiplimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.87,IGKJ3,0.75,DIQMTQSPSSLSASVGDSITITCRAS,LSINTF,LNWYQQKPGKAPNLLIY,AAS,SLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYC,QQSSNTPFT,FGPGTVVDFR,2,Approved,DIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFR,yes,2
204,Cendakimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV2-70,0.79,IGHJ4,0.93,EVTLRESGPGLVKPTQTLTLTCTLY,GFSLSTSDMG,VDWIRQPPGKGLEWLAH,IWWDDVK,RYNPALKSRLTISKDTSKNQVVLKLTSVDPVDTATYYC,ARTVSSGYIYYAMDY,WGQGTLVTVSS,2,Phase-II,EVTLRESGPGLVKPTQTLTLTCTLYGFSLSTSDMGVDWIRQPPGKGLEWLAHIWWDDVKRYNPALKSRLTISKDTSKNQVVLKLTSVDPVDTATYYCARTVSSGYIYYAMDYWGQGTLVTVSS,yes,2
205,Cendakimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.86,IGKJ4,1,DIQMTQSPSSLSASVGDRVTISCRAS,QDIRNY,LNWYQQKPGKAPKLLIF,YTS,KLHSGVPSRFSGSGSGTDYTLTISSLQPEDIATYYC,QQGNTLPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTISCRASQDIRNYLNWYQQKPGKAPKLLIFYTSKLHSGVPSRFSGSGSGTDYTLTISSLQPEDIATYYCQQGNTLPLTFGGGTKVEIK,yes,2
206,Cergutuzumab,Whole_mAb_Fusion,heavy_sequence,IgG1,human,IGHV1-18,0.83,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTEFG,MNWVRQAPGQGLEWMGW,INTKTGEA,TYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYC,ARWDFAYYVEAMDY,WGQGTTVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTEFGMNWVRQAPGQGLEWMGWINTKTGEATYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARWDFAYYVEAMDYWGQGTTVTVSS,yes,2
207,Cergutuzumab,Whole_mAb_Fusion,light_sequence,IgK,human,IGKV1D-39,0.84,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,AAVGTY,VAWYQQKPGKAPKLLIY,SAS,YRKRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,HQYYTYPLFT,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCKASAAVGTYVAWYQQKPGKAPKLLIYSASYRKRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQYYTYPLFTFGQGTKLEIK,yes,2
208,Certolizumab,Fab,heavy_sequence,IgG1,human,IGHV3-23,0.78,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GYVFTDYG,MNWVRQAPGKGLEWMGW,INTYIGEP,IYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYC,ARGYRSYAMDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS,yes,2
209,Certolizumab,Fab,light_sequence,IgK,human,IGKV1-16,0.86,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QNVGTN,VAWYQQKPGKAPKALIY,SAS,FLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNIYPLT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK,yes,2
210,Cetrelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.99,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,IIPIFDTA,NYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYC,ARPGLAAAYDTGSLDY,WGQGTLVTVSS,2,Phase-II/III,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARPGLAAAYDTGSLDYWGQGTLVTVSS,yes,2
211,Cetrelimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.98,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVRSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRNYWPLT,FGQGTKVEIK,2,Phase-II/III,EIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRNYWPLTFGQGTKVEIK,yes,2
212,Cetuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV2-2,0.94,IGHJ3,1,QVQLKQSGPGLVQPSQSLSITCTVS,GFSLTNYG,VHWVRQSPGKGLEWLGV,IWSGGNT,DYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYC,ARALTYYDYEFAY,WGQGTLVTVSA,2,Approved,QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA,yes,2
213,Cetuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV5-48,0.97,IGKJ5,0.92,DILLTQSPVILSVSPGERVSFSCRAS,QSIGTN,IHWYQQRTNGSPRLLIK,YAS,ESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYC,QQNNNWPTT,FGAGTKLELK,2,Approved,DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK,yes,2
214,Cevostamab,Bispecific_mAb,heavy_sequence,IgG1,mouse,IGHV2-4,0.76,IGHJ4,0.79,EVQLVESGPGLVKPSETLSLTCTVS,GFSLTRFG,VHWVRQPPGKGLEWLGV,IWRGGST,DYNAAFVSRLTISKDNSKNQVSLKLSSVTAADTAVYYC,SNHYYGSSDYALDN,WGQGTLVTVSS,4,Phase-I,EVQLVESGPGLVKPSETLSLTCTVSGFSLTRFGVHWVRQPPGKGLEWLGVIWRGGSTDYNAAFVSRLTISKDNSKNQVSLKLSSVTAADTAVYYCSNHYYGSSDYALDNWGQGTLVTVSS,yes,4
215,Cevostamab,Bispecific_mAb,light_sequence,IgK,human,IGKV1-16,0.84,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVRNL,VVWFQQKPGKAPKLLIY,SGS,YRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQHYSPPYT,FGQGTKVEIK,4,Phase-I,DIQMTQSPSSLSASVGDRVTITCKASQDVRNLVVWFQQKPGKAPKLLIYSGSYRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSPPYTFGQGTKVEIK,yes,4
216,Cevostamab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV1-3,0.83,IGHJ4,1,EVQLVQSGAEVKKPGASVKVSCKAS,GFTFTSYY,IHWVRQAPGQGLEWIGW,IYPENDNT,KYNEKFKDRVTITADTSTSTAYLELSSLRSEDTAVYYC,ARDGYSRYYFDY,WGQGTLVTVSS,4,Phase-I,EVQLVQSGAEVKKPGASVKVSCKASGFTFTSYYIHWVRQAPGQGLEWIGWIYPENDNTKYNEKFKDRVTITADTSTSTAYLELSSLRSEDTAVYYCARDGYSRYYFDYWGQGTLVTVSS,yes,4
217,Cevostamab,Bispecific_mAb,light_sequence_bispec,IgK,human,IGKV4-1,0.89,IGKJ1,0.92,DIVMTQSPDSLAVSLGERATINCKSS,QSLLNSRTRKNY,LAWYQQKPGQSPKLLIY,WTS,TRKSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,KQSFILRT,FGQGTKVEIK,4,Phase-I,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRTRKNYLAWYQQKPGQSPKLLIYWTSTRKSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCKQSFILRTFGQGTKVEIK,yes,4
218,Cibisatamab,Bispecific_mAb_with_Domain_Crossover,heavy_sequence,IgG1,human,IGHV1-18,0.83,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTEFG,MNWVRQAPGQGLEWMGW,INTKTGEA,TYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYC,ARWDFAYYVEAMDY,WGQGTTVTVSS,4,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTEFGMNWVRQAPGQGLEWMGWINTKTGEATYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARWDFAYYVEAMDYWGQGTTVTVSS,yes,4
219,Cibisatamab,Bispecific_mAb_with_Domain_Crossover,light_sequence,IgK,human,IGKV1D-39,0.84,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,AAVGTY,VAWYQQKPGKAPKLLIY,SAS,YRKRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,HQYYTYPLFT,FGQGTKLEIK,4,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCKASAAVGTYVAWYQQKPGKAPKLLIYSASYRKRGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQYYTYPLFTFGQGTKLEIK,yes,4
220,Cibisatamab,Bispecific_mAb_with_Domain_Crossover,heavy_sequence_bispec,undefined,human,IGHV1-18,0.83,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTEFG,MNWVRQAPGQGLEWMGW,INTKTGEA,TYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYC,ARWDFAYYVEAMDY,WGQGTTVTVSS,4,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTEFGMNWVRQAPGQGLEWMGWINTKTGEATYVEEFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARWDFAYYVEAMDYWGQGTTVTVSS,yes,4
221,Cibisatamab,Bispecific_mAb_with_Domain_Crossover,light_sequence_bispec,IgL,mouse,IGLV1,0.81,IGLJ1,1,QAVVTQEPSLTVSPGGTVTLTCGSS,TGAVTTSNY,ANWVQEKPGQAFRGLIG,GTN,KRAPGTPARFSGSLLGGKAALTLSGAQPEDEAEYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-I/II,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQEKPGQAFRGLIGGTNKRAPGTPARFSGSLLGGKAALTLSGAQPEDEAEYYCALWYSNLWVFGGGTKLTVL,yes,4
222,Cilgavimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-15,0.96,IGHJ4,1,EVQLVESGGGLVKPGGSLRLSCAAS,GFTFRDVW,MSWVRQAPGKGLEWVGR,IKSKIDGGTT,DYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYC,TTAGSYYYDTVGPGLPEGKFDY,WGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVKPGGSLRLSCAASGFTFRDVWMSWVRQAPGKGLEWVGRIKSKIDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTAGSYYYDTVGPGLPEGKFDYWGQGTLVTVSS,yes,2
223,Cilgavimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.96,IGKJ4,1,DIVMTQSPDSLAVSLGERATINCKSS,QSVLYSSNNKNY,LAWYQQKPGQPPKLLMY,WAS,TRESGVPDRFSGSGSGAEFTLTISSLQAEDVAIYYC,QQYYSTLT,FGGGTKVEIK,2,Phase-III,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLMYWASTRESGVPDRFSGSGSGAEFTLTISSLQAEDVAIYYCQQYYSTLTFGGGTKVEIK,yes,2
224,Cinpanemab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-15,0.84,IGHJ1,0.86,EVQLVESGGGLVEPGGSLRLSCAVS,GFDFEKAW,MSWVRQAPGQGLQWVAR,IKSTADGGTT,SYAAPVEGRFIISRDDSRNMLYLQMNSLKTEDTAVYYC,TSAH,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVEPGGSLRLSCAVSGFDFEKAWMSWVRQAPGQGLQWVARIKSTADGGTTSYAAPVEGRFIISRDDSRNMLYLQMNSLKTEDTAVYYCTSAHWGQGTLVTVSS,yes,2
225,Cinpanemab,Whole_mAb,light_sequence,IgL,human,IGLV3-25,0.87,IGLJ3,0.92,SYELTQPPSVSVSPGQTARITCSGE,ALPMQF,AHWYQQRPGKAPVIVVY,KDS,ERPSGVPERFSGSSSGTTATLTITGVQAEDEADYYC,QSPDSTNTYEV,FGGGTKLTVL,2,Phase-II,SYELTQPPSVSVSPGQTARITCSGEALPMQFAHWYQQRPGKAPVIVVYKDSERPSGVPERFSGSSSGTTATLTITGVQAEDEADYYCQSPDSTNTYEVFGGGTKLTVL,yes,2
228,Cixutumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.99,IGHJ6,1,EVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,IIPIFGTA,NYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARAPLRFLEWSTQDHYYYYYMDV,WGKGTTVTVSS,2,Phase-II,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWSTQDHYYYYYMDVWGKGTTVTVSS,yes,2
229,Cixutumumab,Whole_mAb,light_sequence,IgL,human,IGLV3-19,0.95,IGLJ3,0.92,SSELTQDPAVSVALGQTVRITCQGD,SLRSYY,ATWYQQKPGQAPILVIY,GEN,KRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYC,KSRDGSGQHLV,FGGGTKLTVL,2,Phase-II,SSELTQDPAVSVALGQTVRITCQGDSLRSYYATWYQQKPGQAPILVIYGENKRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCKSRDGSGQHLVFGGGTKLTVL,yes,2
230,Claudiximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-61,0.93,IGHJ2,1,QVQLQQPGAELVRPGASVKLSCKAS,GYTFTSYW,INWVKQRPGQGLEWIGN,IYPSDSYT,NYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYC,TRSWRGNSFDY,WGQGTTLTVSS,2,Phase-III,QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS,yes,2
231,Claudiximab,Whole_mAb,light_sequence,IgK,mouse,IGKV8-19,1,IGKJ4,1,DIVMTQSPSSLTVTAGEKVTMSCKSS,QSLLNSGNQKNY,LTWYQQKPGQPPKLLIY,WAS,TRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYC,QNDYSYPFT,FGSGTKLEIK,2,Phase-III,DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK,yes,2
232,Clazakizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.84,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFSLSNYY,VTWVRQAPGKGLEWVGI,IYGSDET,AYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDDSSDWDAKFNL,WGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS,yes,2
233,Clazakizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-6,0.88,IGKJ4,0.83,AIQMTQSPSSLSASVGDRVTITCQAS,QSINNE,LSWYQQKPGKAPKLLIY,RAS,TLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYC,QQGYSLRNIDNA,FGGGTKVEIK,2,Phase-III,AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK,yes,2
234,Clervonafusp,di-Fab_Fusion,heavy_sequence,IgG1,human,IGHV3-48,0.9,IGHJ4,0.93,EVQLQESGGGVVQPGGSLRLSCAAS,GFTFSNYG,MHWIRQAPGKGLEWVSY,ISSGSSTI,YYADSVKGRFTISRDNSKNTLYLQMNSLRSEDTAVYYC,ARRGLLLDY,WGQGTLVTVSS,2,Phase-I/II,EVQLQESGGGVVQPGGSLRLSCAASGFTFSNYGMHWIRQAPGKGLEWVSYISSGSSTIYYADSVKGRFTISRDNSKNTLYLQMNSLRSEDTAVYYCARRGLLLDYWGQGTLVTVSS,yes,2
235,Clervonafusp,di-Fab_Fusion,light_sequence,IgK,human,IGKV1D-39,0.83,IGKJ2,0.75,DIQMTQSPSSLSASVGDRVTISCRAS,KSVSTSSYSY,MHWYQQKPEKALIK,YAS,YLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYC,QHSRET,FGAGTKLELK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTISCRASKSVSTSSYSYMHWYQQKPEKALIKYASYLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQHSRETFGAGTKLELK,yes,2
236,Clivatuzumab,Whole_mAb_Radiolabelled,heavy_sequence,IgG1,human,IGHV1-2,0.8,IGHJ4,0.93,QVQLQQSGAEVKKPGASVKVSCEAS,GYTFPSYV,LHWVKQAPGQGLEWIGY,INPYNDGT,QYNEKFKGKATLTRDTSINTAYMELSRLRSDDTAVYYC,ARGFGGSYGFAY,WGQGTLVTVSS,2,Phase-III,QVQLQQSGAEVKKPGASVKVSCEASGYTFPSYVLHWVKQAPGQGLEWIGYINPYNDGTQYNEKFKGKATLTRDTSINTAYMELSRLRSDDTAVYYCARGFGGSYGFAYWGQGTLVTVSS,yes,2
237,Clivatuzumab,Whole_mAb_Radiolabelled,light_sequence,IgK,human,IGKV1D-39,0.8,IGKJ5,0.83,DIQLTQSPSSLSASVGDRVTMTCSAS,SSVSSSY,LYWYQQKPGKAPKLWIY,STS,NLASGVPARFSGSGSGTDFTLTISSLQPEDSASYFC,HQWNRYPYT,FGGGTRLEIK,2,Phase-III,DIQLTQSPSSLSASVGDRVTMTCSASSSVSSSYLYWYQQKPGKAPKLWIYSTSNLASGVPARFSGSGSGTDFTLTISSLQPEDSASYFCHQWNRYPYTFGGGTRLEIK,yes,2
238,Cobolimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.92,IGHJ6,0.93,EVQLLESGGGLVQPGGSLRLSCAAA,SGFTFSSYD,MSWVRQAPGKGLDWVST,ISGGGTYT,YYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ASMDY,WGQGTTVTVSS,2,Phase-II/III,EVQLLESGGGLVQPGGSLRLSCAAASGFTFSSYDMSWVRQAPGKGLDWVSTISGGGTYTYYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASMDYWGQGTTVTVSS,yes,2
239,Cobolimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.92,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCRAS,QSIRRY,LNWYHQKPGKAPKLLIY,GAS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAVYYC,QQSHSAPLT,FGGGTKVEIK,2,Phase-II/III,DIQMTQSPSSLSASVGDRVTITCRASQSIRRYLNWYHQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAVYYCQQSHSAPLTFGGGTKVEIK,yes,2
242,Cofetuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-3,0.82,IGHJ4,0.86,QVQLVQSGPEVKKPGASVKVSCKAS,GYTFTDYA,VHWVRQAPGKRLEWIGV,ISTYNDYT,YNNQDFKGRVTMTRDTSASTAYMELSRLRSEDTAVYYC,ARGNSYFYALDY,WGQGTSVTVSS,2,Phase-I,QVQLVQSGPEVKKPGASVKVSCKASGYTFTDYAVHWVRQAPGKRLEWIGVISTYNDYTYNNQDFKGRVTMTRDTSASTAYMELSRLRSEDTAVYYCARGNSYFYALDYWGQGTSVTVSS,yes,2
243,Cofetuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-11,0.88,IGKJ1,0.83,EIVLTQSPATLSLSPGERATLSCRAS,ESVDSYGKSF,MHWYQQKPGQAPRLLIY,RAS,NLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQSNEDPWT,FGGGTKLEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASESVDSYGKSFMHWYQQKPGQAPRLLIYRASNLESGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSNEDPWTFGGGTKLEIK,yes,2
244,Coltuximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-69,0.86,IGHJ4,1,QVQLVQPGAEVVKPGASVKLSCKTS,GYTFTSNW,MHWVKQAPGQGLEWIGE,IDPSDSYT,NYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYC,ARGSNPYYYAMDY,WGQGTSVTVSS,2,Phase-II,QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS,yes,2
245,Coltuximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV4-70,0.9,IGKJ2,1,EIVLTQSPAIMSASPGERVTMTCSAS,SGVNY,MHWYQQKPGTSPRRWIY,DTS,KLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYC,HQRGSYT,FGGGTKLEIK,2,Phase-II,EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK,yes,2
252,Cosfroviximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV8-8,0.75,IGHJ4,0.93,DVKLLESGGGLVQPGGSLKLSCAAS,GFSLSTSGVG,VGWFRQPSGKGLEWLAL,IWWDDDK,YYNPSLKSQLSISKDFSRNQVFLKISNVDIADTATYYC,ARRDPFGYDNAMGY,WGQGTSVTVSS,2,Phase-II,DVKLLESGGGLVQPGGSLKLSCAASGFSLSTSGVGVGWFRQPSGKGLEWLALIWWDDDKYYNPSLKSQLSISKDFSRNQVFLKISNVDIADTATYYCARRDPFGYDNAMGYWGQGTSVTVSS,yes,2
253,Cosfroviximab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-13,0.95,IGKJ5,0.92,DIVMTQSPLSLSTSVGDRVSLTCKAS,QNVGTA,VAWYQQKPGQSPKLLIY,SAS,NRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADYFC,QQYSSYPLT,FGAGTKLELR,2,Phase-II,DIVMTQSPLSLSTSVGDRVSLTCKASQNVGTAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADYFCQQYSSYPLTFGAGTKLELR,yes,2
254,Cosibelimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.94,IGHJ4,0.86,EVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSRSA,ISWVRQAPGQGLEWMGV,IIPAFGEA,NYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYC,ARGRQMFGAGIDF,WGQGTLVTVSS,2,Phase-I,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSRSAISWVRQAPGQGLEWMGVIIPAFGEANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGRQMFGAGIDFWGQGTLVTVSS,yes,2
255,Cosibelimab,Whole_mAb,light_sequence,IgL,human,IGLV6-57,0.99,IGLJ3,0.92,NFMLTQPHSVSESPGKTVTISCTRS,SGSIDSNY,VQWYQQRPGSAPTTVIY,EDN,QRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYC,QSYDSNNRHVI,FGGGTKLTVL,2,Phase-I,NFMLTQPHSVSESPGKTVTISCTRSSGSIDSNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSNNRHVIFGGGTKLTVL,yes,2
258,Crizanlizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.82,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKVS,GYTFTSYD,INWVRQAPGKGLEWMGW,IYPGDGSI,KYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYC,ARRGEYGNYEGAMDY,WGQGTLVTVSS,2,Approved,QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS,yes,2
259,Crizanlizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.92,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCKAS,QSVDYDGHSY,MNWYQQKPGKAPKLLIY,AAS,NLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSDENPLT,FGGGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK,yes,2
260,Crotedumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-7,0.93,IGHJ6,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSNYL,MNWVRQAPGKGLEWLAN,IQEDGIEK,YYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AREPSHYDILTGYDYYYGMDV,WGQGTTVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYLMNWVRQAPGKGLEWLANIQEDGIEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREPSHYDILTGYDYYYGMDVWGQGTTVTVSS,yes,2
261,Crotedumab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.97,IGKJ3,1,DIQMTQSPSSLSASVGDRVTITCRAS,QGIRND,LGWYQQKPGKAPKRLIY,AAS,SLQSGVPSRFSGSGSGTEFILTVSSLQPEDFATYYC,LQYNSNPFT,FGPGTKVDIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFILTVSSLQPEDFATYYCLQYNSNPFTFGPGTKVDIK,yes,2
262,Crovalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.7,IGHJ4,0.86,QVQLVESGGGLVQPGRSLRLSCAAS,GFTVHSSYY,MAWVRQAPGKGLEWVGA,IFTGSGAE,YKAEWAKGRVTISKDTSKNQVVLTMTNMDPVDTATYYC,ASDAGYDYPTHAMHY,WGQGTLVTVSS,2,Phase-III,QVQLVESGGGLVQPGRSLRLSCAASGFTVHSSYYMAWVRQAPGKGLEWVGAIFTGSGAEYKAEWAKGRVTISKDTSKNQVVLTMTNMDPVDTATYYCASDAGYDYPTHAMHYWGQGTLVTVSS,yes,2
263,Crovalimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.9,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSS,LAWYQQKPGKAPKLLIY,GAS,ETESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QNTKVGSSYGNT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASQGISSSLAWYQQKPGKAPKLLIYGASETESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNTKVGSSYGNTFGGGTKVEIK,yes,2
264,Cudarolimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,1,IGHJ3,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,ISYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARGRPWYSETGTSAFDI,WGQGTMVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGRPWYSETGTSAFDIWGQGTMVTVSS,yes,2
265,Cudarolimab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.99,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCQAS,QDISNY,LNWYQQKPGKAPKLLIY,DAS,NLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQSDHYPT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQSDHYPTFGGGTKVEIK,yes,2
266,Cusatuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-48,0.91,IGHJ5,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSVYY,MNWVRQAPGKGLEWVSD,INNEGGTT,YYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYC,ARDAGYSNHVPIFDS,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSVYYMNWVRQAPGKGLEWVSDINNEGGTTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAVYYCARDAGYSNHVPIFDSWGQGTLVTVSS,yes,2
267,Cusatuzumab,Whole_mAb,light_sequence,IgL,human,IGLV8-61,0.8,IGLJ3,0.83,QAVVTQEPSLTVSPGGTVTLTCGLK,SGSVTSDNF,PTWYQQTPGQAPRLLIY,NTN,TRHSGVPDRFSGSILGNKAALTITGAQADDEAEYFC,ALFISNPSVE,FGGGTQLTVL,2,Phase-II,QAVVTQEPSLTVSPGGTVTLTCGLKSGSVTSDNFPTWYQQTPGQAPRLLIYNTNTRHSGVPDRFSGSILGNKAALTITGAQADDEAEYFCALFISNPSVEFGGGTQLTVL,yes,2
270,Daclizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.83,IGHJ4,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTSYR,MHWVRQAPGQGLEWIGY,INPSTGYT,EYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYC,ARGGGVFDY,WGQGTLVTVSS,2,Approved,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS,yes,2
271,Daclizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.85,IGKJ1,0.83,DIQMTQSPSTLSASVGDRVTITCSAS,SSISY,MHWYQQKPGKAPKLLIY,TTS,NLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYC,HQRSTYPLT,FGQGTKVEVK,2,Approved,DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK,yes,2
272,Dafsolimab,Whole_mAb,heavy_sequence,IgG2b,mouse,IGHV1-4,0.96,IGHJ4,1,QVQLQQSGAELARPGASVKMSCKAS,GYTFTSYT,MHWVKQRPGQGLEWIGY,INPSSGYT,NYIQRFKDKATLTADKSSSTAYMQVSSLTSEDSAVYYC,ARGSRYDYYGMDY,WGQGTSVTVSS,2,Phase-III,QVQLQQSGAELARPGASVKMSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPSSGYTNYIQRFKDKATLTADKSSSTAYMQVSSLTSEDSAVYYCARGSRYDYYGMDYWGQGTSVTVSS,yes,2
273,Dafsolimab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-59,1,IGKJ5,1,QIVLTQSPAIMSASPGEKVTMTCSAS,SSVSY,MHWYQQKSGTSPKRWIY,DTS,KLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYC,QQWSSNPLT,FGAGTKLELK,2,Phase-III,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPLTFGAGTKLELK,yes,2
276,Dapirolizumab,Fab,heavy_sequence,IgG1,human,IGHV3-66,0.76,IGHJ4,0.79,EVQLVESGGGLVQPGGSLRLSCAVS,GFSSTNYH,VHWVRQAPGKGLEWMGV,IWGDGDT,SYNSVLKSRFTISRDTSKNTVYLQMNSLRAEDTAVYYC,ARQLTHYYVLAA,WGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAVSGFSSTNYHVHWVRQAPGKGLEWMGVIWGDGDTSYNSVLKSRFTISRDTSKNTVYLQMNSLRAEDTAVYYCARQLTHYYVLAAWGQGTLVTVSS,yes,2
277,Dapirolizumab,Fab,light_sequence,IgK,human,IGKV1-NL1,0.85,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,EDLYYN,LAWYQRKPGKAPKLLIY,DTY,RLADGVPSRFSGSGSGTDYTLTISSLQPEDFASYYC,QQYYKFPFT,FGQGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASEDLYYNLAWYQRKPGKAPKLLIYDTYRLADGVPSRFSGSGSGTDYTLTISSLQPEDFASYYCQQYYKFPFTFGQGTKVEIK,yes,2
278,Daratumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.95,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAVS,GFTFNSFA,MSWVRQAPGKGLEWVSA,ISGSGGGT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFC,AKDKILWFGEPVFDY,WGQGTLVTVSS,2,Approved,EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS,yes,2
279,Daratumumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPT,FGQGTKVEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK,yes,2
280,Datopotamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.8,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTTAG,MQWVRQAPGQGLEWMGW,INTHSGVP,KYAEDFKGRVTISADTSTSTAYLQLSSLKSEDTAVYYC,ARSGFGSSYWYFDV,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTTAGMQWVRQAPGQGLEWMGWINTHSGVPKYAEDFKGRVTISADTSTSTAYLQLSSLKSEDTAVYYCARSGFGSSYWYFDVWGQGTLVTVSS,yes,2
281,Datopotamab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.85,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVSTA,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPSRFSGSGSGTDFTLTISSLQPEDFAVYYC,QQHYITPLT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFAVYYCQQHYITPLTFGQGTKLEIK,yes,2
282,Daxdilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-18,0.98,IGHJ2,0.93,QVQLQQSGAEVKKPGASVKVSCKAS,GYTFTSYG,ISWVRQAPGQGLEWMGW,ISAYNGNT,NYAQKLQGRVTMTIDTSTSTAYMELRSLRSDDTAVYYC,ARNGLWGWDSDAFDI,WGRGTLVTVSS,2,Phase-I,QVQLQQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTIDTSTSTAYMELRSLRSDDTAVYYCARNGLWGWDSDAFDIWGRGTLVTVSS,yes,2
283,Daxdilimab,Whole_mAb,light_sequence,IgL,human,IGLV2-14,1,IGLJ3,0.92,QSALTQPASVSGSPGQSITISCTGT,SSDVGGYNY,VSWYQQHPGKAPKLMIY,DVS,NRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,SSYTSSSTVV,FGGGTKVTVL,2,Phase-I,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTVVFGGGTKVTVL,yes,2
284,Dectrekumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.98,IGHJ3,1,EVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAI,IWYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARLWFGDLDAFDI,WGQGTMVTVSS,2,Phase-II,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAIIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLWFGDLDAFDIWGQGTMVTVSS,yes,2
285,Dectrekumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.97,IGKJ2,1,EIVLTQSPATLSLSPGERAILSCRAG,QSVSSY,LVWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSSWPPVYT,FGQGTKLEIK,2,Phase-II,EIVLTQSPATLSLSPGERAILSCRAGQSVSSYLVWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSSWPPVYTFGQGTKLEIK,yes,2
288,Demupitamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-61,0.9,IGHJ3,1,QVQLQESGPGLVKPSETLSLTCTVS,GGSVSSGDYY,WTWIRQSPGKGLEWIGH,IYYSGNT,NYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYC,VRDRVTGAFDI,WGQGTMVTVSS,2,Phase-I,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS,yes,2
289,Demupitamab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.96,IGKJ4,0.92,DIQMTQSPSTLSASVGDRVTITCQAS,QDISNY,LNWYQQKPGKAPKLLIY,DAS,NLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFC,QHFDHLPLA,FGGGTKVEIK,2,Phase-I,DIQMTQSPSTLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK,yes,2
290,Denintuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV4-31,0.85,IGHJ4,1,QVQLQESGPGLVKPSQTLSLTCTVS,GGSISTSGMG,VGWIRQHPGKGLEWIGH,IWWDDDK,RYNPALKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARMELWSYYFDY,WGQGTLVTVSS,2,Phase-II,QVQLQESGPGLVKPSQTLSLTCTVSGGSISTSGMGVGWIRQHPGKGLEWIGHIWWDDDKRYNPALKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARMELWSYYFDYWGQGTLVTVSS,yes,2
291,Denintuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-11,0.87,IGKJ2,0.92,EIVLTQSPATLSLSPGERATLSCSAS,SSVSY,MHWYQQKPGQAPRLLIY,DTS,KLASGIPARFSGSGSGTDFTLTISSLEPEDVAVYYC,FQGSVYPFT,FGQGTKLEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCSASSSVSYMHWYQQKPGQAPRLLIYDTSKLASGIPARFSGSGSGTDFTLTISSLEPEDVAVYYCFQGSVYPFTFGQGTKLEIK,yes,2
292,Denosumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23D,0.98,IGHJ5,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSG,ITGSGGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKDPGTTVIMSWFDP,WGQGTLVTVSS,2,Approved,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSS,yes,2
293,Denosumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.96,IGKJ1,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVRGRY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYC,QQYGSSPRT,FGQGTKVEIK,2,Approved,EIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIK,yes,2
294,Depatuxizumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV4-30-4,0.82,IGHJ4,0.93,QVQLQESGPGLVKPSQTLSLTCTVS,GYSISSDFA,WNWIRQPPGKGLEWMGY,ISYSGNT,RYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYC,VTAGRGFPY,WGQGTLVTVSS,2,Phase-III,QVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSS,yes,2
295,Depatuxizumab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV14-100,0.86,IGKJ1,1,DIQMTQSPSSMSVSVGDRVTITCHSS,QDINSN,IGWLQQKPGKSFKGLIY,HGT,NLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,VQYAQFPWT,FGGGTKLEIK,2,Phase-III,DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK,yes,2
296,Depemokimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV2-70,0.75,IGHJ4,0.86,QVTLRESGPALVKPTQTLTLTCTVS,GFSLTGSS,VHWVRQPPGKGLEWLGV,IWASGGT,DYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYC,ARDPPSGLLRLDY,WGRGTLVTVSS,2,Phase-III,QVTLRESGPALVKPTQTLTLTCTVSGFSLTGSSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSGLLRLDYWGRGTLVTVSS,yes,2
297,Depemokimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.92,IGKJ4,0.83,DIVMTQSPDSLAVSLGERATINCKSS,QSLLNSGNQKNY,LAWYQQKPGQPPKLLIY,GAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QNVHSFPFT,FGGGTKLEIK,2,Phase-III,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK,yes,2
298,Derlotuximab,Whole_mAb_Radiolabelled,heavy_sequence,IgG1,mouse,IGHV2-6-5,0.99,IGHJ4,1,QVQLKESGPGLVAPSQSLSITCTVS,GFSLTDYG,VRWIRQPPGKGLEWLGV,IWGGGST,YYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYC,AKEKRRGYYYAMDY,WGQGTSVTVSS,2,Approved,QVQLKESGPGLVAPSQSLSITCTVSGFSLTDYGVRWIRQPPGKGLEWLGVIWGGGSTYYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCAKEKRRGYYYAMDYWGQGTSVTVSS,yes,2
299,Derlotuximab,Whole_mAb_Radiolabelled,light_sequence,IgK,mouse,IGKV4-57-1,0.99,IGKJ1,0.92,ENVLTQSPAIMSASPGEKVTMTCRAS,SSVSSSY,LHWYQQKSGASPKLWIY,STS,NLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYC,QQYSGYPLT,FGGGTKLEIK,2,Approved,ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQQYSGYPLTFGGGTKLEIK,yes,2
300,Dezamizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.86,IGHJ5,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GFTFATYN,MHWVRQAPGQGLEWMGY,IYPGDGNA,NYNQQFKGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARGDFDYDGGYYFDS,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGFTFATYNMHWVRQAPGQGLEWMGYIYPGDGNANYNQQFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGDFDYDGGYYFDSWGQGTLVTVSS,yes,2
301,Dezamizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.87,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,ENIYSY,LAWYQQKPGKAPKLLIH,"NAK",TLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QHHYGAPLT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIHNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGAPLTFGQGTKLEIK,yes,2
306,Dinutuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-26,0.81,IGHJ4,0.93,EVQLLQSGPELEKPGASVMISCKAS,GSSFTGYN,MNWVRQNIGKSLEWIGA,IDPYYGGT,SYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYC,VSGMEY,WGQGTSVTVSS,2,Approved,EVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSS,yes,2
307,Dinutuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV1-110,0.87,IGKJ5,1,EIVMTQSPATLSVSPGERATLSCRSS,QSLVHRNGNTY,LHWYLQKPGQSPKLLIH,KVS,NRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFC,SQSTHVPPLT,FGAGTKLELK,2,Approved,EIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK,yes,2
308,Diridavumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.85,IGHJ6,1,EVQLVESGAEVKKPGSSVKVSCKAS,GGPFRSYA,ISWVRQAPGQGPEWMGG,IIPIFGTT,KYAPKFQGRVTITADDFAGTVYMELSSLRSEDTAMYYC,AKHMGYQVRETMDV,WGKGTTVTVSS,2,Phase-II,EVQLVESGAEVKKPGSSVKVSCKASGGPFRSYAISWVRQAPGQGPEWMGGIIPIFGTTKYAPKFQGRVTITADDFAGTVYMELSSLRSEDTAMYYCAKHMGYQVRETMDVWGKGTTVTVSS,yes,2
309,Diridavumab,Whole_mAb,light_sequence,IgL,human,IGLV1-51,0.97,IGLJ3,1,QSVLTQPPSVSAAPGQKVTISCSGS,SSNIGNDY,VSWYQQLPGTAPKLLIY,DNN,KRPSGIPDRFSGSKSGTSATLGITGLQTGDEANYYC,ATWDRRPTAYVV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNDYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEANYYCATWDRRPTAYVVFGGGTKLTVL,yes,2
310,Disitamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-69-2,0.83,IGHJ4,0.93,EVQLVQSGAEVKKPGATVKISCKVS,GYTFTDYY,IHWVQQAPGKGLEWMGR,VNPDHGDS,YYNQKFKDKATITADKSTDTAYMELSSLRSEDTAVYFC,ARNYLFDH,WGQGTLVTVSS,2,Phase-III,EVQLVQSGAEVKKPGATVKISCKVSGYTFTDYYIHWVQQAPGKGLEWMGRVNPDHGDSYYNQKFKDKATITADKSTDTAYMELSSLRSEDTAVYFCARNYLFDHWGQGTLVTVSS,yes,2
311,Disitamab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1-12,0.84,IGKJ4,0.92,DIQMTQSPSSVSASVGDRVTITCKAS,QDVGTA,VAWYQQKPGKAPKLLIY,WAS,IRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,HQFATYT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSVSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASIRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQFATYTFGGGTKVEIK,yes,2
312,Divozilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.87,IGHJ4,0.86,EVQLVQPGAEVVKPGASVKVSCKAS,GYTFTSYN,MHWVRQAPGRGLEWMGA,IYPGNGDT,SYNQKFKGRVTMTRDKSTSTVYMELSSLRSEDTAVYYC,ARSTYYGGDWYFNV,WGQGTLVTVSS,2,Phase-II,EVQLVQPGAEVVKPGASVKVSCKASGYTFTSYNMHWVRQAPGRGLEWMGAIYPGNGDTSYNQKFKGRVTMTRDKSTSTVYMELSSLRSEDTAVYYCARSTYYGGDWYFNVWGQGTLVTVSS,yes,2
313,Divozilimab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.85,IGKJ1,0.83,QIVLSQSPAILSASPGERVTLTCRAS,SSVSY,IHWFQQKPGKAPKPLIY,ATS,NLASGVPSRFSGSGSGTDFSLTISRVEPEDFAVYYC,QQWTSNPPT,FGGGTKVEIK,2,Phase-II,QIVLSQSPAILSASPGERVTLTCRASSSVSYIHWFQQKPGKAPKPLIYATSNLASGVPSRFSGSGSGTDFSLTISRVEPEDFAVYYCQQWTSNPPTFGGGTKVEIK,yes,2
314,Docaravimab,Whole_mAb_(Mouse),heavy_sequence,IgG2b,mouse,IGHV2-6-7,0.93,IGHJ2,1,QVQLKESGPGLLAPSQSLSITCTVS,GFSLTGHG,VNWVRQPPGKGLEWLGI,IWADGTT,NYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTASYYC,AREGDISGYYFDY,WGQGTTLTVSS,2,Approved,QVQLKESGPGLLAPSQSLSITCTVSGFSLTGHGVNWVRQPPGKGLEWLGIIWADGTTNYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTASYYCAREGDISGYYFDYWGQGTTLTVSS,yes,2
315,Docaravimab,Whole_mAb_(Mouse),light_sequence,IgK,mouse,IGKV10-96,0.93,IGKJ1,0.92,DVQMTQTTSSLSASLGDRVTITCRPS,QDINNY,LSWYQQKPDGTVKLLIY,YTS,RLHSGVPSRFSGSGSGTDYSLTISNLEQEDFATYFC,QQGNTLPPT,FGGGTKLEIK,2,Approved,DVQMTQTTSSLSASLGDRVTITCRPSQDINNYLSWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDFATYFCQQGNTLPPTFGGGTKLEIK,yes,2
316,Domagrozumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.95,IGHJ4,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVST,ISSGGSYT,SYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKQDYAMNY,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS,yes,2
317,Domagrozumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.86,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVSTA,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQHYSTPWT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK,yes,2
322,Dostarlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.93,IGHJ6,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYD,MSWVRQAPGKGLEWVST,ISGGGSYT,YYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ASPYYAMDY,WGQGTTVTVSS,2,Preregistration,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSTISGGGSYTYYQDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASPYYAMDYWGQGTTVTVSS,yes,2
323,Dostarlimab,Whole_mAb,light_sequence,IgK,human,IGKV1-9,0.85,IGKJ1,0.92,DIQLTQSPSFLSAYVGDRVTITCKAS,QDVGTA,VAWYQQKPGKAPKLLIY,WAS,TLHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,QHYSSYPWT,FGQGTKLEIK,2,Preregistration,DIQLTQSPSFLSAYVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTLHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQHYSSYPWTFGQGTKLEIK,yes,2
324,Drozitumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-20,0.93,IGHJ4,0.86,EVQLVQSGGGVERPGGSLRLSCAAS,GFTFDDYA,MSWVRQAPGKGLEWVSG,INWQGGST,GYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYC,AKILGAGRGWYFDY,WGKGTTVTVSS,2,Phase-II,EVQLVQSGGGVERPGGSLRLSCAASGFTFDDYAMSWVRQAPGKGLEWVSGINWQGGSTGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDYWGKGTTVTVSS,yes,2
325,Drozitumab,Whole_mAb,light_sequence,IgL,human,IGLV3-19,0.96,IGLJ3,1,SELTQDPAVSVALGQTVRITCSGD,SLRSYY,ASWYQQKPGQAPVLVIY,GAN,NRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYC,NSADSSGNHVV,FGGGTKLTVL,2,Phase-II,SELTQDPAVSVALGQTVRITCSGDSLRSYYASWYQQKPGQAPVLVIYGANNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSADSSGNHVVFGGGTKLTVL,yes,2
326,Duligotuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.84,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTLSGDW,IHWVRQAPGKGLEWVGE,ISAAGGYT,DYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYC,ARESRVSFEAAMDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSS,yes,2
327,Duligotuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QNIATD,VAWYQQKPGKAPKLLIY,SAS,FLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSEPEPYT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIK,yes,2
332,Dusigitumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-8,1,IGHJ6,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYD,INWVRQATGQGLEWMGW,MNPNSGNT,GYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYC,ARDPYYYYYGMDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARDPYYYYYGMDVWGQGTTVTVSS,yes,2
333,Dusigitumab,Whole_mAb,light_sequence,IgL,human,IGLV1-51,0.97,IGLJ3,0.92,QSVLTQPPSVSAAPGQKVTISCSGS,SSNIENNH,VSWYQQLPGTAPKLLIY,DNN,KRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYC,ETWDTSLSAGRV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSVSAAPGQKVTISCSGSSSNIENNHVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCETWDTSLSAGRVFGGGTKLTVL,yes,2
334,Duvortuxizumab,Bispecific_scFv_with_Crossover,heavy_sequence,undefined,human,IGHV2-70,0.89,IGHJ4,0.93,QVTLRESGPALVKPTQTLTLTCTFS,GFSLSTSGMG,VGWIRQPPGKALEWLAH,IWWDDDK,RYNPALKSRLTISKDTSKNQVFLTMTNMDPVDTATYYC,ARMELWSYYFDY,WGQGTTVTVSS,4,Phase-I,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMGVGWIRQPPGKALEWLAHIWWDDDKRYNPALKSRLTISKDTSKNQVFLTMTNMDPVDTATYYCARMELWSYYFDYWGQGTTVTVSS,yes,4
335,Duvortuxizumab,Bispecific_scFv_with_Crossover,light_sequence,IgK,human,IGKV3-11,0.8,IGKJ2,0.92,ENVLTQSPATLSVTPGEKATITCRAS,QSVSY,MHWYQQKPGQAPRLLIY,DAS,NRASGVPSRFSGSGSGTDHTLTISSLEAEDAATYYC,FQGSVYPFT,FGQGTKLEIK,4,Phase-I,ENVLTQSPATLSVTPGEKATITCRASQSVSYMHWYQQKPGQAPRLLIYDASNRASGVPSRFSGSGSGTDHTLTISSLEAEDAATYYCFQGSVYPFTFGQGTKLEIK,yes,4
336,Duvortuxizumab,Bispecific_scFv_with_Crossover,heavy_sequence_bispec,undefined,human,IGHV3-73,0.88,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSTYA,MNWVRQAPGKGLEWVGR,IRSKYNNYAT,YYADSVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,VRHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
337,Duvortuxizumab,Bispecific_scFv_with_Crossover,light_sequence_bispec,IgL,mouse,IGLV1,0.81,IGLJ1,1,QAVVTQEPSLTVSPGGTVTLTCRSS,TGAVTTSNY,ANWVQQKPGQAPRGLIG,GTN,KRAPWTPARFSGSLLGGKAALTITGAQAEDEADYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-I,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWVQQKPGQAPRGLIGGTNKRAPWTPARFSGSLLGGKAALTITGAQAEDEADYYCALWYSNLWVFGGGTKLTVL,yes,4
338,Ebdarokimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.85,IGHJ3,0.93,EVQLVQSGAEVKKPGESLKISCQSS,GYTFTSYW,IGWVRQMPGQGLEWIGI,MSPVDSDI,RYNPMFRGQVTMSVDKSSSTAYLQWSSLKASDTAMYYC,ARRRPGQGYFDF,WGQGTMVTVSS,2,Phase-I/II,EVQLVQSGAEVKKPGESLKISCQSSGYTFTSYWIGWVRQMPGQGLEWIGIMSPVDSDIRYNPMFRGQVTMSVDKSSSTAYLQWSSLKASDTAMYYCARRRPGQGYFDFWGQGTMVTVSS,yes,2
339,Ebdarokimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.86,IGKJ5,0.92,EIVLTQSPATLSASPGERATISCRAS,QSVGTW,VAWYQQKPGQAPRSLIY,AAS,NLQSGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQYNIYPYT,FGQGTRLEIK,2,Phase-I/II,EIVLTQSPATLSASPGERATISCRASQSVGTWVAWYQQKPGQAPRSLIYAASNLQSGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYNIYPYTFGQGTRLEIK,yes,2
340,Ebronucimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-21,0.92,IGHJ3,1,EVQLVESGGGLVQPGRSLRLSCAAS,GFTFSSYS,MNWVRQAPGKGLEWVSG,ISSSSSYI,SYADSVQGRFTISRDNGKNSLYLQMNSLRAEDTALYFC,AREYDFWSAYYDAFDV,WGQGTMVTVSS,2,Phase-II,EVQLVESGGGLVQPGRSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSGISSSSSYISYADSVQGRFTISRDNGKNSLYLQMNSLRAEDTALYFCAREYDFWSAYYDAFDVWGQGTMVTVSS,yes,2
341,Ebronucimab,Whole_mAb,light_sequence,IgL,human,IGLV2-11,0.83,IGLJ1,0.83,QSELTQPRSVSGSPGQSVTISCTGT,SRNIGGGND,VHWYQQHPGKAPKLLIS,GVI,ERSSGVPDRFSGSKSGNTASLTISGLQAEDEADYYC,QSFDGSLSGSV,FGTGTDVTVL,2,Phase-II,QSELTQPRSVSGSPGQSVTISCTGTSRNIGGGNDVHWYQQHPGKAPKLLISGVIERSSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCQSFDGSLSGSVFGTGTDVTVL,yes,2
344,Edrecolomab,Whole_mAb,heavy_sequence,IgG2a,mouse,IGHV1-54,0.99,IGHJ3,1,QVQLQQSGAELVRPGTSVKVSCKAS,GYAFTNYL,IEWVKQRPGQGLEWIGV,INPGSGGT,NYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFC,ARDGPWFAY,WGQGTLVTVSA,2,Approved (w),QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARDGPWFAYWGQGTLVTVSA,yes,2
345,Edrecolomab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-20,0.97,IGKJ2,1,NIVMTQSPKSMSMSVGERVTLTCKAS,ENVVTY,VSWYQQKPEQSPKLLIY,GAS,NRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHC,GQGYSYPYT,FGGGTKLEIK,2,Approved (w),NIVMTQSPKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQGYSYPYTFGGGTKLEIK,yes,2
346,Efalizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.77,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GYSFTGHW,MNWVRQAPGKGLEWVGM,IHPSDSET,RYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYC,ARGIYFYGTTYFDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS,yes,2
347,Efalizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.9,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,KTISKY,LAWYQQKPGKAPKLLIY,SGS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQHNEYPLT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK,yes,2
348,Efungumab,scFv,heavy_sequence,undefined,human,IGHV5-10-1,0.9,IGHJ4,1,EVQLVESGAEVKKPGESLRISCKGS,GCIISSYW,ISWVRQMPGKGLEWMGK,IDPGDSYI,NYSPSFQGHVTISADKSINTAYLQWNSLKASDTAMYYC,ARGGRDFGDSFDY,WGQGTLVTVSS,2,Phase-III,EVQLVESGAEVKKPGESLRISCKGSGCIISSYWISWVRQMPGKGLEWMGKIDPGDSYINYSPSFQGHVTISADKSINTAYLQWNSLKASDTAMYYCARGGRDFGDSFDYWGQGTLVTVSS,yes,2
349,Efungumab,scFv,light_sequence,IgK,human,IGKV1-9,0.88,IGKJ4,0.92,DVVMTQSPSFLSAFVGDRITITCRAS,SGISRY,LAWYQQAPGKAPKLLIY,AAS,TLQTGVPSRFSGSGSGTEFTLTINSLQPEDFATYYC,QHLNSYPLT,FGGGTKVDIK,2,Phase-III,DVVMTQSPSFLSAFVGDRITITCRASSGISRYLAWYQQAPGKAPKLLIYAASTLQTGVPSRFSGSGSGTEFTLTINSLQPEDFATYYCQHLNSYPLTFGGGTKVDIK,yes,2
350,Eldelumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.9,IGHJ6,1,QMQLVESGGGVVQPGRSLRLSCTAS,GFTFSNNG,MHWVRQAPGKGLEWVAV,IWFDGMNK,FYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYC,AREGDGSGIYYYYGMDV,WGQGTTVTVSS,2,Phase-II,QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS,yes,2
351,Eldelumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.99,IGKJ3,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSSPIFT,FGPGTKVDIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK,yes,2
352,Elezanumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-18,0.93,IGHJ6,0.93,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSHG,ISWVRQAPGQGLDWMGW,ISPYSGNT,NYAQKLQGRVTMTTDTSTSTAYMELSSLRSEDTAVYYC,ARVGSGPYYYMDV,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSHGISWVRQAPGQGLDWMGWISPYSGNTNYAQKLQGRVTMTTDTSTSTAYMELSSLRSEDTAVYYCARVGSGPYYYMDVWGQGTLVTVSS,yes,2
353,Elezanumab,Whole_mAb,light_sequence,IgL,human,IGLV2-11,0.93,IGLJ6,0.75,QSALTQPRSVSGSPGQSVTISCTGT,SSSVGDSIY,VSWYQQHPGKAPKLMLY,DVT,KRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYC,YSYAGTDTL,FGGGTKVTVL,2,Phase-II,QSALTQPRSVSGSPGQSVTISCTGTSSSVGDSIYVSWYQQHPGKAPKLMLYDVTKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCYSYAGTDTLFGGGTKVTVL,yes,2
354,Elgemtumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.95,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSA,INSQGKST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARWGDEGFDI,WGQGTLVTVSS,2,Phase-I/II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINSQGKSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARWGDEGFDIWGQGTLVTVSS,yes,2
355,Elgemtumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.95,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISNW,LAWYQQKPGKAPKLLIY,GAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYSSFPTT,FGQGTKVEIK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSFPTTFGQGTKVEIK,yes,2
358,Elotuzumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV4-1,0.9,IGHJ1,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFDFSRYW,MSWVRQAPGKGLEWIGE,INPDSSTI,NYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYC,ARPDGNYWYFDV,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS,yes,2
359,Elotuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.85,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVGIA,VAWYQQKPGKVPKLLIY,WAS,TRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYC,QQYSSYPYT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK,yes,2
360,Eluvixtamab,Bispecific_scFv,heavy_sequence,undefined,human,IGHV1-18,0.83,IGHJ4,0.93,QVQLVQSGAEVKKPGESVKVSCKAS,GYTFTNYG,MNWVKQAPGQGLEWMGW,INTYTGEP,TYADKFQGRVTMTTDTSTSTAYMEIRNLGGDDTAVYYC,ARWSWSDGYYVYFDY,WGQGTSVTVSS,4,Phase-I,QVQLVQSGAEVKKPGESVKVSCKASGYTFTNYGMNWVKQAPGQGLEWMGWINTYTGEPTYADKFQGRVTMTTDTSTSTAYMEIRNLGGDDTAVYYCARWSWSDGYYVYFDYWGQGTSVTVSS,yes,4
361,Eluvixtamab,Bispecific_scFv,light_sequence,IgK,human,IGKV4-1,0.85,IGKJ5,1,DIVMTQSPDSLTVSLGERTTINCKSS,QSVLDSSTNKNS,LAWYQQKPGQPPKLLLS,WAS,TRESGIPDRFSGSGSGTDFTLTIDSPQPEDSATYYC,QQSAHFPIT,FGQGTRLEIK,4,Phase-I,DIVMTQSPDSLTVSLGERTTINCKSSQSVLDSSTNKNSLAWYQQKPGQPPKLLLSWASTRESGIPDRFSGSGSGTDFTLTIDSPQPEDSATYYCQQSAHFPITFGQGTRLEIK,yes,4
362,Eluvixtamab,Bispecific_scFv,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.91,IGHJ3,0.86,EVQLVESGGGLVQPGGSLKLSCAAS,GFTFNKYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYC,VRHGNFGNSYISYWAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISYWAYWGQGTLVTVSS,yes,4
363,Eluvixtamab,Bispecific_scFv,light_sequence_bispec,IgL,human,IGLV7-43,0.85,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCGSS,TGAVTSGNY,PNWVQQKPGQAPRGLIG,GTK,FLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,VLWYSNRWV,FGGGTKLTVL,4,Phase-I,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCVLWYSNRWVFGGGTKLTVL,yes,4
364,Emactuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-18,0.93,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYD,ISWVRQAPGQGLEWMGV,IWTDGGT,NYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARDQRLYFDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGVIWTDGGTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDQRLYFDVWGQGTTVTVSS,yes,2
365,Emactuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.87,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,EDVNTY,VSWYQQKPGKAPKLLIY,AAS,NRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSFSYPT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASEDVNTYVSWYQQKPGKAPKLLIYAASNRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSFSYPTFGQGTKLEIK,yes,2
366,Emapalumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,1,IGHJ5,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSA,ISGSGGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKDGSSGWYVPHWFDP,WGQGTLVTVSS,2,Approved,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSS,yes,2
367,Emapalumab,Whole_mAb,light_sequence,IgL,human,IGLV6-57,0.99,IGLJ3,0.92,NFMLTQPHSVSESPGKTVTISCTRS,SGSIASNY,VQWYQQRPGSSPTTVIY,EDN,QRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYC,QSYDGSNRWM,FGGGTKLTVL,2,Approved,NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVL,yes,2
368,Emerfetamab,Bispecific_scFv,heavy_sequence,undefined,human,IGHV1-18,0.82,IGHJ4,0.93,QVQLVQSGAEVKKPGESVKVSCKAS,GYTFTNYG,MNWVKQAPGQCLEWMGW,INTYTGEP,TYADKFQGRVTMTTDTSTSTAYMEIRNLGGDDTAVYYC,ARWSWSDGYYVYFDY,WGQGTSVTVSS,4,Phase-I,QVQLVQSGAEVKKPGESVKVSCKASGYTFTNYGMNWVKQAPGQCLEWMGWINTYTGEPTYADKFQGRVTMTTDTSTSTAYMEIRNLGGDDTAVYYCARWSWSDGYYVYFDYWGQGTSVTVSS,yes,4
369,Emerfetamab,Bispecific_scFv,light_sequence,IgK,human,IGKV4-1,0.85,IGKJ5,0.92,DIVMTQSPDSLTVSLGERTTINCKSS,QSVLDSSTNKNS,LAWYQQKPGQPPKLLLS,WAS,TRESGIPDRFSGSGSGTDFTLTIDSPQPEDSATYYC,QQSAHFPIT,FGCGTRLEIK,4,Phase-I,DIVMTQSPDSLTVSLGERTTINCKSSQSVLDSSTNKNSLAWYQQKPGQPPKLLLSWASTRESGIPDRFSGSGSGTDFTLTIDSPQPEDSATYYCQQSAHFPITFGCGTRLEIK,yes,4
370,Emerfetamab,Bispecific_scFv,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.91,IGHJ3,0.86,EVQLVESGGGLVQPGGSLKLSCAAS,GFTFNKYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYC,VRHGNFGNSYISYWAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISYWAYWGQGTLVTVSS,yes,4
371,Emerfetamab,Bispecific_scFv,light_sequence_bispec,IgL,human,IGLV7-43,0.85,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCGSS,TGAVTSGNY,PNWVQQKPGQAPRGLIG,GTK,FLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,VLWYSNRWV,FGGGTKLTVL,4,Phase-I,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCVLWYSNRWVFGGGTKLTVL,yes,4
372,Emicizumab,Bispecific_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.76,IGHJ4,0.79,QVQLVQSGSELKKPGASVKVSCKAS,GYTFTDNN,MDWVRQAPGQGLEWMGD,INTRSGGS,IYNEEFQDRVIMTVDKSTDTAYMELSSLRSEDTATYHC,ARRKSYGYYLDE,WGEGTLVTVSS,4,Approved,QVQLVQSGSELKKPGASVKVSCKASGYTFTDNNMDWVRQAPGQGLEWMGDINTRSGGSIYNEEFQDRVIMTVDKSTDTAYMELSSLRSEDTATYHCARRKSYGYYLDEWGEGTLVTVSS,yes,4
373,Emicizumab,Bispecific_mAb,light_sequence,IgK,human,IGKV1-NL1,0.82,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCKAS,RNIERQ,LAWYQQKPGQAPELLIY,QAS,RKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYC,QQYSDPPLT,FGGGTKVEIK,4,Approved,DIQMTQSPSSLSASVGDRVTITCKASRNIERQLAWYQQKPGQAPELLIYQASRKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYCQQYSDPPLTFGGGTKVEIK,yes,4
374,Emicizumab,Bispecific_mAb,heavy_sequence_bispec,IgG4,human,IGHV3-23,0.88,IGHJ4,1,QVQLVESGGGLVQPGGSLRLSCAAS,GFTFSYYD,IQWVRQAPGKGLEWVSS,ISPSGQST,YYRREVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARRTGREYGGGWYFDY,WGQGTLVTVSS,4,Approved,QVQLVESGGGLVQPGGSLRLSCAASGFTFSYYDIQWVRQAPGKGLEWVSSISPSGQSTYYRREVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARRTGREYGGGWYFDYWGQGTLVTVSS,yes,4
375,Emicizumab,Bispecific_mAb,light_sequence_bispec,IgK,human,IGKV1-NL1,0.82,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCKAS,RNIERQ,LAWYQQKPGQAPELLIY,QAS,RKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYC,QQYSDPPLT,FGGGTKVEIK,4,Approved,DIQMTQSPSSLSASVGDRVTITCKASRNIERQLAWYQQKPGQAPELLIYQASRKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYCQQYSDPPLTFGGGTKVEIK,yes,4
376,Emibetuzumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-2,0.89,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYY,MHWVRQAPGQGLEWMGR,VNPNRRGT,TYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARANWLDY,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS,yes,2
377,Emibetuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.86,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCSVS,SSVSSIY,LHWYQQKPGKAPKLLIY,STS,NLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QVYSGYPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK,yes,2
378,Enapotamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-23D,0.96,IGHJ3,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MNWVRQAPGKGLEWVST,TSGSGAST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKIWIAFDI,WGQGTMVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSTTSGSGASTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKIWIAFDIWGQGTMVTVSS,yes,2
379,Enapotamab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-20,0.99,IGKJ2,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSSPYT,FGQGTKLEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK,yes,2
380,Enavatuzumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV6-3,0.86,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYW,MSWVRQAPGKGLEWVAE,IRLKSDNYAT,HYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYC,TGYYADAMDY,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSS,yes,2
381,Enavatuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSVSTSSYSY,MHWYQQKPGKAPKLLIK,YAS,NLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QHSWEIPYT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIK,yes,2
384,Enfortumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-48,0.98,IGHJ6,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYN,MNWVRQAPGKGLEWVSY,ISSSSSTI,YYADSVKGRFTISRDNAKNSLSLQMNSLRDEDTAVYYC,ARAYYYGMDV,WGQGTTVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLSLQMNSLRDEDTAVYYCARAYYYGMDVWGQGTTVTVSS,yes,2
385,Enfortumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1-12,0.97,IGKJ4,0.92,DIQMTQSPSSVSASVGDRVTITCRAS,QGISGW,LAWYQQKPGKAPKFLIY,AAS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQANSFPPT,FGGGTKVEIK,2,Approved,DIQMTQSPSSVSASVGDRVTITCRASQGISGWLAWYQQKPGKAPKFLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGGGTKVEIK,yes,2
386,Enibarcimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.85,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFSRYW,IEWVRQAPGQGLEWIGE,ILPGSGST,NYNQKFQGRVTITADTSTSTAYMELSSLRSEDTAVYYC,TEGYEYDGFDY,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGYTFSRYWIEWVRQAPGQGLEWIGEILPGSGSTNYNQKFQGRVTITADTSTSTAYMELSSLRSEDTAVYYCTEGYEYDGFDYWGQGTTVTVSS,yes,2
387,Enibarcimab,Whole_mAb,light_sequence,IgK,mouse,IGKV1-117,0.89,IGKJ2,1,DVVLTQSPLSLPVTLGQPASISCRSS,QSIVYSNGNTY,LEWYLQRPGQSPRLLIY,RVS,NRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,FQGSHIPYT,FGGGTKLEIK,2,Phase-II,DVVLTQSPLSLPVTLGQPASISCRSSQSIVYSNGNTYLEWYLQRPGQSPRLLIYRVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHIPYTFGGGTKLEIK,yes,2
388,Enoblituzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-48,0.92,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSFG,MHWVRQAPGKGLEWVAY,ISSDSSAI,YYADTVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYC,GRGRENIYYGSRLDY,WGQGTTVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSDSSAIYYADTVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCGRGRENIYYGSRLDYWGQGTTVTVSS,yes,2
389,Enoblituzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-9,0.85,IGKJ2,0.92,DIQLTQSPSFLSASVGDRVTITCKAS,QNVDTN,VAWYQQKPGKAPKALIY,SAS,YRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNNYPFT,FGQGTKLEIK,2,Phase-II,DIQLTQSPSFLSASVGDRVTITCKASQNVDTNVAWYQQKPGKAPKALIYSASYRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNNYPFTFGQGTKLEIK,yes,2
390,Enokizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.88,IGHJ4,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSYYW,IEWVRQAPGQGLEWMGE,ILPGSGTT,NPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYC,ARADYYGSDYVKFDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS,yes,2
391,Enokizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.85,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCKAS,QHVITH,VTWYQQKPGKAPKLLIY,GTS,YSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFYEYPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK,yes,2
392,Enoticumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.91,IGHJ5,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVSF,LWYDGTNK,NYVESVKGRFTISRDNSKNMLYLEMNSLRAEDTAVYYC,ARDHDFRSGYEGWFDP,WGQGTLVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVSFLWYDGTNKNYVESVKGRFTISRDNSKNMLYLEMNSLRAEDTAVYYCARDHDFRSGYEGWFDPWGQGTLVTVSS,yes,2
393,Enoticumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QHRSNWPPT,FGGGTKVEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHRSNWPPTFGGGTKVEIK,yes,2
394,Ensituximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV2-3,0.89,IGHJ4,0.86,QVQLKESGPDLVAPSQSLSITCTVS,GFSLSKFG,VNWVRQPPGKGLEWLGV,IWGDGST,SYNSGLISRLSISKENSKSQVFLKLNSLQADDTATYYC,VKPGGDY,WGHGTSVTVSS,2,Phase-II,QVQLKESGPDLVAPSQSLSITCTVSGFSLSKFGVNWVRQPPGKGLEWLGVIWGDGSTSYNSGLISRLSISKENSKSQVFLKLNSLQADDTATYYCVKPGGDYWGHGTSVTVSS,yes,2
395,Ensituximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-70,0.93,IGKJ1,0.92,QVVLTQSPVIMSASPGEKVTMTCSAS,SSISY,MYWYQQKPGTSPKRWIY,DTS,KLASGVPARFSGSGSGTSYSLTISNMEAGDAATYYC,HQRDSYPWT,FGGGTNLEIK,2,Phase-II,QVVLTQSPVIMSASPGEKVTMTCSASSSISYMYWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISNMEAGDAATYYCHQRDSYPWTFGGGTNLEIK,yes,2
397,Epcoritamab,Bispecific_mAb,heavy_sequence,IgG1,mouse,IGHV10-1,0.93,IGHJ3,0.93,EVKLVESGGGLVQPGGSLRLSCAAS,GFTFNTYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYADSVKDRFTISRDDSKSSLYLQMNNLKTEDTAMYYC,VRHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-III,EVKLVESGGGLVQPGGSLRLSCAASGFTFNTYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRFTISRDDSKSSLYLQMNNLKTEDTAMYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
398,Epcoritamab,Bispecific_mAb,light_sequence,IgL,mouse,IGLV1,0.83,IGLJ1,1,QAVVTQEPSFSVSPGGTVTLTCRSS,TGAVTTSNY,ANWVQQTPGQAFRGLIG,GTN,KRAPGVPARFSGSLIGDKAALTITGAQADDESIYFC,ALWYSNLWV,FGGGTKLTVL,4,Phase-III,QAVVTQEPSFSVSPGGTVTLTCRSSTGAVTTSNYANWVQQTPGQAFRGLIGGTNKRAPGVPARFSGSLIGDKAALTITGAQADDESIYFCALWYSNLWVFGGGTKLTVL,yes,4
399,Epcoritamab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV3-9,0.96,IGHJ6,1,EVQLVESGGGLVQPDRSLRLSCAAS,GFTFHDYA,MHWVRQAPGKGLEWVST,ISWNSGTI,GYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYC,AKDIQYGNYYYGMDV,WGQGTTVTVSS,4,Phase-III,EVQLVESGGGLVQPDRSLRLSCAASGFTFHDYAMHWVRQAPGKGLEWVSTISWNSGTIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS,yes,4
400,Epcoritamab,Bispecific_mAb,light_sequence_bispec,IgK,human,IGKV3-11,1,IGKJ5,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPIT,FGQGTRLEIK,4,Phase-III,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK,yes,4
401,Epratuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.77,IGHJ4,0.79,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTSYW,LHWVRQAPGQGLEWIGY,INPRNDYT,EYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFC,ARRDITTFY,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSS,yes,2
402,Epratuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.84,IGKJ1,0.83,DIQLTQSPSSLSASVGDRVTMSCKSS,QSVLYSANHKNY,LAWYQQKPGKAPKLLIY,WAS,TRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,HQYLSSWT,FGGGTKLEIK,2,Phase-III,DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIK,yes,2
403,Eptinezumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.81,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAVS,GIDLSGYY,MNWVRQAPGKGLEWVGV,IGINGAT,YYASWAKGRFTISRDNSKTTVYLQMNSLRAEDTAVYFC,ARGDI,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAVSGIDLSGYYMNWVRQAPGKGLEWVGVIGINGATYYASWAKGRFTISRDNSKTTVYLQMNSLRAEDTAVYFCARGDIWGQGTLVTVSS,yes,2
404,Eptinezumab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.82,IGKJ4,0.83,QVLTQSPSSLSASVGDRVTINCQAS,QSVYHNTY,LAWYQQKPGKVPKQLIY,DAS,TLASGVPSRFSGSGSGTDFTLTISSLQPEDVATYYC,LGSYDCTNGDCFV,FGGGTKVEIK,2,Approved,QVLTQSPSSLSASVGDRVTINCQASQSVYHNTYLAWYQQKPGKVPKQLIYDASTLASGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLGSYDCTNGDCFVFGGGTKVEIK,yes,2
405,Eramkafusp,Whole_mAb_Fusion,heavy_sequence,IgG1,mouse,IGHV1-12,0.92,IGHJ1,0.93,QVQLQQPGAELVKPGASVKMSCKAS,GYTFTSYN,MHWVKQTPGRGLEWIGA,IYPGNGDT,SYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYC,ARSTYYGGDWYFNV,WGAGTTVTVSS,2,Phase-I,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSS,yes,2
406,Eramkafusp,Whole_mAb_Fusion,light_sequence,IgK,mouse,IGKV4-72,0.96,IGKJ1,0.92,QIVLSQSPAILSASPGEKVTMTCRAS,SSVSY,IHWFQQKPGSSPKPWIY,ATS,NLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYC,QQWTSNPPT,FGGGTKLEIK,2,Phase-I,QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK,yes,2
407,Erenumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-30,0.91,IGHJ6,0.93,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSFG,MHWVRQAPGKGLEWVAV,ISFDGSI,KYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYC,ARDRLNYYDSSGYYHYKYYGMAV,WGQGTTVTVSS,2,Approved,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSS,yes,2
408,Erenumab,Whole_mAb,light_sequence,IgL,human,IGLV1-51,0.99,IGLJ3,1,QSVLTQPPSVSAAPGQKVTISCSGS,SSNIGNNY,VSWYQQLPGTAPKLLIY,DNN,KRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYC,GTWDSRLSAVV,FGGGTKLTVL,2,Approved,QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL,yes,2
409,Erfonrilimab,Bispecific_Single_Domains_(VH-VH'-CH),heavy_sequence,IgG1,human,IGHV3-66,0.76,IGHJ4,0.93,QVQLVEQSGGLVQPGGSLRLSCAAS,GKMSSRRC,MAWFRQAPGKERERVAK,LLTTSGST,YLADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYC,AADSFEDPTCTLVTSSGAFQY,WGQGTLVTVSS,2,Phase-II,QVQLVEQSGGLVQPGGSLRLSCAASGKMSSRRCMAWFRQAPGKERERVAKLLTTSGSTYLADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAADSFEDPTCTLVTSSGAFQYWGQGTLVTVSS,yes,2
410,Erfonrilimab,Bispecific_Single_Domains_(VH-VH'-CH),heavy_sequence_bispec,undefined,human,IGHV3-64,0.86,IGHJ4,0.93,QVQLVESGGGLVQPGGSLRLSCAAS,GYIYSAYC,MGWFRQAPGKGLEGVAA,IYIGGGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AADVIPTETCLGGSWSGPFGY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGLVQPGGSLRLSCAASGYIYSAYCMGWFRQAPGKGLEGVAAIYIGGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAADVIPTETCLGGSWSGPFGYWGQGTLVTVSS,yes,2
411,Etaracizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.88,IGHJ5,0.86,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYD,MSWVRQAPGKGLEWVAK,VSSGGGST,YYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARHLHGSFAS,WGQGTTVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS,yes,2
412,Etaracizumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.84,IGKJ4,1,EIVLTQSPATLSLSPGERATLSCQAS,QSISNF,LHWYQQRPGQAPRLLIR,YRS,QSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQSGSWPLT,FGGGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK,yes,2
413,Etesevimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.97,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTVSSNY,MSWVRQAPGKGLEWVSV,IYSGGST,FYADSVKGRFTISRDNSMNTLFLQMNSLRAEDTAVYYC,ARVLPMYGDYLDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSMNTLFLQMNSLRAEDTAVYYCARVLPMYGDYLDYWGQGTLVTVSS,yes,2
414,Etesevimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.98,IGKJ2,1,DIVMTQSPSSLSASVGDRVTITCRAS,QSISRY,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSYSTPPEYT,FGQGTKLEIK,2,Approved,DIVMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEYTFGQGTKLEIK,yes,2
415,Etevritamab,Bispecific_scFv,heavy_sequence,undefined,human,IGHV3-33,0.94,IGHJ4,1,QVQLVESGGGVVQSGRSLRLSCAAS,GFTFRNYG,MHWVRQAPGKCLEWVAV,IWYDGSDK,YYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDGYDILTGNPRDFDY,WGQGTLVTVSS,4,Phase-I,QVQLVESGGGVVQSGRSLRLSCAASGFTFRNYGMHWVRQAPGKCLEWVAVIWYDGSDKYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGYDILTGNPRDFDYWGQGTLVTVSS,yes,4
416,Etevritamab,Bispecific_scFv,light_sequence,IgK,human,IGKV2-24,0.94,IGKJ1,0.83,DTVMTQTPLSSHVTLGQPASISCRSS,QSLVHSDGNTY,LSWLQQRPGQPPRLLIY,RIS,RRFSGVPDRFSGSGAGTDFTLEISRVEAEDVGVYYC,MQSTHVPRT,FGCGTKVEIK,4,Phase-I,DTVMTQTPLSSHVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYRISRRFSGVPDRFSGSGAGTDFTLEISRVEAEDVGVYYCMQSTHVPRTFGCGTKVEIK,yes,4
417,Etevritamab,Bispecific_scFv,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.91,IGHJ3,0.86,EVQLVESGGGLVQPGGSLKLSCAAS,GFTFNKYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYC,VRHGNFGNSYISYWAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISYWAYWGQGTLVTVSS,yes,4
418,Etevritamab,Bispecific_scFv,light_sequence_bispec,IgL,human,IGLV7-43,0.85,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCGSS,TGAVTSGNY,PNWVQQKPGQAPRGLIG,GTK,FLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,VLWYSNRWV,FGGGTKLTVL,4,Phase-I,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCVLWYSNRWVFGGGTKLTVL,yes,4
421,Etokimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.88,IGHJ4,0.79,QVQLMQSGAEVKKPGASVKVSCKAS,GYTFTSYW,MHWVRQAPGQGLEWMGT,IYPRNSNT,DYNQKFKARVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARPLYYYLTSPPTLF,WGQGTLVTVSS,2,Phase-II,QVQLMQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWMGTIYPRNSNTDYNQKFKARVTMTRDTSTSTVYMELSSLRSEDTAVYYCARPLYYYLTSPPTLFWGQGTLVTVSS,yes,2
422,Etokimab,Whole_mAb,light_sequence,IgK,human,IGKV1-9,0.86,IGKJ2,0.83,DIQLTQSPSFLSASVGDRVTITCKAS,QDVGTA,VAWYQQKPGKAPKLLIY,WAS,TRHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,QQAKTYPFT,FGSGTKLEIK,2,Phase-II,DIQLTQSPSFLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQAKTYPFTFGSGTKLEIK,yes,2
425,Evinacumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-43,0.93,IGHJ3,1,EVQLVESGGGVIQPGGSLRLSCAAS,GFTFDDYA,MNWVRQGPGKGLEWVSA,ISGDGGST,YYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAFFYC,AKDLRNTIFGVVIPDAFDI,WGQGTMVTVSS,2,Approved,EVQLVESGGGVIQPGGSLRLSCAASGFTFDDYAMNWVRQGPGKGLEWVSAISGDGGSTYYADSVKGRFTISRDNSKNSLYLQMNSLRAEDTAFFYCAKDLRNTIFGVVIPDAFDIWGQGTMVTVSS,yes,2
426,Evinacumab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.99,IGKJ2,1,DIQMTQSPSTLSASVGDRVTITCRAS,QSIRSW,LAWYQQKPGKAPKLLIY,KAS,SLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,QQYNSYSYT,FGQGTKLEIK,2,Approved,DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK,yes,2
427,Evolocumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-18,0.94,IGHJ6,1,EVQLVQSGAEVKKPGASVKVSCKAS,GYTLTSYG,ISWVRQAPGQGLEWMGW,VSFYNGNT,NYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYC,ARGYGMDV,WGQGTTVTVSS,2,Approved,EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS,yes,2
428,Evolocumab,Whole_mAb,light_sequence,IgL,human,IGLV2-14,0.97,IGLJ3,0.92,ESALTQPASVSGSPGQSITISCTGT,SSDVGGYNS,VSWYQQHPGKAPKLMIY,EVS,NRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,NSYTSTSMV,FGGGTKLTVL,2,Approved,ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL,yes,2
429,Ezabenlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.87,IGHJ4,0.93,EVMLVESGGGLVQPGGSLRLSCTAS,GFTFSKSA,MSWVRQAPGKGLEWVAY,ISGGGGDT,YYSSSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARHSNYNYYAMDY,WGQGTLVTVSS,2,Phase-II,EVMLVESGGGLVQPGGSLRLSCTASGFTFSKSAMSWVRQAPGKGLEWVAYISGGGGDTYYSSSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARHSNYNYYAMDYWGQGTLVTVSS,yes,2
430,Ezabenlimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.83,IGKJ2,0.92,EIVLTQSPATLSLSPGERATMSCRAS,ENIDVSGISF,MNWYQQKPGQAPKLLIY,VAS,NQGSGIPARFSGSGSGTDFTLTISRLEPEDFAVYYC,QQSKEVPQT,FGQGTKLEIK,2,Phase-II,EIVLTQSPATLSLSPGERATMSCRASENIDVSGISFMNWYQQKPGQAPKLLIYVASNQGSGIPARFSGSGSGTDFTLTISRLEPEDFAVYYCQQSKEVPQTFGQGTKLEIK,yes,2
435,Farletuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.83,IGHJ4,0.86,EVQLVESGGGVVQPGRSLRLSCSAS,GFTFSGYG,LSWVRQAPGKGLEWVAM,ISSGGSYT,YYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFC,ARHGDDPAWFAY,WGQGTPVTVSS,2,Phase-III,EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS,yes,2
436,Farletuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.83,IGKJ1,0.92,DIQLTQSPSSLSASVGDRVTITCSVS,SSISSNN,LHWYQQKPGKAPKPWIY,GTS,NLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYC,QQWSSYPYMYT,FGQGTKVEIK,2,Phase-III,DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK,yes,2
439,Feladilimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.85,IGHJ6,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTDYA,MHWVRQAPGQGLEWMGL,ISIYSDHT,NYNQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,GRNNYGNYGWYFDV,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYAMHWVRQAPGQGLEWMGLISIYSDHTNYNQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCGRNNYGNYGWYFDVWGQGTTVTVSS,yes,2
440,Feladilimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.87,IGKJ2,1,EIVLTQSPATLSLSPGERATLSCSAS,SSVSY,MHWYQQKPGQAPRLLIY,DTS,KLASGIPARFSGSGSGTDYTLTISSLEPEDFAVYYC,FQGSGYPYT,FGQGTKLEIK,2,Phase-III,EIVLTQSPATLSLSPGERATLSCSASSSVSYMHWYQQKPGQAPRLLIYDTSKLASGIPARFSGSGSGTDYTLTISSLEPEDFAVYYCFQGSGYPYTFGQGTKLEIK,yes,2
441,Felzartamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.91,IGHJ4,0.93,QVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYY,MNWVRQAPGKGLEWVSG,ISGDPSNT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDLPLVYTGFAY,WGQGTLVTVSS,2,Phase-III,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYYMNWVRQAPGKGLEWVSGISGDPSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLPLVYTGFAYWGQGTLVTVSS,yes,2
442,Felzartamab,Whole_mAb,light_sequence,IgL,human,IGLV3-1,0.81,IGLJ3,0.92,DIELTQPPSVSVAPGQTARISCSGD,NLRHYY,VYWYQQKPGQAPVLVIY,GDS,KRPSGIPERFSGSNSGNTATLTISGTQAEDEADYYC,QTYTGGASLV,FGGGTKLTVL,2,Phase-III,DIELTQPPSVSVAPGQTARISCSGDNLRHYYVYWYQQKPGQAPVLVIYGDSKRPSGIPERFSGSNSGNTATLTISGTQAEDEADYYCQTYTGGASLVFGGGTKLTVL,yes,2
443,Fezakinumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.92,IGHJ2,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTNYY,MHWVRQAPGQGLEWVGW,INPYTGSA,FYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYC,AREPEKFDSDDSDV,WGRGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWVGWINPYTGSAFYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREPEKFDSDDSDVWGRGTLVTVSS,yes,2
444,Fezakinumab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.97,IGLJ7,0.92,QAVLTQPPSVSGAPGQRVTISCTGS,SSNIGAGYG,VHWYQQLPGTAPKLLIY,GDS,NRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYC,QSYDNSLSGYV,FGGGTQLTVL,2,Phase-I,QAVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGDSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDNSLSGYVFGGGTQLTVL,yes,2
445,Fianlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-33,0.96,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCVAS,GFTFSSYG,MHWVRQAPGKGLEWVAI,IWYDGSNK,YYADSVKGRFTISRDNSKNTQYLQMNSLRAEDTAVYYC,ASVATSGDFDYYGMDV,WGQGTTVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCVASGFTFSSYGMHWVRQAPGKGLEWVAIIWYDGSNKYYADSVKGRFTISRDNSKNTQYLQMNSLRAEDTAVYYCASVATSGDFDYYGMDVWGQGTTVTVSS,yes,2
446,Fianlimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.93,IGKJ4,1,EIVLTQSPATLSLSPGERTTLSCRAS,QRISTY,LAWYQQKPGQAPRLLIY,DAS,KRATGIPARFSGSGSGTGFTLTISSLEPEDFAVYYC,QQRSNWPLT,FGGGTKVEIK,2,Phase-I,EIVLTQSPATLSLSPGERTTLSCRASQRISTYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTGFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,yes,2
447,Fibatuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.92,IGHJ5,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTGYW,MNWVRQAPGQGLEWMGD,IYPGSGNT,NYDEKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYC,ARGGYYEDFDS,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYWMNWVRQAPGQGLEWMGDIYPGSGNTNYDEKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGYYEDFDSWGQGTTVTVSS,yes,2
448,Fibatuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.92,IGKJ2,1,DIQMTQSPSFLSASVGDRVTITCRAS,QGIISY,LAWYQQKPEKAPKRLIY,AAS,SLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,GQYANYPYT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSFLSASVGDRVTITCRASQGIISYLAWYQQKPEKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCGQYANYPYTFGQGTKLEIK,yes,2
449,Ficlatuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.83,IGHJ4,0.93,QVQLVQPGAEVKKPGTSVKLSCKAS,GYTFTTYW,MHWVRQAPGQGLEWIGE,INPTNGHT,NYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYC,ARNYVGSIFDY,WGQGTLLTVSS,2,Phase-II,QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS,yes,2
450,Ficlatuzumab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-20,0.86,IGKJ2,0.92,DIVMTQSPDSLAMSLGERVTLNCKAS,ENVVSY,VSWYQQKPGQSPKLLIY,GAS,NRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHC,GQSYNYPYT,FGQGTKLEIK,2,Phase-II,DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK,yes,2
451,Figitumumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23D,0.94,IGHJ6,1,EVQLLESGGGLVQPGGSLRLSCTAS,GFTFSSYA,MNWVRQAPGKGLEWVSA,ISGSGGTT,FYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYC,AKDLGWSDSYYYYYGMDV,WGQGTTVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCTASGFTFSSYAMNWVRQAPGKGLEWVSAISGSGGTTFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSYYYYYGMDVWGQGTTVTVSS,yes,2
452,Figitumumab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.96,IGKJ2,0.83,DIQMTQFPSSLSASVGDRVTITCRAS,QGIRND,LGWYQQKPGKAPKRLIY,AAS,RLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,LQHNSYPCS,FGQGTKLEIK,2,Phase-I,DIQMTQFPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASRLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPCSFGQGTKLEIK,yes,2
453,Firivumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.87,IGHJ5,1,QVQLVQSGAEVKMPGSSVKVSCKTS,GVFFSSHA,ISWVRQAPGQGLEWMGG,ISPMFGTT,HYAQKFQGRVTITADQSTTTAYMELTSLTSEDTAVYYC,ARDGAGSYYPLNWFDP,WGQGTLVTVSS,2,Preclinical,QVQLVQSGAEVKMPGSSVKVSCKTSGVFFSSHAISWVRQAPGQGLEWMGGISPMFGTTHYAQKFQGRVTITADQSTTTAYMELTSLTSEDTAVYYCARDGAGSYYPLNWFDPWGQGTLVTVSS,yes,2
454,Firivumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.84,IGKJ3,0.83,EIVLTQSPATLSLSPGERATLSCRAS,ENIWNN,LAWYQQKPGQAPRLLIS,GAS,TGATGVPSRFRGSGSRTEFTLTISSLQSEDFAIYFC,QQYNSWPRT,FGPGTKVEIK,2,Preclinical,EIVLTQSPATLSLSPGERATLSCRASENIWNNLAWYQQKPGQAPRLLISGASTGATGVPSRFRGSGSRTEFTLTISSLQSEDFAIYFCQQYNSWPRTFGPGTKVEIK,yes,2
457,Flanvotumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV7-4-1,0.95,IGHJ4,0.93,QVQLVQSGSELKKPGASVKISCKAS,GYTFTSYA,MNWVRQAPGQGLESMGW,INTNTGNP,TYAQGFTGRFVFSMDTSVSTAYLQISSLKAEDTAIYYC,APRYSSSWYLDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGSELKKPGASVKISCKASGYTFTSYAMNWVRQAPGQGLESMGWINTNTGNPTYAQGFTGRFVFSMDTSVSTAYLQISSLKAEDTAIYYCAPRYSSSWYLDYWGQGTLVTVSS,yes,2
458,Flanvotumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ2,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWLMYT,FGQGTKLEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWLMYTFGQGTKLEIK,yes,2
459,Fletikumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-3,0.89,IGHJ6,1,QVQLVQSGAEVKRPGASVKVSCKAS,GYTFTNDI,IHWVRQAPGQRLEWMGW,INAGYGNT,QYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYC,AREPLWFGESSPHDYYGMDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS,yes,2
460,Fletikumab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,1,IGKJ4,1,AIQLTQSPSSLSASVGDRVTITCRAS,QGISSA,LAWYQQKPGKAPKLLIY,DAS,SLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFNSYPLT,FGGGTKVEIK,2,Phase-II,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,yes,2
461,Flotetuzumab,Bispecific_scFv_with_Crossover,heavy_sequence,undefined,human,IGHV1-46,0.84,IGHJ4,0.93,EVQLVQSGAELKKPGASVKVSCKAS,GYTFTDYY,MKWVRQAPGQGLEWIGD,IIPSNGAT,FYNQKFKGRVTITVDKSTSTAYMELSSLRSEDTAVYYC,ARSHLLRASWFAY,WGQGTLVTVSS,4,Phase-I/II,EVQLVQSGAELKKPGASVKVSCKASGYTFTDYYMKWVRQAPGQGLEWIGDIIPSNGATFYNQKFKGRVTITVDKSTSTAYMELSSLRSEDTAVYYCARSHLLRASWFAYWGQGTLVTVSS,yes,4
462,Flotetuzumab,Bispecific_scFv_with_Crossover,light_sequence,IgK,mouse,IGKV8-19,0.91,IGKJ2,0.92,DFVMTQSPDSLAVSLGERVTMSCKSS,QSLLNSGNQKNY,LTWYQQKPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QNDYSYPYT,FGQGTKLEIK,4,Phase-I/II,DFVMTQSPDSLAVSLGERVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK,yes,4
463,Flotetuzumab,Bispecific_scFv_with_Crossover,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.89,IGHJ3,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSTYA,MNWVRQAPGKGLEWVGR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,VRHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKDRFTISRDDSKNSLYLQMNSLKTEDTAVYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
464,Flotetuzumab,Bispecific_scFv_with_Crossover,light_sequence_bispec,IgL,mouse,IGLV1,0.81,IGLJ1,1,QAVVTQEPSLTVSPGGTVTLTCRSS,TGAVTTSNY,ANWVQQKPGQAPRGLIG,GTN,KRAPWTPARFSGSLLGGKAALTITGAQAEDEADYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-I/II,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWVQQKPGQAPRGLIGGTNKRAPWTPARFSGSLLGGKAALTITGAQAEDEADYYCALWYSNLWVFGGGTKLTVL,yes,4
467,Foralumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.96,IGHJ2,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFKFSGYG,MHWVRQAPGKGLEWVAV,IWYDGSKK,YYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARQMGYWHFDL,WGRGTLVTVSS,2,Phase-I/II,QVQLVESGGGVVQPGRSLRLSCAASGFKFSGYGMHWVRQAPGKGLEWVAVIWYDGSKKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGYWHFDLWGRGTLVTVSS,yes,2
468,Foralumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ4,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPLT,FGGGTKVEIK,2,Phase-I/II,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPLTFGGGTKVEIK,yes,2
469,Foravirumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.96,IGHJ4,1,QVQLVESGGGAVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,ILYDGSDK,FYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKVAVAGTHFDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGAVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVILYDGSDKFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKVAVAGTHFDYWGQGTLVTVSS,yes,2
470,Foravirumab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.96,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGIRND,LGWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQLNSYPPT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPPTFGGGTKVEIK,yes,2
471,Fremanezumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-7,0.85,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSNYW,ISWVRQAPGKGLEWVAE,IRSESDASAT,HYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,LAYFDYGLAIQNY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS,yes,2
472,Fremanezumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.86,IGKJ2,1,EIVLTQSPATLSLSPGERATLSCKAS,KRVTTY,VSWYQQKPGQAPRLLIY,GAS,NRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,SQSYNYPYT,FGQGTKLEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK,yes,2
473,Fresolimumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.89,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFSSNV,ISWVRQAPGQGLEWMGG,VIPIVDIA,NYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYC,ASTLGLVLDAMDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGSSVKVSCKASGYTFSSNVISWVRQAPGQGLEWMGGVIPIVDIANYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLVLDAMDYWGQGTLVTVSS,yes,2
474,Fresolimumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.95,IGKJ5,1,ETVLTQSPGTLSLSPGERATLSCRAS,QSLGSSY,LAWYQQKPGQAPRLLIY,GAS,SRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYADSPIT,FGQGTRLEIK,2,Phase-I,ETVLTQSPGTLSLSPGERATLSCRASQSLGSSYLAWYQQKPGQAPRLLIYGASSRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYADSPITFGQGTRLEIK,yes,2
477,Fulranumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-48,0.93,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTLRSYS,MNWVRQAPGKGLEWVSY,ISRSSHTI,FYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYC,ARVYSSGWHVSDYFDY,WGQGILVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSS,yes,2
478,Fulranumab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,1,IGKJ4,1,AIQLTQSPSSLSASVGDRVTITCRAS,QGISSA,LAWYQQKPGKAPKLLIY,DAS,SLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFNSYPLT,FGGGTKVEIK,2,Phase-III,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,yes,2
479,Futuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1S5,0.92,IGHJ4,1,EVQLQQPGSELVRPGASVKLSCKAS,GYTFTSYW,MHWVKQRPGQGLEWIGN,IYPGSRST,NYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYC,TRNGDYYVSSGDAMDY,WGQGTSVTVSS,2,Phase-II,EVQLQQPGSELVRPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSRSTNYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRNGDYYVSSGDAMDYWGQGTSVTVSS,yes,2
480,Futuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV10-96,0.91,IGKJ1,0.92,DIQMTQTTSSLSASLGDRVTISCRTS,QDIGNY,LNWYQQKPDGTVKLLIY,YTS,RLHSGVPSRFSGSGSGTDFSLTINNVEQEDVATYFC,QHYNTVPPT,FGGGTKLEIK,2,Phase-II,DIQMTQTTSSLSASLGDRVTISCRTSQDIGNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDFSLTINNVEQEDVATYFCQHYNTVPPTFGGGTKLEIK,yes,2
481,Galcanezumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.83,IGHJ4,0.86,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFGNYW,MQWVRQAPGQGLEWMGA,IYEGTGKT,VYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARLSDYVSGFGY,WGQGTTVTVSS,2,Approved,QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS,yes,2
482,Galcanezumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,KDISKY,LNWYQQKPGKAPKLLIY,YTS,GYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQGDALPPT,FGGGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK,yes,2
483,Galiximab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-38-2,0.89,IGHJ4,0.79,QVQLQESGPGLVKPSETLSLTCAVS,GGSISGGYG,WGWIRQPPGKGLEWIGS,FYSSSGNT,YYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYC,VRDRLFSVVGMVYNNWFDV,WGPGVLVTVSS,2,Phase-II,QVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSS,yes,2
484,Galiximab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.84,IGLJ3,0.83,ESALTQPPSVSGAPGQKVTISCTGS,TSNIGGYD,LHWYQQLPGTAPKLLIY,DIN,KRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYC,QSYDSSLNAQV,FGGGTRLTVL,2,Phase-II,ESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVL,yes,2
485,Gancotamab,scFv,heavy_sequence,undefined,human,IGHV3-23,0.95,IGHJ4,1,QVQLVESGGGLVQPGGSLRLSCAAS,GFTFRSYA,MSWVRQAPGKGLEWVSA,ISGRGDNT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKMTSNAFAFDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGLVQPGGSLRLSCAASGFTFRSYAMSWVRQAPGKGLEWVSAISGRGDNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMTSNAFAFDYWGQGTLVTVSS,yes,2
486,Gancotamab,scFv,light_sequence,IgL,human,IGLV1-40,0.97,IGLJ3,1,QSVLTQPPSVSGAPGQRVTISCTGS,SSNIGAGYG,VHWYQQLPGTAPKLLIY,GNT,NRPSGVPDRFSGFKSGTSASLAITGLQAEDEADYYC,QSYDSSLSGWV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGFKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL,yes,2
489,Gantenerumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.93,IGHJ4,0.93,QVELVESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSA,INASGTRT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARGKGNTHKPYGYVRYFDV,WGQGTLVTVSS,2,Phase-III,QVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSS,yes,2
490,Gantenerumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.91,IGKJ1,0.92,DIVLTQSPATLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GAS,SRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYC,LQIYNMPIT,FGQGTKVEIK,2,Phase-III,DIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIK,yes,2
491,Garadacimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23D,0.88,IGHJ6,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSKYI,MQWVRQAPGKGLEWVSG,IDIPTKGT,VYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARALPRSGYLISPHYYYYALDV,WGQGTTVTVSS,2,Phase-III,EVQLLESGGGLVQPGGSLRLSCAASGFTFSKYIMQWVRQAPGKGLEWVSGIDIPTKGTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARALPRSGYLISPHYYYYALDVWGQGTTVTVSS,yes,2
492,Garadacimab,Whole_mAb,light_sequence,IgL,human,IGLV1-47,0.99,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGRNY,VYWYQQLPGTAPKLLIY,SNN,QRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,AAWDASLRGV,FGGGTKLTVL,2,Phase-III,QSVLTQPPSASGTPGQRVTISCSGSSSNIGRNYVYWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDASLRGVFGGGTKLTVL,yes,2
495,Garivulimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.84,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAVS,GFSLTSYG,VHWVRQAPGKGLEWVAV,IWAGGST,NYADSVKGRFTISKDTSKNTVYLQMNSLRAEDTAVYYC,AKPYGTSAMDY,WGQGTLVTVSS,2,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAVSGFSLTSYGVHWVRQAPGKGLEWVAVIWAGGSTNYADSVKGRFTISKDTSKNTVYLQMNSLRAEDTAVYYCAKPYGTSAMDYWGQGTLVTVSS,yes,2
496,Garivulimab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.85,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVGIV,VAWYQQKPGKAPKLLIY,WAS,IRHTGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,QQYSNYPLYT,FGQGTKVEIK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCKASQDVGIVVAWYQQKPGKAPKLLIYWASIRHTGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYSNYPLYTFGQGTKVEIK,yes,2
501,Gedivumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.89,IGHJ4,0.86,EVQLVESGGGVVQPGKSLRLSCAAS,GLTFSSYA,VHWVRQAPGKGLEWVTL,ISYDGANQ,YYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTAVYYC,AVPGPVFGIFPPWSYFDN,WGQGILVTVSS,2,Phase-II,EVQLVESGGGVVQPGKSLRLSCAASGLTFSSYAVHWVRQAPGKGLEWVTLISYDGANQYYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTAVYYCAVPGPVFGIFPPWSYFDNWGQGILVTVSS,yes,2
502,Gedivumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.89,IGKJ4,1,EIVLTQSPATLSVSPGERATLSCRAS,QVISHN,LAWYQQKPGQAPRLLIY,GAS,TRASGIPARFSGSGSGTDYTLTITSLQSEDFAVYYC,QHYSNWPPRLT,FGGGTKVEIK,2,Phase-II,EIVLTQSPATLSVSPGERATLSCRASQVISHNLAWYQQKPGQAPRLLIYGASTRASGIPARFSGSGSGTDYTLTITSLQSEDFAVYYCQHYSNWPPRLTFGGGTKVEIK,yes,2
505,Geptanolimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV7-4-1,0.86,IGHJ4,1,QIQLVQSGSELKKPGASVKVSCKAS,GYTFTNFG,MNWVRQAPGQGLKWMGW,ISGYTREP,TYAADFKGRFVISLDTSVSTAYLQISSLKAEDTAVYYC,ARDVFDY,WGQGTLVTVSS,2,Preregistration,QIQLVQSGSELKKPGASVKVSCKASGYTFTNFGMNWVRQAPGQGLKWMGWISGYTREPTYAADFKGRFVISLDTSVSTAYLQISSLKAEDTAVYYCARDVFDYWGQGTLVTVSS,yes,2
506,Geptanolimab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-5,0.9,IGKJ1,0.83,DIVLTQSPASLAVSPGQRATITCRAS,ESVDNYGYSF,MNWFQQKPGQPPKLLIY,RAS,NLESGVPARFSGSGSRTDFTLTINPVEADDTANYYC,QQSNADPT,FGQGTKLEIK,2,Preregistration,DIVLTQSPASLAVSPGQRATITCRASESVDNYGYSFMNWFQQKPGQPPKLLIYRASNLESGVPARFSGSGSRTDFTLTINPVEADDTANYYCQQSNADPTFGQGTKLEIK,yes,2
507,Gevokizumab,Whole_mAb,heavy_sequence,IgG2,mouse,IGHV8-8,0.82,IGHJ3,0.79,QVQLQESGPGLVKPSQTLSLTCSFS,GFSLSTSGMG,VGWIRQPSGKGLEWLAH,IWWDGDE,SYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFC,ARNRYDPPWFVD,WGQGTLVTVSS,2,Phase-III,QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS,yes,2
508,Gevokizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV10-96,0.85,IGKJ1,0.92,DIQMTQSTSSLSASVGDRVTITCRAS,QDISNY,LSWYQQKPGKAVKLLIY,YTS,KLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFC,LQGKMLPWT,FGQGTKLEIK,2,Phase-III,DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK,yes,2
509,Giloralimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-59,0.9,IGHJ4,0.86,EVQLQESGPGLVKPSETLSLTCTVS,GYSITSNYY,WNWIRQPPGKGLEWMGY,IRYDGSN,NYNPSLKNRVTISRDTSKNQFSLKLSSVTAADTAVYYC,ARLDY,WGQGTTVTVSS,2,Phase-I,EVQLQESGPGLVKPSETLSLTCTVSGYSITSNYYWNWIRQPPGKGLEWMGYIRYDGSNNYNPSLKNRVTISRDTSKNQFSLKLSSVTAADTAVYYCARLDYWGQGTTVTVSS,yes,2
510,Giloralimab,Whole_mAb,light_sequence,IgK,mouse,IGKV1-122,0.89,IGKJ4,0.92,DIVMTQTPLSLSVTPGQPASISCRSS,QSLENTNGNTF,LNWYLQKPGQSPQLLIY,RVS,NRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,LQVTHVPFT,FGQGTKLEIK,2,Phase-I,DIVMTQTPLSLSVTPGQPASISCRSSQSLENTNGNTFLNWYLQKPGQSPQLLIYRVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQVTHVPFTFGQGTKLEIK,yes,2
511,Gimsilumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-74,0.85,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSRHW,MHWLRQVPGKGPVWVSR,INGAGTSI,TYADSVRGRFTISRDNANNTLFLQMNSLRADDTALYFC,ARANSVWFRGLFDY,WGQGTPVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMHWLRQVPGKGPVWVSRINGAGTSITYADSVRGRFTISRDNANNTLFLQMNSLRADDTALYFCARANSVWFRGLFDYWGQGTPVTVSS,yes,2
512,Gimsilumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.9,IGKJ2,0.92,EIVLTQSPVTLSVSPGERVTLSCRAS,QSVSTN,LAWYQQKLGQGPRLLIY,GAS,TRATDIPARFSGSGSETEFTLTISSLQSEDFAVYYC,QQYDKWPDT,FGQGTKLEIK,2,Phase-I,EIVLTQSPVTLSVSPGERVTLSCRASQSVSTNLAWYQQKLGQGPRLLIYGASTRATDIPARFSGSGSETEFTLTISSLQSEDFAVYYCQQYDKWPDTFGQGTKLEIK,yes,2
513,Girentuximab,Whole_mAb_Radiolabelled,heavy_sequence,IgG1,mouse,IGHV5-6-2,0.95,IGHJ4,1,DVKLVESGGGLVKLGGSLKLSCAAS,GFTFSNYY,MSWVRQTPEKRLELVAA,INSDGGIT,YYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYC,ARHRSGYFSMDY,WGQGTSVTVSS,2,Phase-III,DVKLVESGGGLVKLGGSLKLSCAASGFTFSNYYMSWVRQTPEKRLELVAAINSDGGITYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSGYFSMDYWGQGTSVTVSS,yes,2
514,Girentuximab,Whole_mAb_Radiolabelled,light_sequence,IgK,mouse,IGKV6-13,0.95,IGKJ1,1,DIVMTQSQRFMSTTVGDRVSITCKAS,QNVVSA,VAWYQQKPGQSPKLLIY,SAS,NRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFC,QQYSNYPWT,FGGGTKLEIK,2,Phase-III,DIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIK,yes,2
515,Glembatumumab,Whole_mAb_ADC,heavy_sequence,IgG2,human,IGHV4-31,0.95,IGHJ4,1,QVQLQESGPGLVKPSQTLSLTCTVS,GGSISSFNYY,WSWIRHHPGKGLEWIGY,IYYSGST,YSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYC,ARGYNWNYFDY,WGQGTLVTVSS,2,Phase-III,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS,yes,2
516,Glembatumumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-15,0.97,IGKJ1,1,EIVMTQSPATLSVSPGERATLSCRAS,QSVDNN,LVWYQQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQYNNWPPWT,FGQGTKVEIK,2,Phase-III,EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK,yes,2
523,Golimumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.95,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFIFSSYA,MHWVRQAPGNGLEWVAF,MSYDGSNK,KYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDRGIAAGGNYYYYGMDV,WGQGTTVTVSS,2,Approved,QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSS,yes,2
524,Golimumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ3,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVYSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPFT,FGPGTKVDIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,yes,2
525,Gomiliximab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-11,0.82,IGHJ5,0.86,EVQLVESGGGLAKPGGSLRLSCAAS,GFRFTFNNYY,MDWVRQAPGQGLEWVSR,ISSSGDPT,WYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYC,ASLTTGSDS,WGQGVLVTVSS,2,Phase-II,EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS,yes,2
526,Gomiliximab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDIRYY,LNWYQQKPGKAPKLLIY,VAS,SLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYC,LQVYSTPRT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK,yes,2
527,Gontivimab,Bispecific_Single_Domains_(VH-VH'-VH),heavy_sequence,undefined,human,IGHV3-23,0.65,IGHJ4,0.79,DVQLVESGGGLVQAGGSLSISCAAS,GGSLSNYV,LGWFRQAPGKEREFVAA,INWRGDIT,IGPPNVEGRFTISRDNAKNTGYLQMNSLAPDDTAVYYC,GAGTPLNPGAYIYDWSYDY,WGRGTQVTVSS,2,Phase-II,DVQLVESGGGLVQAGGSLSISCAASGGSLSNYVLGWFRQAPGKEREFVAAINWRGDITIGPPNVEGRFTISRDNAKNTGYLQMNSLAPDDTAVYYCGAGTPLNPGAYIYDWSYDYWGRGTQVTVSS,yes,2
528,Gontivimab,Bispecific_Single_Domains_(VH-VH'-VH),heavy_sequence_bispec,undefined,human,IGHV3-23,0.66,IGHJ4,0.79,EVQLVESGGGLVQAGGSLSISCAAS,GGSLSNYV,LGWFRQAPGKEREFVAA,INWRGDIT,IGPPNVEGRFTISRDNAKNTGYLQMNSLAPDDTAVYYC,GAGTPLNPGAYIYDWSYDY,WGRGTQVTVSS,2,Phase-II,EVQLVESGGGLVQAGGSLSISCAASGGSLSNYVLGWFRQAPGKEREFVAAINWRGDITIGPPNVEGRFTISRDNAKNTGYLQMNSLAPDDTAVYYCGAGTPLNPGAYIYDWSYDYWGRGTQVTVSS,yes,2
535,Grisnilimab,Whole_mAb,heavy_sequence,IgG2a,mouse,IGHV9-3-1,0.98,IGHJ2,1,QIQLVQSGPELKKPGETVKISCKAS,GYTFTNYG,MNWVKQAPGKGLMWLGW,INTYTGEP,TYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFC,ARWAYFYGSSPYFFDY,WGQGTTLTVSS,2,Phase-I/II,QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLMWLGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARWAYFYGSSPYFFDYWGQGTTLTVSS,yes,2
536,Grisnilimab,Whole_mAb,light_sequence,IgL,mouse,IGLV1,0.99,IGLJ1,0.92,QAVVTQESALTTSPGETVTLTCRSS,TGAVTTSNY,ANWVQEKPDHLFTGLIG,GTN,NRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFC,ALWCSNHLV,FGGGTKLTVL,2,Phase-I/II,QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWCSNHLVFGGGTKLTVL,yes,2
537,Guselkumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.94,IGHJ4,0.93,EVQLVQSGAEVKKPGESLKISCKGS,GYSFSNYW,IGWVRQMPGKGLEWMGI,IDPSNSYT,RYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYC,ARWYYKPFDV,WGQGTLVTVSS,2,Approved,EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS,yes,2
538,Guselkumab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.94,IGLJ3,1,QSVLTQPPSVSGAPGQRVTISCTGS,SSNIGSGYD,VHWYQQLPGTAPKLLIY,GNS,KRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYC,ASWTDGLSLVV,FGGGTKLTVL,2,Approved,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL,yes,2
539,Ianalumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV6-1,0.95,IGHJ5,1,QVQLQQSGPGLVKPSQTLSLTCAIS,GDSVSSNSAA,WGWIRQSPGRGLEWLGR,IYYRSKWYN,SYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYC,ARYQWVPKIGVFDS,WGQGTLVTVSS,2,Phase-II/III,QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWGWIRQSPGRGLEWLGRIYYRSKWYNSYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARYQWVPKIGVFDSWGQGTLVTVSS,yes,2
540,Ianalumab,Whole_mAb,light_sequence,IgK,human,IGKV3D-7,0.87,IGKJ1,0.92,DIVLTQSPATLSLSPGERATLSCRAS,QFILPEY,LSWYQQKPGQAPRLLIY,GSS,SRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQFYSSPLT,FGQGTKVEIK,2,Phase-II/III,DIVLTQSPATLSLSPGERATLSCRASQFILPEYLSWYQQKPGQAPRLLIYGSSSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQFYSSPLTFGQGTKVEIK,yes,2
541,Ibalizumab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV1S12,0.81,IGHJ3,0.93,QVQLQQSGPEVVKPGASVKMSCKAS,GYTFTSYV,IHWVRQKPGQGLDWIGY,INPYNDGT,DYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYC,AREKDNYATGAWFAY,WGQGTLVTVSS,2,Approved,QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS,yes,2
542,Ibalizumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.93,IGKJ4,0.83,DIVMTQSPDSLAVSLGERVTMNCKSS,QSLLYSTNQKNY,LAWYQQKPGQSPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYC,QQYYSYRT,FGGGTKLEIK,2,Approved,DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK,yes,2
545,Icrucumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.94,IGHJ6,0.93,QAQVVESGGGVVQSGRSLRLSCAAS,GFAFSSYG,MHWVRQAPGKGLEWVAV,IWYDGSNK,YYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYC,ARDHYGSGVHHYFYYGLDV,WGQGTTVTVSS,2,Phase-II,QAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSS,yes,2
546,Icrucumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.99,IGKJ4,1,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSSPLT,FGGGTKVEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK,yes,2
547,Idactamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-34,0.97,IGHJ4,1,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSGYY,WSWIRQPPGKGLEWIGE,IHHSGGA,NYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARGQGKNWHYDYFDY,WGQGTLVTVSS,2,Phase-I,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEIHHSGGANYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGQGKNWHYDYFDYWGQGTLVTVSS,yes,2
548,Idactamab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.95,IGKJ1,0.92,DIQMTQSPSTLSASVGDRVTITCRAS,QSIRSW,LAWYQQKPGKAPKLLIY,KAS,ILKIGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,QQYYSYSRT,FGQGTKVEIK,2,Phase-I,DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASILKIGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYYSYSRTFGQGTKVEIK,yes,2
549,Idarucizumab,Fab,heavy_sequence,IgG1,human,IGHV4-4,0.81,IGHJ4,0.93,QVQLQESGPGLVKPSETLSLTCTVS,GFSLTSYI,VDWIRQPPGKGLEWIGV,IWAGGST,GYNSALRSRVSITKDTSKNQFSLKLSSVTAADTAVYYC,ASAAYYSYYNYDGFAY,WGQGTLVTVSS,2,Approved,QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYIVDWIRQPPGKGLEWIGVIWAGGSTGYNSALRSRVSITKDTSKNQFSLKLSSVTAADTAVYYCASAAYYSYYNYDGFAYWGQGTLVTVSS,yes,2
550,Idarucizumab,Fab,light_sequence,IgK,human,IGKV2-30,0.89,IGKJ4,0.92,DVVMTQSPLSLPVTLGQPASISCKSS,QSLLYTDGKTY,LYWFLQRPGQSPRRLIY,LVS,KLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,LQSTHFPHT,FGGGTKVEIK,2,Approved,DVVMTQSPLSLPVTLGQPASISCKSSQSLLYTDGKTYLYWFLQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQSTHFPHTFGGGTKVEIK,yes,2
553,Ifabotuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.92,IGHJ5,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTGYW,MNWVRQAPGQGLEWMGD,IYPGSGNT,NYDEKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYC,ARGGYYEDFDS,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYWMNWVRQAPGQGLEWMGDIYPGSGNTNYDEKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGYYEDFDSWGQGTTVTVSS,yes,2
554,Ifabotuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.92,IGKJ2,1,DIQMTQSPSFLSASVGDRVTITCRAS,QGIISY,LAWYQQKPEKAPKRLIY,AAS,SLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,GQYANYPYT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSFLSASVGDRVTITCRASQGIISYLAWYQQKPEKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCGQYANYPYTFGQGTKLEIK,yes,2
555,Iladatuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-48,0.18,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAA,SGYTFSS,YWIEWVRQAPGKGLEWI,GEILPGGG,DTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVY,YCTRRVPIRLDY,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,yes,2
556,Iladatuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ1,0.92,DIQLTQSPSSLSASVGDRVTITCKAS,QSVDYEGDSF,LNWYQQKPGKAPKLLIY,AAS,NLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSNEDPLT,FGQGTKVEIK,2,Phase-I,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK,yes,2
557,Imalumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.92,IGHJ6,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSIYS,MNWVRQAPGKGLEWVSS,IGSSGGTT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AGSQWLYGMDV,WGQGTTVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYSMNWVRQAPGKGLEWVSSIGSSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAGSQWLYGMDVWGQGTTVTVSS,yes,2
558,Imalumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.86,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCRSS,QRIMTY,LNWYQQKPGKAPKLLIF,VAS,HSQSGVPSRFRGSGSETDFTLTISGLQPEDSATYYC,QQSFWTPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRSSQRIMTYLNWYQQKPGKAPKLLIFVASHSQSGVPSRFRGSGSETDFTLTISGLQPEDSATYYCQQSFWTPLTFGGGTKVEIK,yes,2
559,Imaprelimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV2-26,0.79,IGHJ4,0.93,QVTLKESGPVLVKPTETLTLTCTVS,GFSLTSNA,VSWVRQPPGKALEWIAA,ISSGGTT,YYNSAFKSRLTISRDTSKSQVVLTMTNMDPVDTATYYC,ARRYGYGWYFDF,WGQGTLVTVSS,2,Phase-I,QVTLKESGPVLVKPTETLTLTCTVSGFSLTSNAVSWVRQPPGKALEWIAAISSGGTTYYNSAFKSRLTISRDTSKSQVVLTMTNMDPVDTATYYCARRYGYGWYFDFWGQGTLVTVSS,yes,2
560,Imaprelimab,Whole_mAb,light_sequence,IgK,human,IGKV1-16,0.85,IGKJ2,1,DIQMTQSPSSLSASVGDRVTINCKAS,QNIYNS,LAWYQQKPGKAPKVLIF,"NAN",SLQTGIPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFYSGYT,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTINCKASQNIYNSLAWYQQKPGKAPKVLIFNANSLQTGIPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYSGYTFGQGTKLEIK,yes,2
561,Imdevimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.96,IGHJ4,0.86,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSNYA,MYWVRQAPGKGLEWVAV,ISYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYC,ASGSDYGDYLLVY,WGQGTLVTVSS,2,Approved,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCASGSDYGDYLLVYWGQGTLVTVSS,yes,2
562,Imdevimab,Whole_mAb,light_sequence,IgL,human,IGLV2-14,0.96,IGLJ3,1,QSALTQPASVSGSPGQSITISCTGT,SSDVGGYNY,VSWYQQHPGKAPKLMIY,DVS,KRPSGVSNRFSGSKSGNTASLTISGLQSEDEADYYC,NSLTSISTWV,FGGGTKLTVL,2,Approved,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQSEDEADYYCNSLTSISTWVFGGGTKLTVL,yes,2
563,Imgatuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.87,IGHJ6,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GFTFTDYK,IHWVRQAPGQGLEWMGY,FNPNSGYS,TYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARLSPGGYYVMDA,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGFTFTDYKIHWVRQAPGQGLEWMGYFNPNSGYSTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSPGGYYVMDAWGQGTTVTVSS,yes,2
564,Imgatuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.91,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGINNY,LNWYQQKPGKAPKRLIY,NTN,NLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,LQHNSFPT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGINNYLNWYQQKPGKAPKRLIYNTNNLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSFPTFGQGTKLEIK,yes,2
567,Inclacumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-13,0.95,IGHJ5,1,EVQLVESGGGLVRPGGSLRLSCAAS,GFTFSNYD,MHWVRQATGKGLEWVSA,ITAAGDI,YYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYC,ARGRYSGSGSYYNDWFDP,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSS,yes,2
568,Inclacumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ4,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPLT,FGGGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK,yes,2
569,Indatuximab,Whole_mAb_ADC,heavy_sequence,IgG4,mouse,IGHV1-9,0.87,IGHJ4,1,QVQLQQSGSELMMPGASVKISCKAT,GYTFSNYW,IEWVKQRPGHGLEWIGE,ILPGTGRT,IYNEKFKGKATFTADISSNTVQMQLSSLTSEDSAVYYC,ARRDYYGNFYYAMDY,WGQGTSVTVSS,2,Phase-II,QVQLQQSGSELMMPGASVKISCKATGYTFSNYWIEWVKQRPGHGLEWIGEILPGTGRTIYNEKFKGKATFTADISSNTVQMQLSSLTSEDSAVYYCARRDYYGNFYYAMDYWGQGTSVTVSS,yes,2
570,Indatuximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV10-94,0.93,IGKJ1,0.92,DIQMTQSTSSLSASLGDRVTISCSAS,QGINNY,LNWYQQKPDGTVELLIY,YTS,TLQSGVPSRFSGSGSGTDYSLTISNLEPEDIGTYYC,QQYSKLPRT,FGGGTKLEIK,2,Phase-II,DIQMTQSTSSLSASLGDRVTISCSASQGINNYLNWYQQKPDGTVELLIYYTSTLQSGVPSRFSGSGSGTDYSLTISNLEPEDIGTYYCQQYSKLPRTFGGGTKLEIK,yes,2
571,Indusatumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV4-34,0.95,IGHJ4,0.93,QVQLQQWGAGLLKPSETLSLTCAVF,GGSFSGYY,WSWIRQPPGKGLEWIGE,INHRGNT,NDNPSLKSRVTISVDTSKNQFALKLSSVTAADTAVYYC,ARERGYTYGNFDH,WGQGTLVTVSS,2,Phase-II,QVQLQQWGAGLLKPSETLSLTCAVFGGSFSGYYWSWIRQPPGKGLEWIGEINHRGNTNDNPSLKSRVTISVDTSKNQFALKLSSVTAADTAVYYCARERGYTYGNFDHWGQGTLVTVSS,yes,2
572,Indusatumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-15,0.97,IGKJ1,0.83,EIVMTQSPATLSVSPGERATLSCRAS,QSVSRN,LAWYQQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTIGSLQSEDFAVYYC,QQYKTWPRT,FGQGTNVEIK,2,Phase-II,EIVMTQSPATLSVSPGERATLSCRASQSVSRNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTIGSLQSEDFAVYYCQQYKTWPRTFGQGTNVEIK,yes,2
573,Inebilizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.82,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSSW,MNWVRQAPGKGLEWVGR,IYPGDGDT,NYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,ARSGFITTVRDFDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSWMNWVRQAPGKGLEWVGRIYPGDGDTNYNVKFKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITTVRDFDYWGQGTLVTVSS,yes,2
574,Inebilizumab,Whole_mAb,light_sequence,IgK,human,IGKV6-21,0.85,IGKJ4,0.92,EIVLTQSPDFQSVTPKEKVTITCRAS,ESVDTFGISF,MNWFQQKPDQSPKLLIH,EAS,NQGSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYC,QQSKEVPFT,FGGGTKVEIK,2,Approved,EIVLTQSPDFQSVTPKEKVTITCRASESVDTFGISFMNWFQQKPDQSPKLLIHEASNQGSGVPSRFSGSGSGTDFTLTINSLEAEDAATYYCQQSKEVPFTFGGGTKVEIK,yes,2
575,Infliximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV6-6,0.89,IGHJ2,0.93,EVKLEESGGGLVQPGGSMKLSCVAS,GFIFSNHW,MNWVRQSPEKGLEWVAE,IRSKSINSAT,HYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYC,SRNYYGSTYDY,WGQGTTLTVSS,2,Approved,EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS,yes,2
576,Infliximab,Whole_mAb,light_sequence,IgK,mouse,IGKV5-48,0.93,IGKJ4,0.83,DILLTQSPAILSVSPGERVSFSCRAS,QFVGSS,IHWYQQRTNGSPRLLIK,YAS,ESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYC,QQSHSWPFT,FGSGTNLEVK,2,Approved,DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK,yes,2
579,Intetumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.92,IGHJ3,1,QVQLVESGGGVVQPGRSRRLSCAAS,GFTFSRYT,MHWVRQAPGKGLEWVAV,ISFDGSNK,YYVDSVKGRFTISRDNSENTLYLQVNILRAEDTAVYYC,AREARGSYAFDI,WGQGTMVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSRRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAVISFDGSNKYYVDSVKGRFTISRDNSENTLYLQVNILRAEDTAVYYCAREARGSYAFDIWGQGTMVTVSS,yes,2
580,Intetumumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ3,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPFT,FGPGTKVDIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK,yes,2
583,Iratumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-34,0.94,IGHJ4,0.79,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSAYY,WSWIRQPPGKGLEWIGD,INHGGGT,NYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYC,ASLTAY,WGQGSLVTVSS,2,Phase-II,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSAYYWSWIRQPPGKGLEWIGDINHGGGTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCASLTAYWGQGSLVTVSS,yes,2
584,Iratumumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.97,IGKJ5,1,DIQMTQSPTSLSASVGDRVTITCRAS,QGISSW,LTWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYDSYPIT,FGQGTRLEIK,2,Phase-II,DIQMTQSPTSLSASVGDRVTITCRASQGISSWLTWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPITFGQGTRLEIK,yes,2
585,Isatuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-87,0.84,IGHJ4,0.93,QVQLVQSGAEVAKPGTSVKLSCKAS,GYTFTDYW,MQWVKQRPGQGLEWIGT,IYPGDGDT,GYAQKFQGKATLTADKSSKTVYMHLSSLASEDSAVYYC,ARGDYYGSNSLDY,WGQGTSVTVSS,2,Approved,QVQLVQSGAEVAKPGTSVKLSCKASGYTFTDYWMQWVKQRPGQGLEWIGTIYPGDGDTGYAQKFQGKATLTADKSSKTVYMHLSSLASEDSAVYYCARGDYYGSNSLDYWGQGTSVTVSS,yes,2
586,Isatuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-17,0.9,IGKJ2,1,DIVMTQSHLSMSTSLGDPVSITCKAS,QDVSTV,VAWYQQKPGQSPRRLIY,SAS,YRYIGVPDRFTGSGAGTDFTFTISSVQAEDLAVYYC,QQHYSPPYT,FGGGTKLEIK,2,Approved,DIVMTQSHLSMSTSLGDPVSITCKASQDVSTVVAWYQQKPGQSPRRLIYSASYRYIGVPDRFTGSGAGTDFTFTISSVQAEDLAVYYCQQHYSPPYTFGGGTKLEIK,yes,2
587,Iscalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.94,IGHJ4,0.93,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,ISYEESNR,YHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYC,ARDGGIAAPGPDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS,yes,2
588,Iscalimab,Whole_mAb,light_sequence,IgK,human,IGKV2D-28,0.95,IGKJ3,0.92,DIVMTQSPLSLTVTPGEPASISCRSS,QSLLYSNGYNY,LDWYLQKPGQSPQVLIS,LGS,NRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,MQARQTPFT,FGPGTKVDIR,2,Phase-II,DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR,yes,2
589,Isecarosmab,Bispecific_Single_Domains_(VH-VH'),heavy_sequence,undefined,human,IGHV3-23,0.79,IGHJ4,0.86,DVQLVESGGGVVQPGGSLRLSCAAS,GRTVSSYA,MGWFRQAPGKEREFVAG,ISRSAERT,YYVDSLKGRFTISRDNSKNTVYLQMNSLRPEDTALYYC,AADLDPNRIFSREEYAY,WGQGTLVTVSS,2,Phase-I,DVQLVESGGGVVQPGGSLRLSCAASGRTVSSYAMGWFRQAPGKEREFVAGISRSAERTYYVDSLKGRFTISRDNSKNTVYLQMNSLRPEDTALYYCAADLDPNRIFSREEYAYWGQGTLVTVSS,yes,2
590,Isecarosmab,Bispecific_Single_Domains_(VH-VH'),heavy_sequence_bispec,undefined,human,IGHV3-23,0.86,IGHJ4,0.64,EVQLVESGGGVVQPGNSLRLSCAAS,GFTFSSFG,MSWVRQAPGKGLEWVSS,ISGSGSDT,LYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTALYYC,TIGGSLSR,SSQGTLVTVSS,2,Phase-I,EVQLVESGGGVVQPGNSLRLSCAASGFTFSSFGMSWVRQAPGKGLEWVSSISGSGSDTLYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTALYYCTIGGSLSRSSQGTLVTVSS,yes,2
591,Istiratumab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ4,0.93,EVQLLQSGGGLVQPGGSLRLSCAAS,GFMFSRYP,MHWVRQAPGKGLEWVGS,ISGSGGAT,PYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKDFYQILTGNAFDY,WGQGTTVTVSS,4,Phase-II,EVQLLQSGGGLVQPGGSLRLSCAASGFMFSRYPMHWVRQAPGKGLEWVGSISGSGGATPYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDFYQILTGNAFDYWGQGTTVTVSS,yes,4
592,Istiratumab,Bispecific_Mixed_mAb_and_scFv,light_sequence,IgK,human,IGKV1-27,0.92,IGKJ4,1,DIQMTQSPSSLSASLGDRVTITCRAS,QGISSY,LAWYQQKPGKAPKLLIY,AKS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDSATYYC,QQYWTFPLT,FGGGTKVEIK,4,Phase-II,DIQMTQSPSSLSASLGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAKSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDSATYYCQQYWTFPLTFGGGTKVEIK,yes,4
593,Istiratumab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence_bispec,undefined,human,IGHV3-9,0.93,IGHJ4,1,QVQLVQSGGGLVQPGGSLRLSCAAS,GFTFDDYA,MHWVRQAPGKGLEWVAG,ISWDSGST,GYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYC,ARDLGAYQWVEGFDY,WGQGTLVTVSS,4,Phase-II,QVQLVQSGGGLVQPGGSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVAGISWDSGSTGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCARDLGAYQWVEGFDYWGQGTLVTVSS,yes,4
594,Istiratumab,Bispecific_Mixed_mAb_and_scFv,light_sequence_bispec,IgL,human,IGLV3-19,0.97,IGLJ3,0.92,SYELTQDPAVSVALGQTVRITCQGD,SLRSYY,ASWYQQKPGQAPVLVIY,GKN,NRPSGIPDRFSGSTSGNSASLTITGAQAEDEADYYC,NSRDSPGNQWV,FGGGTKVTVL,4,Phase-II,SYELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSTSGNSASLTITGAQAEDEADYYCNSRDSPGNQWVFGGGTKVTVL,yes,4
595,Itepekimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.89,IGHJ6,0.93,EVQLVESGGNLEQPGGSLRLSCTAS,GFTFSRSA,MNWVRRAPGKGLEWVSG,ISGSGGRT,YYADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAAYYC,AKDSYTTSWYGGMDV,WGHGTTVTVSS,2,Phase-III,EVQLVESGGNLEQPGGSLRLSCTASGFTFSRSAMNWVRRAPGKGLEWVSGISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLSAEDTAAYYCAKDSYTTSWYGGMDVWGHGTTVTVSS,yes,2
596,Itepekimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.98,IGKJ5,1,DIQMTQSPSSVSASVGDRVTITCRAS,QGIFSW,LAWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAIYYC,QQANSVPIT,FGQGTRLEIK,2,Phase-III,DIQMTQSPSSVSASVGDRVTITCRASQGIFSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAIYYCQQANSVPITFGQGTRLEIK,yes,2
597,Itolizumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV5-9-3,0.94,IGHJ2,0.79,EVQLVESGGGLVKPGGSLKLSCAAS,GFKFSRYA,MSWVRQAPGKRLEWVAT,ISSGGSYI,YYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYC,ARRDYDLDYFDS,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS,yes,2
598,Itolizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV14-126,0.89,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,RDIRSY,LTWYQQKPGKAPKTLIY,YAT,SLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYC,LQHGESPFT,LGSGTKLEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK,yes,2
599,Ivuxolimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-48,0.99,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYS,MNWVRQAPGKGLEWVSY,ISSSSSTI,DYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYC,ARESGWYLFDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIDYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARESGWYLFDYWGQGTLVTVSS,yes,2
600,Ivuxolimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,1,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNSYPPT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGGGTKVEIK,yes,2
607,Labetuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV4-1,0.79,IGHJ3,0.86,EVQLVESGGGVVQPGRSLRLSCSAS,GFDFTTYW,MSWVRQAPGKGLEWIGE,IHPDSSTI,NYAPSLKDRFTISRDNAKNTLFLQMDSLRPEDTGVYFC,ASLYFGFPWFAY,WGQGTPVTVSS,2,Phase-II,EVQLVESGGGVVQPGRSLRLSCSASGFDFTTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDRFTISRDNAKNTLFLQMDSLRPEDTGVYFCASLYFGFPWFAYWGQGTPVTVSS,yes,2
608,Labetuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1-33,0.85,IGKJ1,0.83,DIQLTQSPSSLSASVGDRVTITCKAS,QDVGTS,VAWYQQKPGKAPKLLIY,WTS,TRHTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQYSLYRS,FGQGTKVEIK,2,Phase-II,DIQLTQSPSSLSASVGDRVTITCKASQDVGTSVAWYQQKPGKAPKLLIYWTSTRHTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYSLYRSFGQGTKVEIK,yes,2
609,Lacnotuzumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV3-2,0.86,IGHJ4,0.93,QVQLQESGPGLVKPSQTLSLTCTVS,DYSITSDYA,WNWIRQFPGKGLEWMGY,ISYSGST,SYNPSLKSRITISRDTSKNQFSLQLNSVTAADTAVYYC,ASFDYAHAMDY,WGQGTTVTVSS,2,Phase-II,QVQLQESGPGLVKPSQTLSLTCTVSDYSITSDYAWNWIRQFPGKGLEWMGYISYSGSTSYNPSLKSRITISRDTSKNQFSLQLNSVTAADTAVYYCASFDYAHAMDYWGQGTTVTVSS,yes,2
610,Lacnotuzumab,Whole_mAb,light_sequence,IgK,mouse,IGKV5-48,0.82,IGKJ1,0.92,DIVLTQSPAFLSVTPGEKVTFTCQAS,QSIGTS,IHWYQQKTDQAPKLLIK,YAS,ESISGIPSRFSGSGSGTDFTLTISSVEAEDAADYYC,QQINSWPTT,FGGGTKLEIK,2,Phase-II,DIVLTQSPAFLSVTPGEKVTFTCQASQSIGTSIHWYQQKTDQAPKLLIKYASESISGIPSRFSGSGSGTDFTLTISSVEAEDAADYYCQQINSWPTTFGGGTKLEIK,yes,2
611,Lacutamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV7-4-1,0.85,IGHJ6,0.93,QIQLVQSGSELKKPGASVKVSCKAS,GYTFTTAG,MQWVRQAPGQGLEWIGW,INSHSGVP,KYAEDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYFC,ARGGDEGVMDY,WGQGTTVTVSS,2,Phase-II,QIQLVQSGSELKKPGASVKVSCKASGYTFTTAGMQWVRQAPGQGLEWIGWINSHSGVPKYAEDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYFCARGGDEGVMDYWGQGTTVTVSS,yes,2
612,Lacutamab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-25,0.87,IGKJ1,0.92,DIQMTQSPSFLSASVGDRVTITCKAS,QDVSTA,VAWYQQKPGQPPKLLIY,WTS,TRHTGVPDRFSGSGSGTDYTLTISSLQAEDVAVYYC,QQHYSTPWT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSFLSASVGDRVTITCKASQDVSTAVAWYQQKPGQPPKLLIYWTSTRHTGVPDRFSGSGSGTDYTLTISSLQAEDVAVYYCQQHYSTPWTFGGGTKVEIK,yes,2
615,Lambrolizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-2,0.8,IGHJ4,0.93,QVQLVQSGVEVKKPGASVKVSCKAS,GYTFTNYY,MYWVRQAPGQGLEWMGG,INPSNGGT,NFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYC,ARRDYRFDMGFDY,WGQGTTVTVSS,2,Approved,QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS,yes,2
616,Lambrolizumab,Whole_mAb,light_sequence,IgK,human,IGKV3D-11,0.86,IGKJ4,1,EIVLTQSPATLSLSPGERATLSCRAS,KGVSTSGYSY,LHWYQQKPGQAPRLLIY,LAS,YLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QHSRDLPLT,FGGGTKVEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK,yes,2
617,Lampalizumab,Fab,heavy_sequence,IgG1,human,IGHV7-4-1,0.89,IGHJ4,0.79,EVQLVQSGPELKKPGASVKVSCKAS,GYTFTNYG,MNWVRQAPGQGLEWMGW,INTYTGET,TYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYC,EREGGVNN,WGQGTLVTVSS,2,Phase-III,EVQLVQSGPELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGETTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCEREGGVNNWGQGTLVTVSS,yes,2
618,Lampalizumab,Fab,light_sequence,IgK,human,IGKV1D-39,0.78,IGKJ1,0.92,DIQVTQSPSSLSASVGDRVTITCITS,TDIDDD,MNWYQQKPGKVPKLLIS,GGN,TLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYC,LQSDSLPYT,FGQGTKVEIK,2,Phase-III,DIQVTQSPSSLSASVGDRVTITCITSTDIDDDMNWYQQKPGKVPKLLISGGNTLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCLQSDSLPYTFGQGTKVEIK,yes,2
621,Landogrozumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.9,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GLTFSRYP,MSWVRQAPGKGLVWVSA,ITSSGGST,YYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYC,ARLPDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGLTFSRYPMSWVRQAPGKGLVWVSAITSSGGSTYYSDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARLPDYWGQGTLVTVSS,yes,2
622,Landogrozumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.87,IGKJ4,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,SSVSSSY,LHWYQQKPGQAPRLLIY,STS,NLVAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QHHSGYHFT,FGGGTKVEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASSSVSSSYLHWYQQKPGQAPRLLIYSTSNLVAGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHHSGYHFTFGGGTKVEIK,yes,2
623,Laprituximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-87,0.89,IGHJ4,0.93,QVQLVQSGAEVAKPGASVKLSCKAS,GYTFTSYW,MQWVKQRPGQGLECIGT,IYPGDGDT,TYTQKFQGKATLTADKSSSTAYMQLSSLRSEDSAVYYC,ARYDAPGYAMDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVAKPGASVKLSCKASGYTFTSYWMQWVKQRPGQGLECIGTIYPGDGDTTYTQKFQGKATLTADKSSSTAYMQLSSLRSEDSAVYYCARYDAPGYAMDYWGQGTLVTVSS,yes,2
624,Laprituximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV19-93,0.9,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDINNY,LAWYQHKPGKGPKLLIH,YTS,TLHPGIPSRFSGSGSGRDYSFSISSLEPEDIATYYC,LQYDNLLYT,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQDINNYLAWYQHKPGKGPKLLIHYTSTLHPGIPSRFSGSGSGRDYSFSISSLEPEDIATYYCLQYDNLLYTFGQGTKLEIK,yes,2
625,Larcaviximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-42,0.86,IGHJ3,1,EVQLQESGPELEMPGASVKISCKAS,GSSFTGFS,MNWVKQSNGKSLEWIGN,IDTYYGGT,TYNQKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYC,ARSAYYGSTFAY,WGQGTLVTVSA,2,Phase-II,EVQLQESGPELEMPGASVKISCKASGSSFTGFSMNWVKQSNGKSLEWIGNIDTYYGGTTYNQKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSAYYGSTFAYWGQGTLVTVSA,yes,2
626,Larcaviximab,Whole_mAb,light_sequence,IgK,mouse,IGKV12-44,0.97,IGKJ4,0.92,DIQMTQSPASLSASVGETVTITCRAS,ENIYSY,LAWYQQKQGKSPQLLVY,"NAK",TLIEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYFC,QHHFGTPFT,FGSGTELEIK,2,Phase-II,DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLIEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYFCQHHFGTPFTFGSGTELEIK,yes,2
629,Lebrikizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV2-70,0.8,IGHJ4,0.79,QVTLRESGPALVKPTQTLTLTCTVS,GFSLSAYS,VNWIRQPPGKALEWLAM,IWGDGKI,VYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYC,AGDGYYPYAMDN,WGQGSLVTVSS,2,Phase-III,QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS,yes,2
630,Lebrikizumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.81,IGKJ4,0.92,DIVMTQSPDSLSVSLGERATINCRAS,KSVDSYGNSF,MHWYQQKPGQPPKLLIY,LAS,NLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQNNEDPRT,FGGGTKVEIK,2,Phase-III,DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK,yes,2
633,Lemzoparlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-15,0.92,IGHJ3,1,EVQLVESGGGLVKPGGSLRLSCAAS,GLTFERAW,MNWVRQAPGKGLEWVGR,IKRKTDGETT,DYAAPVKGRFSISRDDSKNTLYLQMNSLKTEDTAVYYC,AGSNRAFDI,WGQGTMVTVSS,2,Phase-I/II,EVQLVESGGGLVKPGGSLRLSCAASGLTFERAWMNWVRQAPGKGLEWVGRIKRKTDGETTDYAAPVKGRFSISRDDSKNTLYLQMNSLKTEDTAVYYCAGSNRAFDIWGQGTMVTVSS,yes,2
634,Lemzoparlimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.91,IGKJ4,0.83,DIVMTQSPDSLAVSLGERATINCKSS,QSVLYAGNNRNY,LAWYQQKPGQPPKLLIN,QAS,TRASGVPDRFSGSGSGTEFTLIISSLQAEDVAIYYC,QQYYTPPLA,FGGGTKLEIK,2,Phase-I/II,DIVMTQSPDSLAVSLGERATINCKSSQSVLYAGNNRNYLAWYQQKPGQPPKLLINQASTRASGVPDRFSGSGSGTEFTLIISSLQAEDVAIYYCQQYYTPPLAFGGGTKLEIK,yes,2
635,Lenvervimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-21,0.84,IGHJ6,0.93,EVQLVESGGGLVKPGGSLRLSCSAS,GFSLTKYK,MTWVRQAPGKGLEWVSS,ISSTSRDI,DYADSVKGRFTISRDNAKNSLFLQMSSLRVDDTAVYYC,TRDGWLWGWDVRSNYYYNALDV,WGQGTTVTVSS,2,Phase-III,EVQLVESGGGLVKPGGSLRLSCSASGFSLTKYKMTWVRQAPGKGLEWVSSISSTSRDIDYADSVKGRFTISRDNAKNSLFLQMSSLRVDDTAVYYCTRDGWLWGWDVRSNYYYNALDVWGQGTTVTVSS,yes,2
636,Lenvervimab,Whole_mAb,light_sequence,IgK,human,IGKV1-NL1,0.88,IGKJ2,0.92,DIVVTQSPSSLSASVGDRVTITCRAS,QGIYNS,IAWYQQKPGKAPKLLLY,STS,TLLSGVPSRFSGSGSGTDYTLTITNLQPEDFATYYC,QQYFVTPET,FGQGTKLEIK,2,Phase-III,DIVVTQSPSSLSASVGDRVTITCRASQGIYNSIAWYQQKPGKAPKLLLYSTSTLLSGVPSRFSGSGSGTDYTLTITNLQPEDFATYYCQQYFVTPETFGQGTKLEIK,yes,2
637,Lenzilumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.95,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYSFTNYY,IHWVRQAPGQRLEWMGW,INAGNGNT,KYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYC,VRRQRFPYYFDY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYSFTNYYIHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRFPYYFDYWGQGTLVTVSS,yes,2
638,Lenzilumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.86,IGKJ4,1,EIVLTQSPATLSVSPGERATLSCRAS,QSVGTN,VAWYQQKPGQAPRVLIY,STS,SRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQFNKSPLT,FGGGTKVEIK,2,Phase-III,EIVLTQSPATLSVSPGERATLSCRASQSVGTNVAWYQQKPGQAPRVLIYSTSSRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFNKSPLTFGGGTKVEIK,yes,2
643,Letaplimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-59,1,IGHJ4,0.79,QVQLQESGPGLVKPSETLSLTCTVS,GGSISSYY,WSWIRQPPGKGLEWIGY,IYYSGST,NYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARGKTGSAA,WGQGTLVTVSS,2,Phase-I/II,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGKTGSAAWGQGTLVTVSS,yes,2
644,Letaplimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.97,IGKJ4,0.92,DIQMTQSPSSVSASVGDRVTITCRAS,QGISRW,LAWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQTVSFPIT,FGGGTKVEIK,2,Phase-I/II,DIQMTQSPSSVSASVGDRVTITCRASQGISRWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTVSFPITFGGGTKVEIK,yes,2
645,Letolizumab,Single_Domain_Variable_Fragment;H,heavy_sequence,IgG1,human,IGHV3-23D,0.88,IGHJ4,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFNWEL,MGWARQAPGKGLEWVSG,IEGPGDVT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,VKVGKDAKSDY,RGQGTLVTVSS,1,Phase-I/II,EVQLLESGGGLVQPGGSLRLSCAASGFTFNWELMGWARQAPGKGLEWVSGIEGPGDVTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCVKVGKDAKSDYRGQGTLVTVSS,yes,1
646,Levilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.86,IGHJ4,0.86,QVQLVQSGGGLVQPGGSLRLSCAAS,GFTFSSYY,MSWVRQAPGKGLEWVSG,IYSDGTT,HYGDSVKGRFTISRDNAKNTVYLQLNSLRAEDTAMYYC,AKGAGPTWWYALDA,WGQGTLVTVSS,2,Approved,QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYYMSWVRQAPGKGLEWVSGIYSDGTTHYGDSVKGRFTISRDNAKNTVYLQLNSLRAEDTAMYYCAKGAGPTWWYALDAWGQGTLVTVSS,yes,2
647,Levilimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.79,IGKJ2,0.92,DIQLTQSPSSVSVSVGERVTIDCKSS,QSVLSASNTY,LNWYQQKPGQAPQLLIY,YAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDAAVYYC,QQAYRAPVT,FGQGTKLEIK,2,Approved,DIQLTQSPSSVSVSVGERVTIDCKSSQSVLSASNTYLNWYQQKPGQAPQLLIYYASTRESGVPDRFSGSGSGTDFTLTISSLQAEDAAVYYCQQAYRAPVTFGQGTKLEIK,yes,2
648,Lexatumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-20,0.95,IGHJ2,0.86,EVQLVQSGGGVERPGGSLRLSCAAS,GFTFDDYG,MSWVRQAPGKGLEWVSG,INWNGGST,GYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYC,AKILGAGRGWYFDL,WGKGTTVTVSS,2,Phase-I,EVQLVQSGGGVERPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDLWGKGTTVTVSS,yes,2
649,Lexatumumab,Whole_mAb,light_sequence,IgL,human,IGLV3-19,1,IGLJ3,1,SSELTQDPAVSVALGQTVRITCQGD,SLRSYY,ASWYQQKPGQAPVLVIY,GKN,NRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYC,NSRDSSGNHVV,FGGGTKLTVL,2,Phase-I,SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL,yes,2
650,Licaminlimab,scFv,heavy_sequence,undefined,human,IGHV3-66,0.76,IGHJ6,0.86,EVQLVESGGSVQPGGSLRLSCTAS,GFTISRSYW,ICWVRQAPGKGLEWVGC,IYGDNDITP,LYANWAKGRFTISRDTSKNTVYLQMNSLRAEDTATYYC,ARLGYDFYAYDL,WGQGTTVTVSS,2,Phase-II,EVQLVESGGSVQPGGSLRLSCTASGFTISRSYWICWVRQAPGKGLEWVGCIYGDNDITPLYANWAKGRFTISRDTSKNTVYLQMNSLRAEDTATYYCARLGYDFYAYDLWGQGTTVTVSS,yes,2
651,Licaminlimab,scFv,light_sequence,IgL,human,IGKV1-5,0.82,IGKJ2,0.67,EIVMTQSPSTLSASVGDRVIITCQSS,QSVYGNIW,MAWYQQKPGRAPKLLIY,QAS,KLASGVPSRFSGSGSGAEFTLTISSLQPDDFATYYC,QGNFNTGDRYA,FGQGTKLTVL,2,Phase-II,EIVMTQSPSTLSASVGDRVIITCQSSQSVYGNIWMAWYQQKPGRAPKLLIYQASKLASGVPSRFSGSGSGAEFTLTISSLQPDDFATYYCQGNFNTGDRYAFGQGTKLTVL,yes,2
654,Ligelizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.81,IGHJ4,1,QVQLVQSGAEVMKPGSSVKVSCKAS,GYTFSWYW,LEWVRQAPGHGLEWMGE,IDPGTFTT,NYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYC,ARFSHFSGSNYDYFDY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS,yes,2
655,Ligelizumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.87,IGKJ4,0.92,EIVMTQSPATLSVSPGERATLSCRAS,QSIGTN,IHWYQQKPGQAPRLLIY,YAS,ESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQSWSWPTT,FGGGTKVEIK,2,Phase-III,EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK,yes,2
656,Lilotomab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1S45,0.87,IGHJ4,1,EIQLQQSGPELVKPGASVKVSCKAS,GYSFTDYN,MYWVKQSHGKSLEWIGY,IDPYNGDT,TYNQKFKGKATLTVDKSSSTAFIHLNSLTSEDSAVYYC,ARSPYGHYAMDY,WGQGTSVTVSS,2,Phase-II,EIQLQQSGPELVKPGASVKVSCKASGYSFTDYNMYWVKQSHGKSLEWIGYIDPYNGDTTYNQKFKGKATLTVDKSSSTAFIHLNSLTSEDSAVYYCARSPYGHYAMDYWGQGTSVTVSS,yes,2
657,Lilotomab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV6-25,0.93,IGKJ4,1,DIVMTQSHKLLSTSVGDRVSITCKAS,QDVSTA,VDWYQQKPGQSPKLLIN,WAS,TRHTGVPDRFTGSGSGTDYTLTISSMQAEDLALYYC,RQHYSTPFT,FGSGTKLEIK,2,Phase-II,DIVMTQSHKLLSTSVGDRVSITCKASQDVSTAVDWYQQKPGQSPKLLINWASTRHTGVPDRFTGSGSGTDYTLTISSMQAEDLALYYCRQHYSTPFTFGSGTKLEIK,yes,2
660,Lirentelimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.79,IGHJ6,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFSLTIYG,AHWVRQAPGKGLEWVGV,IWAGGST,NYNSALMSRFTISKDNSKNTVYLQMNSLRAEDTAVYYC,ARDGSSPYYYSMEY,WGQGTTVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFSLTIYGAHWVRQAPGKGLEWVGVIWAGGSTNYNSALMSRFTISKDNSKNTVYLQMNSLRAEDTAVYYCARDGSSPYYYSMEYWGQGTTVTVSS,yes,2
661,Lirentelimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.88,IGKJ3,0.92,EIVLTQSPATLSLSPGERATLSCSAT,SSVSY,MHWFQQKPGQAPRLLIY,STS,NLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSSYPFT,FGPGTKLDIK,2,Phase-III,EIVLTQSPATLSLSPGERATLSCSATSSVSYMHWFQQKPGQAPRLLIYSTSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSSYPFTFGPGTKLDIK,yes,2
662,Lirilumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.96,IGHJ6,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSFYA,ISWVRQAPGQGLEWMGG,FIPIFGAA,NYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYC,ARIPSGSYYYDYDMDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSFYAISWVRQAPGQGLEWMGGFIPIFGAANYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYCARIPSGSYYYDYDMDVWGQGTTVTVSS,yes,2
663,Lirilumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ2,1,EIVLTQSPVTLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWMYT,FGQGTKLEIK,2,Phase-II,EIVLTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWMYTFGQGTKLEIK,yes,2
664,Lodapolimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,1,IGHJ6,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,IIPIFGTA,NYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARSPDYSPYYYYGMDV,WGQGTTVTVSS,2,Phase-I,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARSPDYSPYYYYGMDVWGQGTTVTVSS,yes,2
665,Lodapolimab,Whole_mAb,light_sequence,IgL,human,IGLV1-44,0.94,IGLJ3,0.83,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGSNT,VNWYQQLPGTAPKLLIY,GNS,NRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYC,QSYDSSLSGSV,FGGGIKLTVL,2,Phase-I,QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCQSYDSSLSGSVFGGGIKLTVL,yes,2
666,Lodelcizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.9,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFSTMY,MSWVRQAPGQGLEWMGR,IDPANEHT,NYAQKFQGRVTMTRDTSISTAYMELSRLTSDDTAVYYC,ARSYYYYNMDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFSTMYMSWVRQAPGQGLEWMGRIDPANEHTNYAQKFQGRVTMTRDTSISTAYMELSRLTSDDTAVYYCARSYYYYNMDYWGQGTLVTVSS,yes,2
667,Lodelcizumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.85,IGKJ2,0.92,QIVLTQSPATLSVSPGERATLSCRAS,QSVSY,MHWYQQKPGQAPRLLIY,GVF,RRATGIPDRFSGSGSGTDFTLTIGRLEPEDFAVYYC,LQWSSDPPT,FGQGTKLEIK,2,Phase-II,QIVLTQSPATLSVSPGERATLSCRASQSVSYMHWYQQKPGQAPRLLIYGVFRRATGIPDRFSGSGSGTDFTLTIGRLEPEDFAVYYCLQWSSDPPTFGQGTKLEIK,yes,2
668,Loncastuximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-69,0.86,IGHJ4,1,QVQLVQPGAEVVKPGASVKLSCKTS,GYTFTSNW,MHWVKQAPGQGLEWIGE,IDPSDSYT,NYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYC,ARGSNPYYYAMDY,WGQGTSVTVSS,2,Preregistration,QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS,yes,2
669,Loncastuximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV4-70,0.91,IGKJ2,1,EIVLTQSPAIMSASPGERVTMTCSAS,SGVNY,MHWYQQKPGTSPRRWIY,DTS,KLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYC,HQRGSYT,FGGGTKLEIK,2,Preregistration,EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK,yes,2
670,Lonigutamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.92,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYY,IHWVRQAPGQGLEWMGW,IWPGDGST,KYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYFC,ASPMITPNYAMDY,WGQGTLVTVSS,2,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWMGWIWPGDGSTKYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYFCASPMITPNYAMDYWGQGTLVTVSS,yes,2
671,Lonigutamab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.88,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISKY,LNWYQQKPGKAPKLLIY,YTS,RLQSGVPSRFSGRGSGTDYSLTISSLQPEDFATYFC,QQGSTLPYT,FGGGTKVEIK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCRASQDISKYLNWYQQKPGKAPKLLIYYTSRLQSGVPSRFSGRGSGTDYSLTISSLQPEDFATYFCQQGSTLPYTFGGGTKVEIK,yes,2
672,Lorukafusp,Whole_mAb_Fusion,heavy_sequence,IgG1,mouse,IGHV1-26,0.77,IGHJ4,0.93,EVQLVQSGAEVEKPGASVKISCKAS,GSSFTGYN,MNWVRQNIGKSLEWIGA,IDPYYGGT,SYNQKFKGRATLTVDKSTSTAYMHLKSLRSEDTAVYYC,VSGMEY,WGQGTSVTVSS,2,Phase-II,EVQLVQSGAEVEKPGASVKISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSTSTAYMHLKSLRSEDTAVYYCVSGMEYWGQGTSVTVSS,yes,2
673,Lorukafusp,Whole_mAb_Fusion,light_sequence,IgK,mouse,IGKV1-110,0.94,IGKJ5,1,DVVMTQTPLSLPVTPGEPASISCRSS,QSLVHRNGNTY,LHWYLQKPGQSPKLLIH,KVS,NRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFC,SQSTHVPPLT,FGAGTKLELK,2,Phase-II,DVVMTQTPLSLPVTPGEPASISCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK,yes,2
676,Losatuxizumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV4-30-4,0.8,IGHJ4,0.93,EVQLQESGPGLVKPSQTLSLTCTVS,GYSISRDFA,WNWIRQPPGKGLEWMGY,ISYNGNT,RYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYC,VTASRGFPY,WGQGTLVTVSS,2,Phase-I,EVQLQESGPGLVKPSQTLSLTCTVSGYSISRDFAWNWIRQPPGKGLEWMGYISYNGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTASRGFPYWGQGTLVTVSS,yes,2
677,Losatuxizumab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV14-100,0.86,IGKJ1,1,DIQMTQSPSSMSVSVGDRVTITCHSS,QDINSN,IGWLQQKPGKSFKGLIY,HGT,NLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,VQYAQFPWT,FGGGTKLEIK,2,Phase-I,DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK,yes,2
678,Lucatumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.94,IGHJ4,0.93,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,ISYEESNR,YHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYC,ARDGGIAAPGPDY,WGQGTLVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS,yes,2
679,Lucatumumab,Whole_mAb,light_sequence,IgK,human,IGKV2D-28,0.95,IGKJ3,0.92,DIVMTQSPLSLTVTPGEPASISCRSS,QSLLYSNGYNY,LDWYLQKPGQSPQVLIS,LGS,NRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,MQARQTPFT,FGPGTKVDIR,2,Phase-I,DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR,yes,2
681,Lumiliximab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-11,0.82,IGHJ5,0.86,EVQLVESGGGLAKPGGSLRLSCAAS,GFRFTFNNYY,MDWVRQAPGQGLEWVSR,ISSSGDPT,WYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYC,ASLTTGSDS,WGQGVLVTVSS,2,Phase-II,EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS,yes,2
682,Lumiliximab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDIRYY,LNWYQQKPGKAPKLLIY,VAS,SLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYC,LQVYSTPRT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK,yes,2
683,Lumretuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-18,0.9,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFRSSY,ISWVRQAPGQGLEWMGW,IYAGTGSP,SYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARHRDYYSNSLTY,WGQGTLVTVSS,2,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGYTFRSSYISWVRQAPGQGLEWMGWIYAGTGSPSYNQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARHRDYYSNSLTYWGQGTLVTVSS,yes,2
684,Lumretuzumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.94,IGKJ2,1,DIVMTQSPDSLAVSLGERATINCKSS,QSVLNSGNQKNY,LTWYQQKPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QSDYSYPYT,FGQGTKLEIK,2,Phase-I/II,DIVMTQSPDSLAVSLGERATINCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQSDYSYPYTFGQGTKLEIK,yes,2
685,Lupartumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-48,0.93,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSNAW,MSWVRQAPGKGLEWVSY,ISSSGSTI,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AREGLWAFDY,WGQGTLVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREGLWAFDYWGQGTLVTVSS,yes,2
686,Lupartumab,Whole_mAb_ADC,light_sequence,IgL,human,IGLV1-40,0.88,IGLJ3,0.92,ESVLTQPPSVSGAPGQRVTISCTGS,SSNIGAGYV,VHWYQQLPGTAPKLLIY,DNN,KRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,AAWDDRLNGPV,FGGGTKLTVL,2,Phase-I,ESVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYVVHWYQQLPGTAPKLLIYDNNKRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDRLNGPVFGGGTKLTVL,yes,2
687,Lusvertikimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-11,0.91,IGHJ4,1,QVQLVESGGGLVKPGGSLRLSCAVS,GFTLSDYY,MAWIRQAPGKGLEWVST,ISASGLRT,YYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARPLSAHYGFNYFDY,WGQGTLVTVSS,2,Phase-I,QVQLVESGGGLVKPGGSLRLSCAVSGFTLSDYYMAWIRQAPGKGLEWVSTISASGLRTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARPLSAHYGFNYFDYWGQGTLVTVSS,yes,2
688,Lusvertikimab,Whole_mAb,light_sequence,IgK,human,IGKV1-NL1,0.88,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRTS,EDIYQG,LAWYQQKPGKAPKLLLY,SAN,TLHIGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,QQYYDYPLA,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRTSEDIYQGLAWYQQKPGKAPKLLLYSANTLHIGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYYDYPLAFGGGTKVEIK,yes,2
693,Maftivimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.96,IGHJ3,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTSSSYA,MNWVRQAPGKGLEWVST,ISGMGGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKRGYPHSFDI,WGQGTMVTVSS,2,Preregistration,EVQLVESGGGLVQPGGSLRLSCAASGFTSSSYAMNWVRQAPGKGLEWVSTISGMGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRGYPHSFDIWGQGTMVTVSS,yes,2
694,Maftivimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.99,IGKJ5,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSISSF,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSYSTLT,FGQGTRLEIK,2,Preregistration,DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLTFGQGTRLEIK,yes,2
697,Manelimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-20,0.93,IGHJ5,0.86,EVQLVESGGGVVRPGGSLRLSCAAS,GFTFDDYA,MSWVRQAPGKGLEWVSD,ISWSGSNT,NYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHC,ARAPLLLAMTFGVGS,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYAMSWVRQAPGKGLEWVSDISWSGSNTNYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYHCARAPLLLAMTFGVGSWGQGTLVTVSS,yes,2
698,Manelimab,Whole_mAb,light_sequence,IgL,human,IGLV8-61,0.86,IGLJ3,0.83,QTVVTQEPSLSVSPGGTVTLTCGLS,SGTVTAINY,PGWYQQTPGQAPRTLIY,NTN,TRHSGVPDRFSGSISGNKAALTITGAQAEDEADYYC,ALYMGNGGHM,FGGGTKLTVL,2,Phase-I,QTVVTQEPSLSVSPGGTVTLTCGLSSGTVTAINYPGWYQQTPGQAPRTLIYNTNTRHSGVPDRFSGSISGNKAALTITGAQAEDEADYYCALYMGNGGHMFGGGTKLTVL,yes,2
699,Margetuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV14-3,0.88,IGHJ4,0.93,QVQLQQSGPELVKPGASLKLSCTAS,GFNIKDTY,IHWVKQRPEQGLEWIGR,IYPTNGYT,RYDPKFQDKATITADTSSNTAYLQVSRLTSEDTAVYYC,SRWGGDGFYAMDY,WGQGASVTVSS,2,Approved,QVQLQQSGPELVKPGASLKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYDPKFQDKATITADTSSNTAYLQVSRLTSEDTAVYYCSRWGGDGFYAMDYWGQGASVTVSS,yes,2
700,Margetuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-17,0.96,IGKJ1,0.83,DIVMTQSHKFMSTSVGDRVSITCKAS,QDVNTA,VAWYQQKPGHSPKLLIY,SAS,FRYTGVPDRFTGSRSGTDFTFTISSVQAEDLAVYYC,QQHYTTPPT,FGGGTKVEIK,2,Approved,DIVMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRYTGVPDRFTGSRSGTDFTFTISSVQAEDLAVYYCQQHYTTPPTFGGGTKVEIK,yes,2
701,Marstacimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.99,IGHJ3,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSA,ISGSGGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AILGATSLSAFDI,WGQGTMVTVSS,2,Phase-III,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAILGATSLSAFDIWGQGTMVTVSS,yes,2
702,Marstacimab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,1,IGLJ3,0.92,QSVLTQPPSVSGAPGQRVTISCTGS,SSNIGAGYD,VHWYQQLPGTAPKLLIY,GNS,NRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYC,QSYDSSLSGSGV,FGGGTKLTVL,2,Phase-III,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSGVFGGGTKLTVL,yes,2
703,Matuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.82,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSHW,MHWVRQAPGQGLEWIGE,FNPSNGRT,NYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYC,ASRDYDYDGRYFDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS,yes,2
704,Matuzumab,Whole_mAb,light_sequence,undefined,human,IGKV1-33,0.85,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCSAS,SSVTY,MYWYQQKPGKAPKLLIY,DTS,NLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYC,QQWSSHIFT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK,yes,2
705,Mavezelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-58,0.85,IGHJ6,0.93,QMQLVQSGPEVKKPGTSVKVSCKAS,GYTFTDYN,VDWVRQARGQRLEWIGD,INPNDGGT,IYAQKFQERVTITVDKSTSTAYMELSSLRSEDTAVYYC,ARNYRWFGAMDH,WGQGTTVTVSS,2,Phase-II,QMQLVQSGPEVKKPGTSVKVSCKASGYTFTDYNVDWVRQARGQRLEWIGDINPNDGGTIYAQKFQERVTITVDKSTSTAYMELSSLRSEDTAVYYCARNYRWFGAMDHWGQGTTVTVSS,yes,2
706,Mavezelimab,Whole_mAb,light_sequence,IgK,human,IGKV2D-29,0.84,IGKJ4,0.92,DIVMTQTPLSLSVTPGQPASISCKAS,QSLDYEGDSD,MNWYLQKPGQPPQLLIY,GAS,NLESGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,QQSTEDPRT,FGGGTKVEIK,2,Phase-II,DIVMTQTPLSLSVTPGQPASISCKASQSLDYEGDSDMNWYLQKPGQPPQLLIYGASNLESGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCQQSTEDPRTFGGGTKVEIK,yes,2
707,Mavrilimumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-24,0.93,IGHJ3,0.79,QVQLVQSGAEVKKPGASVKVSCKVS,GYTLTELS,IHWVRQAPGKGLEWMGG,FDPEENEI,VYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYC,AIVGSFSPLTLGL,WGQGTMVTVSS,2,Phase-II/III,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS,yes,2
708,Mavrilimumab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.89,IGLJ3,0.92,QSVLTQPPSVSGAPGQRVTISCTGS,GSNIGAPYD,VSWYQQLPGTAPKLLIY,HNN,KRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYC,ATVEAGLSGSV,FGGGTKLTVL,2,Phase-II/III,QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL,yes,2
709,Melrilimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23D,0.92,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSIYD,MIWVRQAPGKGLEWVSS,IRGEGGGT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDPWSTEGSFFVLDY,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYDMIWVRQAPGKGLEWVSSIRGEGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPWSTEGSFFVLDYWGQGTLVTVSS,yes,2
710,Melrilimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.95,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVDDD,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQYITAPLT,FGQGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCRASQSVDDDLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYITAPLTFGQGTKVEIK,yes,2
711,Mepolizumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV2-9,0.75,IGHJ4,0.79,QVTLRESGPALVKPTQTLTLTCTVS,GFSLTSYS,VHWVRQPPGKGLEWLGV,IWASGGT,DYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYC,ARDPPSSLLRLDY,WGRGTPVTVSS,2,Approved,QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS,yes,2
712,Mepolizumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.92,IGKJ4,0.83,DIVMTQSPDSLAVSLGERATINCKSS,QSLLNSGNQKNY,LAWYQQKPGQPPKLLIY,GAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QNVHSFPFT,FGGGTKLEIK,2,Approved,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK,yes,2
713,Mezagitamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.89,IGHJ1,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFDDYG,MSWVRQAPGKGLEWVSD,ISWNGGKT,HYVDSVKGQFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARGSLFHDSSGFYFGH,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSDISWNGGKTHYVDSVKGQFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSLFHDSSGFYFGHWGQGTLVTVSS,yes,2
714,Mezagitamab,Whole_mAb,light_sequence,IgL,human,IGLV1-47,0.92,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCSGS,SSNIGDNY,VSWYQQLPGTAPKLLIY,RDS,QRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,QSYDSSLSGSV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCSGSSSNIGDNYVSWYQQLPGTAPKLLIYRDSQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCQSYDSSLSGSVFGGGTKLTVL,yes,2
715,Mibavademab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-30,0.87,IGHJ2,1,QVQLVESGGSVVQPGRSLRLSCAAS,GFTFSTYA,MYWVRQTPGKGLEWVAV,LYSDGSNK,YYIDSVKGRFTISRDTSTNTLYLQMSSLRADDSALYYC,ARLNWDYWYFDL,WGRGTLVTVSS,2,Phase-II,QVQLVESGGSVVQPGRSLRLSCAASGFTFSTYAMYWVRQTPGKGLEWVAVLYSDGSNKYYIDSVKGRFTISRDTSTNTLYLQMSSLRADDSALYYCARLNWDYWYFDLWGRGTLVTVSS,yes,2
716,Mibavademab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,1,IGKJ5,1,DIQMTQSPSSLSASVGDRVTITCRAS,QSISSY,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSYSTPPIT,FGQGTRLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPITFGQGTRLEIK,yes,2
717,Milatuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV7-4-1,0.82,IGHJ4,0.93,QVQLQQSGSELKKPGASVKVSCKAS,GYTFTNYG,VNWIKQAPGQGLQWMGW,INPNTGEP,TFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFC,SRSRGKNEAWFAY,WGQGTLVTVSS,2,Phase-I/II,QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGVNWIKQAPGQGLQWMGWINPNTGEPTFDDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCSRSRGKNEAWFAYWGQGTLVTVSS,yes,2
718,Milatuzumab,Whole_mAb,light_sequence,IgK,human,IGKV2-30,0.86,IGKJ5,0.83,DIQLTQSPLSLPVTLGQPASISCRSS,QSLVHRNGNTY,LHWFQQRPGQSPRLLIY,TVS,NRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFC,SQSSHVPPT,FGAGTRLEIK,2,Phase-I/II,DIQLTQSPLSLPVTLGQPASISCRSSQSLVHRNGNTYLHWFQQRPGQSPRLLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYFCSQSSHVPPTFGAGTRLEIK,yes,2
719,Mipasetamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.93,IGHJ6,0.93,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MSWVRQAPGKGLEWVAT,ISSGGSYT,YYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARHPIYYTYDDTMDY,WGQGTTVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHPIYYTYDDTMDYWGQGTTVTVSS,yes,2
720,Mipasetamab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.86,IGKJ1,0.83,EIVLTQSPGTLSLSPGERATLSCSAS,SSVSSGN,FHWYQQKPGLAPRLLIY,RTS,NLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQWSGYPWT,FGGGTKLEIK,2,Phase-I,EIVLTQSPGTLSLSPGERATLSCSASSSVSSGNFHWYQQKPGLAPRLLIYRTSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQWSGYPWTFGGGTKLEIK,yes,2
721,Miptenalimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-33,0.79,IGHJ4,0.93,QVTLVESGGGVVQPGRSLRLSCAFS,GFSLSTSDMG,VGWIRQAPGKGLEWVAH,IWWDDVK,RYNPALKSRFTISRDNSKNTLYLQMNSLRAEDTAVYFC,ARIEDYGVSYYFDY,WGQGTTVTVSS,2,Phase-II,QVTLVESGGGVVQPGRSLRLSCAFSGFSLSTSDMGVGWIRQAPGKGLEWVAHIWWDDVKRYNPALKSRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARIEDYGVSYYFDYWGQGTTVTVSS,yes,2
722,Miptenalimab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-17,0.86,IGKJ4,0.83,DIQMTQSPSFLSASVGDRVSITCKAS,QDVSTA,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPDRFSGSGSGTDFTLTISSLQPEDFATYYC,QQHYSIPLT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSFLSASVGDRVSITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSIPLTFGQGTKLEIK,yes,2
723,Mirikizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.83,IGHJ6,0.79,QVQLVQSGAEVKKPGSSVKVSCKAS,GYKFTRYV,MHWVRQAPGQGLEWMGY,INPYNDGT,NYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARNWDTGL,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGSSVKVSCKASGYKFTRYVMHWVRQAPGQGLEWMGYINPYNDGTNYNEKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNWDTGLWGQGTTVTVSS,yes,2
724,Mirikizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.85,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,DHILKF,LTWYQQKPGKAPKLLIY,GAT,SLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QMYWSTPFT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCKASDHILKFLTWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQMYWSTPFTFGGGTKVEIK,yes,2
725,Miromavimab,Whole_mAb_(Mouse),heavy_sequence,IgG1,mouse,IGHV1S35,0.91,IGHJ1,0.93,QVQLQQPGSVLVRPGASVKLSCKTS,GYAFTSSW,MHWAKQRPGQGLEWIGQ,THPNSGYT,NYNEKFKGKATLTVDTSSSTAYVDLSSLTSEDSAVYYC,ARESGDGPHWYFDV,WGAGTAVTVSS,2,Approved,QVQLQQPGSVLVRPGASVKLSCKTSGYAFTSSWMHWAKQRPGQGLEWIGQTHPNSGYTNYNEKFKGKATLTVDTSSSTAYVDLSSLTSEDSAVYYCARESGDGPHWYFDVWGAGTAVTVSS,yes,2
726,Miromavimab,Whole_mAb_(Mouse),light_sequence,IgK,mouse,IGKV6-17,1,IGKJ1,0.83,DIVMTQSHKFMSTSVGDRVSITCKAS,QDVSTA,VAWYQQKPGQSPKLLIY,SAS,YRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYC,QQHYSSPHT,FGGGTKLETK,2,Approved,DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSSPHTFGGGTKLETK,yes,2
727,Mirvetuximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-37,0.88,IGHJ4,0.93,QVQLVQSGAEVVKPGASVKISCKAS,GYTFTGYF,MNWVKQSPGQSLEWIGR,IHPYDGDT,FYNQKFQGKATLTVDKSSNTAHMELLSLTSEDFAVYYC,TRYDGSRAMDY,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVVKPGASVKISCKASGYTFTGYFMNWVKQSPGQSLEWIGRIHPYDGDTFYNQKFQGKATLTVDKSSNTAHMELLSLTSEDFAVYYCTRYDGSRAMDYWGQGTTVTVSS,yes,2
728,Mirvetuximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV3-9,0.79,IGKJ2,1,DIVLTQSPLSLAVSLGQPAIISCKAS,QSVSFAGTSL,MHWYHQKPGQQPRLLIY,RAS,NLEAGVPDRFSGSGSKTDFTLTISPVEAEDAATYYC,QQSREYPYT,FGGGTKLEIK,2,Phase-III,DIVLTQSPLSLAVSLGQPAIISCKASQSVSFAGTSLMHWYHQKPGQQPRLLIYRASNLEAGVPDRFSGSGSKTDFTLTISPVEAEDAATYYCQQSREYPYTFGGGTKLEIK,yes,2
729,Mirzotamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV3-1,0.85,IGHJ2,0.86,EVQLQESGPGLVKPSETLSLTCAVT,GYSITSGYS,WHWIRQFPGNGLEWMGY,IHSSGST,NYNPSLKSRISISRDTSKNQFFLKLSSVTAADTAVYYC,AGYDDYFEY,WGQGTTVTVSS,2,Phase-I,EVQLQESGPGLVKPSETLSLTCAVTGYSITSGYSWHWIRQFPGNGLEWMGYIHSSGSTNYNPSLKSRISISRDTSKNQFFLKLSSVTAADTAVYYCAGYDDYFEYWGQGTTVTVSS,yes,2
730,Mirzotamab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-15,0.83,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QNVGFN,VAWYQQKPGKSPKALIY,SAS,YRYSGVPSRFSGSGSGTDFTLTISSLQPEDFAEYFC,QQYNWYPFT,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCKASQNVGFNVAWYQQKPGKSPKALIYSASYRYSGVPSRFSGSGSGTDFTLTISSLQPEDFAEYFCQQYNWYPFTFGQGTKLEIK,yes,2
731,Mitazalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-48,0.87,IGHJ4,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSTYG,MHWVRQAPGKGLEWLSY,ISGGSSYI,FYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYC,ARILRGGSGMDL,WGQGTLVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSS,yes,2
732,Mitazalimab,Whole_mAb,light_sequence,IgL,human,IGLV1-47,0.91,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCTGS,SSNIGAGYN,VYWYQQLPGTAPKLLIY,GNI,NRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,AAWDKSISGLV,FGGGTKLTVL,2,Phase-I,QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVL,yes,2
733,Modakafusp,Whole_mAb_Fusion,heavy_sequence,IgG4,human,IGHV1-69-2,0.9,IGHJ4,0.86,EVQLVQSGAEVKKPGATVKISCKVS,GYTFTDSV,MNWVQQAPGKGLEWMGW,IDPEYGRT,DVAEKFQGRVTITADTSTDTAYMELSSLRSEDTAVYYC,ARTKYNSGYGFPY,WGQGTTVTVSS,2,Phase-I/II,EVQLVQSGAEVKKPGATVKISCKVSGYTFTDSVMNWVQQAPGKGLEWMGWIDPEYGRTDVAEKFQGRVTITADTSTDTAYMELSSLRSEDTAVYYCARTKYNSGYGFPYWGQGTTVTVSS,yes,2
734,Modakafusp,Whole_mAb_Fusion,light_sequence,IgK,human,IGKV1-33,0.85,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QNVDSD,VDWYQQKPGKAPKLLIY,KAS,NDYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,MQSNTHPRT,FGGGTKVEIK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCKASQNVDSDVDWYQQKPGKAPKLLIYKASNDYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCMQSNTHPRTFGGGTKVEIK,yes,2
735,Modotuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-64,0.9,IGHJ4,1,QVQLQQPGAELVEPGGSVKLSCKAS,GYTFTSHW,MHWVKQRPGQGLEWIGE,INPSSGRN,NYNEKFKSKATLTVDKSSSTAYMQFSSLTSEDSAVYYC,VRYYGYDEAMDY,WGQGTSVTVSS,2,Phase-II,QVQLQQPGAELVEPGGSVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEINPSSGRNNYNEKFKSKATLTVDKSSSTAYMQFSSLTSEDSAVYYCVRYYGYDEAMDYWGQGTSVTVSS,yes,2
736,Modotuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV2-109,1,IGKJ2,1,DIVMTQAAFSNPVTLGTSASISCRSS,KSLLHSNGITY,LYWYLQKPGQSPQLLIY,QMS,NLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYC,AQNLELPYT,FGGGTKLEIK,2,Phase-II,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK,yes,2
739,Monalizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-18,0.9,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYW,MNWVRQAPGQGLEWMGR,IDPYDSET,HYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARGGYDFDVGTLYWFFDV,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSS,yes,2
740,Monalizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.88,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,ENIYSY,LAWYQQKPGKAPKLLIY,"NAK",TLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QHHYGTPRT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGTPRTFGGGTKVEIK,yes,2
745,Motavizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV2-70,0.86,IGHJ6,0.93,QVTLRESGPALVKPTQTLTLTCTFS,GFSLSTAGMS,VGWIRQPPGKALEWLAD,IWWDDKK,HYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYC,ARDMIFNFYFDV,WGQGTTVTVSS,2,Phase-III,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS,yes,2
746,Motavizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.84,IGKJ4,0.92,DIQMTQSPSTLSASVGDRVTITCSAS,SRVGY,MHWYQQKPGKAPKLLIY,DTS,KLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,FQGSGYPFT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK,yes,2
747,Moxetumomab,Fv_Fusion,heavy_sequence,undefined,mouse,IGHV5-12-1,0.97,IGHJ3,1,EVQLVESGGGLVKPGGSLKLSCAAS,GFAFSIYD,MSWVRQTPEKCLEWVAY,ISSGGGTT,YYPDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYC,ARHSGYGTHWGVLFAY,WGQGTLVTVSA,2,Approved,EVQLVESGGGLVKPGGSLKLSCAASGFAFSIYDMSWVRQTPEKCLEWVAYISSGGGTTYYPDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHSGYGTHWGVLFAYWGQGTLVTVSA,yes,2
748,Moxetumomab,Fv_Fusion,light_sequence,IgK,mouse,IGKV10-96,0.98,IGKJ1,0.83,DIQMTQTTSSLSASLGDRVTISCRAS,QDISNY,LNWYQQKPDGTVKLLIY,YTS,ILHSGVPSRFSGSGSGTDYSLTISNLEQEDFATYFC,QQGNTLPWT,FGCGTKLEI,2,Approved,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSILHSGVPSRFSGSGSGTDYSLTISNLEQEDFATYFCQQGNTLPWTFGCGTKLEI,yes,2
751,Muromonab,Whole_mAb,heavy_sequence,IgG2a,mouse,IGHV1-4,0.96,IGHJ2,0.93,QVQLQQSGAELARPGASVKMSCKAS,GYTFTRYT,MHWVKQRPGQGLEWIGY,INPSRGYT,NYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYC,ARYYDDHYCLDY,WGQGTTLTVSS,2,Approved,QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS,yes,2
752,Muromonab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-59,0.96,IGKJ4,0.92,QIVLTQSPAIMSASPGEKVTMTCSAS,SSVSY,MNWYQQKSGTSPKRWIY,DTS,KLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYC,QQWSSNPFT,FGSGTKLEIN,2,Approved,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN,yes,2
753,Nadecnemab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.96,IGHJ6,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSV,ISGSGGST,YYADAVKGRFTISRDNSKHTLYLQMNSLRAEDTAVYYC,TKPSSYSSSNFYYGMDV,WGQGTTVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSVISGSGGSTYYADAVKGRFTISRDNSKHTLYLQMNSLRAEDTAVYYCTKPSSYSSSNFYYGMDVWGQGTTVTVSS,yes,2
754,Nadecnemab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.99,IGKJ3,0.92,DIQMTQSPSSVSASVGDRVTITCRAS,QGISSW,LAWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQTNSFPFP,FGPGTKVDIK,2,Phase-II,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTNSFPFPFGPGTKVDIK,yes,2
755,Namilumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.9,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAF,GYPFTDYL,LHWVRQAPGQGLEWVGW,LNPYSGDT,NYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYC,TRTTLISVYFDY,WGQGTMVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKAFGYPFTDYLLHWVRQAPGQGLEWVGWLNPYSGDTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCTRTTLISVYFDYWGQGTMVTVSS,yes,2
756,Namilumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ4,0.83,DIQMTQSPSSVSASVGDRVTIACRAS,QNIRNI,LNWYQQRPGKAPQLLIY,AAS,NLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYC,QQSYSMPRT,FGGGTKLEIK,2,Phase-II,DIQMTQSPSSVSASVGDRVTIACRASQNIRNILNWYQQRPGKAPQLLIYAASNLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYSMPRTFGGGTKLEIK,yes,2
757,Naptumomab,Fab_Fusion,heavy_sequence,IgG1,mouse,IGHV1-26,0.89,IGHJ4,1,EVQLQQSGPDLVKPGASVKISCKAS,GYSFTGYY,MHWVKQSPGKGLEWIGR,INPNNGVT,LYNQKFKDKATLTVDKSSTTAYMELRSLTSEDSAVYYC,ARSTMITNYVMDY,WGQGTSVTVSS,2,Phase-III,EVQLQQSGPDLVKPGASVKISCKASGYSFTGYYMHWVKQSPGKGLEWIGRINPNNGVTLYNQKFKDKATLTVDKSSTTAYMELRSLTSEDSAVYYCARSTMITNYVMDYWGQGTSVTVSS,yes,2
758,Naptumomab,Fab_Fusion,light_sequence,IgK,mouse,IGKV6-32,0.89,IGKJ1,0.92,SIVMTQTPTSLLVSAGDRVTITCKAS,QSVSND,VAWYQQKPGQSPKLLIS,YTS,SRYAGVPDRFSGSGYGTDFTLTISSVQAEDAAVYFC,QQDYNSPPT,FGGGTKLEIK,2,Phase-III,SIVMTQTPTSLLVSAGDRVTITCKASQSVSNDVAWYQQKPGQSPKLLISYTSSRYAGVPDRFSGSGYGTDFTLTISSVQAEDAAVYFCQQDYNSPPTFGGGTKLEIK,yes,2
761,Narnatumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.96,IGHJ6,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYL,MTWVRQAPGKGLEWVAN,IKQDGSEK,YYVDSVKGRFTISRDNAKNSLNLQMNSLRAEDTAVYYC,TRDGYSSGRHYGMDV,WGQGTTVIVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYLMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLNLQMNSLRAEDTAVYYCTRDGYSSGRHYGMDVWGQGTTVIVSS,yes,2
762,Narnatumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSRY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPRT,FGQGTKVEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK,yes,2
763,Narsoplimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV2-26,0.93,IGHJ4,0.93,QVTLKESGPVLVKPTETLTLTCTVS,GFSLSRGKMG,VSWIRQPPGKALEWLAH,IFSSDEK,SYRTSLKSRLTISKDTSKNQVVLTMTNMDPVDTATYYC,ARIRRGGIDY,WGQGTLVTVSS,2,Preregistration,QVTLKESGPVLVKPTETLTLTCTVSGFSLSRGKMGVSWIRQPPGKALEWLAHIFSSDEKSYRTSLKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIRRGGIDYWGQGTLVTVSS,yes,2
764,Narsoplimab,Whole_mAb,light_sequence,IgL,human,IGLV3-1,0.9,IGLJ3,0.92,QPVLTQPPSLSVSPGQTASITCSGE,KLGDKY,AYWYQQKPGQSPVLVMY,QDK,QRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYC,QAWDSSTAV,FGGGTKLTVL,2,Preregistration,QPVLTQPPSLSVSPGQTASITCSGEKLGDKYAYWYQQKPGQSPVLVMYQDKQRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL,yes,2
773,Naxitamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV2-9,0.78,IGHJ4,0.86,QVQLVESGPGVVQPGRSLRISCAVS,GFSVTNYG,VHWVRQPPGKGLEWLGV,IWAGGIT,NYNSAFMSRLTISKDNSKNTVYLQMNSLRAEDTAMYYC,ASRGGHYGYALDY,WGQGTLVTVSS,2,Approved,QVQLVESGPGVVQPGRSLRISCAVSGFSVTNYGVHWVRQPPGKGLEWLGVIWAGGITNYNSAFMSRLTISKDNSKNTVYLQMNSLRAEDTAMYYCASRGGHYGYALDYWGQGTLVTVSS,yes,2
774,Naxitamab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-32,0.84,IGKJ4,0.75,EIVMTQTPATLSVSAGERVTITCKAS,QSVSND,VTWYQQKPGQAPRLLIY,SAS,NRYSGVPARFSGSGYGTEFTFTISSVQSEDFAVYFC,QQDYSS,FGQGTKLEIK,2,Approved,EIVMTQTPATLSVSAGERVTITCKASQSVSNDVTWYQQKPGQAPRLLIYSASNRYSGVPARFSGSGYGTEFTFTISSVQSEDFAVYFCQQDYSSFGQGTKLEIK,yes,2
775,Necitumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-30-4,0.96,IGHJ4,1,QVQLQESGPGLVKPSQTLSLTCTVS,GGSISSGDYY,WSWIRQPPGKGLEWIGY,IYYSGST,DYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYC,ARVSIFGVGTFDY,WGQGTLVTVSS,2,Approved,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS,yes,2
776,Necitumumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.96,IGKJ4,0.92,EIVMTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,HQYGSTPLT,FGGGTKAEIK,2,Approved,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK,yes,2
777,Nemolizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.84,IGHJ4,0.79,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTGYI,MNWVRQAPGQGLEWMGL,INPYNGGT,DYNPQFQDRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARDGYDDGPYTLET,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYIMNWVRQAPGQGLEWMGLINPYNGGTDYNPQFQDRVTITADKSTSTAYMELSSLRSEDTAVYYCARDGYDDGPYTLETWGQGTLVTVSS,yes,2
778,Nemolizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.84,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCQAS,EDIYSF,VAWYQQKPGKAPKLLIY,"NAQ",TEAQGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QHHYDSPLT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCQASEDIYSFVAWYQQKPGKAPKLLIYNAQTEAQGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYDSPLTFGGGTKVEIK,yes,2
779,Nesvacumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-13,0.98,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYD,IHWVRQATGKGLEWVSA,IGPAGDT,YYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYC,ARGLITFGGLIAPFDY,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDIHWVRQATGKGLEWVSAIGPAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGLITFGGLIAPFDYWGQGTLVTVSS,yes,2
780,Nesvacumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.96,IGKJ1,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSTY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QHYDNSQT,FGQGTKVEIK,2,Phase-I,EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYDNSQTFGQGTKVEIK,yes,2
781,Netakimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.74,IGHJ5,0.93,QVQLVQSGGGLVQAGGSLRLSCAAS,GGTFATSP,MGWLRQAPGKGTEFVAA,ISPSGGDR,IYADSVKGRFTISRDNAGYFIYLQMNSLKPEDTAVYYC,AVRRRFDGTSYYTGDYDS,WGQGTLVTVSS,2,Approved,QVQLVQSGGGLVQAGGSLRLSCAASGGTFATSPMGWLRQAPGKGTEFVAAISPSGGDRIYADSVKGRFTISRDNAGYFIYLQMNSLKPEDTAVYYCAVRRRFDGTSYYTGDYDSWGQGTLVTVSS,yes,2
782,Netakimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.97,IGKJ1,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,DAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYSYSPVT,FGQGTKVEIK,2,Approved,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYSYSPVTFGQGTKVEIK,yes,2
785,Nimacimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.87,IGHJ4,0.86,QVQLVQSGAEVKKPGSSVKVSCKAS,GYEFSYYW,MNWVRQAPGQGLEWMGQ,IYPGDGET,KYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYC,ARSHGNYLPY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGYEFSYYWMNWVRQAPGQGLEWMGQIYPGDGETKYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARSHGNYLPYWGQGTLVTVSS,yes,2
786,Nimacimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.9,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSSY,LHWYQQKPGQAPRLLIY,STS,NLASGIPARFSGSGSGTDFTLTISRLEPEDFAVYYC,HQYHRSPPT,FGQGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCRASQSVSSSYLHWYQQKPGQAPRLLIYSTSNLASGIPARFSGSGSGTDFTLTISRLEPEDFAVYYCHQYHRSPPTFGQGTKVEIK,yes,2
789,Nipocalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ4,0.79,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSTYA,MGWVRQAPGKGLEWVSS,IGASGSQT,RYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARLAIGDSY,WGQGTMVTVSS,2,Phase-III,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMGWVRQAPGKGLEWVSSIGASGSQTRYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLAIGDSYWGQGTMVTVSS,yes,2
790,Nipocalimab,Whole_mAb,light_sequence,IgL,human,IGLV2-23,0.95,IGLJ1,1,QSALTQPASVSGSPGQSITISCTGT,GSDVGSYNL,VSWYQQHPGKAPKLMIY,GDS,ERPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,SSYAGSGIYV,FGTGTKVTVL,2,Phase-III,QSALTQPASVSGSPGQSITISCTGTGSDVGSYNLVSWYQQHPGKAPKLMIYGDSERPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYAGSGIYVFGTGTKVTVL,yes,2
791,Nirsevimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.82,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVMVSCQAS,GGLLEDYI,INWVRQAPGQGPEWMGG,IIPVLGTV,HYGPKFQGRVTITADESTDTAYMELSSLRSEDTAMYYC,ATETALVVSETYLPHYFDN,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGSSVMVSCQASGGLLEDYIINWVRQAPGQGPEWMGGIIPVLGTVHYGPKFQGRVTITADESTDTAYMELSSLRSEDTAMYYCATETALVVSETYLPHYFDNWGQGTLVTVSS,yes,2
792,Nirsevimab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.93,IGKJ4,1,DIQMTQSPSSLSAAVGDRVTITCQAS,QDIVNY,LNWYQQKPGKAPKLLIY,VAS,NLETGVPSRFSGSGSGTDFSLTISSLQPEDVATYYC,QQYDNLPLT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSAAVGDRVTITCQASQDIVNYLNWYQQKPGKAPKLLIYVASNLETGVPSRFSGSGSGTDFSLTISSLQPEDVATYYCQQYDNLPLTFGGGTKVEIK,yes,2
793,Nivatrotamab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence,IgG1,mouse,IGHV2-9,0.78,IGHJ4,0.86,QVQLVESGPGVVQPGRSLRISCAVS,GFSVTNYG,VHWVRQPPGKGLEWLGV,IWAGGIT,NYNSAFMSRLTISKDNSKNTVYLQMNSLRAEDTAMYYC,ASRGGHYGYALDY,WGQGTLVTVSS,4,Phase-I/II,QVQLVESGPGVVQPGRSLRISCAVSGFSVTNYGVHWVRQPPGKGLEWLGVIWAGGITNYNSAFMSRLTISKDNSKNTVYLQMNSLRAEDTAMYYCASRGGHYGYALDYWGQGTLVTVSS,yes,4
794,Nivatrotamab,Bispecific_Mixed_mAb_and_scFv,light_sequence,IgK,mouse,IGKV6-32,0.84,IGKJ4,0.75,EIVMTQTPATLSVSAGERVTITCKAS,QSVSND,VTWYQQKPGQAPRLLIY,SAS,NRYSGVPARFSGSGYGTEFTFTISSVQSEDFAVYFC,QQDYSS,FGQGTKLEIK,4,Phase-I/II,EIVMTQTPATLSVSAGERVTITCKASQSVSNDVTWYQQKPGQAPRLLIYSASNRYSGVPARFSGSGYGTEFTFTISSVQSEDFAVYFCQQDYSSFGQGTKLEIK,yes,4
795,Nivatrotamab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence_bispec,undefined,human,IGHV3-30,0.7,IGHJ4,0.86,QVQLVQSGGGVVQPGRSLRLSCKAS,GYTFTRYT,MHWVRQAPGKCLEWIGY,INPSRGYT,NYNQKFKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFC,ARYYDDHYSLDY,WGQGTPVTVSS,4,Phase-I/II,QVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKCLEWIGYINPSRGYTNYNQKFKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYSLDYWGQGTPVTVSS,yes,4
796,Nivatrotamab,Bispecific_Mixed_mAb_and_scFv,light_sequence_bispec,IgK,human,IGKV1D-39,0.82,IGKJ3,0.67,DIQMTQSPSSLSASVGDRVTITCSAS,SSVSY,MNWYQQTPGKAPKRWIY,DTS,KLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYC,QQWSSNPFT,FGCGTKLQIT,4,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSNPFTFGCGTKLQIT,yes,4
797,Nivolumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-33,0.91,IGHJ4,0.93,QVQLVESGGGVVQPGRSLRLDCKAS,GITFSNSG,MHWVRQAPGKGLEWVAV,IWYDGSKR,YYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYC,ATNDDY,WGQGTLVTVSS,2,Approved,QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS,yes,2
798,Nivolumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQSSNWPRT,FGQGTKVEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK,yes,2
801,Obexelimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.73,IGHJ4,1,EVQLVESGGGLVKPGGSLKLSCAAS,GYTFTSYV,MHWVRQAPGKGLEWIGY,INPYNDGT,KYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYC,ARGTYYYGTRVFDY,WGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS,yes,2
802,Obexelimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.76,IGKJ5,0.83,DIVMTQSPATLSLSPGERATLSCRSS,KSLQNVNGNTY,LYWFQQKPGQSPQLLIY,RMS,NLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYC,MQHLEYPIT,FGAGTKLEIK,2,Phase-III,DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK,yes,2
803,Obiltoxaximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-82,0.87,IGHJ4,0.93,QVQLQQSGPELKKPGASVKVSCKDS,GYAFSSSW,MNWVRQAPGQGLEWIGR,IYPGDGDT,NYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFC,ARSGLLRYAMDY,WGQGTLVTVSS,2,Approved,QVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSS,yes,2
804,Obiltoxaximab,Whole_mAb,light_sequence,IgK,mouse,IGKV10-96,0.86,IGKJ1,0.75,DIQMTQSPSSLSASVGDRVTITCRAS,QDIRNY,LNWYQQKPGKAVKLLIY,YTS,RLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFC,QQGNTLPWT,FGQGTKVEIR,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIR,yes,2
807,Obrindatamab,Bispecific_scFv_with_Domain_Crossover,heavy_sequence,undefined,human,IGHV3-48,0.92,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSFG,MHWVRQAPGKGLEWVAY,ISSDSSAI,YYADTVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYC,GRGRENIYYGSRLDY,WGQGTTVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSDSSAIYYADTVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCGRGRENIYYGSRLDYWGQGTTVTVSS,yes,4
808,Obrindatamab,Bispecific_scFv_with_Domain_Crossover,light_sequence,IgK,human,IGKV1-9,0.85,IGKJ2,0.92,DIQLTQSPSFLSASVGDRVTITCKAS,QNVDTN,VAWYQQKPGKAPKALIY,SAS,YRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNNYPFT,FGQGTKLEIK,4,Phase-I,DIQLTQSPSFLSASVGDRVTITCKASQNVDTNVAWYQQKPGKAPKALIYSASYRYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNNYPFTFGQGTKLEIK,yes,4
809,Obrindatamab,Bispecific_scFv_with_Domain_Crossover,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.89,IGHJ3,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSTYA,MNWVRQAPGKGLEWVGR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,VRHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKDRFTISRDDSKNSLYLQMNSLKTEDTAVYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
810,Obrindatamab,Bispecific_scFv_with_Domain_Crossover,light_sequence_bispec,IgL,mouse,IGLV1,0.81,IGLJ1,1,QAVVTQEPSLTVSPGGTVTLTCRSS,TGAVTTSNY,ANWVQQKPGQAPRGLIG,GTN,KRAPWTPARFSGSLLGGKAALTITGAQAEDEADYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-I,QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWVQQKPGQAPRGLIGGTNKRAPWTPARFSGSLLGGKAALTITGAQAEDEADYYCALWYSNLWVFGGGTKLTVL,yes,4
811,Ocaratuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.84,IGHJ6,0.93,EVQLVQSGAEVKKPGESLKISCKGS,GRTFTSYN,MHWVRQMPGKGLEWMGA,IYPLTGDT,SYNQKSKLQVTISADKSISTAYLQWSSLKASDTAMYYC,ARSTYVGGDWQFDV,WGKGTTVTVSS,2,Phase-II,EVQLVQSGAEVKKPGESLKISCKGSGRTFTSYNMHWVRQMPGKGLEWMGAIYPLTGDTSYNQKSKLQVTISADKSISTAYLQWSSLKASDTAMYYCARSTYVGGDWQFDVWGKGTTVTVSS,yes,2
812,Ocaratuzumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.86,IGKJ2,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,SSVPY,IHWYQQKPGQAPRLLIY,ATS,ALASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQWLSNPPT,FGQGTKLEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASSSVPYIHWYQQKPGQAPRLLIYATSALASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQWLSNPPTFGQGTKLEIK,yes,2
813,Ociperlimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.89,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCASS,GFTFSDYY,MYWVRQAPGKGLEWVAY,ITKGGGST,YYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYC,ARQTNYDFTMDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCASSGFTFSDYYMYWVRQAPGKGLEWVAYITKGGGSTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARQTNYDFTMDYWGQGTLVTVSS,yes,2
814,Ociperlimab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.89,IGKJ4,1,EIVMTQSPATLSVSPGERATLSCKAS,QDVGTS,VAWYQQKPGQAPRLLIY,WAS,ARHTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQYSSYPLT,FGGGTKVEIK,2,Phase-II,EIVMTQSPATLSVSPGERATLSCKASQDVGTSVAWYQQKPGQAPRLLIYWASARHTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYSSYPLTFGGGTKVEIK,yes,2
817,Odesivimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-13,1,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYD,MHWVRQATGKGLEWVSA,IGTAGDT,YYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYC,ARTWFGELYFDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARTWFGELYFDYWGQGTLVTVSS,yes,2
818,Odesivimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.98,IGKJ4,1,DIVMTQSPDSLAVSLGERATINCKSS,QSVLYSSNNKNY,LAWYQQKPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTEFTLTITSLQAEDVAVYYC,QQYYSSPLT,FGGGTKVEIK,2,Approved,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTEFTLTITSLQAEDVAVYYCQQYYSSPLTFGGGTKVEIK,yes,2
819,Odronextamab,Bispecific_mAb,heavy_sequence,IgG4,human,IGHV3-9,0.95,IGHJ6,1,EVQLVESGGGLVQPGRSLRLSCVAS,GFTFNDYA,MHWVRQAPGKGLEWVSV,ISWNSDSI,GYADSVKGRFTISRDNAKNSLYLQMHSLRAEDTALYYC,AKDNHYGSGSYYYYQYGMDV,WGQGTTVTVSS,4,Phase-II,EVQLVESGGGLVQPGRSLRLSCVASGFTFNDYAMHWVRQAPGKGLEWVSVISWNSDSIGYADSVKGRFTISRDNAKNSLYLQMHSLRAEDTALYYCAKDNHYGSGSYYYYQYGMDVWGQGTTVTVSS,yes,4
820,Odronextamab,Bispecific_mAb,light_sequence,IgK,human,IGKV3-15,0.98,IGKJ4,1,EIVMTQSPATLSVSPGERATLSCRAS,QSVSSN,LAWYQQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QHYINWPLT,FGGGTKVEIK,4,Phase-II,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYINWPLTFGGGTKVEIK,yes,4
821,Odronextamab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV3-9,0.98,IGHJ6,0.93,EVQLVESGGGLVQPGRSLRLSCAAS,GFTFDDYT,MHWVRQAPGKGLEWVSG,ISWNSGSI,GYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYC,AKDNSGYGHYYYGMDV,WGQGTTVTVAS,4,Phase-II,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYTMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDNSGYGHYYYGMDVWGQGTTVTVAS,yes,4
822,Odronextamab,Bispecific_mAb,light_sequence_bispec,IgK,human,IGKV3-15,0.98,IGKJ4,1,EIVMTQSPATLSVSPGERATLSCRAS,QSVSSN,LAWYQQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QHYINWPLT,FGGGTKVEIK,4,Phase-II,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQHYINWPLTFGGGTKVEIK,yes,4
823,Ofatumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-9,0.97,IGHJ6,1,EVQLVESGGGLVQPGRSLRLSCAAS,GFTFNDYA,MHWVRQAPGKGLEWVST,ISWNSGSI,GYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYC,AKDIQYGNYYYGMDV,WGQGTTVTVSS,2,Approved,EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS,yes,2
824,Ofatumumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ5,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPIT,FGQGTRLEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK,yes,2
825,Olaratumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-39,0.91,IGHJ4,0.86,QLQLQESGPGLVKPSETLSLTCTVS,GGSINSSSYY,WGWLRQSPGKGLEWIGS,FFYTGST,YYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYC,ARQSTYYYGSGNYYGWFDR,WDQGTLVTVSS,2,Approved,QLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSS,yes,2
826,Olaratumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ1,0.83,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPA,FGQGTKVEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIK,yes,2
827,Oleclumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.97,IGHJ2,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,YSWVRQAPGKGLEWVSA,ISGSGGRT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARLGYGRVDE,WGRGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAYSWVRQAPGKGLEWVSAISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLGYGRVDEWGRGTLVTVSS,yes,2
828,Oleclumab,Whole_mAb,light_sequence,IgL,human,IGLV1-44,0.91,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCSGS,LSNIGRNP,VNWYQQLPGTAPKLLIY,LDN,LRLSGVPDRFSGSKSGTSASLAISGLQSEDEADYYC,ATWDDSHPGWT,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCSGSLSNIGRNPVNWYQQLPGTAPKLLIYLDNLRLSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSHPGWTFGGGTKLTVL,yes,2
829,Olendalizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.88,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYS,MDWVRQAPGQGLEWMGA,IHLNTGYT,NYNQKFKGRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARGFYDGYSPMDY,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYSMDWVRQAPGQGLEWMGAIHLNTGYTNYNQKFKGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGFYDGYSPMDYWGQGTTVTVSS,yes,2
830,Olendalizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,ESVDSYGNSF,MHWYQQKPGKAPKLLIY,RAS,NLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSNEDPYT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASESVDSYGNSFMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPYTFGGGTKVEIK,yes,2
831,Olinvacimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.85,IGHJ4,1,QMQLVQSGAEVKKPGASVKLSCKAS,GYTFSSYW,MHWVRQAPGQRLEWMGE,INPGNGHT,NYNEKFKSRVTITVDKSASTAYMELSSLRSEDTAVYYC,AKIWGPSLTSPFDY,WGQGTLVTVSS,2,Phase-II,QMQLVQSGAEVKKPGASVKLSCKASGYTFSSYWMHWVRQAPGQRLEWMGEINPGNGHTNYNEKFKSRVTITVDKSASTAYMELSSLRSEDTAVYYCAKIWGPSLTSPFDYWGQGTLVTVSS,yes,2
832,Olinvacimab,Whole_mAb,light_sequence,IgL,human,IGLV3-21,0.85,IGLJ1,1,NFMLTQPPSVSVSPGKTARITCRGD,NLGDVN,VHWYQQRPGQAPVLVMY,YDA,DRPSGIPERFSGSNSGNTATLTISGVEAGDEADYYC,QVWDRTSEYV,FGTGTKVTVL,2,Phase-II,NFMLTQPPSVSVSPGKTARITCRGDNLGDVNVHWYQQRPGQAPVLVMYYDADRPSGIPERFSGSNSGNTATLTISGVEAGDEADYYCQVWDRTSEYVFGTGTKVTVL,yes,2
833,Olokizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-72,0.84,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFNFNDYF,MNWVRQAPGKGLEWVAQ,MRNKNYQYGT,YYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,ARESYYGFTSY,WGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS,yes,2
834,Olokizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.86,IGKJ2,1,DIQMTQSPSSLSASVGDRVTITCQAS,QDIGIS,LSWYQQKPGKAPKLLIY,"NAN",NLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,LQHNSAPYT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK,yes,2
835,Omalizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.78,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAVS,GYSITSGYS,WNWIRQAPGKGLEWVAS,ITYDGST,NYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYC,ARGSHYFGHWHFAV,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS,yes,2
836,Omalizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.92,IGKJ1,0.92,DIQLTQSPSSLSASVGDRVTITCRAS,QSVDYDGDSY,MNWYQQKPGKAPKLLIY,AAS,YLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSHEDPYT,FGQGTKVEIK,2,Approved,DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK,yes,2
837,Omburtamab,Whole_mAb_Radiolabelled,heavy_sequence,IgG1,mouse,IGHV1-85,0.89,IGHJ3,1,QVQLQQSGAELVKPGASVKLSCKAS,GYTFTNYD,INWVRQRPEQGLEWIGW,IFPGDGST,QYNEKFKGKATLTTDTSSSTAYMQLSRLTSEDSAVYFC,ARQTTATWFAY,WGQGTLVTVSA,2,Phase-II/III,QVQLQQSGAELVKPGASVKLSCKASGYTFTNYDINWVRQRPEQGLEWIGWIFPGDGSTQYNEKFKGKATLTTDTSSSTAYMQLSRLTSEDSAVYFCARQTTATWFAYWGQGTLVTVSA,yes,2
838,Omburtamab,Whole_mAb_Radiolabelled,light_sequence,IgK,mouse,IGKV5-39,1,IGKJ5,1,DIVMTQSPATLSVTPGDRVSLSCRAS,QSISDY,LHWYQQKSHESPRLLIK,YAS,QSISGIPSRFSGSGSGSDFTLSINSVEPEDVGVYYC,QNGHSFPLT,FGAGTKLELK,2,Phase-II/III,DIVMTQSPATLSVTPGDRVSLSCRASQSISDYLHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGSDFTLSINSVEPEDVGVYYCQNGHSFPLTFGAGTKLELK,yes,2
839,Omodenbamab,Whole_mAb,heavy_sequence,IgG3,human,IGHV3-23,0.91,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSTYG,MSWVRQAPGKGLEWVSS,ITGSGRST,FYADSVKGRFTISRDNSTNTLSLQMNSLRAEDTAVYYC,ARSPADIVTGYYPWWFDL,WGQGTLVTVSS,2,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYGMSWVRQAPGKGLEWVSSITGSGRSTFYADSVKGRFTISRDNSTNTLSLQMNSLRAEDTAVYYCARSPADIVTGYYPWWFDLWGQGTLVTVSS,yes,2
840,Omodenbamab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ5,0.92,DIQMTQSPSSLSASIGDRVTITCRAS,QSINTY,LNWYQQKPGKAPRLLIA,GAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQANSFPLT,FGQGTRLEIK,2,Phase-I/II,DIQMTQSPSSLSASIGDRVTITCRASQSINTYLNWYQQKPGKAPRLLIAGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPLTFGQGTRLEIK,yes,2
849,Ontuxizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-30-4,0.68,IGHJ4,0.79,QVQLQESGPGLVRPSQTLSLTCTAS,GYTFTDYV,IHWVKQPPGRGLEWIGY,INPYDDDT,TYNQKFKGRVTMLVDTSSNTAYLRLSSVTAEDTAVYYC,ARRGNSYDGYFDYSMDY,WGSGTPVTVSS,2,Phase-II,QVQLQESGPGLVRPSQTLSLTCTASGYTFTDYVIHWVKQPPGRGLEWIGYINPYDDDTTYNQKFKGRVTMLVDTSSNTAYLRLSSVTAEDTAVYYCARRGNSYDGYFDYSMDYWGSGTPVTVSS,yes,2
850,Ontuxizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.84,IGKJ1,0.83,DIQMTQSPSSLSASVGDRVTITCRAS,QNVGTA,VAWLQQTPGKAPKLLIY,SAS,NRYTGVPSRFSGSGSGTDYTFTISSLQPEDIATYYC,QQYTNYPMYT,FGQGTKVQIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQNVGTAVAWLQQTPGKAPKLLIYSASNRYTGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQYTNYPMYTFGQGTKVQIK,yes,2
851,Onvatilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,1,IGHJ4,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,IIPIFGTA,NYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYC,ARSSYGWSYEFDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARSSYGWSYEFDYWGQGTLVTVSS,yes,2
852,Onvatilimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.95,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSIDTR,LNWYQQKPGKAPKLLIY,SAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSAYNPIT,FGQGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQSIDTRLNWYQQKPGKAPKLLIYSASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSAYNPITFGQGTKVEIK,yes,2
853,Opicinumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ3,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSAYE,MKWVRQAPGKGLEWVSV,IGPSGGFT,FYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ATEGDNDAFDI,WGQGTTVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSS,yes,2
854,Opicinumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.97,IGKJ2,1,DIQMTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPMYT,FGQGTKLEIK,2,Phase-II,DIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIK,yes,2
859,Ordesekimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.96,IGHJ4,1,EVQLVQSGAEVKKPGESLKISCKVS,GYFFTTYW,IGWVRQMPGKGLEYMGI,IYPGDSDT,RYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYC,ARGGNWNCFDY,WGQGTLVTVSS,2,Phase-I/II,EVQLVQSGAEVKKPGESLKISCKVSGYFFTTYWIGWVRQMPGKGLEYMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGGNWNCFDYWGQGTLVTVSS,yes,2
860,Ordesekimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.97,IGKJ2,0.83,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GAS,RRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QRYGSSHT,FGQGTKLEIS,2,Phase-I/II,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASRRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQRYGSSHTFGQGTKLEIS,yes,2
861,Orilanolimab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV1-81,0.93,IGHJ1,0.79,QVQLVQSGAELKKPGASVKLSCKAS,GYTFTSYG,ISWVKQATGQGLEWIGE,IYPRSGNT,YYNEKFKGRATLTADKSTSTAYMELRSLRSEDSAVYFC,ARSTTVRPPGI,WGTGTTVTVSS,2,Phase-II,QVQLVQSGAELKKPGASVKLSCKASGYTFTSYGISWVKQATGQGLEWIGEIYPRSGNTYYNEKFKGRATLTADKSTSTAYMELRSLRSEDSAVYFCARSTTVRPPGIWGTGTTVTVSS,yes,2
862,Orilanolimab,Whole_mAb,light_sequence,IgK,mouse,IGKV13-85,0.88,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,DHINNW,LAWYQQKPGQAPRLLIS,GAT,SLETGVPSRFSGSGTGKDYTLTISSLQPEDFATYYC,QQYWSTPYT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCKASDHINNWLAWYQQKPGQAPRLLISGATSLETGVPSRFSGSGTGKDYTLTISSLQPEDFATYYCQQYWSTPYTFGGGTKVEIK,yes,2
863,Orticumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.9,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSNAW,MSWVRQAPGKGLEWVSS,ISVGGHRT,YYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARIRVGPSGGAFDY,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSSISVGGHRTYYADSVKGRSTISRDNSKNTLYLQMNSLRAEDTAVYYCARIRVGPSGGAFDYWGQGTLVTVSS,yes,2
864,Orticumab,Whole_mAb,light_sequence,IgL,human,IGLV1-47,0.91,IGLJ3,1,QSVLTQPPSASGTPGQRVTISCSGS,NTNIGKNY,VSWYQQLPGTAPKLLIY,ANS,NRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,ASWDASLNGWV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCSGSNTNIGKNYVSWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCASWDASLNGWVFGGGTKLTVL,yes,2
865,Osocimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.91,IGHJ6,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSQYG,MDWVRQAPGKGLEWVSG,IGPSGGST,VYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,TRGGPYYYYGMDV,WGQGTTVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSQYGMDWVRQAPGKGLEWVSGIGPSGGSTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGGPYYYYGMDVWGQGTTVTVSS,yes,2
866,Osocimab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.99,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCQAS,QDISNY,LNWYQQKPGKAPKLLIY,DAS,NLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQADSFPVT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQADSFPVTFGGGTKVEIK,yes,2
869,Otilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-64,0.9,IGHJ4,0.86,QVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYW,MNWVRQAPGKGLEWVSG,IENKYAGGAT,YYAASVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARGFGTDF,WGQGTLVTVSS,2,Phase-III,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMNWVRQAPGKGLEWVSGIENKYAGGATYYAASVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGFGTDFWGQGTLVTVSS,yes,2
870,Otilimab,Whole_mAb,light_sequence,IgL,human,IGLV3-1,0.81,IGLJ3,0.92,DIELTQPPSVSVAPGQTARISCSGD,SIGKKY,AYWYQQKPGQAPVLVIY,KK,RPSGIPERFSGSNSGNTATLTISGTQAEDEADYYC,SAWGDKGMV,FGGGTKLTVL,2,Phase-III,DIELTQPPSVSVAPGQTARISCSGDSIGKKYAYWYQQKPGQAPVLVIYKKRPSGIPERFSGSNSGNTATLTISGTQAEDEADYYCSAWGDKGMVFGGGTKLTVL,yes,2
873,Oxelumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.95,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFNSYA,MSWVRQAPGKGLEWVSI,ISGSGGFT,YYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYC,AKDRLVAPGTFDY,WGQGALVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFNSYAMSWVRQAPGKGLEWVSIISGSGGFTYYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDRLVAPGTFDYWGQGALVTVSS,yes,2
874,Oxelumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,1,IGKJ2,1,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNSYPYT,FGQGTKLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIK,yes,2
875,Ozanezumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.85,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYW,MHWVRQAPGQGLEWIGN,INPSNGGT,NYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYC,ELMQGY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS,yes,2
876,Ozanezumab,Whole_mAb,light_sequence,IgK,mouse,IGKV2-112,0.9,IGKJ4,0.83,DIVMTQSPLSNPVTLGQPVSISCRSS,KSLLYKDGKTY,LNWFLQRPGQSPQLLIY,LMS,TRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYC,QQLVEYPLT,FGQGTKLEIK,2,Phase-II,DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK,yes,2
877,Ozoralizumab,Bispecific_Single_Domains_(VH-VH'-VH),heavy_sequence,undefined,human,IGHV3-74,0.89,IGHJ4,0.79,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSDYW,MYWVRQAPGKGLEWVSE,INTNGLIT,KYPDSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYC,ARSPSGFN,RGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYWMYWVRQAPGKGLEWVSEINTNGLITKYPDSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYCARSPSGFNRGQGTLVTVSS,yes,2
878,Ozoralizumab,Bispecific_Single_Domains_(VH-VH'-VH),heavy_sequence_bispec,undefined,human,IGHV3-23,0.88,IGHJ4,0.64,EVQLVESGGGLVQPGNSLRLSCAAS,GFTFSSFG,MSWVRQAPGKGLEWVSS,ISGSGSDT,LYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYC,TIGGSLSR,SSQGTLVTVSS,2,Phase-III,EVQLVESGGGLVQPGNSLRLSCAASGFTFSSFGMSWVRQAPGKGLEWVSSISGSGSDTLYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYCTIGGSLSRSSQGTLVTVSS,yes,2
885,Pacmilimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23D,0.93,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSS,IWRNGIVT,VYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKWSAAFDY,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSSIWRNGIVTVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKWSAAFDYWGQGTLVTVSS,yes,2
886,Pacmilimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.98,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSISSY,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQDNGYPST,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQDNGYPSTFGGGTKVEIK,yes,2
887,Palivizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV2-70,0.87,IGHJ6,0.86,QVTLRESGPALVKPTQTLTLTCTFS,GFSLSTSGMS,VGWIRQPPGKALEWLAD,IWWDDKK,DYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYC,ARSMITNWYFDV,WGAGTTVTVSS,2,Approved,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS,yes,2
888,Palivizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.83,IGKJ4,0.83,DIQMTQSPSTLSASVGDRVTITCKCQ,LSVGY,MHWYQQKPGKAPKLLIY,DTS,KLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,FQGSGYPFT,FGGGTKLEIK,2,Approved,DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK,yes,2
889,Pamrevlumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-13,0.85,IGHJ4,0.93,EGQLVQSGGGLVHPGGSLRLSCAGS,GFTFSSYG,MHWVRQAPGKGLEWVSG,IGTGGGT,YSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYC,ARGDYYGSGSFFDC,WGQGTLVTVSS,2,Phase-III,EGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSS,yes,2
890,Pamrevlumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,1,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNSYPPT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIK,yes,2
891,Panitumumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-61,0.9,IGHJ3,1,QVQLQESGPGLVKPSETLSLTCTVS,GGSVSSGDYY,WTWIRQSPGKGLEWIGH,IYYSGNT,NYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYC,VRDRVTGAFDI,WGQGTMVTVSS,2,Approved,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS,yes,2
892,Panitumumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.97,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCQAS,QDISNY,LNWYQQKPGKAPKLLIY,DAS,NLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFC,QHFDHLPLA,FGGGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK,yes,2
895,Panobacumab,Whole_mAb,heavy_sequence,IgM,human,IGHV3-74,0.92,IGHJ3,0.79,EEQVVESGGGFVQPGGSLRLSCAAS,GFTFSPYW,MHWVRQAPGKGLVWVSR,INSDGST,YYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYC,ARDRYYGPEM,WGQGTMVTVSS,2,Phase-II,EEQVVESGGGFVQPGGSLRLSCAASGFTFSPYWMHWVRQAPGKGLVWVSRINSDGSTYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRYYGPEMWGQGTMVTVSS,yes,2
896,Panobacumab,Whole_mAb,light_sequence,IgK,human,IGKV2-30,1,IGKJ4,1,DVVMTQSPLSLPVTLGQPASISCRSS,QSLVYSDGNTY,LNWFQQRPGQSPRRLIY,KVS,NRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,MQGTHWPLT,FGGGTKVEIK,2,Phase-II,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIK,yes,2
899,Pasotuxizumab,Bispecific_scFv,heavy_sequence,undefined,human,IGHV3-11,0.86,IGHJ4,0.93,QVQLVESGGGLVKPGESLRLSCAAS,GFTFSDYY,MYWVRQAPGKGLEWVAI,ISDGGYYT,YYSDIIKGRFTISRDNAKNSLYLQMNSLKAEDTAVYYC,ARGFPLLRHGAMDY,WGQGTLVTVSS,4,Phase-I,QVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMYWVRQAPGKGLEWVAIISDGGYYTYYSDIIKGRFTISRDNAKNSLYLQMNSLKAEDTAVYYCARGFPLLRHGAMDYWGQGTLVTVSS,yes,4
900,Pasotuxizumab,Bispecific_scFv,light_sequence,IgK,human,IGKV1-16,0.8,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QNVDTN,VAWYQQKPGQAPKSLIY,SAS,YRYSDVPSRFSGSASGTDFTLTISSVQSEDFATYYC,QQYDSYPYT,FGGGTKLEIK,4,Phase-I,DIQMTQSPSSLSASVGDRVTITCKASQNVDTNVAWYQQKPGQAPKSLIYSASYRYSDVPSRFSGSASGTDFTLTISSVQSEDFATYYCQQYDSYPYTFGGGTKLEIK,yes,4
901,Pasotuxizumab,Bispecific_scFv,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.91,IGHJ3,0.86,EVQLVESGGGLVQPGGSLKLSCAAS,GFTFNKYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYC,VRHGNFGNSYISYWAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISYWAYWGQGTLVTVSS,yes,4
902,Pasotuxizumab,Bispecific_scFv,light_sequence_bispec,IgL,human,IGLV7-43,0.85,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCGSS,TGAVTSGNY,PNWVQQKPGQAPRGLIG,GTK,FLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,VLWYSNRWV,FGGGTKLTVL,4,Phase-I,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCVLWYSNRWVFGGGTKLTVL,yes,4
905,Patritumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-34,0.99,IGHJ2,1,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSGYY,WSWIRQPPGKGLEWIGE,INHSGST,NYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYC,ARDKWTWYFDL,WGRGTLVTVSS,2,Phase-III,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCARDKWTWYFDLWGRGTLVTVSS,yes,2
906,Patritumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.95,IGKJ1,0.92,DIEMTQSPDSLAVSLGERATINCRSS,QSVLYSSSNRNY,LAWYQQNPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQYYSTPRT,FGQGTKVEIK,2,Phase-III,DIEMTQSPDSLAVSLGERATINCRSSQSVLYSSSNRNYLAWYQQNPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK,yes,2
915,Pelgifatamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-33,0.97,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFAFSRYG,MHWVRQAPGKGLEWVAV,IWYDGSNK,YYADSVKGRFTISRDNSKNTQYLQMNSLRAEDTAVYYC,ARGGDFLYYYYYGMDV,WGQGTTVTVSS,2,Phase-I,QVQLVESGGGVVQPGRSLRLSCAASGFAFSRYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTQYLQMNSLRAEDTAVYYCARGGDFLYYYYYGMDVWGQGTTVTVSS,yes,2
916,Pelgifatamab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1-27,0.95,IGKJ3,1,DIQMTQSPSSLSASVGDRVTITCRAS,QGISNY,LAWYQQKTGKVPKFLIY,EAS,TLQSGVPSRFSGGGSGTDFTLTISSLQPEDVATYYC,QNYNSAPFT,FGPGTKVDIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKTGKVPKFLIYEASTLQSGVPSRFSGGGSGTDFTLTISSLQPEDVATYYCQNYNSAPFTFGPGTKVDIK,yes,2
917,Pembrolizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-2,0.8,IGHJ4,0.93,QVQLVQSGVEVKKPGASVKVSCKAS,GYTFTNYY,MYWVRQAPGQGLEWMGG,INPSNGGT,NFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYC,ARRDYRFDMGFDY,WGQGTTVTVSS,2,Approved,QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS,yes,2
918,Pembrolizumab,Whole_mAb,light_sequence,IgK,human,IGKV3D-11,0.86,IGKJ4,1,EIVLTQSPATLSLSPGERATLSCRAS,KGVSTSGYSY,LHWYQQKPGQAPRLLIY,LAS,YLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QHSRDLPLT,FGGGTKVEIK,2,Approved,EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK,yes,2
919,Penpulimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.88,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFAFSSYD,MSWVRQAPGKGLDWVAT,ISGGGRYT,YYPDSVKGRFTISRDNSKNNLYLQMNSLRAEDTALYYC,ANRYGEAWFAY,WGQGTLVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFAFSSYDMSWVRQAPGKGLDWVATISGGGRYTYYPDSVKGRFTISRDNSKNNLYLQMNSLRAEDTALYYCANRYGEAWFAYWGQGTLVTVSS,yes,2
920,Penpulimab,Whole_mAb,light_sequence,IgK,mouse,IGKV14-111,0.86,IGKJ5,1,DIQMTQSPSSMSASVGDRVTFTCRAS,QDINTY,LSWFQQKPGKSPKTLIY,RAN,RLVSGVPSRFSGSGSGQDYTLTISSLQPEDMATYYC,LQYDEFPLT,FGAGTKLELK,2,Phase-III,DIQMTQSPSSMSASVGDRVTFTCRASQDINTYLSWFQQKPGKSPKTLIYRANRLVSGVPSRFSGSGSGQDYTLTISSLQPEDMATYYCLQYDEFPLTFGAGTKLELK,yes,2
921,Pepinemab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.83,IGHJ6,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYSFSDYY,MHWVRQAPGQGLEWMGQ,INPTTGGA,SYNQKFKGKATITVDKSTSTAYMELSSLRSEDTAVYYC,ARYYYGRHFDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGYSFSDYYMHWVRQAPGQGLEWMGQINPTTGGASYNQKFKGKATITVDKSTSTAYMELSSLRSEDTAVYYCARYYYGRHFDVWGQGTTVTVSS,yes,2
922,Pepinemab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.84,IGKJ2,1,DIVMTQSPDSLAVSLGERATINCKAS,QSVDYDGDSY,MNWYQQKPGQPPKLLIY,AAS,NLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQSNEDPYT,FGQGTKLEIK,2,Phase-II,DIVMTQSPDSLAVSLGERATINCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSNEDPYTFGQGTKLEIK,yes,2
923,Perakizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.91,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSDYT,MLWVRQAPGKGLEWVAI,IKSGGSYS,YYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARDGDYGSSYGAMDY,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYTMLWVRQAPGKGLEWVAIIKSGGSYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGDYGSSYGAMDYWGQGTLVTVSS,yes,2
924,Perakizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV14-111,0.85,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDINSY,LSWFQQKPGKAPKSLIV,RAN,RLVDGVPSRFSGSGSGQDYSLTISSLQPEDFATYYC,LQYDAFPPYT,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQDINSYLSWFQQKPGKAPKSLIVRANRLVDGVPSRFSGSGSGQDYSLTISSLQPEDFATYYCLQYDAFPPYTFGQGTKLEIK,yes,2
925,Pertuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.78,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFTDYT,MDWVRQAPGKGLEWVAD,VNPNSGGS,IYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYC,ARNLGPSFYFDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS,yes,2
926,Pertuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-NL1,0.86,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVSIG,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYYIYPYT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK,yes,2
931,Pidilizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV7-4-1,0.82,IGHJ4,0.93,QVQLVQSGSELKKPGASVKISCKAS,GYTFTNYG,MNWVRQAPGQGLQWMGW,INTDSGES,TYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFC,VRVGYDALDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGSELKKPGASVKISCKASGYTFTNYGMNWVRQAPGQGLQWMGWINTDSGESTYAEEFKGRFVFSLDTSVNTAYLQITSLTAEDTGMYFCVRVGYDALDYWGQGTLVTVSS,yes,2
932,Pidilizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-57,0.79,IGKJ1,0.92,EIVLTQSPSSLSASVGDRVTITCSAR,SSVSY,MHWFQQKPGKAPKLWIY,RTS,NLASGVPSRFSGSGSGTSYCLTINSLQPEDFATYYC,QQRSSFPLT,FGGGTKLEIK,2,Phase-II,EIVLTQSPSSLSASVGDRVTITCSARSSVSYMHWFQQKPGKAPKLWIYRTSNLASGVPSRFSGSGSGTSYCLTINSLQPEDFATYYCQQRSSFPLTFGGGTKLEIK,yes,2
933,Pimivalimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.97,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFPSYY,MHWVRQAPGQGLEWMGI,INPEGGST,AYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARGGTYYDYTY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFPSYYMHWVRQAPGQGLEWMGIINPEGGSTAYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGGTYYDYTYWGQGTLVTVSS,yes,2
934,Pimivalimab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.99,IGKJ4,0.92,DIQMTQSPSTLSASVGDRVTITCRAS,QSISSW,LAWYQQKPGKAPKLLIY,EAS,SLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,QQYNSFPPT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSFPPTFGGGTKVEIK,yes,2
935,Pimurutamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-48,0.78,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFSLTNYG,VHWVRQAPGKGLESWLGV,IWSGGNT,DYGNEFTSRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARALDYYDYEFAY,WGQGTMVTVSS,2,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAASGFSLTNYGVHWVRQAPGKGLESWLGVIWSGGNTDYGNEFTSRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARALDYYDYEFAYWGQGTMVTVSS,yes,2
936,Pimurutamab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.85,IGKJ4,0.83,EIVLTQSPATLSLSPGERATLSCRAS,QSIGTN,IHWYQQKPGQAPRLLIK,YAS,ESISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQNNNWPTS,FGGGTKVEIK,2,Phase-I/II,EIVLTQSPATLSLSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIKYASESISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQNNNWPTSFGGGTKVEIK,yes,2
944,Plozalizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-73,0.86,IGHJ4,0.79,EVQLVESGGGLVKPGGSLRLSCAAS,GFTFSAYA,MNWVRQAPGKGLEWVGR,IRTKNNNYAT,YYADSVKDRFTISRDDSKNTLYLQMNSLKTEDTAVYYC,TTFYGNGV,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYAMNWVRQAPGKGLEWVGRIRTKNNNYATYYADSVKDRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTFYGNGVWGQGTLVTVSS,yes,2
945,Plozalizumab,Whole_mAb,light_sequence,IgK,human,IGKV2-30,0.91,IGKJ5,0.92,DVVMTQSPLSLPVTLGQPASISCKSS,QSLLDSDGKTF,LNWFQQRPGQSPRRLIY,LVS,KLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,WQGTHFPYT,FGQGTRLEIK,2,Phase-II,DVVMTQSPLSLPVTLGQPASISCKSSQSLLDSDGKTFLNWFQQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPYTFGQGTRLEIK,yes,2
946,Pogalizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.8,IGHJ4,0.86,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDSY,MSWVRQAPGQGLEWIGD,MYPDNGDS,SYNQKFRERVTITRDTSTSTAYLELSSLRSEDTAVYYC,VLAPRWYFSV,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDSYMSWVRQAPGQGLEWIGDMYPDNGDSSYNQKFRERVTITRDTSTSTAYLELSSLRSEDTAVYYCVLAPRWYFSVWGQGTLVTVSS,yes,2
947,Pogalizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISNY,LNWYQQKPGKAPKLLIY,YTS,RLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQGHTLPPT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGHTLPPTFGQGTKVEIK,yes,2
948,Polatuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-48,0.18,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAA,SGYTFSS,YWIEWVRQAPGKGLEWI,GEILPGGG,DTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVY,YCTRRVPIRLDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,yes,2
949,Polatuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ1,0.92,DIQLTQSPSSLSASVGDRVTITCKAS,QSVDYEGDSF,LNWYQQKPGKAPKLLIY,AAS,NLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSNEDPLT,FGQGTKVEIK,2,Approved,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK,yes,2
950,Ponezumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.85,IGHJ4,0.79,QVQLVQSGAEVKKPGASVKVSCKAS,GYYTEAYY,IHWVRQAPGQGLEWMGR,IDPATGNT,KYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ASLYSLPVY,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSS,yes,2
951,Ponezumab,Whole_mAb,light_sequence,IgK,human,IGKV2-30,0.9,IGKJ5,0.83,DVVMTQSPLSLPVTLGQPASISCKSS,QSLLYSDAKTY,LNWFQQRPGQSPRRLIY,QIS,RLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC,LQGTHYPVL,FGQGTRLEIK,2,Phase-II,DVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIK,yes,2
954,Porgaviximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV6-6,0.95,IGHJ4,1,EVQLQESGGGLMQPGGSMKLSCVAS,GFTFSNYW,MNWVRQSPEKGLEWVAE,IRLKSNNYAT,HYAESVKGRFTISRDDSKRSVYLQMNTLRAEDTGIYYC,TRGNGNYRAMDY,WGQGTSVTVSS,2,Phase-II,EVQLQESGGGLMQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYATHYAESVKGRFTISRDDSKRSVYLQMNTLRAEDTGIYYCTRGNGNYRAMDYWGQGTSVTVSS,yes,2
955,Porgaviximab,Whole_mAb,light_sequence,IgK,mouse,IGKV12-46,0.95,IGKJ2,1,DIQMTQSPASLSVSVGETVSITCRAS,ENIYSS,LAWYQQKQGKSPQLLVY,SAT,ILADGVPSRFSGSGSGTQYSLKINSLQSEDFGTYYC,QHFWGTPYT,FGGGTKLEIK,2,Phase-II,DIQMTQSPASLSVSVGETVSITCRASENIYSSLAWYQQKQGKSPQLLVYSATILADGVPSRFSGSGSGTQYSLKINSLQSEDFGTYYCQHFWGTPYTFGGGTKLEIK,yes,2
956,Plonmarlimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.86,IGHJ6,0.93,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSHY,LHWVRQAPGQGLEWMGW,IFPGDDKT,KYNEKFKGRVTMTSDTSISTAYMELSRLRSDDTAVYYC,ARGTKYLNWNFDV,WGQGTTVTVSS,2,Phase-II/III,EVQLVQSGAEVKKPGASVKVSCKASGYTFTSHYLHWVRQAPGQGLEWMGWIFPGDDKTKYNEKFKGRVTMTSDTSISTAYMELSRLRSDDTAVYYCARGTKYLNWNFDVWGQGTTVTVSS,yes,2
957,Plonmarlimab,Whole_mAb,light_sequence,IgK,human,IGKV1-9,0.79,IGKJ4,0.92,DIQLTQSPSFLSASVGDRVTITCKAN,QNVGTT,LAWYQQKPGKSPKALIY,SAS,YRYSGVPDRFSGSGSGTDFTLTISSLQPEDFATYFC,HQYTTYPLT,FGGGTVEIK,2,Phase-II/III,DIQLTQSPSFLSASVGDRVTITCKANQNVGTTLAWYQQKPGKSPKALIYSASYRYSGVPDRFSGSGSGTDFTLTISSLQPEDFATYFCHQYTTYPLTFGGGTVEIK,yes,2
960,Prasinezumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.88,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSNYG,MSWVRQAPGKGLEWVAS,ISSGGGST,YYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYC,ARGGAGIDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS,yes,2
961,Prasinezumab,Whole_mAb,light_sequence,IgK,human,IGKV1-16,0.86,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCKSI,QTLLYSSNQKNY,LAWFQQKPGKAPKLLIY,WAS,IRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYC,QQYYSYPLT,FGGGTKLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK,yes,2
962,Prezalumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-7,0.98,IGHJ4,0.79,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYW,MSWVRQAPGKGLEWVAY,IKQDGNEK,YYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AREGILWFGDLPTF,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS,yes,2
963,Prezalumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.98,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISNW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYDSYPRT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK,yes,2
964,Pritoxaximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-12,0.85,IGHJ2,1,QVQLQESGAELVRSGASVRMSCKAS,GYTFTSYN,MHWVKQTPGQGLEWIGY,IYPGNGGT,NYIQKFKGKAILTADTSSSTAYMQISSLTSEDSAVYFC,TRSPSHYSSDPYFDY,WGQGTTLTVSS,2,Phase-II,QVQLQESGAELVRSGASVRMSCKASGYTFTSYNMHWVKQTPGQGLEWIGYIYPGNGGTNYIQKFKGKAILTADTSSSTAYMQISSLTSEDSAVYFCTRSPSHYSSDPYFDYWGQGTTLTVSS,yes,2
965,Pritoxaximab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-23,0.96,IGKJ5,0.92,DIVMSQSHKFMSTSVGDRVSITCKAS,QDVGTA,VAWYQQNPGQSPKFLIY,WAS,TRHTGVPDRFTGSGSGTDFTLTITNVQSEDLADYFC,QQYSSYPLT,FGAGTSLELK,2,Phase-II,DIVMSQSHKFMSTSVGDRVSITCKASQDVGTAVAWYQQNPGQSPKFLIYWASTRHTGVPDRFTGSGSGTDFTLTITNVQSEDLADYFCQQYSSYPLTFGAGTSLELK,yes,2
966,Prolgolimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-64,0.86,IGHJ4,0.86,QVQLVQSGGGLVQPGGSLRLSCAAS,GFTFSSYW,MYWVRQVPGKGLEWVSA,IDTGGGRT,YYADSVKGRFAISRVNAKNTMYLQMNSLRAEDTAVYYC,ARDEGGGTGWGVLKDWPYGLDA,WGQGTLVTVSS,2,Phase-III,QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYWMYWVRQVPGKGLEWVSAIDTGGGRTYYADSVKGRFAISRVNAKNTMYLQMNSLRAEDTAVYYCARDEGGGTGWGVLKDWPYGLDAWGQGTLVTVSS,yes,2
967,Prolgolimab,Whole_mAb,light_sequence,IgL,human,IGLV3-9,0.97,IGLJ3,0.83,QPVLTQPLSVSVALGQTARITCGGN,NIGSKN,VHWYQQKPGQAPVLVIY,RDS,NRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYC,QVWDSSTAV,FGTGTKLTVL,2,Phase-III,QPVLTQPLSVSVALGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVIYRDSNRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYCQVWDSSTAVFGTGTKLTVL,yes,2
968,Pucotenlimab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV5-9-2,0.88,IGHJ3,0.93,EVQLVQSGGGLVQPGGSLKLSCAAS,GFTFSSYG,MSWVRQAPGKGLDWVAT,ISGGGRDT,YYPDSVKGRFTISRDNSKNNLYLQMNSLRAEDTALYYC,ARQKGEAWFAY,WGQGTLVTVSS,2,Phase-II,EVQLVQSGGGLVQPGGSLKLSCAASGFTFSSYGMSWVRQAPGKGLDWVATISGGGRDTYYPDSVKGRFTISRDNSKNNLYLQMNSLRAEDTALYYCARQKGEAWFAYWGQGTLVTVSS,yes,2
969,Pucotenlimab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-2,0.91,IGKJ1,1,DIVLTQSPASLAVSPGQRATITCRAS,ESVDNYGISF,MNWFQQKPGQPPKLLIY,AAS,NKGTGVPARFSGSGSGTDFTLNINPMEENDTAMYFC,QQSKEVPWT,FGGGTKLEIK,2,Phase-II,DIVLTQSPASLAVSPGQRATITCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNKGTGVPARFSGSGSGTDFTLNINPMEENDTAMYFCQQSKEVPWTFGGGTKLEIK,yes,2
970,Quavonlimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-72,0.83,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSDNW,MNWVRQAPGKGLEWLAQ,IRNKPYNYET,YYSASVKGRFTISRDDSKNSVYLQMNSLKTEDTGVYYC,TAQFAY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDNWMNWVRQAPGKGLEWLAQIRNKPYNYETYYSASVKGRFTISRDDSKNSVYLQMNSLKTEDTGVYYCTAQFAYWGQGTLVTVSS,yes,2
971,Quavonlimab,Whole_mAb,light_sequence,IgK,mouse,IGKV12-89,0.83,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCRTS,ENIYGG,LNWYQRKPGKSPKLLIY,GAT,NLASGVSSRFSGSGSGTDYTLTISSLQPEDVATYYC,QNVLRSPFT,FGSGTKLEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRTSENIYGGLNWYQRKPGKSPKLLIYGATNLASGVSSRFSGSGSGTDYTLTISSLQPEDVATYYCQNVLRSPFTFGSGTKLEIK,yes,2
972,Quetmolimab,Whole_mAb,heavy_sequence,IgG2,mouse,IGHV1S56,0.8,IGHJ2,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTNYY,IHWVKQAPGQGLEWIGW,IYPGDGSP,KFNERFKGRTTLTADKSTNTAYMLLSSLRSEDTAVYFC,ATGPTDGDYFDY,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVKQAPGQGLEWIGWIYPGDGSPKFNERFKGRTTLTADKSTNTAYMLLSSLRSEDTAVYFCATGPTDGDYFDYWGQGTTVTVSS,yes,2
973,Quetmolimab,Whole_mAb,light_sequence,IgK,human,IGKV1-NL1,0.85,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,GNIHNF,LAWYQQKPGKAPKLLIY,NEK,TLADGVPSRFSGSGSGTDYTLTISSLQPEDFATYFC,QQFWSTPYT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASGNIHNFLAWYQQKPGKAPKLLIYNEKTLADGVPSRFSGSGSGTDYTLTISSLQPEDFATYFCQQFWSTPYTFGGGTKVEIK,yes,2
976,Racotumomab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-85,0.9,IGHJ2,1,QVQLQQSGAELVKPGASVKLSCKAS,GYTFTSYD,INWVRQRPEQGLEWIGW,IFPGDGST,KYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFC,AREDYYDNSYYFDY,WGQGTTLTVSS,2,Approved,QVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSS,yes,2
977,Racotumomab,Whole_mAb,light_sequence,IgK,mouse,IGKV10-96,1,IGKJ1,1,DIQMTQTTSSLSASLGDRVTISCRAS,QDISNY,LNWYQQKPDGTVKLLIY,YTS,RLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFC,QQGNTLPWT,FGGGTKLEIK,2,Approved,DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK,yes,2
980,Rafivirumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.91,IGHJ5,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFNRYT,VNWVRQAPGQGLEWMGG,IIPIFGTA,NYAQRFQGRLTITADESTSTAYMELSSLRSDDTAVYFC,ARENLDNSGTYYYFSGWFDP,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGGTFNRYTVNWVRQAPGQGLEWMGGIIPIFGTANYAQRFQGRLTITADESTSTAYMELSSLRSDDTAVYFCARENLDNSGTYYYFSGWFDPWGQGTLVTVSS,yes,2
981,Rafivirumab,Whole_mAb,light_sequence,IgL,human,IGLV2-11,0.96,IGLJ3,1,QSALTQPRSVSGSPGQSVTISCTGT,SSDIGGYNF,VSWYQQHPGKAPKLMIY,DAT,KRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYC,CSYAGDYTPGVV,FGGGTKLTVL,2,Phase-II,QSALTQPRSVSGSPGQSVTISCTGTSSDIGGYNFVSWYQQHPGKAPKLMIYDATKRPSGVPDRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGDYTPGVVFGGGTKLTVL,yes,2
982,Ragifilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.81,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKGS,GYTFTDYA,MYWVRQAPGQGLEWIGV,IRTYSGDV,TYNQKFKDRATMTVDKSISTAYMELSRLRSDDTAVYYC,AKSGTVRGFAY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKGSGYTFTDYAMYWVRQAPGQGLEWIGVIRTYSGDVTYNQKFKDRATMTVDKSISTAYMELSRLRSDDTAVYYCAKSGTVRGFAYWGQGTLVTVSS,yes,2
983,Ragifilimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.92,IGKJ2,1,DIVMTQSPDSLAVSLGERATINCKSS,QSLLNSGNQKNY,LTWYQQKPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYHC,QNDYSYPYT,FGQGTKLEIK,2,Phase-II,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYHCQNDYSYPYTFGQGTKLEIK,yes,2
984,Ralpancizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.92,IGHJ6,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYY,MHWVRQAPGQGLEWMGE,IHPSGGRT,NYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARERPLYASDL,WGQGTTVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEIHPSGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,yes,2
985,Ralpancizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.86,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVHTA,VAWYQQKPGKAPKLLIY,HAS,YRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQRYSLWRT,FGQGTKLEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYHASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK,yes,2
986,Ramucirumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-21,0.99,IGHJ3,1,EVQLVQSGGGLVKPGGSLRLSCAAS,GFTFSSYS,MNWVRQAPGKGLEWVSS,ISSSSSYI,YYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARVTDAFDI,WGQGTMVTVSS,2,Approved,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS,yes,2
987,Ramucirumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.86,IGKJ3,0.83,DIQMTQSPSSVSASIGDRVTITCRAS,QGIDNW,LGWYQQKPGKAPKLLIY,DAS,NLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFC,QQAKAFPPT,FGGGTKVDIK,2,Approved,DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK,yes,2
990,Ravagalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-21,0.9,IGHJ6,0.93,EVQLVESGGGLVKPGGSLRLSCAAS,GFTFSDYG,MNWVRQAPGKGLEWIAY,ISSGRGNI,YYADTVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARSWGYFDV,WGQGTTVTVSS,2,Phase-II,EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYGMNWVRQAPGKGLEWIAYISSGRGNIYYADTVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARSWGYFDVWGQGTTVTVSS,yes,2
991,Ravagalimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.91,IGKJ2,0.92,DIVMTQSPDSLAVSLGERATINCKSS,QSLLNRGNQKNY,LTWFQQKPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QNDYTYPLT,FGQGTKLEIK,2,Phase-II,DIVMTQSPDSLAVSLGERATINCKSSQSLLNRGNQKNYLTWFQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYTYPLTFGQGTKLEIK,yes,2
994,Recaticimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.9,IGHJ6,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYW,MHWVRQAPGQGLEWMGY,INPSSGFT,KYHQNFKDRVTMTRDTSISTAYMELSRLRSDDTAVYYC,ARQYDYDEDWYFDV,WGQGTTVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYWMHWVRQAPGQGLEWMGYINPSSGFTKYHQNFKDRVTMTRDTSISTAYMELSRLRSDDTAVYYCARQYDYDEDWYFDVWGQGTTVTVSS,yes,2
995,Recaticimab,Whole_mAb,light_sequence,IgK,mouse,IGKV8-21,0.85,IGKJ4,0.92,DIVMSQSPSSLSASVGDRVTITCKSS,QSLLNSRTRKNF,LAWYQQKPGKSPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQPEDFATYYC,KQSFNLFT,FGQGTKLEIK,2,Phase-I,DIVMSQSPSSLSASVGDRVTITCKSSQSLLNSRTRKNFLAWYQQKPGKSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCKQSFNLFTFGQGTKLEIK,yes,2
996,Refanezumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV7-4-1,0.94,IGHJ4,0.93,QVQLVQSGSELKKPGASVKVSCKAS,GYTFTNYG,MNWVRQAPGQGLEWMGW,INTYTGEP,TYADDFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYC,ARNPINYYGINYEGYVMDY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGSELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARNPINYYGINYEGYVMDYWGQGTLVTVSS,yes,2
997,Refanezumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.96,IGKJ2,0.92,DIVMTQSPDSLAVSLGERATINCKSS,HSVLYSSNQKNY,LAWYQQKPGQPPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,HQYLSSLT,FGQGTKLEIK,2,Phase-II,DIVMTQSPDSLAVSLGERATINCKSSHSVLYSSNQKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHQYLSSLTFGQGTKLEIK,yes,2
998,Regdanvimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV2-70,0.91,IGHJ6,1,QITLKESGPTLVKPTQTLTLTCSFS,GFSLSTSGVG,VGWIRQPPGKALEWLAL,IDWDDNK,YHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYC,ARIPGFLRYRNRYYYYGMDV,WGQGTTVTVSS,2,Approved,QITLKESGPTLVKPTQTLTLTCSFSGFSLSTSGVGVGWIRQPPGKALEWLALIDWDDNKYHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIPGFLRYRNRYYYYGMDVWGQGTTVTVSS,yes,2
999,Regdanvimab,Whole_mAb,light_sequence,IgL,human,IGLV1-51,0.98,IGLJ3,0.83,ELVLTQPPSVSAAPGQKVTISCSGS,SSNIGNNY,VSWYQQLPGTAPKLLIY,DNN,KRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYC,GTWDSSLSAGV,FGGGTELTVL,2,Approved,ELVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTELTVL,yes,2
1000,Relatlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-34,0.92,IGHJ5,1,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSDYY,WNWIRQPPGKGLEWIGE,INHRGST,NSNPSLKSRVTLSLDTSKNQFSLKLRSVTAADTAVYYC,AFGYSDYEYNWFDP,WGQGTLVTVSS,2,Phase-II/III,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWNWIRQPPGKGLEWIGEINHRGSTNSNPSLKSRVTLSLDTSKNQFSLKLRSVTAADTAVYYCAFGYSDYEYNWFDPWGQGTLVTVSS,yes,2
1001,Relatlimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ5,0.83,EIVLTQSPATLSLSPGERATLSCRAS,QSISSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPLT,FGQGTNLEIK,2,Phase-II/III,EIVLTQSPATLSLSPGERATLSCRASQSISSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGQGTNLEIK,yes,2
1002,Remtolumab,Bispecific_Dual_Variable_Domain_IG,heavy_sequence,IgG1,human,IGHV3-9,0.93,IGHJ4,0.93,EVQLVESGGGLVQPGRSLRLSCAAS,GFTFDDYA,MHWVRQAPGKGLEWVSA,ITWNSGHI,DYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AKVSYLSTASSLDY,WGQGTLVTVSS,4,Phase-II,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS,yes,4
1003,Remtolumab,Bispecific_Dual_Variable_Domain_IG,light_sequence,IgK,human,IGKV1-27,0.97,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGIRNY,LAWYQQKPGKAPKLLIY,AAS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYC,QRYNRAPYT,FGQGTKVEIK,4,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK,yes,4
1004,Remtolumab,Bispecific_Dual_Variable_Domain_IG,heavy_sequence_bispec,undefined,human,IGHV1-69,0.86,IGHJ5,0.93,EVQLVQSGAEVKKPGSSVKVSCKAS,GGSFGGYG,IGWVRQAPGQGLEWMGG,ITPFFGFA,DYAQKFQGRVTITADESTTTAYMELSGLTSDDTAVYYC,ARDPNEFWNGYYSTHDFDS,WGQGTTVTVSS,4,Phase-II,EVQLVQSGAEVKKPGSSVKVSCKASGGSFGGYGIGWVRQAPGQGLEWMGGITPFFGFADYAQKFQGRVTITADESTTTAYMELSGLTSDDTAVYYCARDPNEFWNGYYSTHDFDSWGQGTTVTVSS,yes,4
1005,Remtolumab,Bispecific_Dual_Variable_Domain_IG,light_sequence_bispec,IgK,human,IGKV6-21,0.9,IGKJ3,0.92,EIVLTQSPDFQSVTPKEKVTITCRAS,QDIGSE,LHWYQQKPDQPPKLLIK,YAS,HSTSGVPSRFSGSGSGTDFTLTINGLEAEDAGTYYC,HQTDSLPYT,FGPGTKVDIK,4,Phase-II,EIVLTQSPDFQSVTPKEKVTITCRASQDIGSELHWYQQKPDQPPKLLIKYASHSTSGVPSRFSGSGSGTDFTLTINGLEAEDAGTYYCHQTDSLPYTFGPGTKVDIK,yes,4
1008,Retifanlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.82,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYSFTSYW,MNWVRQAPGQGLEWIGV,IHPSDSET,WLDQKFKDRVTITVDKSTSTAYMELSSLRSEDTAVYYC,AREHYGTSPFAY,WGQGTLVTVSS,2,Preregistration,QVQLVQSGAEVKKPGASVKVSCKASGYSFTSYWMNWVRQAPGQGLEWIGVIHPSDSETWLDQKFKDRVTITVDKSTSTAYMELSSLRSEDTAVYYCAREHYGTSPFAYWGQGTLVTVSS,yes,2
1009,Retifanlimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.8,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCRAS,ESVDNYGMSF,MNWFQQKPGQPPKLLIH,AAS,NQGSGVPSRFSGSGSGTDFTLTISSLEPEDFAVYFC,QQSKEVPYT,FGGGTKVEIK,2,Preregistration,EIVLTQSPATLSLSPGERATLSCRASESVDNYGMSFMNWFQQKPGQPPKLLIHAASNQGSGVPSRFSGSGSGTDFTLTISSLEPEDFAVYFCQQSKEVPYTFGGGTKVEIK,yes,2
1010,Retlirafusp,Whole_mAb_Fusion,heavy_sequence,IgG4,human,IGHV1-46,0.9,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYW,MHWVRQAPGQGLEWMGR,IGPNSGFT,SYNEKFKNRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARGGSSYDYFDY,WGQGTTVTVSS,2,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWMGRIGPNSGFTSYNEKFKNRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGGSSYDYFDYWGQGTTVTVSS,yes,2
1011,Retlirafusp,Whole_mAb_Fusion,light_sequence,IgK,mouse,IGKV3-5,0.84,IGKJ4,0.83,DIVLTQSPASLAVSPGQRATITCRAS,ESVSIHGTHL,MHWYQQKPGQPPKLLIY,AAS,NLESGVPARFSGSGSGTDFTLTINPVEAEDTANYYC,QQSFEDPLT,FGQGTKLEIK,2,Phase-I/II,DIVLTQSPASLAVSPGQRATITCRASESVSIHGTHLMHWYQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLTINPVEAEDTANYYCQQSFEDPLTFGQGTKLEIK,yes,2
1012,Revdofilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.89,IGHJ6,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSRYG,MSWVRQAPGKGLELVAT,INSNGGRT,YYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AREGITTAYAMDY,WGQGTTVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYGMSWVRQAPGKGLELVATINSNGGRTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGITTAYAMDYWGQGTTVTVSS,yes,2
1013,Revdofilimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.84,IGKJ4,0.92,DIVMTQSPDSLAVSLGERATINCKAS,QSVDYDGDSY,MHWYQQKPGQPPKLLIY,AAS,ILESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQSNEDPRT,FGGGTKVEIK,2,Phase-I,DIVMTQSPDSLAVSLGERATINCKASQSVDYDGDSYMHWYQQKPGQPPKLLIYAASILESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSNEDPRTFGGGTKVEIK,yes,2
1014,Rilotumumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-59,0.97,IGHJ4,1,QVQLQESGPGLVKPSETLSLTCTVS,GGSISIYY,WSWIRQPPGKGLEWIGY,VYYSGST,NYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYC,ARGGYDFWSGYFDY,WGQGTLVTVSS,2,Phase-II,QVQLQESGPGLVKPSETLSLTCTVSGGSISIYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDFWSGYFDYWGQGTLVTVSS,yes,2
1015,Rilotumumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.97,IGKJ5,1,EIVMTQSPATLSVSPGERATLSCRAS,QSVDSN,LAWYRQKPGQAPRLLIY,GAS,TRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQYINWPPIT,FGQGTRLEIK,2,Phase-II,EIVMTQSPATLSVSPGERATLSCRASQSVDSNLAWYRQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYINWPPITFGQGTRLEIK,yes,2
1016,Rinucumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-39,0.93,IGHJ5,1,QLQLQESGPGLVKPSETLSLTCTVS,GGSITSSSYY,WGWIRQPPGKGLEWIGS,IYYRGST,NYNPSLKSRVTISVDSSKNQFYLKVSSVTAVDTAVYYC,ARQNGAARPSWFDP,WGQGTLVTVSS,2,Phase-II,QLQLQESGPGLVKPSETLSLTCTVSGGSITSSSYYWGWIRQPPGKGLEWIGSIYYRGSTNYNPSLKSRVTISVDSSKNQFYLKVSSVTAVDTAVYYCARQNGAARPSWFDPWGQGTLVTVSS,yes,2
1017,Rinucumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.91,IGKJ3,0.92,EIVLTQSPDTISLSPGERATLSCRAS,QSISSIY,LAWYQQKPGQAPRLLIY,GAS,SRVTGIPDRFSVSGSGTDFTLTISRLEPEDFAVYYC,QHYGISPFT,FGPGTKVDIR,2,Phase-II,EIVLTQSPDTISLSPGERATLSCRASQSISSIYLAWYQQKPGQAPRLLIYGASSRVTGIPDRFSVSGSGTDFTLTISRLEPEDFAVYYCQHYGISPFTFGPGTKVDIR,yes,2
1018,Ripertamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-12,0.92,IGHJ1,0.86,QVQLQQPGAELVKPGASVKMSCKAS,GYTFTSYN,MHWVKQTPGRGLEWIGA,IYPGNGDT,SYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYC,ARSTYYGGDWYFNV,WGAGTTVTVSA,2,Phase-III,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA,yes,2
1019,Ripertamab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.96,IGKJ1,0.92,QIVLSQSPAILSASPGEKVTMTCRAS,SSVSY,IHWFQQKPGSSPKPWIY,ATS,NLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYC,QQWTSNPPT,FGGGTKLEIK,2,Phase-III,QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK,yes,2
1020,Risankizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.79,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTDQT,IHWMRQAPGQGLEWIGY,IYPRDDSP,KYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYC,AIPDRSGYAWFIY,WGQGTLVTVSS,2,Approved,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS,yes,2
1021,Risankizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.8,IGKJ2,0.83,DIQMTQSPSSLSASVGDRVTITCKAS,RDVAIA,VAWYQQKPGKVPKLLIY,WAS,TRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFC,HQYSSYPFT,FGSGTKLEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK,yes,2
1022,Rituximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-12,0.92,IGHJ1,0.86,QVQLQQPGAELVKPGASVKMSCKAS,GYTFTSYN,MHWVKQTPGRGLEWIGA,IYPGNGDT,SYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYC,ARSTYYGGDWYFNV,WGAGTTVTVSA,2,Approved,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA,yes,2
1023,Rituximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.96,IGKJ1,0.92,QIVLSQSPAILSASPGEKVTMTCRAS,SSVSY,IHWFQQKPGSSPKPWIY,ATS,NLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYC,QQWTSNPPT,FGGGTKLEIK,2,Approved,QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK,yes,2
1026,Robatumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-21,0.87,IGHJ6,1,EVQLVQSGGGLVKPGGSLRLSCAAS,GFTFSSFA,MHWVRQAPGKGLEWISV,IDTRGAT,YYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARLGNFYYGMDV,WGQGTTVTVSS,2,Phase-II,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS,yes,2
1027,Robatumumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.84,IGKJ1,0.92,EIVLTQSPGTLSVSPGERATLSCRAS,QSIGSS,LHWYQQKPGQAPRLLIK,YAS,QSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,HQSSRLPHT,FGQGTKVEIK,2,Phase-II,EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK,yes,2
1028,Roledumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.87,IGHJ3,0.93,QVQLVESGGGVVQPGRSLRLSCTAS,GFTFKNYA,MHWVRQAPAKGLEWVAT,ISYDGRNI,QYADSVKGRFTFSRDNSQDTLYLQLNSLRPEDTAVYYC,ARPVRSRWLQLGLEDAFHI,WGQGTMVTVSS,2,Phase-II/III,QVQLVESGGGVVQPGRSLRLSCTASGFTFKNYAMHWVRQAPAKGLEWVATISYDGRNIQYADSVKGRFTFSRDNSQDTLYLQLNSLRPEDTAVYYCARPVRSRWLQLGLEDAFHIWGQGTMVTVSS,yes,2
1029,Roledumab,Whole_mAb,light_sequence,IgK,human,IGKV1-8,0.91,IGKJ5,0.75,AIRMTQSPSSFSASTGDRVTITCRAS,QDIRNY,VAWYQQKSGKAPKFLIY,AAS,TLQSGVPSRFSGSGSGTDFTLTINSLQSEDFATYYC,QQYYNSPPT,FGQGTRVEIT,2,Phase-II/III,AIRMTQSPSSFSASTGDRVTITCRASQDIRNYVAWYQQKSGKAPKFLIYAASTLQSGVPSRFSGSGSGTDFTLTINSLQSEDFATYYCQQYYNSPPTFGQGTRVEIT,yes,2
1030,Rolinsatamab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-69,0.83,IGHJ3,0.86,EVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTTYW,MHWVRQAPGQGLEWIGE,IDPSDSYS,NYNQKFKDRATLTVDKSTSTAYMELSSLRSEDTAVYYC,ARNGGLGPAWFSY,WGQGTLVTVSS,2,Phase-I,EVQLVQSGAEVKKPGSSVKVSCKASGYTFTTYWMHWVRQAPGQGLEWIGEIDPSDSYSNYNQKFKDRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNGGLGPAWFSYWGQGTLVTVSS,yes,2
1031,Rolinsatamab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV6-13,0.82,IGKJ1,0.92,DIQMTQSPSSVSASVGDRVTITCKAS,QYVGTA,VAWYQQKPGKSPKLLIY,SAS,NRYTGVPSRFSDSGSGTDFTLTISSLQPEDFATYFC,QQYSSYPWT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSVSASVGDRVTITCKASQYVGTAVAWYQQKPGKSPKLLIYSASNRYTGVPSRFSDSGSGTDFTLTISSLQPEDFATYFCQQYSSYPWTFGGGTKVEIK,yes,2
1032,Romilkimab,Bispecific_Dual_Variable_Domain_IG,heavy_sequence,IgG1,mouse,IGHV2-6-7,0.84,IGHJ4,0.93,EVQLKESGPGLVAPGGSLSITCTVS,GFSLTDSS,INWVRQPPGKGLEWLGM,IWGDGRI,DYADALKSRLSISKDSSKSQVFLEMTSLRTDDTATYYC,ARDGYFPYAMDF,WGQGTSVTVSS,4,Phase-II,EVQLKESGPGLVAPGGSLSITCTVSGFSLTDSSINWVRQPPGKGLEWLGMIWGDGRIDYADALKSRLSISKDSSKSQVFLEMTSLRTDDTATYYCARDGYFPYAMDFWGQGTSVTVSS,yes,4
1033,Romilkimab,Bispecific_Dual_Variable_Domain_IG,light_sequence,IgK,mouse,IGKV3-10,0.91,IGKJ1,0.92,DIVLTQSPASLAVSLGQRATISCRAS,ESVDSYGQSY,MHWYQQKAGQPPKLLIY,LAS,NLESGVPARFSGSGSRTDFTLTIDPVQAEDAATYYC,QQNAEDSRT,FGGGTKLEIK,4,Phase-II,DIVLTQSPASLAVSLGQRATISCRASESVDSYGQSYMHWYQQKAGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVQAEDAATYYCQQNAEDSRTFGGGTKLEIK,yes,4
1034,Romilkimab,Bispecific_Dual_Variable_Domain_IG,heavy_sequence_bispec,undefined,mouse,IGHV1-66,0.81,IGHJ1,0.93,QVQLQQSGPELVKPGASVKISCKAS,GYSFTSYW,IHWIKQRPGQGLEWIGM,IDPSDGET,RLNQRFQGRATLTVDESTSTAYMQLRSPTSEDSAVYYC,TRLKEYGNYDSFYFDV,WGAGTLVTVSS,4,Phase-II,QVQLQQSGPELVKPGASVKISCKASGYSFTSYWIHWIKQRPGQGLEWIGMIDPSDGETRLNQRFQGRATLTVDESTSTAYMQLRSPTSEDSAVYYCTRLKEYGNYDSFYFDVWGAGTLVTVSS,yes,4
1035,Romilkimab,Bispecific_Dual_Variable_Domain_IG,light_sequence_bispec,IgK,human,IGKV1-33,0.78,IGKJ4,0.83,DIQMTQSPASLSVSVGDTITLTCHAS,QNIDVW,LSWFQQKPGNIPKLLIY,KAS,NLHTGVPSRFSGSGSGTGFTLTISSLQPEDIATYYC,QQAHSYPFT,FGGGTKLEIK,4,Phase-II,DIQMTQSPASLSVSVGDTITLTCHASQNIDVWLSWFQQKPGNIPKLLIYKASNLHTGVPSRFSGSGSGTGFTLTISSLQPEDIATYYCQQAHSYPFTFGGGTKLEIK,yes,4
1036,Romosozumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-2,0.88,IGHJ6,0.93,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYN,MHWVRQAPGQGLEWMGE,INPNSGGA,GYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARLGYDDIYDDWYFDV,WGQGTTVTVSS,2,Approved,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS,yes,2
1037,Romosozumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISNY,LNWYQQKPGKAPKLLIY,YTS,RLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQGDTLPYT,FGGGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK,yes,2
1040,Rosmantuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.84,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYS,IHWVRQAPGQGLEWIGY,IYPSNGDS,GYNQKFKNRVTMTRDTSTSTAYMELSRLRSEDTAVYYC,ATYFANNFDY,WGQGTTLTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYSIHWVRQAPGQGLEWIGYIYPSNGDSGYNQKFKNRVTMTRDTSTSTAYMELSRLRSEDTAVYYCATYFANNFDYWGQGTTLTVSS,yes,2
1041,Rosmantuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.89,IGKJ4,0.75,DIQMTQSPSSLSASVGDRVTITCKAS,QSVDYDGDSY,MNWYQQKPGKAPKLLIY,AAS,NLESGVPSRFSGSGSGTDFTLTISPVQAEDFATYYC,QQSNEDPLT,FGAGTKLELK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISPVQAEDFATYYCQQSNEDPLTFGAGTKLELK,yes,2
1042,Rosopatamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-26,0.78,IGHJ2,0.93,EVQLVQSGPEVKKPGATVKISCKTS,GYTFTEYT,IHWVKQAPGKGLEWIGN,INPNNGGT,TYNQKFEDKATLTVDKSTDTAYMELSSLRSEDTAVYYC,AAGWNFDY,WGQGTLLTVSS,2,Phase-II,EVQLVQSGPEVKKPGATVKISCKTSGYTFTEYTIHWVKQAPGKGLEWIGNINPNNGGTTYNQKFEDKATLTVDKSTDTAYMELSSLRSEDTAVYYCAAGWNFDYWGQGTLLTVSS,yes,2
1043,Rosopatamab,Whole_mAb,light_sequence,IgK,mouse,IGKV6-23,0.8,IGKJ4,0.67,DIQMTQSPSSLSTSVGDRVTLTCKAS,QDVGTA,VDWYQQKPGPSPKLLIY,WAS,TRHTGIPSRFSGSGSGTDFTLTISSLQPEDFADYYC,QQYNSYPLT,FGPGTKVDIK,2,Phase-II,DIQMTQSPSSLSTSVGDRVTLTCKASQDVGTAVDWYQQKPGPSPKLLIYWASTRHTGIPSRFSGSGSGTDFTLTISSLQPEDFADYYCQQYNSYPLTFGPGTKVDIK,yes,2
1044,Rovalpituzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-18,0.87,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTNYG,MNWVRQAPGQGLEWMGW,INTYTGEP,TYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARIGDSSPSDY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS,yes,2
1045,Rovalpituzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3-15,0.89,IGKJ1,0.92,EIVMTQSPATLSVSPGERATLSCKAS,QSVSND,VVWYQQKPGQAPRLLIY,YAS,NRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQDYTSPWT,FGQGTKLEIK,2,Phase-III,EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK,yes,2
1046,Rozanolixizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-7,0.85,IGHJ4,0.93,EVPLVESGGGLVQPGGSLRLSCAVS,GFTFSNYG,MVWVRQAPGKGLEWVAY,IDSDGDNT,YYRDSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYC,TTGIVRPFLY,WGQGTLVTVSS,2,Phase-III,EVPLVESGGGLVQPGGSLRLSCAVSGFTFSNYGMVWVRQAPGKGLEWVAYIDSDGDNTYYRDSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCTTGIVRPFLYWGQGTLVTVSS,yes,2
1047,Rozanolixizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.82,IGKJ2,0.92,DIQMTQSPSSLSASVGDRVTITCKSS,QSLVGASGKTY,LYWLFQKPGKAPKRLIY,LVS,TLDSGIPSRFSGSGSGTEFTLTISSLQPEDFATYYC,LQGTHFPHT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCKSSQSLVGASGKTYLYWLFQKPGKAPKRLIYLVSTLDSGIPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQGTHFPHTFGQGTKLEIK,yes,2
1048,Rozibafusp,Whole_mAb_Fusion,heavy_sequence,IgG2,human,IGHV3-7,0.98,IGHJ4,0.79,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYW,MSWVRQAPGKGLEWVAY,IKQDGNEK,YYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AREGILWFGDLPTF,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS,yes,2
1049,Rozibafusp,Whole_mAb_Fusion,light_sequence,IgK,human,IGKV1D-16,0.98,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISNW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYDSYPRT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK,yes,2
1054,Ruplizumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-53,0.84,IGHJ4,0.86,QVQLVQSGAEVVKPGASVKLSCKAS,GYIFTSYY,MYWVKQAPGQGLEWIGE,INPSNGDT,NFNEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYC,TRSDGRNDMDS,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSS,yes,2
1055,Ruplizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-7,0.86,IGKJ1,0.92,DIVLTQSPATLSVSPGERATISCRAS,QRVSSSTYSY,MHWYQQKPGQPPKLLIK,YAS,NLESGVPARFSGSGSGTDFTLTISSVEPEDFATYYC,QHSWEIPPT,FGGGTKLEIK,2,Phase-II,DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEIPPTFGGGTKLEIK,yes,2
1056,Sabatolimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.88,IGHJ6,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTSYN,MHWVRQAPGQGLEWMGD,IYPGNGDT,SYNQKFKGRVTITADKSTSTVYMELSSLRSEDTAVYYC,ARVGGAFPMDY,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVRQAPGQGLEWMGDIYPGNGDTSYNQKFKGRVTITADKSTSTVYMELSSLRSEDTAVYYCARVGGAFPMDYWGQGTTVTVSS,yes,2
1057,Sabatolimab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,0.86,IGKJ4,0.92,AIQLTQSPSSLSASVGDRVTITCRAS,ESVEYYGTSL,MQWYQQKPGKAPKLLIY,AAS,NVESGVPSRFSGSGSGTDFTLTISSLQPEDFATYFC,QQSRKDPST,FGGGTKVEIK,2,Phase-III,AIQLTQSPSSLSASVGDRVTITCRASESVEYYGTSLMQWYQQKPGKAPKLLIYAASNVESGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCQQSRKDPSTFGGGTKVEIK,yes,2
1058,Sacituzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV7-4-1,0.86,IGHJ4,0.86,QVQLQQSGSELKKPGASVKVSCKAS,GYTFTNYG,MNWVKQAPGQGLKWMGW,INTYTGEP,TYTDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFC,ARGGFGSSYWYFDV,WGQGSLVTVSS,2,Approved,QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGMNWVKQAPGQGLKWMGWINTYTGEPTYTDDFKGRFAFSLDTSVSTAYLQISSLKADDTAVYFCARGGFGSSYWYFDVWGQGSLVTVSS,yes,2
1059,Sacituzumab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV6-17,0.84,IGKJ5,0.83,DIQLTQSPSSLSASVGDRVSITCKAS,QDVSIA,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPDRFSGSGSGTDFTLTISSLQPEDFAVYYC,QQHYITPLT,FGAGTKVEIK,2,Approved,DIQLTQSPSSLSASVGDRVSITCKASQDVSIAVAWYQQKPGKAPKLLIYSASYRYTGVPDRFSGSGSGTDFTLTISSLQPEDFAVYYCQQHYITPLTFGAGTKVEIK,yes,2
1060,Samalizumab,Whole_mAb,heavy_sequence,IgG2,mouse,IGHV1-66,0.73,IGHJ2,1,QVQLQQSGSELKKPGASVKISCKAS,GYSFTDYI,ILWVRQNPGKGLEWIGH,IDPYYGSS,NYNLKFKGRVTITADQSTTTAYMELSSLRSEDTAVYYC,GRSKRDYFDY,WGQGTTLTVSS,2,Phase-I,QVQLQQSGSELKKPGASVKISCKASGYSFTDYIILWVRQNPGKGLEWIGHIDPYYGSSNYNLKFKGRVTITADQSTTTAYMELSSLRSEDTAVYYCGRSKRDYFDYWGQGTTLTVSS,yes,2
1061,Samalizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV14-111,0.85,IGKJ2,1,DIQMTQSPSSLSASIGDRVTITCKAS,QDINSY,LSWFQQKPGKAPKLLIY,RAN,RLVDGVPSRFSGSGSGTDYTLTISSLQPEDFAVYYC,LQYDEFPYT,FGGGTKLEIK,2,Phase-I,DIQMTQSPSSLSASIGDRVTITCKASQDINSYLSWFQQKPGKAPKLLIYRANRLVDGVPSRFSGSGSGTDYTLTISSLQPEDFAVYYCLQYDEFPYTFGGGTKLEIK,yes,2
1062,Samrotamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-2,0.78,IGHJ4,0.93,EVQLVQSGAEVKKPGASVKVSCKAS,GYKFSSYW,IEWVKQAPGQGLEWIGE,ILPGSDTT,NYNEKFKDRATFTSDTSINTAYMELSRLRSDDTAVYYC,ARDRGNYRAWFGY,WGQGTLVTVSS,2,Phase-I,EVQLVQSGAEVKKPGASVKVSCKASGYKFSSYWIEWVKQAPGQGLEWIGEILPGSDTTNYNEKFKDRATFTSDTSINTAYMELSRLRSDDTAVYYCARDRGNYRAWFGYWGQGTLVTVSS,yes,2
1063,Samrotamab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV10-96,0.86,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISNY,LNWYQQKPGGAVKFLIY,YTS,RLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYFC,QQGEALPWT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGGAVKFLIYYTSRLHSGVPSRFSGSGSGTDYTLTISSLQPEDFATYFCQQGEALPWTFGGGTKVEIK,yes,2
1064,Sapelizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-59,0.76,IGHJ4,0.86,QVQLQESGPGLVKPSETLSLTCAVS,GHSISHDHA,WSWVRQPPGEGLEWIGF,ISYSGIT,NYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARSLARTTAMDY,WGEGTLVTVSS,2,Approved,QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS,yes,2
1065,Sapelizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.83,IGKJ1,0.83,DIQMTQSPSSLSASVGDSVTITCQAS,TDISSH,LNWYQQKPGKAPELLIY,YGS,HLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYC,GQGNRLPYT,FGQGTKVEIE,2,Approved,DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE,yes,2
1066,Sarilumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-9,0.94,IGHJ3,1,EVQLVESGGGLVQPGRSLRLSCAAS,RFTFDDYA,MHWVRQAPGKGLEWVSG,ISWNSGRI,GYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYC,AKGRDSFDI,WGQGTMVTVSS,2,Approved,EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS,yes,2
1067,Sarilumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.97,IGKJ2,1,DIQMTQSPSSVSASVGDRVTITCRAS,QGISSW,LAWYQQKPGKAPKLLIY,GAS,SLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYC,QQANSFPYT,FGQGTKLEIK,2,Approved,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK,yes,2
1068,Sasanlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.86,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYW,INWVRQAPGQGLEWMGN,IYPGSSLT,NYNEKFKNRVTMTRDTSTSTVYMELSSLRSEDTAVYYC,ARLSTGTFAY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWINWVRQAPGQGLEWMGNIYPGSSLTNYNEKFKNRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLSTGTFAYWGQGTLVTVSS,yes,2
1069,Sasanlimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.89,IGKJ4,0.92,DIVMTQSPDSLAVSLGERATINCKSS,QSLWDSGNQKNF,LTWYQQKPGQPPKLLIY,WTS,YRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QNDYFYPHT,FGGGTKVEIK,2,Phase-III,DIVMTQSPDSLAVSLGERATINCKSSQSLWDSGNQKNFLTWYQQKPGQPPKLLIYWTSYRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYFYPHTFGGGTKVEIK,yes,2
1070,Satralizumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-59,0.76,IGHJ4,0.86,QVQLQESGPGLVKPSETLSLTCAVS,GHSISHDHA,WSWVRQPPGEGLEWIGF,ISYSGIT,NYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARSLARTTAMDY,WGEGTLVTVSS,2,Approved,QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS,yes,2
1071,Satralizumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.83,IGKJ1,0.83,DIQMTQSPSSLSASVGDSVTITCQAS,TDISSH,LNWYQQKPGKAPELLIY,YGS,HLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYC,GQGNRLPYT,FGQGTKVEIE,2,Approved,DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE,yes,2
1072,Secukinumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.93,IGHJ2,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSNYW,MNWVRQAPGKGLEWVAA,INQDGSEK,YYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYC,VRDYYDILTDYYIHYWYFDL,WGRGTLVTVSS,2,Approved,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS,yes,2
1073,Secukinumab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.99,IGKJ5,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVSSSY,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYGSSPCT,FGQGTRLEIK,2,Approved,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK,yes,2
1074,Selicrelumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-2,0.98,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTGYY,MHWVRQAPGQGLEWMGW,INPDSGGT,NYAQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYYC,ARDQPLGYCTNGVCSYFDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPDSGGTNYAQKFQGRVTMTRDTSISTAYMELNRLRSDDTAVYYCARDQPLGYCTNGVCSYFDYWGQGTLVTVSS,yes,2
1075,Selicrelumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.96,IGKJ4,1,DIQMTQSPSSVSASVGDRVTITCRAS,QGIYSW,LAWYQQKPGKAPNLLIY,TAS,TLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQANIFPLT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSVSASVGDRVTITCRASQGIYSWLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANIFPLTFGGGTKVEIK,yes,2
1078,Serclutamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV4-30-4,0.8,IGHJ4,0.93,EVQLQESGPGLVKPSQTLSLTCTVS,GYSISRDFA,WNWIRQPPGKGLEWMGY,ISYNGNT,RYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYC,VTASRGFPY,WGQGTLVTVSS,2,Phase-I,EVQLQESGPGLVKPSQTLSLTCTVSGYSISRDFAWNWIRQPPGKGLEWMGYISYNGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTASRGFPYWGQGTLVTVSS,yes,2
1079,Serclutamab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV14-100,0.86,IGKJ1,1,DIQMTQSPSSMSVSVGDRVTITCHSS,QDINSN,IGWLQQKPGKSFKGLIY,HGT,NLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,VQYAQFPWT,FGGGTKLEIK,2,Phase-I,DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK,yes,2
1080,Seribantumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23D,0.91,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSHYV,MAWVRQAPGKGLEWVSS,ISSSGGWT,LYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,TRGLKMATIFDY,WGQGTLVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYVMAWVRQAPGKGLEWVSSISSSGGWTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMATIFDYWGQGTLVTVSS,yes,2
1081,Seribantumab,Whole_mAb,light_sequence,IgL,human,IGLV2-23,0.96,IGLJ3,0.83,QSALTQPASVSGSPGQSITISCTGT,SSDVGSYNV,VSWYQQHPGKAPKLIIY,EVS,QRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYC,CSYAGSSIFVI,FGGGTKVTVL,2,Phase-II,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNVVSWYQQHPGKAPKLIIYEVSQRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCCSYAGSSIFVIFGGGTKVTVL,yes,2
1082,Serplulimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-11,0.92,IGHJ4,0.79,QVQLVESGGGLVKPGGSLRLSCAAS,GFTFSNYG,MSWIRQAPGKGLEWVST,ISGGGSNI,YYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,VSYYYGIDF,WGQGTSVTVSS,2,Phase-III,QVQLVESGGGLVKPGGSLRLSCAASGFTFSNYGMSWIRQAPGKGLEWVSTISGGGSNIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCVSYYYGIDFWGQGTSVTVSS,yes,2
1083,Serplulimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.85,IGKJ1,0.83,DIQMTQSPSSLSASVGDRVTITCKAS,QDVTTA,VAWYQQKPGKAPKLLIY,WAS,TRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQHYTIPWT,FGGGTKLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCKASQDVTTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYTIPWTFGGGTKLEIK,yes,2
1084,Setoxaximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-39,0.85,IGHJ1,0.86,EVQLQQPGPELEKPGASVKLSCKAS,GYSFTDYN,MNWVKQNNGESLEWIGK,IDPYYGGP,SYNQKFKDKATLTVDKSSSTAYMQLKSLTSEDSAVYYC,TRGGNRDWYFDV,WGAGTTLTVSA,2,Phase-II,EVQLQQPGPELEKPGASVKLSCKASGYSFTDYNMNWVKQNNGESLEWIGKIDPYYGGPSYNQKFKDKATLTVDKSSSTAYMQLKSLTSEDSAVYYCTRGGNRDWYFDVWGAGTTLTVSA,yes,2
1085,Setoxaximab,Whole_mAb,light_sequence,IgK,mouse,IGKV8-30,0.95,IGKJ5,1,DIVLSQSPSSLVVSVGEKVTMSCKSS,QSLLYSRNQKNY,LAWYQQKPGQSPKVLIY,WAS,TRESGVPDRLTGSGSGTDFTLTISSVKAEDLAVYYC,QQYYSYPLT,FGAGTKLELK,2,Phase-II,DIVLSQSPSSLVVSVGEKVTMSCKSSQSLLYSRNQKNYLAWYQQKPGQSPKVLIYWASTRESGVPDRLTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK,yes,2
1086,Setrusumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-74,0.9,IGHJ4,1,QVQLVESGGGLVQPGGSLRLSCAAS,GFTFRSHW,LSWVRQAPGKGLEWVSN,INYDGSST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDTYLHFDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSS,yes,2
1087,Setrusumab,Whole_mAb,light_sequence,IgL,human,IGLV2-14,0.91,IGLJ3,0.92,DIALTQPASVSGSPGQSITISCTGT,SSDVGDIND,VSWYQQHPGKAPKLMIY,DVN,NRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYC,QSYAGSYLSEV,FGGGTKLTVL,2,Phase-II,DIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVL,yes,2
1088,Sibeprenlimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV1-46,0.86,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYT,IHWVRQATGQGLEWMGW,IYPLRGSI,NYAQKFQGRVTMTADKSISTVYMELSSLRSEDTAVYFC,ARHGAYYSNAFDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYTIHWVRQATGQGLEWMGWIYPLRGSINYAQKFQGRVTMTADKSISTVYMELSSLRSEDTAVYFCARHGAYYSNAFDYWGQGTLVTVSS,yes,2
1089,Sibeprenlimab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.91,IGKJ4,0.92,EIVMTQSPATLSVSPGERATLSCRAS,ESVDNDGIRF,LHWYQQKPGQAPRLLIY,RAS,TRATGIPARFSGSGSRTEFTLTISSLQSEDFAVYYC,QQSNKDPYT,FGGGTKVEIK,2,Phase-I,EIVMTQSPATLSVSPGERATLSCRASESVDNDGIRFLHWYQQKPGQAPRLLIYRASTRATGIPARFSGSGSRTEFTLTISSLQSEDFAVYYCQQSNKDPYTFGGGTKVEIK,yes,2
1092,Siltuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV5-9-4,0.96,IGHJ4,0.93,EVQLVESGGKLLKPGGSLKLSCAAS,GFTFSSFA,MSWFRQSPEKRLEWVAE,ISSGGSYT,YYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYC,ARGLWGYYALDY,WGQGTSVTVSS,2,Approved,EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS,yes,2
1093,Siltuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-55,0.99,IGKJ2,1,QIVLIQSPAIMSASPGEKVTMTCSAS,SSVSY,MYWYQQKPGSSPRLLIY,DTS,NLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYC,QQWSGYPYT,FGGGTKLEIK,2,Approved,QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK,yes,2
1094,Simlukafusp,Whole_mAb_Fusion,heavy_sequence,IgG1,human,IGHV3-23D,0.98,IGHJ4,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSA,IIGSGAST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKGWFGGFNY,WGQGTLVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAIIGSGASTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGWFGGFNYWGQGTLVTVSS,yes,2
1095,Simlukafusp,Whole_mAb_Fusion,light_sequence,IgK,human,IGKV3-20,0.92,IGKJ1,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVTSSY,LAWYQQKPGQAPRLLIN,VGS,RRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQGIMLPPT,FGQGTKVEIK,2,Phase-I,EIVLTQSPGTLSLSPGERATLSCRASQSVTSSYLAWYQQKPGQAPRLLINVGSRRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQGIMLPPTFGQGTKVEIK,yes,2
1098,Sintilimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.94,IGHJ4,1,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGL,IIPMFDTA,GYAQKFQGRVAITVDESTSTAYMELSSLRSEDTAVYYC,ARAEHSSTGTFDY,WGQGTLVTVSS,2,Approved,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGLIIPMFDTAGYAQKFQGRVAITVDESTSTAYMELSSLRSEDTAVYYCARAEHSSTGTFDYWGQGTLVTVSS,yes,2
1099,Sintilimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.99,IGKJ4,0.92,DIQMTQSPSSVSASVGDRVTITCRAS,QGISSW,LAWYQQKPGKAPKLLIS,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQANHLPFT,FGGGTKVEIK,2,Approved,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANHLPFTFGGGTKVEIK,yes,2
1102,Sirukumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.88,IGHJ6,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSPFA,MSWVRQAPGKGLEWVAK,ISPGGSWT,YYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARQLWGYYALDI,WGQGTTVTVSS,2,Phase-III,EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS,yes,2
1103,Sirukumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.89,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCSAS,ISVSY,MYWYQQKPGQAPRLLIY,DMS,NLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,MQWSGYPYT,FGGGTKVEIK,2,Phase-III,EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK,yes,2
1108,Solitomab,Bispecific_scFv,heavy_sequence,undefined,mouse,IGHV1-54,0.87,IGHJ4,0.93,EVQLLEQSGAELVRPGTSVKISCKAS,GYAFTNYW,LGWVKQRPGHGLEWIGD,IFPGSGNI,HYNEKFKGKATLTADKSSSTAYMQLSSLTFEDSAVYFC,ARLRNWDEPMDY,WGQGTTVTVSS,4,Phase-I,EVQLLEQSGAELVRPGTSVKISCKASGYAFTNYWLGWVKQRPGHGLEWIGDIFPGSGNIHYNEKFKGKATLTADKSSSTAYMQLSSLTFEDSAVYFCARLRNWDEPMDYWGQGTTVTVSS,yes,4
1109,Solitomab,Bispecific_scFv,light_sequence,IgK,mouse,IGKV8-19,0.98,IGKJ5,0.92,ELVMTQSPSSLTVTAGEKVTMSCKSS,QSLLNSGNQKNY,LTWYQQKPGQPPKLLIY,WAS,TRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYC,QNDYSYPLT,FGAGTKLEIK,4,Phase-I,ELVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPLTFGAGTKLEIK,yes,4
1110,Solitomab,Bispecific_scFv,heavy_sequence_bispec,undefined,human,IGHV1-46,0.82,IGHJ4,0.86,DVQLVQSGAEVKKPGASVKVSCKAS,GYTFTRYT,MHWVRQAPGQGLEWIGY,INPSRGYT,NYADSVKGRFTITTDKSTSTAYMELSSLRSEDTATYYC,ARYYDDHYCLDY,WGQGTTVTVSS,4,Phase-I,DVQLVQSGAEVKKPGASVKVSCKASGYTFTRYTMHWVRQAPGQGLEWIGYINPSRGYTNYADSVKGRFTITTDKSTSTAYMELSSLRSEDTATYYCARYYDDHYCLDYWGQGTTVTVSS,yes,4
1111,Solitomab,Bispecific_scFv,light_sequence_bispec,IgK,mouse,IGKV4-59,0.8,IGKJ1,0.83,DIVLTQSPATLSLSPGERATLSCRAS,QSVSY,MNWYQQKPGKAPKRWIY,DTS,KVASGVPARFSGSGSGTDYSLTINSLEAEDAATYYC,QQWSSNPLT,FGGGTKVEIK,4,Phase-I,DIVLTQSPATLSLSPGERATLSCRASQSVSYMNWYQQKPGKAPKRWIYDTSKVASGVPARFSGSGSGTDYSLTINSLEAEDAATYYCQQWSSNPLTFGGGTKVEIK,yes,4
1114,Sotrovimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-18,0.93,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYPFTSYG,ISWVRQAPGQGLEWMGW,ISTYQGNT,NYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYC,ARDYTRGAWFGESLIGGFDN,WGQGTLVTVSS,2,Preregistration,QVQLVQSGAEVKKPGASVKVSCKASGYPFTSYGISWVRQAPGQGLEWMGWISTYQGNTNYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYCARDYTRGAWFGESLIGGFDNWGQGTLVTVSS,yes,2
1115,Sotrovimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.94,IGKJ4,1,EIVLTQSPGTLSLSPGERATLSCRAS,QTVSSTS,LAWYQQKPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQHDTSLT,FGGGTKVEIK,2,Preregistration,EIVLTQSPGTLSLSPGERATLSCRASQTVSSTSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQHDTSLTFGGGTKVEIK,yes,2
1116,Spartalizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-69,0.74,IGHJ4,0.79,EVQLVQSGAEVKKPGESLRISCKGS,GYTFTTYW,MHWVRQATGQGLEWMGN,IYPGTGGS,NFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYC,TRWTTGTGAY,WGQGTTVTVSS,2,Phase-II,EVQLVQSGAEVKKPGESLRISCKGSGYTFTTYWMHWVRQATGQGLEWMGNIYPGTGGSNFDEKFKNRVTITADKSTSTAYMELSSLRSEDTAVYYCTRWTTGTGAYWGQGTTVTVSS,yes,2
1117,Spartalizumab,Whole_mAb,light_sequence,IgK,human,IGKV3D-7,0.78,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCKSS,QSLLDSGNQKNF,LTWYQQKPGQAPRLLIY,WAS,TRESGVPSRFSGSGSGTDFTFTISSLEAEDAATYYC,QNDYSYPYT,FGQGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCKSSQSLLDSGNQKNFLTWYQQKPGQAPRLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLEAEDAATYYCQNDYSYPYTFGQGTKVEIK,yes,2
1118,Spesolimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.8,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYSFTSSW,IHWVKQAPGQGLEWMGE,INPGNVRT,NYNENFRNKVTMTVDTSISTAYMELSRLRSDDTAVYYC,TVVFYGEPYFPY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYSFTSSWIHWVKQAPGQGLEWMGEINPGNVRTNYNENFRNKVTMTVDTSISTAYMELSRLRSDDTAVYYCTVVFYGEPYFPYWGQGTLVTVSS,yes,2
1119,Spesolimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.78,IGKJ4,0.83,QIVLTQSPGTLSLSPGERATMTCTAS,SSVSSSY,FHWYQQKPGQAPRLWIY,RTS,RLASGVPDRFSGSGSGTDFTLTISRLEPEDAATYYC,HQFHRSPLT,FGAGTKLEIK,2,Phase-III,QIVLTQSPGTLSLSPGERATMTCTASSSVSSSYFHWYQQKPGQAPRLWIYRTSRLASGVPDRFSGSGSGTDFTLTISRLEPEDAATYYCHQFHRSPLTFGAGTKLEIK,yes,2
1120,Sudubrilimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.86,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSETW,LHWVRQAPGKGLEWVAW,VSPFGGST,YYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYC,ARRHWPGGFDY,WGQGTLVTVSS,2,Unknown,EVQLVESGGGLVQPGGSLRLSCAASGFTFSETWLHWVRQAPGKGLEWVAWVSPFGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS,yes,2
1121,Sudubrilimab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,0.89,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDVSTA,VAWYQQKPGKAPKLLIY,SAS,FLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFLYHPAT,FGQGTKVEIK,2,Unknown,DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFLYHPATFGQGTKVEIK,yes,2
1122,Sugemalimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23D,0.98,IGHJ4,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSG,ISGSGGFT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,AKPPRGYNYGPFDY,WGQGTLVTVSS,2,Phase-III,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGGFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPPRGYNYGPFDYWGQGTLVTVSS,yes,2
1123,Sugemalimab,Whole_mAb,light_sequence,IgL,human,IGLV3-21,1,IGLJ3,1,SYVLTQPPSVSVAPGQTARITCGGN,NIGSKS,VHWYQQKPGQAPVLVVY,DDS,DRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYC,QVWDSSSDHVV,FGGGTKLTVL,2,Phase-III,SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,yes,2
1124,Suptavumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-9,0.88,IGHJ6,0.93,EVQLVESGGDLVQPGRSLRLSCVAS,GFTFDDYA,MHWVRQAPGKGLEWVSG,VSWSGSTV,GYADSVKGRFTVSRDNAQKSLYLQMNSLRAEDTALYYC,VKDAYKFNYYYYGLDV,WGQGTTVTVSS,2,Phase-III,EVQLVESGGDLVQPGRSLRLSCVASGFTFDDYAMHWVRQAPGKGLEWVSGVSWSGSTVGYADSVKGRFTVSRDNAQKSLYLQMNSLRAEDTALYYCVKDAYKFNYYYYGLDVWGQGTTVTVSS,yes,2
1125,Suptavumab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.95,IGKJ4,1,EIVMTQSPATLSVSPGERATLSCRAS,QTILSN,LAWYLQKPGQAPRLLIY,GAS,TRATGLPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQYNNWPLT,FGGGTKVEIK,2,Phase-III,EIVMTQSPATLSVSPGERATLSCRASQTILSNLAWYLQKPGQAPRLLIYGASTRATGLPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK,yes,2
1126,Surzebiclimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.91,IGHJ4,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSRYA,MSWVRQAPGKGLEWVAA,ISSGGSL,YYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYC,ARGREADGGYFDY,WGQGTLVTVSS,2,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYAMSWVRQAPGKGLEWVAAISSGGSLYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARGREADGGYFDYWGQGTLVTVSS,yes,2
1127,Surzebiclimab,Whole_mAb,light_sequence,IgK,human,IGKV3-15,0.86,IGKJ4,1,EIVLTQSPATLSVSPGERATLSCRAS,ESVEYYGTSL,MQWYQQKPGQAPRLLIY,AAS,NVESGIPARFSGSGSGTEFTLTISSLQSEDFAVYYC,QQSLKVPLT,FGGGTKVEIK,2,Phase-I/II,EIVLTQSPATLSVSPGERATLSCRASESVEYYGTSLMQWYQQKPGQAPRLLIYAASNVESGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSLKVPLTFGGGTKVEIK,yes,2
1128,Sutimlimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.9,IGHJ4,0.93,EVQLVESGGGLVKPGGSLRLSCAAS,GFTFSNYA,MSWVRQAPGKGLEWVAT,ISSGGSHT,YYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYC,ARLFTGYAMDY,WGQGTLVTVSS,2,Preregistration,EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSS,yes,2
1129,Sutimlimab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-74,0.82,IGKJ4,0.83,QIVLTQSPATLSLSPGERATMSCTAS,SSVSSSY,LHWYQQKPGKAPKLWIY,STS,NLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,HQYYRLPPIT,FGQGTKLEIK,2,Preregistration,QIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIK,yes,2
1134,Tabalumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-34,1,IGHJ4,1,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSGYY,WSWIRQPPGKGLEWIGE,INHSGST,NYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARGYYDILTGYYYYFDY,WGQGTLVTVSS,2,Phase-III,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS,yes,2
1135,Tabalumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.98,IGKJ1,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSRY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYC,QQRSNWPRT,FGQGTKVEIK,2,Phase-III,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK,yes,2
1136,Tabituximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV14-3,0.99,IGHJ3,1,EVQLQQSGAELVKPGASVKLSCTAS,GFNINDTY,MHWVKQRPEQGLEWIGR,IDPANGNT,KYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYC,ARGARGSRFAY,WGQGTLVTVSA,2,Phase-I,EVQLQQSGAELVKPGASVKLSCTASGFNINDTYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARGARGSRFAYWGQGTLVTVSA,yes,2
1137,Tabituximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV12-46,0.99,IGKJ2,1,DIQMTQSPASLSVSVGETVTITCRAS,ENIYSN,LAWYQQKQGKSPQLLVY,VAT,NLADGVPSRFSGSGSGTQYSLKINSLQSEDFGSYYC,QHFWGTPYT,FGGGTKLEIK,2,Phase-I,DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYVATNLADGVPSRFSGSGSGTQYSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTKLEIK,yes,2
1140,Tafasitamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.73,IGHJ4,1,EVQLVESGGGLVKPGGSLKLSCAAS,GYTFTSYV,MHWVRQAPGKGLEWIGY,INPYNDGT,KYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYC,ARGTYYYGTRVFDY,WGQGTLVTVSS,2,Approved,EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS,yes,2
1141,Tafasitamab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.76,IGKJ5,0.83,DIVMTQSPATLSLSPGERATLSCRSS,KSLQNVNGNTY,LYWFQQKPGQSPQLLIY,RMS,NLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYC,MQHLEYPIT,FGAGTKLEIK,2,Approved,DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK,yes,2
1142,Tafolecimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-39,0.96,IGHJ5,0.93,QLQLQESGPGLVKPSETLSLTCTVS,GGSISSASYY,WSWIRQPPGKGLEWIGS,INYRGST,YYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARENSGVVPAAGPNWFGP,WGQGTLVTVSS,2,Phase-III,QLQLQESGPGLVKPSETLSLTCTVSGGSISSASYYWSWIRQPPGKGLEWIGSINYRGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARENSGVVPAAGPNWFGPWGQGTLVTVSS,yes,2
1143,Tafolecimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.99,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRRNWFT,FGGGTKVEIK,2,Phase-III,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRRNWFTFGGGTKVEIK,yes,2
1144,Talacotuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.83,IGHJ4,0.86,EVQLVQSGAEVKKPGESLKISCKGS,GYSFTDYY,MKWARQMPGKGLEWMGD,IIPSNGAT,FYNQKFKGQVTISADKSISTTYLQWSSLKASDTAMYYC,ARSHLLRASWFAY,WGQGTMVTVSS,2,Phase-III,EVQLVQSGAEVKKPGESLKISCKGSGYSFTDYYMKWARQMPGKGLEWMGDIIPSNGATFYNQKFKGQVTISADKSISTTYLQWSSLKASDTAMYYCARSHLLRASWFAYWGQGTMVTVSS,yes,2
1145,Talacotuzumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.91,IGKJ2,1,DIVMTQSPDSLAVSLGERATINCESS,QSLLNSGNQKNY,LTWYQQKPGQPPKPLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QNDYSYPYT,FGQGTKLEIK,2,Phase-III,DIVMTQSPDSLAVSLGERATINCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK,yes,2
1146,Talquetamab,Bispecific_mAb,heavy_sequence,IgG4,human,IGHV1-18,0.9,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYSFTGYT,MNWVRQAPGQGLEWMGL,INPYNSDT,NYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARVALRVALDY,WGQGTLVTVSS,4,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYSFTGYTMNWVRQAPGQGLEWMGLINPYNSDTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVALRVALDYWGQGTLVTVSS,yes,4
1147,Talquetamab,Bispecific_mAb,light_sequence,IgK,human,IGKV1-17,0.86,IGKJ2,1,DIQMTQSPSSLSASVGDRVTITCKAS,QNVATH,VGWYQQKPGKAPKRLIY,SAS,YRYSGVPSRFSGSGSGTEFTLTISNLQPEDFATYYC,QQYNRYPYT,FGQGTKLEIK,4,Phase-II,DIQMTQSPSSLSASVGDRVTITCKASQNVATHVGWYQQKPGKAPKRLIYSASYRYSGVPSRFSGSGSGTEFTLTISNLQPEDFATYYCQQYNRYPYTFGQGTKLEIK,yes,4
1148,Talquetamab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV3-72,0.88,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFNTYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,ARHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFNTYAMNWVRQAPGKGLEWVARIRSKYNNYATYYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
1149,Talquetamab,Bispecific_mAb,light_sequence_bispec,IgL,human,IGLV7-43,0.82,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCRSS,TGAVTTSNY,ANWVQQKPGQAPRGLIG,GTN,KRAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-II,QTVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWVQQKPGQAPRGLIGGTNKRAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCALWYSNLWVFGGGTKLTVL,yes,4
1150,Tamrintamab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-69,0.86,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYW,IEWVRQAPGQGLEWMGE,ILPGSGNT,YYNERFKDRVTITADESTSTAYMELSSLRSEDTAVYYC,ARRAAAYYSNPEWFAY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYWIEWVRQAPGQGLEWMGEILPGSGNTYYNERFKDRVTITADESTSTAYMELSSLRSEDTAVYYCARRAAAYYSNPEWFAYWGQGTLVTVSS,yes,2
1151,Tamrintamab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV3D-20,0.87,IGKJ2,1,EIVLTQSPATLSLSPGERATLSCTAS,SSVNSFY,LHWYQQKPGLAPRLLIY,STS,NLASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,HQYHRSPYT,FGQGTKLEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCTASSSVNSFYLHWYQQKPGLAPRLLIYSTSNLASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQYHRSPYTFGQGTKLEIK,yes,2
1152,Tanezumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV4-38-2,0.83,IGHJ4,1,QVQLQESGPGLVKPSETLSLTCTVS,GFSLIGYD,LNWIRQPPGKGLEWIGI,IWGDGTT,DYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYC,ARGGYWYATSYYFDY,WGQGTLVTVSS,2,Preregistration,QVQLQESGPGLVKPSETLSLTCTVSGFSLIGYDLNWIRQPPGKGLEWIGIIWGDGTTDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARGGYWYATSYYFDYWGQGTLVTVSS,yes,2
1153,Tanezumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.88,IGKJ2,1,DIQMTQSPSSLSASVGDRVTITCRAS,QSISNN,LNWYQQKPGKAPKLLIY,YTS,RFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQEHTLPYT,FGQGTKLEIK,2,Preregistration,DIQMTQSPSSLSASVGDRVTITCRASQSISNNLNWYQQKPGKAPKLLIYYTSRFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQEHTLPYTFGQGTKLEIK,yes,2
1154,Tanibirumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.85,IGHJ4,1,QMQLVQSGAEVKKPGASVKLSCKAS,GYTFSSYW,MHWVRQAPGQRLEWMGE,INPGNGHT,NYNEKFKSRVTITVDKSASTAYMELSSLRSEDTAVYYC,AKIWGPSLTSPFDY,WGQGTLVTVSS,2,Phase-II,QMQLVQSGAEVKKPGASVKLSCKASGYTFSSYWMHWVRQAPGQRLEWMGEINPGNGHTNYNEKFKSRVTITVDKSASTAYMELSSLRSEDTAVYYCAKIWGPSLTSPFDYWGQGTLVTVSS,yes,2
1155,Tanibirumab,Whole_mAb,light_sequence,IgL,human,IGLV3-21,0.85,IGLJ1,1,NFMLTQPPSVSVSPGKTARITCRGD,NLGDVN,VHWYQQRPGQAPVLVMY,YDA,DRPSGIPERFSGSNSGNTATLTISGVEAGDEADYYC,QVWDRTSEYV,FGTGTKVTVL,2,Phase-II,NFMLTQPPSVSVSPGKTARITCRGDNLGDVNVHWYQQRPGQAPVLVMYYDADRPSGIPERFSGSNSGNTATLTISGVEAGDEADYYCQVWDRTSEYVFGTGTKVTVL,yes,2
1156,Tarextumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23,0.93,IGHJ4,0.79,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSSG,MSWVRQAPGKGLEWVSV,IASSGSNT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARSIFYTT,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSS,yes,2
1157,Tarextumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.93,IGKJ1,0.92,DIVLTQSPATLSLSPGERATLSCRAS,QSVRSNY,LAWYQQKPGQAPRLLIY,GAS,SRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQYSNFPIT,FGQGTKVEIK,2,Phase-II,DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIK,yes,2
1158,Tarlatamab,Bispecific_scFv,heavy_sequence,undefined,human,IGHV4-59,0.96,IGHJ4,1,QVQLQESGPGLVKPSETLSLTCTVS,GGSISSYY,WSWIRQPPGKCLEWIGY,VYYSGTT,NYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ASIAVTGFYFDY,WGQGTLVTVSS,4,Phase-I,QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKCLEWIGYVYYSGTTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCASIAVTGFYFDYWGQGTLVTVSS,yes,4
1159,Tarlatamab,Bispecific_scFv,light_sequence,IgK,human,IGKV3-20,0.92,IGKJ4,0.83,EIVLTQSPGTLSLSPGERVTLSCRAS,QRVNNNY,LAWYQQRPGQAPRLLIY,GAS,SRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,QQYDRSPLT,FGCGTKLEIK,4,Phase-I,EIVLTQSPGTLSLSPGERVTLSCRASQRVNNNYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYDRSPLTFGCGTKLEIK,yes,4
1160,Tarlatamab,Bispecific_scFv,heavy_sequence_bispec,undefined,mouse,IGHV10-1,0.91,IGHJ3,0.86,EVQLVESGGGLVQPGGSLKLSCAAS,GFTFNKYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYC,VRHGNFGNSYISYWAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISYWAYWGQGTLVTVSS,yes,4
1161,Tarlatamab,Bispecific_scFv,light_sequence_bispec,IgL,human,IGLV7-43,0.85,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCGSS,TGAVTSGNY,PNWVQQKPGQAPRGLIG,GTK,FLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,VLWYSNRWV,FGGGTKLTVL,4,Phase-I,QTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCVLWYSNRWVFGGGTKLTVL,yes,4
1168,Tebotelimab,Bispecific_scFv_with_Crossover,heavy_sequence,IgG4,human,IGHV1-46,0.82,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYSFTSYW,MNWVRQAPGQGLEWIGV,IHPSDSET,WLDQKFKDRVTITVDKSTSTAYMELSSLRSEDTAVYYC,AREHYGTSPFAY,WGQGTLVTVSS,4,Phase-II/III,QVQLVQSGAEVKKPGASVKVSCKASGYSFTSYWMNWVRQAPGQGLEWIGVIHPSDSETWLDQKFKDRVTITVDKSTSTAYMELSSLRSEDTAVYYCAREHYGTSPFAYWGQGTLVTVSS,yes,4
1169,Tebotelimab,Bispecific_scFv_with_Crossover,light_sequence,IgK,human,IGKV3-11,0.8,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCRAS,ESVDNYGMSF,MNWFQQKPGQPPKLLIH,AAS,NQGSGVPSRFSGSGSGTDFTLTISSLEPEDFAVYFC,QQSKEVPYT,FGGGTKVEIK,4,Phase-II/III,EIVLTQSPATLSLSPGERATLSCRASESVDNYGMSFMNWFQQKPGQPPKLLIHAASNQGSGVPSRFSGSGSGTDFTLTISSLEPEDFAVYFCQQSKEVPYTFGGGTKVEIK,yes,4
1170,Tebotelimab,Bispecific_scFv_with_Crossover,heavy_sequence_bispec,undefined,human,IGHV1-18,0.87,IGHJ4,0.86,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYN,MDWVRQAPGQGLEWMGD,INPDNGVT,IYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,AREADYFYFDY,WGQGTTLTVSS,4,Phase-II/III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMDWVRQAPGQGLEWMGDINPDNGVTIYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCAREADYFYFDYWGQGTTLTVSS,yes,4
1171,Tebotelimab,Bispecific_scFv_with_Crossover,light_sequence_bispec,IgK,human,IGKV1D-39,0.88,IGKJ1,0.83,DIQMTQSPSSLSASVGDRVTITCRAS,QDVSSV,VAWYQQKPGKAPKLLIY,SAS,YRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQHYSTPWT,FGGGTKLEIK,4,Phase-II/III,DIQMTQSPSSLSASVGDRVTITCRASQDVSSVVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKLEIK,yes,4
1172,Teclistamab,Bispecific_mAb,heavy_sequence,IgG4,human,IGHV4-39,0.97,IGHJ4,1,QLQLQESGPGLVKPSETLSLTCTVS,GGSISSGSYF,WGWIRQPPGKGLEWIGS,IYYSGIT,YYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARHDGAVAGLFDY,WGQGTLVTVSS,4,Phase-II,QLQLQESGPGLVKPSETLSLTCTVSGGSISSGSYFWGWIRQPPGKGLEWIGSIYYSGITYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARHDGAVAGLFDYWGQGTLVTVSS,yes,4
1173,Teclistamab,Bispecific_mAb,light_sequence,IgL,human,IGLV3-21,0.97,IGLJ3,1,SYVLTQPPSVSVAPGQTARITCGGN,NIGSKS,VHWYQQPPGQAPVVVVY,DDS,DRPSGIPERFSGSNSGNTATLTISRVEAGDEAVYYC,QVWDSSSDHVV,FGGGTKLTVL,4,Phase-II,SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQPPGQAPVVVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEAVYYCQVWDSSSDHVVFGGGTKLTVL,yes,4
1174,Teclistamab,Bispecific_mAb,heavy_sequence_bispec,undefined,human,IGHV3-72,0.88,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFNTYA,MNWVRQAPGKGLEWVAR,IRSKYNNYAT,YYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYC,ARHGNFGNSYVSWFAY,WGQGTLVTVSS,4,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFNTYAMNWVRQAPGKGLEWVARIRSKYNNYATYYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARHGNFGNSYVSWFAYWGQGTLVTVSS,yes,4
1175,Teclistamab,Bispecific_mAb,light_sequence_bispec,IgL,human,IGLV7-43,0.82,IGLJ3,1,QTVVTQEPSLTVSPGGTVTLTCRSS,TGAVTTSNY,ANWVQQKPGQAPRGLIG,GTN,KRAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYC,ALWYSNLWV,FGGGTKLTVL,4,Phase-II,QTVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWVQQKPGQAPRGLIGGTNKRAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYYCALWYSNLWVFGGGTKLTVL,yes,4
1178,Telisotuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV1-2,0.93,IGHJ4,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYIFTAYT,MHWVRQAPGQGLEWMGW,IKPNNGLA,NYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYC,ARSEITTEFDY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVKKPGASVKVSCKASGYIFTAYTMHWVRQAPGQGLEWMGWIKPNNGLANYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSEITTEFDYWGQGTLVTVSS,yes,2
1179,Telisotuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV4-1,0.87,IGKJ4,1,DIVMTQSPDSLAVSLGERATINCKSS,ESVDSYANSF,LHWYQQKPGQPPKLLIY,RAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQSKEDPLT,FGGGTKVEIK,2,Phase-I,DIVMTQSPDSLAVSLGERATINCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEDPLTFGGGTKVEIK,yes,2
1180,Temelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-46,0.8,IGHJ4,0.93,QVQLVQSGAEVKKPGSSVKVSCKAS,GYTFTDYE,MHWVRQAPGQGLEWIGA,VAPETGGT,AYNQKFKGRATITADKSTSTAYMELSSLRSEDTAVYYC,TSTVVPFAY,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYEMHWVRQAPGQGLEWIGAVAPETGGTAYNQKFKGRATITADKSTSTAYMELSSLRSEDTAVYYCTSTVVPFAYWGQGTLVTVSS,yes,2
1181,Temelimab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.82,IGKJ4,1,QIQLTQSPSSLSASVGDRVTITCSAS,SSVSY,MYWYQQKPGKAPKAWIY,RTS,NLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,QQYQSLPLT,FGGGTKVEIK,2,Phase-II,QIQLTQSPSSLSASVGDRVTITCSASSSVSYMYWYQQKPGKAPKAWIYRTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYQSLPLTFGGGTKVEIK,yes,2
1184,Teplizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-30,0.72,IGHJ4,0.86,QVQLVQSGGGVVQPGRSLRLSCKAS,GYTFTRYT,MHWVRQAPGKGLEWIGY,INPSRGYT,NYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFC,ARYYDDHYCLDY,WGQGTPVTVSS,2,Preregistration,QVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKGLEWIGYINPSRGYTNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYCLDYWGQGTPVTVSS,yes,2
1185,Teplizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.82,IGKJ2,0.75,DIQMTQSPSSLSASVGDRVTITCSAS,SSVSY,MNWYQQTPGKAPKRWIY,DTS,KLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYC,QQWSSNPFT,FGQGTKLQIT,2,Preregistration,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSNPFTFGQGTKLQIT,yes,2
1192,Tesidolumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.97,IGHJ4,1,EVQLVQSGAEVKKPGSSVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,IGPFFGTA,NYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYC,ARDTPYFDY,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIGPFFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARDTPYFDYWGQGTLVTVSS,yes,2
1193,Tesidolumab,Whole_mAb,light_sequence,IgL,human,IGLV3-9,0.88,IGLJ3,0.92,SYELTQPLSVSVALGQTARITCSGD,SIPNYY,VYWYQQKPGQAPVLVIY,DDS,NRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYC,QSFDSSLNAEV,FGGGTKLTVL,2,Phase-II,SYELTQPLSVSVALGQTARITCSGDSIPNYYVYWYQQKPGQAPVLVIYDDSNRPSGIPERFSGSNSGNTATLTISRAQAGDEADYYCQSFDSSLNAEVFGGGTKLTVL,yes,2
1196,Tezepelumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-33,0.94,IGHJ3,1,QMQLVESGGGVVQPGRSLRLSCAAS,GFTFRTYG,MHWVRQAPGKGLEWVAV,IWYDGSNK,HYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYC,ARAPQWELVHEAFDI,WGQGTMVTVSS,2,Phase-III,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS,yes,2
1197,Tezepelumab,Whole_mAb,light_sequence,IgL,human,IGLV3-21,0.97,IGLJ3,1,SYVLTQPPSVSVAPGQTARITCGGN,NLGSKS,VHWYQQKPGQAPVLVVY,DDS,DRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYC,QVWDSSSDHVV,FGGGTKLTVL,2,Phase-III,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,yes,2
1202,Ticilimumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-33,1,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,IWYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDPRGATLYYYYYGMDV,WGQGTTVTVSS,2,Phase-III,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS,yes,2
1203,Ticilimumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.97,IGKJ3,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSINSY,LDWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYYSTPFT,FGPGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK,yes,2
1204,Tidutamab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence,IgG1,human,IGHV3-48,0.91,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSDYG,MAWFRQAPGKGLEWVSF,ISNLGYSI,YYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,ARAPYDYDSFDPMDY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGMAWFRQAPGKGLEWVSFISNLGYSIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARAPYDYDSFDPMDYWGQGTLVTVSS,yes,4
1205,Tidutamab,Bispecific_Mixed_mAb_and_scFv,light_sequence,IgK,human,IGKV4-1,0.92,IGKJ1,0.92,DIVMTQSPDSLAVSLGERATINCKSS,QSLLNSRNRKNY,LAWYQQKPDQSPKLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,KQSYYLWT,FGGGTKVEIK,4,Phase-I,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRNRKNYLAWYQQKPDQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCKQSYYLWTFGGGTKVEIK,yes,4
1206,Tidutamab,Bispecific_Mixed_mAb_and_scFv,heavy_sequence_bispec,undefined,human,IGHV3-73,0.87,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSTYA,MNWVRQAPGKGLEWVGR,IRSKYNNYAT,YYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYC,VRHGNFGDSYVSWFAY,WGQGTLVTVSS,4,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYVSWFAYWGQGTLVTVSS,yes,4
1207,Tidutamab,Bispecific_Mixed_mAb_and_scFv,light_sequence_bispec,IgL,mouse,IGLV1,0.81,IGLJ1,1,QAVVTQEPSLTVSPGGTVTLTCGSS,TGAVTTSNY,ANWVQQKPGKSPRGLIG,GTN,KRAPGVPARFSGSLLGGKAALTISGAQPEDEADYYC,ALWYSNHWV,FGGGTKLTVL,4,Phase-I,QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNKRAPGVPARFSGSLLGGKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVL,yes,4
1208,Tigatuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-7,0.91,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSSYV,MSWVRQAPGKGLEWVAT,ISSGGSYT,YYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYC,ARRGDSMITTDY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS,yes,2
1209,Tigatuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1-33,0.85,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKAS,QDVGTA,VAWYQQKPGKAPKLLIY,WAS,TRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYSSYRT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK,yes,2
1210,Tilavonemab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV6-3,0.92,IGHJ2,0.86,EVKVVESGGGLVQPGGSMKLSCVVS,GFTFSNYW,VNWVRQAPGKGLEWVAQ,IRLKSDNYAT,HYEESVKGRFTISRDDSKSSVYLQMNNLRAEDSGIYYC,TNWEDY,WGQGTTVTVSS,2,Phase-II,EVKVVESGGGLVQPGGSMKLSCVVSGFTFSNYWVNWVRQAPGKGLEWVAQIRLKSDNYATHYEESVKGRFTISRDDSKSSVYLQMNNLRAEDSGIYYCTNWEDYWGQGTTVTVSS,yes,2
1211,Tilavonemab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-7,0.88,IGKJ4,0.83,DIVLTQSPDSLAVSLGERATISCRAS,QSVSTSRYSY,IHWYQQKPGQPPKLLIK,YAS,NLESGVPSRFGSGSGTDFTLNIHPLEPEDFATYYC,HHSWEIPLT,FGQGTKLEIK,2,Phase-II,DIVLTQSPDSLAVSLGERATISCRASQSVSTSRYSYIHWYQQKPGQPPKLLIKYASNLESGVPSRFGSGSGTDFTLNIHPLEPEDFATYYCHHSWEIPLTFGQGTKLEIK,yes,2
1214,Tilogotamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-3,0.85,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GFNIKDTH,MHWVRQAPGQRLEWIGR,IDPANGNT,EYDQKFQGRVTITVDTSASTAYMELSSLRSEDTAVYYC,ARWGTNVYFAY,WGQGTLVTVSS,2,Phase-I/II,QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTHMHWVRQAPGQRLEWIGRIDPANGNTEYDQKFQGRVTITVDTSASTAYMELSSLRSEDTAVYYCARWGTNVYFAYWGQGTLVTVSS,yes,2
1215,Tilogotamab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.84,IGKJ4,0.83,DIQLTQSPSSLSASVGDRVTITCSAS,SSVSY,MYWYQQKPGKAPKPWIY,RTS,NLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYHSYPPT,FGGGTVEIK,2,Phase-I/II,DIQLTQSPSSLSASVGDRVTITCSASSSVSYMYWYQQKPGKAPKPWIYRTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYHSYPPTFGGGTVEIK,yes,2
1220,Timolumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-33,0.92,IGHJ4,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFFSYA,MHWVRQTPGKGLEWVAV,IWFDGSNE,NYVDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYC,ARDAWSYFDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFFSYAMHWVRQTPGKGLEWVAVIWFDGSNENYVDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDAWSYFDYWGQGTLVTVSS,yes,2
1221,Timolumab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,0.97,IGKJ4,1,VIQLTQSPSSLSASVGDRVTITCRAS,QGISRA,LAWYQQKPGKGPKLLIY,DAS,SLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQFNSYPLT,FGGGTKVEIK,2,Phase-II,VIQLTQSPSSLSASVGDRVTITCRASQGISRALAWYQQKPGKGPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,yes,2
1222,Tinurilimab,Whole_mAb,heavy_sequence,IgG2,human,IGHV2-70,0.91,IGHJ4,0.86,QVTLRESGPALVKPTQTLTLTCTFS,GFSLSTYGIG,VGWIRQPPGKALEWLAH,IWWNDNK,YYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYC,ARISLPYFDY,WGQGTTLTVSS,2,Phase-I,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTYGIGVGWIRQPPGKALEWLAHIWWNDNKYYSTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARISLPYFDYWGQGTTLTVSS,yes,2
1223,Tinurilimab,Whole_mAb,light_sequence,IgK,human,IGKV1-9,0.85,IGKJ4,1,DIQLTQSPSFLSASVGDRVTITCKAS,QNVGTA,VAWYQQKPGKAPKLLIY,SAS,NRYTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,QQYSSYPLT,FGGGTKVEIK,2,Phase-I,DIQLTQSPSFLSASVGDRVTITCKASQNVGTAVAWYQQKPGKAPKLLIYSASNRYTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQYSSYPLTFGGGTKVEIK,yes,2
1224,Tiragolumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV6-1,0.93,IGHJ4,1,EVQLQQSGPGLVKPSQTLSLTCAIS,GDSVSSNSAA,WNWIRQSPSRGLEWLGK,TYYRFKWYS,DYAVSVKGRITINPDTSKNQFSLQLNSVTPEDTAVFYC,TRESTTYDLLAGPFDY,WGQGTLVTVSS,2,Phase-III,EVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGKTYYRFKWYSDYAVSVKGRITINPDTSKNQFSLQLNSVTPEDTAVFYCTRESTTYDLLAGPFDYWGQGTLVTVSS,yes,2
1225,Tiragolumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.97,IGKJ3,0.92,DIVMTQSPDSLAVSLGERATINCKSS,QTVLYSSNNKKY,LAWYQQKPGQPPNLLIY,WAS,TRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,QQYYSTPFT,FGPGTKVEIK,2,Phase-III,DIVMTQSPDSLAVSLGERATINCKSSQTVLYSSNNKKYLAWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPFTFGPGTKVEIK,yes,2
1226,Tislelizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-4,0.89,IGHJ6,0.93,QVQLQESGPGLVKPSETLSLTCTVS,GFSLTSYG,VHWIRQPPGKGLEWIGV,IYADGST,NYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYC,ARAYGNYWYIDV,WGQGTTVTVSS,2,Approved,QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSS,yes,2
1227,Tislelizumab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.81,IGKJ2,1,DIVMTQSPDSLAVSLGERATINCKSS,ESVSND,VAWYQQKPGQPPKLLIN,YAF,HRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYC,HQAYSSPYT,FGQGTKLEIK,2,Approved,DIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIK,yes,2
1228,Tisotumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23,0.94,IGHJ5,0.93,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSNYA,MSWVRQAPGKGLEWVSS,ISGSGDYT,YYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARSPWGYYLDS,WGQGTLVTVSS,2,Preregistration,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSSISGSGDYTYYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSPWGYYLDSWGQGTLVTVSS,yes,2
1229,Tisotumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.97,IGKJ2,1,DIQMTQSPPSLSASAGDRVTITCRAS,QGISSR,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNSYPYT,FGQGTKLEIK,2,Preregistration,DIQMTQSPPSLSASAGDRVTITCRASQGISSRLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIK,yes,2
1232,Tocilizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-59,0.86,IGHJ4,0.86,QVQLQESGPGLVRPSQTLSLTCTVS,GYSITSDHA,WSWVRQPPGRGLEWIGY,ISYSGIT,TYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYC,ARSLARTTAMDY,WGQGSLVTVSS,2,Approved,QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS,yes,2
1233,Tocilizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.9,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISSY,LNWYQQKPGKAPKLLIY,YTS,RLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYC,QQGNTLPYT,FGQGTKVEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK,yes,2
1236,Tomuzotuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV2-2,0.94,IGHJ3,0.93,QVQLKQSGPGLVQPSQSLSITCTVS,GFSLTNYG,VHWVRQSPGKGLEWLGV,IWSGGNT,DYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYC,ARALTYYDYEFAY,WGQGTLVTVST,2,Phase-II,QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVST,yes,2
1237,Tomuzotuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV5-48,0.97,IGKJ5,0.92,DILLTQSPVILSVSPGERVSFSCRAS,QSIGTN,IHWYQQRTNGSPRLLIK,YAS,ESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYC,QQNNNWPTT,FGAGTKLELK,2,Phase-II,DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK,yes,2
1240,Torudokimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.96,IGHJ4,0.86,EVQLVETGGGLIQPGGSLRLSCAAS,GFTFSFYA,MSWVRQAPGKGLEWVSA,ISGSGGST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARTIHGIRAAYDAFII,WGQGTLVTVSS,2,Phase-II,EVQLVETGGGLIQPGGSLRLSCAASGFTFSFYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTIHGIRAAYDAFIIWGQGTLVTVSS,yes,2
1241,Torudokimab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.9,IGKJ4,0.92,EIVLTQSPGTLSLSPGERATLSCRAS,QSVGIN,LSWYQQKPGQAPRLLIY,GAS,HRLTGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,HQYSQPPPFT,FGGGTKVEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRASQSVGINLSWYQQKPGQAPRLLIYGASHRLTGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQYSQPPPFTFGGGTKVEIK,yes,2
1242,Tosatoxumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.82,IGHJ3,0.86,EVQMVQSGAEVKKPGEPLKISCKGS,GYKFGTHW,IGWVRQRPGKGLEWMGI,IHPADSET,KYSPSFQGQVSFSADKSSNTAYLHWSTLRASDTAMYYC,ARRSGSSSWYALDF,WGQGTMVTVSS,2,Phase-III,EVQMVQSGAEVKKPGEPLKISCKGSGYKFGTHWIGWVRQRPGKGLEWMGIIHPADSETKYSPSFQGQVSFSADKSSNTAYLHWSTLRASDTAMYYCARRSGSSSWYALDFWGQGTMVTVSS,yes,2
1243,Tosatoxumab,Whole_mAb,light_sequence,IgL,human,IGLV1-44,0.94,IGLJ1,1,QSVLTQSPSASGTPGQRVTISCSGG,SSNIGSNT,VNWYQQFPGAAPKLLIY,TNN,QRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYC,ATWDDSLNGLYV,FGTGTKVTVL,2,Phase-III,QSVLTQSPSASGTPGQRVTISCSGGSSNIGSNTVNWYQQFPGAAPKLLIYTNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGLYVFGTGTKVTVL,yes,2
1244,Tovetumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-11,0.98,IGHJ6,1,QVQLVESGGGLVKPGGSLRLSCAAS,GFTFSDYY,MNWIRQAPGKGLEWVSY,ISSSGSII,YYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYC,AREGRIAARGMDV,WGQGTTVTVSS,2,Phase-II,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS,yes,2
1245,Tovetumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.9,IGKJ5,0.92,DIQMTQSPSSLSASVGDRVSITCRPS,QSFSRY,INWYQQKPGKAPKLLIH,AAS,SLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQTYSNPPIT,FGQGTRLEMK,2,Phase-II,DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK,yes,2
1246,Tozorakimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.94,IGHJ4,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYA,MSWVRQAPGKGLEWVSG,ISAIDQST,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARQKFMQLWGGGLRYPFGY,WGQGTMVTVSS,2,Phase-II,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISAIDQSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQKFMQLWGGGLRYPFGYWGQGTMVTVSS,yes,2
1247,Tozorakimab,Whole_mAb,light_sequence,IgL,human,IGLV3-1,0.88,IGLJ3,0.92,SYVLTQPPSVSVSPGQTASITCSGE,GMGDKY,AAWYQQKPGQSPVLVIY,RDT,KRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYC,GVIQDNTGV,FGGGTKLTVL,2,Phase-II,SYVLTQPPSVSVSPGQTASITCSGEGMGDKYAAWYQQKPGQSPVLVIYRDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCGVIQDNTGVFGGGTKLTVL,yes,2
1248,Tralokinumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-18,0.93,IGHJ2,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTNYG,LSWVRQAPGQGLEWMGW,ISANNGDT,NYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARDSSSSWARWFFDL,WGRGTLVTVSS,2,Preregistration,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSS,yes,2
1249,Tralokinumab,Whole_mAb,light_sequence,IgL,human,IGLV3-21,0.95,IGLJ3,1,SYVLTQPPSVSVAPGKTARITCGGN,IIGSKL,VHWYQQKPGQAPVLVIY,DDG,DRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYC,QVWDTGSDPVV,FGGGTKLTVL,2,Preregistration,SYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVL,yes,2
1254,Tremelimumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-33,1,IGHJ6,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,IWYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDPRGATLYYYYYGMDV,WGQGTTVTVSS,2,Phase-III,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS,yes,2
1255,Tremelimumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.97,IGKJ3,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QSINSY,LDWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYYSTPFT,FGPGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK,yes,2
1256,Trevogrumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23D,0.94,IGHJ6,0.86,EVQVLESGGDLVQPGGSLRLSCAAS,GFTFSAYA,MTWVRQAPGKGLEWVSA,ISGSGGSA,YYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYC,AKDGAWKMSGLDV,WGQGTTVIVSS,2,Phase-II,EVQVLESGGDLVQPGGSLRLSCAASGFTFSAYAMTWVRQAPGKGLEWVSAISGSGGSAYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAKDGAWKMSGLDVWGQGTTVIVSS,yes,2
1257,Trevogrumab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.9,IGKJ4,1,DIQMTQSPASLSASVGDRVTITCRAS,QDISDY,LAWYQQKPGKIPRLLIY,TTS,TLQSGVPSRFRGSGSGTDFTLTISSLQPEDVATYYC,QKYDSAPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPASLSASVGDRVTITCRASQDISDYLAWYQQKPGKIPRLLIYTTSTLQSGVPSRFRGSGSGTDFTLTISSLQPEDVATYYCQKYDSAPLTFGGGTKVEIK,yes,2
1258,Tusamitamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV5-12-1,0.86,IGHJ3,0.93,EVQLQESGPGLVKPGGSLSLSCAAS,GFVFSSYD,MSWVRQTPERGLEWVAY,ISSGGGIT,YAPSTVKGRFTVSRDNAKNTLYLQMNSLTSEDTAVYYC,AAHYFGSSGPFAY,WGQGTLVTVSS,2,Phase-III,EVQLQESGPGLVKPGGSLSLSCAASGFVFSSYDMSWVRQTPERGLEWVAYISSGGGITYAPSTVKGRFTVSRDNAKNTLYLQMNSLTSEDTAVYYCAAHYFGSSGPFAYWGQGTLVTVSS,yes,2
1259,Tusamitamab,Whole_mAb,light_sequence,IgK,mouse,IGKV12-44,0.87,IGKJ4,1,DIQMTQSPASLSASVGDRVTITCRAS,ENIFSY,LAWYQQKPGKSPKLLVY,NTR,TLAEGVPSRFSGSGSGTDFSLTISSLQPEDFATYYC,QHHYGTPFT,FGSGTKLEIK,2,Phase-III,DIQMTQSPASLSASVGDRVTITCRASENIFSYLAWYQQKPGKSPKLLVYNTRTLAEGVPSRFSGSGSGTDFSLTISSLQPEDFATYYCQHHYGTPFTFGSGTKLEIK,yes,2
1260,Ublituximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-12,0.98,IGHJ4,1,QAYLQQSGAELVRPGASVKMSCKAS,GYTFTSYN,MHWVKQTPRQGLEWIGG,IYPGNGDT,SYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFC,ARYDYNYAMDY,WGQGTSVTVSS,2,Preregistration,QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSS,yes,2
1261,Ublituximab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.98,IGKJ1,0.83,QIVLSQSPAILSASPGEKVTMTCRAS,SSVSY,MHWYQQKPGSSPKPWIY,ATS,NLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYC,QQWTFNPPT,FGGGTRLEIK,2,Preregistration,QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIK,yes,2
1262,Uliledlimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-38-2,0.87,IGHJ6,0.86,EVQLQESGPGLVKPSETLSLTCAVS,GYSITSGYY,WNWIRQPPGKKLEWMGY,INYGGSN,GYNPSLKSRITISRDTSKNQFSLKLSSVTAADTAVYYC,ARDYDAYYEALDD,WGQGTTVTVSS,2,Phase-I/II,EVQLQESGPGLVKPSETLSLTCAVSGYSITSGYYWNWIRQPPGKKLEWMGYINYGGSNGYNPSLKSRITISRDTSKNQFSLKLSSVTAADTAVYYCARDYDAYYEALDDWGQGTTVTVSS,yes,2
1263,Uliledlimab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.8,IGKJ1,0.83,EIVLSQSPATLSLSPGERATLSCRAS,SRVNY,MHWYQQKPGQSPRPWIS,ATS,NLASGVPARFSGSGSGTSYTLTISSLEPEDFAVYYC,QQWSSNPPT,FGGGTKVEIK,2,Phase-I/II,EIVLSQSPATLSLSPGERATLSCRASSRVNYMHWYQQKPGQSPRPWISATSNLASGVPARFSGSGSGTSYTLTISSLEPEDFAVYYCQQWSSNPPTFGGGTKVEIK,yes,2
1264,Ulocuplumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-48,0.97,IGHJ6,1,EVQLVESGGGLVQPGGSLRLSCAAA,GFTFSSYS,MNWVRQAPGKGLEWVSY,ISSRSRTI,YYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYC,ARDYGGQPPYYYYYGMDV,WGQGTTVTVSS,2,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAAAGFTFSSYSMNWVRQAPGKGLEWVSYISSRSRTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARDYGGQPPYYYYYGMDVWGQGTTVTVSS,yes,2
1265,Ulocuplumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.99,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFVTYYC,QQYNSYPRT,FGQGTKVEIK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFVTYYCQQYNSYPRTFGQGTKVEIK,yes,2
1266,Unasnemab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV6-6,0.87,IGHJ2,0.71,EVQLVESGGGLVQPGRSLRLSCTAS,GFTFSDAW,MDWVRQAPGKGLEWVAE,IRSKANNHAT,YYAESVKGRFTISRDDSKSIVYLQMNSLRTEDTALYYC,TRRDGAY,WGKGTTVTVSS,2,Phase-I,EVQLVESGGGLVQPGRSLRLSCTASGFTFSDAWMDWVRQAPGKGLEWVAEIRSKANNHATYYAESVKGRFTISRDDSKSIVYLQMNSLRTEDTALYYCTRRDGAYWGKGTTVTVSS,yes,2
1267,Unasnemab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.89,IGKJ1,0.75,DIQMTQSPSSVSASVGDRVTITCRAS,QDISSY,LNWYQQKPGKAPKLLIY,YTS,RLHSGVPSRFSGSGSGTDFTLTISSLQPEDFASYFC,QQLNTLPWT,FGGGTKVEME,2,Phase-I,DIQMTQSPSSVSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTLTISSLQPEDFASYFCQQLNTLPWTFGGGTKVEME,yes,2
1268,Upifitamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.82,IGHJ4,0.93,QVQLVQSGAEVVKPGASVKMSCKAS,GYTFTGYN,IHWVKQAPGQGLEWIGA,IYPGNGDT,SYKQKFRGRATLTADTSTSTVYMELSSLRSEDSAVYYC,ARGETARATFAY,WGQGTLVTVSS,2,Phase-I,QVQLVQSGAEVVKPGASVKMSCKASGYTFTGYNIHWVKQAPGQGLEWIGAIYPGNGDTSYKQKFRGRATLTADTSTSTVYMELSSLRSEDSAVYYCARGETARATFAYWGQGTLVTVSS,yes,2
1269,Upifitamab,Whole_mAb,light_sequence,IgK,human,IGKV1-16,0.85,IGKJ2,0.83,DIQMTQSPSSLSASVGDRVTITCSAS,QDIGNF,LNWYQQKPGKTVKVLIY,YTS,SLYSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYC,QQYSKLPLT,FGQGTKLELK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCSASQDIGNFLNWYQQKPGKTVKVLIYYTSSLYSGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYSKLPLTFGQGTKLELK,yes,2
1270,Urabrelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-4,0.95,IGHJ6,0.93,QVQLQESGPGLVKPSGTLSLTCAVS,GVSIRSINW,WNWVRQPPGKGLEWIGE,IYHSGST,NYNPSLKSRVTISVDKSKNQFSLKLNSVTAADTAVYYC,ARDGGIAVTDYYYYGLDV,WGQGTTVTVSS,2,Phase-I,QVQLQESGPGLVKPSGTLSLTCAVSGVSIRSINWWNWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLNSVTAADTAVYYCARDGGIAVTDYYYYGLDVWGQGTTVTVSS,yes,2
1271,Urabrelimab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,0.96,IGKJ4,0.92,EIVLTQSPATLSLSPGERATLSCRAS,ESVSSN,LAWYQQKPGQAPRLLIY,GAF,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSDWFT,FGGGTKVEIK,2,Phase-I,EIVLTQSPATLSLSPGERATLSCRASESVSSNLAWYQQKPGQAPRLLIYGAFNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSDWFTFGGGTKVEIK,yes,2
1272,Urelumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-34,0.93,IGHJ2,1,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSGYY,WSWIRQSPEKGLEWIGE,INHGGYV,TYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARDYGPGNYDWYFDL,WGRGTLVTVSS,2,Phase-II,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSS,yes,2
1273,Urelumab,Whole_mAb,light_sequence,IgK,human,IGKV3-11,1,IGKJ4,1,EIVLTQSPATLSLSPGERATLSCRAS,QSVSSY,LAWYQQKPGQAPRLLIY,DAS,NRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYC,QQRSNWPPALT,FGGGTKVEIK,2,Phase-II,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK,yes,2
1274,Ustekinumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV5-51,0.88,IGHJ4,0.93,EVQLVQSGAEVKKPGESLKISCKGS,GYSFTTYW,LGWVRQMPGKGLDWIGI,MSPVDSDI,RYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYC,ARRRPGQGYFDF,WGQGTLVTVSS,2,Approved,EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSS,yes,2
1275,Ustekinumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,1,IGKJ2,1,DIQMTQSPSSLSASVGDRVTITCRAS,QGISSW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNIYPYT,FGQGTKLEIK,2,Approved,DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIK,yes,2
1276,Utomilumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV5-10-1,0.95,IGHJ4,1,EVQLVQSGAEVKKPGESLRISCKGS,GYSFSTYW,ISWVRQMPGKGLEWMGK,IYPGDSYT,NYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYC,ARGYGIFDY,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,yes,2
1277,Utomilumab,Whole_mAb,light_sequence,IgL,human,IGLV3-1,0.89,IGLJ3,0.92,SYELTQPPSVSVSPGQTASITCSGD,NIGDQY,AHWYQQKPGQSPVLVIY,QDK,NRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYC,ATYTGFGSLAV,FGGGTKLTVL,2,Phase-II,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,yes,2
1278,Vadastuximab,Whole_mAb_ADC,heavy_sequence,IgG1,mouse,IGHV1-85,0.82,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTNYD,INWVRQAPGQGLEWIGW,IYPGDGST,KYNEKFKAKATLTADTSTSTAYMELRSLRSDDTAVYYC,ASGYEDAMDY,WGQGTTVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQAPGQGLEWIGWIYPGDGSTKYNEKFKAKATLTADTSTSTAYMELRSLRSDDTAVYYCASGYEDAMDYWGQGTTVTVSS,yes,2
1279,Vadastuximab,Whole_mAb_ADC,light_sequence,IgK,mouse,IGKV14-111,0.86,IGKJ1,0.83,DIQMTQSPSSLSASVGDRVTINCKAS,QDINSY,LSWFQQKPGKAPKTLIY,RAN,RLVDGVPSRFSGSGSGQDYTLTISSLQPEDFATYYC,LQYDEFPLT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTINCKASQDINSYLSWFQQKPGKAPKTLIYRANRLVDGVPSRFSGSGSGQDYTLTISSLQPEDFATYYCLQYDEFPLTFGGGTKVEIK,yes,2
1280,Valanafusp,Whole_mAb_Fusion,heavy_sequence,IgG1,mouse,IGHV1S56,0.92,IGHJ3,0.93,QVQLQQSGPELVKPGALVKISCKAS,GYTFTNYD,IHWVKQRPGQGLEWIGW,IYPGDGST,KYNEKFKGKATLTADKSSSTAYMHLSSLTSEKSAVYFC,AREWAY,WGQGTLVTVSA,2,Phase-II,QVQLQQSGPELVKPGALVKISCKASGYTFTNYDIHWVKQRPGQGLEWIGWIYPGDGSTKYNEKFKGKATLTADKSSSTAYMHLSSLTSEKSAVYFCAREWAYWGQGTLVTVSA,yes,2
1281,Valanafusp,Whole_mAb_Fusion,light_sequence,IgK,mouse,IGKV9-120,0.95,IGKJ1,0.92,DIQMTQSPSSLSASLGERVSLTCRAS,QDIGGN,LYWLQQGPDGTIKRLIY,ATS,SLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYC,LQYSSSPWT,FGGGTKMEIK,2,Phase-II,DIQMTQSPSSLSASLGERVSLTCRASQDIGGNLYWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYSSSPWTFGGGTKMEIK,yes,2
1282,Vanalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-48,0.87,IGHJ4,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSTYG,MHWVRQAPGKGLEWLSY,ISGGSSYI,FYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYC,ARILRGGSGMDL,WGQGTLVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTISRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSS,yes,2
1283,Vanalimab,Whole_mAb,light_sequence,IgL,human,IGLV1-47,0.91,IGLJ3,0.92,QSVLTQPPSASGTPGQRVTISCTGS,SSNIGAGYN,VYWYQQLPGTAPKLLIY,GNI,NRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYC,AAWDKSISGLV,FGGGTKLTVL,2,Phase-I,QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVL,yes,2
1284,Vandortuzumab,Whole_mAb_ADC,heavy_sequence,IgG1,human,IGHV3-23,0.82,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAVS,GYSITSDYA,WNWVRQAPGKGLEWVGY,ISNSGST,SYNPSLKSRFTISRDTSKNTLYLQMNSLRAEDTAVYYC,ARERNYDYDDYYYAMDY,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSDYAWNWVRQAPGKGLEWVGYISNSGSTSYNPSLKSRFTISRDTSKNTLYLQMNSLRAEDTAVYYCARERNYDYDDYYYAMDYWGQGTLVTVSS,yes,2
1285,Vandortuzumab,Whole_mAb_ADC,light_sequence,IgK,human,IGKV1-NL1,0.88,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCKSS,QSLLYRSNQKNY,LAWYQQKPGKAPKLLIY,WAS,TRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYYNYPRT,FGQGTKVEIK,2,Phase-I,DIQMTQSPSSLSASVGDRVTITCKSSQSLLYRSNQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYNYPRTFGQGTKVEIK,yes,2
1286,Vantictumab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-23,0.91,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSHYT,LSWVRQAPGKGLEWVSV,ISGDGSYT,YYADSVKGRFTISSDNSKNTLYLQMNSLRAEDTAVYYC,ARNFIKYVFAN,WGQGTLVTVSS,2,Phase-I,EVQLVESGGGLVQPGGSLRLSCAASGFTFSHYTLSWVRQAPGKGLEWVSVISGDGSYTYYADSVKGRFTISSDNSKNTLYLQMNSLRAEDTAVYYCARNFIKYVFANWGQGTLVTVSS,yes,2
1287,Vantictumab,Whole_mAb,light_sequence,IgL,human,IGLV3-9,0.81,IGLJ3,0.92,DIELTQPPSVSVAPGQTARISCSGD,NIGSFY,VHWYQQKPGQAPVLVIY,DKS,NRPSGIPERFSGSNSGNTATLTISGTQAEDEADYYC,QSYANTLSLV,FGGGTKLTVL,2,Phase-I,DIELTQPPSVSVAPGQTARISCSGDNIGSFYVHWYQQKPGQAPVLVIYDKSNRPSGIPERFSGSNSGNTATLTISGTQAEDEADYYCQSYANTLSLVFGGGTKLTVL,yes,2
1292,Varisacumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-24,0.9,IGHJ6,1,QVQLVQSGAEVKKPGASVKVSCKAS,GGTFSSYA,ISWVRQAPGQGLEWMGG,FDPEDGET,IYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYC,ATGRSMVRGVIIPFNGMDV,WGQGTTVTVSS,2,Phase-II/III,QVQLVQSGAEVKKPGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGRSMVRGVIIPFNGMDVWGQGTTVTVSS,yes,2
1293,Varisacumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.99,IGKJ4,1,DIRMTQSPSSLSASVGDRVTITCRAS,QSISSY,LNWYQQKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSYSTPLT,FGGGTKVEIK,2,Phase-II/III,DIRMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK,yes,2
1294,Varlilumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.99,IGHJ4,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYD,MHWVRQAPGKGLEWVAV,IWYDGSNK,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARGSGNWGFFDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSS,yes,2
1295,Varlilumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-16,0.99,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QGISRW,LAWYQQKPEKAPKSLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQYNTYPRT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIK,yes,2
1296,Vatelizumab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-4,0.79,IGHJ4,0.93,QVQLQESGPGLVKPSETLSLTCTVS,GFSLTNYG,IHWIRQPPGKGLEWLGV,IWARGFT,NYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYC,ARANDGVYYAMDY,WGQGTLVTVSS,2,Phase-II/III,QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS,yes,2
1297,Vatelizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-59,0.75,IGKJ4,0.75,DFVMTQSPAFLSVTPGEKVTITCSAQ,SSVNY,IHWYQQKPDQAPKKLIY,DTS,KLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYC,QQWTTNPLT,FGQGTKVEIK,2,Phase-II/III,DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK,yes,2
1300,Veltuzumab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-12,0.81,IGHJ1,0.93,QVQLQQSGAEVKKPGSSVKVSCKAS,GYTFTSYN,MHWVKQAPGQGLEWIGA,IYPGMGDT,SYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYC,ARSTYYGGDWYFDV,WGQGTTVTVSS,2,Phase-II,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS,yes,2
1301,Veltuzumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.79,IGKJ4,0.83,DIQLTQSPSSLSASVGDRVTMTCRAS,SSVSY,IHWFQQKPGKAPKPWIY,ATS,NLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYC,QQWTSNPPT,FGGGTKLEIK,2,Phase-II,DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK,yes,2
1308,Vibostolimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-69,0.85,IGHJ6,0.93,EVQLVQSGAEVKKPGSSVKVSCKAS,GYTFSSYV,MHWVRQAPGQGLEWIGY,IDPYNDGA,KYAQKFQGRVTLTSDKSTSTAYMELSSLRSEDTAVYYC,ARGGPYGWYFDV,WGQGTTVTVSS,2,Phase-III,EVQLVQSGAEVKKPGSSVKVSCKASGYTFSSYVMHWVRQAPGQGLEWIGYIDPYNDGAKYAQKFQGRVTLTSDKSTSTAYMELSSLRSEDTAVYYCARGGPYGWYFDVWGQGTTVTVSS,yes,2
1309,Vibostolimab,Whole_mAb,light_sequence,IgK,human,IGKV1-27,0.87,IGKJ5,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,EHIYSY,LSWYQQKPGKVPKLLIY,"NAK",TLAEGVPSRFSGSGSGTDFTLTISSLQPEDVATYYC,QHHFGSPLT,FGQGTRLEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCRASEHIYSYLSWYQQKPGKVPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQHHFGSPLTFGQGTRLEIK,yes,2
1310,Vilobelimab,Whole_mAb,heavy_sequence,IgG4,mouse,IGHV1-61,0.82,IGHJ3,0.93,QVQLQQSGPQLVRPGTSVKISCKAS,GYSFTTFW,MDWVKQRPGQGLEWIGR,IDPSDSES,RLDQRFKDRATLTVDKSSSTVYMQLSSPTSEDSAVYYC,ARGNDGYYGFAY,WGQGTLVTVSS,2,Phase-III,QVQLQQSGPQLVRPGTSVKISCKASGYSFTTFWMDWVKQRPGQGLEWIGRIDPSDSESRLDQRFKDRATLTVDKSSSTVYMQLSSPTSEDSAVYYCARGNDGYYGFAYWGQGTLVTVSS,yes,2
1311,Vilobelimab,Whole_mAb,light_sequence,IgK,mouse,IGKV3-4,0.97,IGKJ2,1,DIVLTQSPASLAVSLGQRATISCKAS,QSVDYDGDSY,MKWYQQKPGQPPKLLIY,AAS,NLQSGIPARFSGSGSGTDFTLNIHPVEEEDAATYYC,QQSNEDPYT,FGGGTKLEIK,2,Phase-III,DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMKWYQQKPGQPPKLLIYAASNLQSGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPYTFGGGTKLEIK,yes,2
1312,Visilizumab,Whole_mAb,heavy_sequence,IgG2,mouse,IGHV1-4,0.84,IGHJ3,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFISYT,MHWVRQAPGQGLEWMGY,INPRSGYT,HYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYC,ARSAYYDYDGFAY,WGQGTLVTVSS,2,Phase-III,QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSS,yes,2
1313,Visilizumab,Whole_mAb,light_sequence,undefined,human,IGKV1D-39,0.87,IGKJ4,0.92,DIQMTQSPSSLSASVGDRVTITCSAS,SSVSY,MNWYQQKPGKAPKRLIY,DTS,KLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQWSSNPPT,FGGGTKVEIK,2,Phase-III,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIK,yes,2
1314,Vixarelimab,Whole_mAb,heavy_sequence,IgG4-G1,human,IGHV1-8,0.96,IGHJ6,1,QVQLVQSGAEVKKPGASVKVSCKAS,GYTFTSYE,INWVRQATGQGLEWMGW,MNPNSGYT,GYAQKFQGRVTMTRDTSISTAYMEMSSLRSEDTAVYYC,ARDIVAANTDYYFYYGMDV,WGQGTTVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYEINWVRQATGQGLEWMGWMNPNSGYTGYAQKFQGRVTMTRDTSISTAYMEMSSLRSEDTAVYYCARDIVAANTDYYFYYGMDVWGQGTTVTVSS,yes,2
1315,Vixarelimab,Whole_mAb,light_sequence,IgL,human,IGLV1-44,0.91,IGLJ3,1,QSVLTQPPSASGTPGQRVTISCSGS,NSNIGSNT,VNWYHQLPGTAPKLLIY,NIN,KRPSGVPDRFSGSKSGSSASLAISGLQSEDEADYYC,STWDDSLDGVV,FGGGTKLTVL,2,Phase-II,QSVLTQPPSASGTPGQRVTISCSGSNSNIGSNTVNWYHQLPGTAPKLLIYNINKRPSGVPDRFSGSKSGSSASLAISGLQSEDEADYYCSTWDDSLDGVVFGGGTKLTVL,yes,2
1320,Vobarilizumab,Bispecific_Single_Domains_(VH-VH'),heavy_sequence,undefined,human,IGHV3-66,0.82,IGHJ4,0.86,EVQLVESGGGLVQPGGSLRLSCAAS,GSVFKINV,MAWYRQAPGKGRELVAG,IISGGST,SYADSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYC,AFITTESDYDLGRRY,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGSVFKINVMAWYRQAPGKGRELVAGIISGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYCAFITTESDYDLGRRYWGQGTLVTVSS,yes,2
1321,Vobarilizumab,Bispecific_Single_Domains_(VH-VH'),heavy_sequence_bispec,undefined,human,IGHV3-23,0.88,IGHJ4,0.64,EVQLVESGGGLVQPGNSLRLSCAAS,GFTFSSFG,MSWVRQAPGKGLEWVSS,ISGSGSDT,LYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYC,TIGGSLSR,SSQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGNSLRLSCAASGFTFSSFGMSWVRQAPGKGLEWVSSISGSGSDTLYADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYCTIGGSLSRSSQGTLVTVSS,yes,2
1322,Vofatamab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.87,IGHJ4,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFTSTG,ISWVRQAPGKGLEWVGR,IYPTSGST,NYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYC,ARTYGIYDLYVDYTEYVMDY,WGQGTLVTVSS,2,Phase-I/II,EVQLVESGGGLVQPGGSLRLSCAASGFTFTSTGISWVRQAPGKGLEWVGRIYPTSGSTNYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARTYGIYDLYVDYTEYVMDYWGQGTLVTVSS,yes,2
1323,Vofatamab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.88,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDVDTS,LAWYKQKPGKAPKLLIY,SAS,FLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQSTGHPQT,FGQGTKVEIK,2,Phase-I/II,DIQMTQSPSSLSASVGDRVTITCRASQDVDTSLAWYKQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSTGHPQTFGQGTKVEIK,yes,2
1324,Volagidemab,Whole_mAb,heavy_sequence,IgG2,human,IGHV3-33,0.96,IGHJ6,0.93,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSSYG,MHWVRQAPGKGLEWVAV,MWYDGSNK,DYVDSVKGRFTISRDNSKNTLYLQMNRLRAEDTAVYYC,AREKDHYDILTGYNYYYGLDV,WGQGTTVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVMWYDGSNKDYVDSVKGRFTISRDNSKNTLYLQMNRLRAEDTAVYYCAREKDHYDILTGYNYYYGLDVWGQGTTVTVSS,yes,2
1325,Volagidemab,Whole_mAb,light_sequence,IgK,human,IGKV1-17,0.98,IGKJ4,1,DIQMTQSPSSLSASVGDRVTITCRAS,QGIRND,LGWYQQKPGKAPKRLIY,AAS,SLQSGVPSRFSGSGSGTEFTLTISSVQPEDFVTYYC,LQHNSNPLT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTEFTLTISSVQPEDFVTYYCLQHNSNPLTFGGGTKVEIK,yes,2
1326,Vonlerolizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.8,IGHJ4,0.86,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDSY,MSWVRQAPGQGLEWIGD,MYPDNGDS,SYNQKFRERVTITRDTSTSTAYLELSSLRSEDTAVYYC,VLAPRWYFSV,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDSYMSWVRQAPGQGLEWIGDMYPDNGDSSYNQKFRERVTITRDTSTSTAYLELSSLRSEDTAVYYCVLAPRWYFSVWGQGTLVTVSS,yes,2
1327,Vonlerolizumab,Whole_mAb,light_sequence,IgK,human,IGKV1D-39,0.91,IGKJ1,0.92,DIQMTQSPSSLSASVGDRVTITCRAS,QDISNY,LNWYQQKPGKAPKLLIY,YTS,RLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQGHTLPPT,FGQGTKVEIK,2,Phase-II,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLRSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGHTLPPTFGQGTKVEIK,yes,2
1328,Vopratelimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-74,0.89,IGHJ5,1,EVQLVESGGGLVQPGGSLRLSCAAS,GFTFSDYW,MDWVRQAPGKGLVWVSN,IDEDGSIT,EYSPFVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYC,TRWGRFGFDS,WGQGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYWMDWVRQAPGKGLVWVSNIDEDGSITEYSPFVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCTRWGRFGFDSWGQGTLVTVSS,yes,2
1329,Vopratelimab,Whole_mAb,light_sequence,IgK,human,IGKV4-1,0.85,IGKJ3,0.92,DIVMTQSPDSLAVSLGERATINCKSS,QSLLSGSFNY,LTWYQQKPGQPPKLLIF,YAS,TRHTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC,HHHYNAPPT,FGPGTKVDIK,2,Phase-II,DIVMTQSPDSLAVSLGERATINCKSSQSLLSGSFNYLTWYQQKPGQPPKLLIFYASTRHTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHHHYNAPPTFGPGTKVDIK,yes,2
1338,Vunakizumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-2,0.83,IGHJ4,0.93,EVQLVQSGAEVKKPGASVKVSCKAS,GYTFTDYE,VHWVRQAPGQGLEWMGV,IDPGTGGV,AYNQKFEGRVTMTADTSTSTAYMELRSLRSDDTAVYYC,TRYSLFYGSSPYAMDY,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEVHWVRQAPGQGLEWMGVIDPGTGGVAYNQKFEGRVTMTADTSTSTAYMELRSLRSDDTAVYYCTRYSLFYGSSPYAMDYWGQGTLVTVSS,yes,2
1339,Vunakizumab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-57,0.81,IGKJ1,0.92,EIVLTQSPDFQSVTPKEKVTITCSAS,SSVNY,MHWFQQKPDQSPKLWIY,RTS,NLASGVPSRFSGSGSGTDYTLTINSLEAEDAATYYC,QQRSSYPWT,FGQGTKLEIK,2,Phase-II,EIVLTQSPDFQSVTPKEKVTITCSASSSVNYMHWFQQKPDQSPKLWIYRTSNLASGVPSRFSGSGSGTDYTLTINSLEAEDAATYYCQQRSSYPWTFGQGTKLEIK,yes,2
1340,Xentuzumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-64,0.89,IGHJ5,1,QVELVESGGGLVQPGGSLRLSCAAS,GFTFTSYW,MSWVRQAPGKGLELVSS,ITSYGSFT,YYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARNMYTHFDS,WGQGTLVTVSS,2,Phase-II,QVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSS,yes,2
1341,Xentuzumab,Whole_mAb,light_sequence,IgL,human,IGLV1-40,0.86,IGLJ3,1,DIVLTQPPSVSGAPGQRVTISCSGS,SSNIGSNS,VSWYQQLPGTAPKLLIY,DNS,KRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYC,QSRDTYGYYWV,FGGGTKLTVL,2,Phase-II,DIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVL,yes,2
1342,Zagotenemab,Whole_mAb,heavy_sequence,IgG4,human,IGHV5-51,0.85,IGHJ4,0.86,EVQLVQSGAEVKKPGESLKISCKGS,GYTFSNYW,IEWVRQMPGKGLEWMGE,ILPGSDSI,KYEKNFKGQVTISADKSISTAYLQWSSLKASDTAMYYC,ARRGNYVDD,WGQGTLVTVSS,2,Phase-II,EVQLVQSGAEVKKPGESLKISCKGSGYTFSNYWIEWVRQMPGKGLEWMGEILPGSDSIKYEKNFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARRGNYVDDWGQGTLVTVSS,yes,2
1343,Zagotenemab,Whole_mAb,light_sequence,IgK,human,IGKV3-20,0.84,IGKJ4,1,EIVLTQSPGTLSLSPGERATLSCRSS,QSLVHSNQNTY,LHWYQQKPGQAPRLLIY,KVD,NRFSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC,SQSTLVPLT,FGGGTKVEIK,2,Phase-II,EIVLTQSPGTLSLSPGERATLSCRSSQSLVHSNQNTYLHWYQQKPGQAPRLLIYKVDNRFSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCSQSTLVPLTFGGGTKVEIK,yes,2
1346,Zalutumumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-33,0.96,IGHJ4,1,QVQLVESGGGVVQPGRSLRLSCAAS,GFTFSTYG,MHWVRQAPGKGLEWVAV,IWDDGSYK,YYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYC,ARDGITMVRGVMKDYFDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS,yes,2
1347,Zalutumumab,Whole_mAb,light_sequence,IgK,human,IGKV1-13,0.97,IGKJ4,1,AIQLTQSPSSLSASVGDRVTITCRAS,QDISSA,LVWYQQKPGKAPKLLIY,DAS,SLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYC,QQFNSYPLT,FGGGTKVEIK,2,Phase-II,AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,yes,2
1348,Zampilimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV3-23,0.9,IGHJ4,0.86,EVQLLESGGGLVQPGGSLRLSCAAS,GFTLSTHA,MSWVRQAPGKGLEWVAT,ISSGGRST,YYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFC,ARLISTY,WGQGTLVTVSS,2,Phase-I/II,EVQLLESGGGLVQPGGSLRLSCAASGFTLSTHAMSWVRQAPGKGLEWVATISSGGRSTYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCARLISTYWGQGTLVTVSS,yes,2
1349,Zampilimab,Whole_mAb,light_sequence,IgK,mouse,IGKV14-111,0.83,IGKJ2,0.83,DITMTQSPSSLSASVGDRVTITCKAS,QDINSY,LTWFQQKPGKAPKILIY,LVN,RLVDGVPSRFSGSGSGQDYALTISSLQPEDFATYYC,LQYDDFPYT,FGQGTKVEIK,2,Phase-I/II,DITMTQSPSSLSASVGDRVTITCKASQDINSYLTWFQQKPGKAPKILIYLVNRLVDGVPSRFSGSGSGQDYALTISSLQPEDFATYYCLQYDDFPYTFGQGTKVEIK,yes,2
1354,Zanolimumab,Whole_mAb,heavy_sequence,IgG1,human,IGHV4-34,1,IGHJ5,1,QVQLQQWGAGLLKPSETLSLTCAVY,GGSFSGYY,WSWIRQPPGKGLEWIGE,INHSGST,NYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYC,ARVINWFDP,WGQGTLVTVSS,2,Phase-III,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVINWFDPWGQGTLVTVSS,yes,2
1355,Zanolimumab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.98,IGKJ2,1,DIQMTQSPSSVSASVGDRVTITCRAS,QDISSW,LAWYQHKPGKAPKLLIY,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQANSFPYT,FGQGTKLEIK,2,Phase-III,DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPYTFGQGTKLEIK,yes,2
1356,Zansecimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV1-18,0.87,IGHJ4,0.93,QVQLVQSGAEVKKPGASVKVSCKAS,GYSFTDYN,MVWVRQAPGQGLEWMGY,IDPYNGGT,GYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYC,ARTRDRYDVWYFDV,WGQGTLVTVSS,2,Phase-II,QVQLVQSGAEVKKPGASVKVSCKASGYSFTDYNMVWVRQAPGQGLEWMGYIDPYNGGTGYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARTRDRYDVWYFDVWGQGTLVTVSS,yes,2
1357,Zansecimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.84,IGKJ4,0.92,DIQMTQSPSSVSASVGDRVTITCKAS,QDVYIA,VAWYQQKPGKAPKLLIY,WAS,TRDTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,HQYSSYPPT,FGGGTKVEIK,2,Phase-II,DIQMTQSPSSVSASVGDRVTITCKASQDVYIAVAWYQQKPGKAPKLLIYWASTRDTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQYSSYPPTFGGGTKVEIK,yes,2
1358,Zatuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1S5,0.92,IGHJ4,1,EVQLQQPGSELVRPGASVKLSCKAS,GYTFTSYW,MHWVKQRPGQGLEWIGN,IYPGSRST,NYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYC,TRNGDYYVSSGDAMDY,WGQGTSVTVSS,2,Phase-II,EVQLQQPGSELVRPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSRSTNYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRNGDYYVSSGDAMDYWGQGTSVTVSS,yes,2
1359,Zatuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV10-96,0.91,IGKJ1,0.92,DIQMTQTTSSLSASLGDRVTISCRTS,QDIGNY,LNWYQQKPDGTVKLLIY,YTS,RLHSGVPSRFSGSGSGTDFSLTINNVEQEDVATYFC,QHYNTVPPT,FGGGTKLEIK,2,Phase-II,DIQMTQTTSSLSASLGDRVTISCRTSQDIGNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDFSLTINNVEQEDVATYFCQHYNTVPPTFGGGTKLEIK,yes,2
1360,Zelminemab,Whole_mAb,heavy_sequence,IgG1,human,IGHV1-46,0.81,IGHJ4,0.93,QVQLVESGAEVVKPGASVKVSCKAS,GFTFSRFA,MHWVRQAPGQGLEWMGV,ISYDGGNK,YYAESVKGRVTMTRDTSTSTLYMELSSLRSEDTAVYYC,ARGYDVLTGYPDY,WGQGTLVTVSS,2,Phase-II,QVQLVESGAEVVKPGASVKVSCKASGFTFSRFAMHWVRQAPGQGLEWMGVISYDGGNKYYAESVKGRVTMTRDTSTSTLYMELSSLRSEDTAVYYCARGYDVLTGYPDYWGQGTLVTVSS,yes,2
1361,Zelminemab,Whole_mAb,light_sequence,IgK,human,IGKV1-9,0.86,IGKJ3,1,DIQLTQSPSFLSASVGDRVTITCRAS,QSIGRS,LHWYQQKPGKAPKLLIK,YAS,QSLSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYC,HQSSRLPFT,FGPGTKVDIK,2,Phase-II,DIQLTQSPSFLSASVGDRVTITCRASQSIGRSLHWYQQKPGKAPKLLIKYASQSLSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCHQSSRLPFTFGPGTKVDIK,yes,2
1362,Zeluvalimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-23D,0.92,IGHJ6,1,EVQLLESGGGLVQPGGSLRLSCAAS,GFTFSSYD,MSWVRQAPGKGLEWVSL,ISGGGSQT,YYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFC,ASPSGHYFYAMDV,WGQGTTVTVSS,2,Phase-I,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSLISGGGSQTYYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCASPSGHYFYAMDVWGQGTTVTVSS,yes,2
1363,Zeluvalimab,Whole_mAb,light_sequence,IgK,human,IGKV1-12,0.96,IGKJ4,0.92,DIQMTQSPSSVSASVGDRVTITCRAS,QDISNW,LAWYQQKPGKAPKLLIF,AAS,SLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC,QQAESFPHT,FGGGTKVEIK,2,Phase-I,DIQMTQSPSSVSASVGDRVTITCRASQDISNWLAWYQQKPGKAPKLLIFAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAESFPHTFGGGTKVEIK,yes,2
1368,Ziltivekimab,Whole_mAb,heavy_sequence,IgG1,human,IGHV3-66,0.9,IGHJ2,0.93,EVQLVESGGGLVQPGGSLRLSCAAS,GFTISSNY,MIWVRQAPGKGLEWVSD,LYYYAGDT,YYADSVKGRFTMSRDISKNTVYLQMNSLRAEDTAVYYC,ARWADDHPPWIDL,WGRGTLVTVSS,2,Phase-II,EVQLVESGGGLVQPGGSLRLSCAASGFTISSNYMIWVRQAPGKGLEWVSDLYYYAGDTYYADSVKGRFTMSRDISKNTVYLQMNSLRAEDTAVYYCARWADDHPPWIDLWGRGTLVTVSS,yes,2
1369,Ziltivekimab,Whole_mAb,light_sequence,IgK,human,IGKV1-5,0.95,IGKJ2,0.83,DIQMTQSPSTLSASVGDRVTITCRAS,QGISSW,LAWYQQKPGKAPKVLIY,KAS,TLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYC,QQSWLGGS,FGQGTKLEIK,2,Phase-II,DIQMTQSPSTLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKVLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQSWLGGSFGQGTKLEIK,yes,2
1372,Zimberelimab,Whole_mAb,heavy_sequence,IgG4,human,IGHV4-39,0.88,IGHJ4,1,QLQLQESGPGLVKPSETLTLTCTVS,ADSISSTTYY,WVWIRQPPGKGLEWIGS,ISYSGST,YYNPSLKSRVTVSVDTSKNQFSLKLNSVAATDTALYYC,ARHLGYNGRYLPFDY,WGQGTLVTVSS,2,Preregistration,QLQLQESGPGLVKPSETLTLTCTVSADSISSTTYYWVWIRQPPGKGLEWIGSISYSGSTYYNPSLKSRVTVSVDTSKNQFSLKLNSVAATDTALYYCARHLGYNGRYLPFDYWGQGTLVTVSS,yes,2
1373,Zimberelimab,Whole_mAb,light_sequence,IgL,human,IGLV2-14,0.97,IGLJ3,1,QSALTQPASVSGSPGQSITISCTGT,SSDVGFYNY,VSWYQQHPGKAPELMIY,DVS,NRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYC,SSYTSISTWV,FGGGTKLTVL,2,Preregistration,QSALTQPASVSGSPGQSITISCTGTSSDVGFYNYVSWYQQHPGKAPELMIYDVSNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSISTWVFGGGTKLTVL,yes,2
1374,Zolbetuximab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-61,0.93,IGHJ2,1,QVQLQQPGAELVRPGASVKLSCKAS,GYTFTSYW,INWVKQRPGQGLEWIGN,IYPSDSYT,NYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYC,TRSWRGNSFDY,WGQGTTLTVSS,2,Phase-III,QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS,yes,2
1375,Zolbetuximab,Whole_mAb,light_sequence,IgK,mouse,IGKV8-19,1,IGKJ4,1,DIVMTQSPSSLTVTAGEKVTMSCKSS,QSLLNSGNQKNY,LTWYQQKPGQPPKLLIY,WAS,TRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYC,QNDYSYPFT,FGSGTKLEIK,2,Phase-III,DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK,yes,2
1376,Zolimomab,Whole_mAb,heavy_sequence,IgG2a,mouse,IGHV1-4,0.96,IGHJ2,0.93,QVQLQQSGAELARPGASVKMSCKAS,GYTFTRYT,MHWVKQRPGQGLEWIGY,INPSRGYT,NYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYC,ARYYDDHYCLDY,WGQGTTLTVSS,2,Approved,QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS,yes,2
1377,Zolimomab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-59,0.96,IGKJ4,0.92,QIVLTQSPAIMSASPGEKVTMTCSAS,SSVSY,MNWYQQKSGTSPKRWIY,DTS,KLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYC,QQWSSNPFT,FGSGTKLEIN,2,Approved,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN,yes,2
1378,Zuberitamab,Whole_mAb,heavy_sequence,IgG1,mouse,IGHV1-12,0.96,IGHJ1,1,EVQLQQSGAELVRPGASVKMSCKAS,GYTFTSYN,MHWVKQTPRQGLEWIGA,IYPGNGDY,SYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFC,ARVVYYSNSYWYFDV,WGTGTTVTVSS,2,Phase-II,EVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDYSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSS,yes,2
1379,Zuberitamab,Whole_mAb,light_sequence,IgK,mouse,IGKV4-72,0.97,IGKJ1,0.83,DIELSQSPAILSASPGEKVTMTCRAS,SSVSY,MHWYQQKPGSSPKPWIY,APS,NLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYC,QQWSFNPPT,FGAGTKLEIK,2,Phase-II,DIELSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGAGTKLEIK,yes,2
